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Abstract 
The dissertation deals with the synthesis of fused-heterocycle-ring-system which are potential 
candidates for applications in organic materials and pharmacology. Site-selective Suzuki 
reactions of polyhalogenated substrates with o-bromophenylboronic acid followed by two-
fold C-N cross-coupling reactions afforded the final products. The physical properties were 
investigated and explained based on DFT theoretical calculations. Most compounds exhibit 
high quantum yields and narrow band gaps.  
Moreover, biscarbazoles were synthesized via C-N coupling and C-H bond activation as key 
steps. A highly efficient strategy is developed requiring only four steps from simple starting 
materials to afford both 3,9’- and 2,9’-biscarbazoles. 
 
Zusammenfassung 
Diese Arbeit behandelt die Synthese von kondensierten, heterozyklischen Ringsystemen, die 
potentiell für Anwendungen in den Materialwissenschaften sowie der Pharmazie in Frage 
kommen. Positionsselektive Suzuki Reaktionen an polyhalogenierten Startmaterialien 2-
Bromphenyl Boronsäure, gefolgt von einer zweifachen C-N- Kupplungsreaktion lieferte das 
Zielprodukt. Die physikalischen Eigenschaften wurden untersucht und durch theoretische 
DFT-Rechnungen unterstützt. Viele Verbindungen besitzen hohe Quantenausbeuten und 
geringe HOMO-LUMO-Abstände. 
Weiterhin wurden Dicarbazole mittels C-N-Kupplung und einer C-H-Aktivierung als 
Schlüsselreaktion synthetisiert. Eine sehr effiziente Methodik wurde entwickelt, welche in 
nur 4 Stufen, ausgehend von einfachen Ausgangsverbindungen, zu den gewünschten 3,9‘- 
und 2,9‘-Dicarbazolen führt. 
  
General introduction  1 
 
 
1 General introduction 
1.1 Pd-Catalyzed Cross-coupling reactions  
Since Palladium catalyzed cross-coupling reactions were firstly applied in organic synthesis 
over last 40 years, they have played important roles in synthesis of pharmaceuticals, natural 
products and novel materials.
1
 Located in the second row of transition metals and belonging 
to the Ni triad, Pd has the tendency of transferring two electrons to afford complexes in 
oxidative state 0 and 2
+
. Due to the important feature of quite high electronegativity (2.2 
according to Pauling scale)
2
, the Pd-C bond is relatively stable, non-polar and useful for 
synthetic processes. Due to the interactive ability of Pd with non-polar π-bonds, heteroatom 
containing lone pair electrons readily get involved in the oxidative addition, transmetalation 
and reductive elimination processes, which make Pd become an optimal metal to be used in 
organic transformations.
3
  
 
Figure 1.1 Timeline of discovery and development of cross-coupling reaction
3
 (This picture 
was copied from Angew. Chem. Int. Ed. 2012, 51, 5062–5085) 
Notably, for their very important contributions, Heck, Suzuki and Negishi were pioneers in 
the development of palladium catalyzed cross-coupling reactions and received the Nobel 
Prize in 2010. In addition, many efforts of chemists have been made to investigate the 
mechanism and broaden the scope of substrates in this field over the last decade. The term of 
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cross coupling implies reactions between two different partners with the aid of metal catalyst. 
The general cross coupling reactions are depicted in figure 1.2. 
 
Figure 1.2. Palladium-catalyzed cross coupling reactions in organic synthesis  
 
 
Figure 1.3. The development of cross-coupling reactions in the number of publications and 
patents
1
 (This picture was copied from Angew. Chem. Int. Ed. 2012, 51, 5062–5085)  
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1.1.1 General mechanism of cross-coupling reactions  
 
Figure 1.4. General mechanism of cross coupling reactions 
 
A palladium(0) complex containing 18 electrons in the outer shell (stable state) is in situ 
activated to afford a Pd(0) species with 14 electrons in the outer shell by a dissociation 
process of ligands. Once the active Pd(0) is formed, the combination with electrophile R-X in 
the oxidative addition stage affords the complex LnR-Pd(II)-X. This stage is slow and 
regarded as rate determinating of the reaction. The oxidative addition followed three general 
mechanisms including concerted (for non-polar substrate), nucleophile displacement (for 
polar substrate) and radical (for both polar and non-polar substrate) mechanism. 
Subsequently, the organic group R
2
, derived from on organometallic compound, is transferred 
to palladium (II) center with no change in the oxidation state, namely the transmetalation 
stage. The last stage, reductive elimination, affords the corresponding product and 
regenerates the Pd(0) complex for a new catalytic cycle.  
The electrophilic substrates have significant influence on the rate and selectivity of the 
reaction. The activity of halides in cross-coupling reactions follows the rule: R-I > ROTf ≈ R-
Br >> R-Cl >>> R-F (nearly unreactive). The bond dissociation energy of C-I, C-Br, C-Cl is 
65±1, 80.4 ± 1.5, 95 ± 1.5 kcal/mol, respectively.
4
  
When inactive palladium precursor (Pd (II) salts) such as Pd(OAc)2, PdCl2, Na2PdCl4 is 
employed, reduction of Pd(II) to Pd(0) is required prior to enter the catalytic cycle.
5
 The 
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reduction mechanism is still unclear in some reactions. Some general mechanism involving 
reduction of the Pd(II) reagent may include tertiary aliphatic amines, phosphines (using as 
ligand), ethylene reagents,
6
 or the action of solvents, such as 1,4-dioxane, THF, DMF, 
DMSO, toluene, etc. Alternatively, Pd nanoparticles,
7
 palladium supported on solid supports 
could become highly active catalysts in some cases.
8
  
 
Figure 1.5. Mechanism of reduction from Pd(II) to Pd(0) 
 
The employment of ligands in combination with Pd is believed to stabilize the Pd complex 
center. Moreover, electron rich phosphine ligands promote the oxidative addition stage. 
Conversely, stericilly hindered ligands accelerate the reductive elimination stage by their 
large cone angle effect.
9
 Because of competition with β-hydride elimination, faster reductive 
elimination processes minimize side-products in these reactions. Triphenyl phosphine is 
known as the most common ligand in cross-coupling reactions.
10
 As early as 1979, Dppf was 
used by Kumada and gave benefit.
11
 It is noteworthy that monodentate biaryl phosphine 
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ligands developed by Buchwald and coworkers showed significant advantages in Pd 
catalyzed cross-coupling reactions. Until now, a lot of efficient monodentate and bidentate 
ligands were invented and successfully applied in Pd-catalyzed cross coupling reactions 
under mild condition.
5b,12
 It showed advantages in cross-coupling reactions of inactive aryl 
chlorides, highly steric substrates and heterocycles. The features of dialkylbiarylphosphine 
ligands are depicted in figure 1.5. According to theory, the ratio of metal and ligand is 
expected to be 1:1. But in case of inactive substrates, difficult and slow reactions, an excess 
amount of ligand is required. Additionally, an additional amount of ligand assists to activate 
catalyst and stabilizes the Pd metal center to give high turn-over-numbers (TON).
13
 Besides, 
Fu’s ligands, including PCy3, P(tBu)3, also proved beneficial in some reactions. Especially in 
the case of less active aryl chlorides, these ligands give high yield and show high 
selectivity.
12f
 Notably, Beller et al. developed diadamantylalkylphosphanes CataCXium A 
which showed highly efficient catalytic activity with very low catalyst loading and resulting 
in high yield.
8a
 In addition to phosphine ligands, N-heterocyclic carbenes (NHCs) exhibit a 
wide range of application in cross coupling reactions under mild condition and allow the 
usage of water as solvent.
4,14
 NHCs, regarding as tertiary phosphine mimics, have improved 
catalyst performance (depicted in figure 1.5). NHCs in salt form and phosphines share the 
point of easy handling. However, in the case of NHCs∙HX, the use of a base is required to 
liberate free NHC to the reaction. Comparing to phosphine ligands, NHCs are binding to 
metal, forming more stable NHC-Metal complexes.  
 
Figure 1.6. Feature of dialkylbiarylphosphane ligands structure.
5b
 (This picture was copied 
from Chem. Sci. 2011, 2, 27–50) 
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(S) denotes saturated imidazolium backbone 
Figure 1.7. Common NHC ligands and feature. 
 
In cross coupling reactions, the solvent plays dual roles. Firstly, the solvent choice bases on 
high solubility of components in reaction, low solubility of inorganic by-product and 
effectively allows respective temperature range of reactions. Secondly, it stabilizes 
intermediates in the catalytic cycle. Both single solvent and mixture of two solvents in 
homogenous or heterogeneous phase (monophase or biphase) are employed in various 
reactions.
1e,15
 The most common solvents include toluene, 1,4-dioxane, THF, DMF, DMA, 
DMSO. Water is the ideal solvent, but until now the applications are still limited.
16
 Solvents 
have to be deoxygenated to avoid impact on the catalyst system. 
Temperature influences on the rate of the reaction and formation of side products. Ideal 
conditions can be obtained by optimization of some factors, such as, Pd source, ligand, base, 
solvent and temperature in order to achieve the highest yield of desired product. 
1.1.2 Suzuki-Miyaura Cross-coupling reactions 
Beginning with the first report of Miyaura
17
 in 1979, palladium-catalyzed cross-coupling 
reactions between aryl halide and 1-alkenylboranes, Suzuki-Miyaura reactions (SMR), had 
become extremely popular in the last decade (depicted in figure 1.3).
1b,g,18
 Today, the Suzuki-
Myaura reaction concept is the cross-coupling reaction of alkenyl, aryl halides (or pseudo-
halides) with a variety of organoboron reagents (boranes, boronic acids, boronic esters).  
Many papers and patents regarding the Suzuki-Myaura reaction were reported to improve 
site-selectivity, chemo-selectivity, low catalyst loading, expansion of substrates scope and 
applications of greener process-conditions (green solvent, low catalyst loading, recycling 
catalyst, low temperature, minimizing site-products).
14c,19
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The boron electronegativity is relative small (2.0 according to Pauling scale)
2
 and make the 
C-B bond rather unpolar and more stable as compared to the bond of other metal-C bonds, 
such as Mg, Li, Zr, Al, Cu, Si, Sn. Thereby, oganoboranes are nontoxic, air and moisture 
stable and easy to handle. With such advantages of mild and convenient conditions, tolerance 
to functional groups and facile removal of toxic inorganic by-products, SMR became the 
most useful and versatile method in industrial applications.
20
  
Initially, alkenylboranes, as starting materials for SMR, were synthesized by reaction of 
terminal alkynes with catecholborane. The reaction of Grignard or Lithium reagents with 
boronic ester is also widely employed to construct organoboranes.
21
 In 1993, Miyaura and 
Suzuki reported a novel method to add boron ester to triple bond via Platinum catalysis under 
convenient condition. Two years later, Miyaura found that the B2(pin)2 
(bis(pinacolato)diboron) reagent undergoes coupling with aryl halide in the present of 
[Pd(dppf)Cl2] as catalyst.
22
 Nowadays, B2(pin)2 or HB(pin) are widely employed to form 
organoboranes.
21a,23
  
 
Figure 1.8. General mechanism of Suzuki-Myaura cross-coupling reaction and role of base in 
SMR
24
 
Similar to the mechanism of other cross coupling reactions, the SMR mechanism begins with 
the oxidative addition step, followed by the transmetalation step and finishes with the 
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reductive elimination step. Here, the role of the base is of importance. In most organoboron 
species, the carbon-boron bond is highly covalent. Therefore, the complex does not readily 
involve a transmetalation. It is noteworthy that the role of the base in SMR activates the 
organoboron derivative by forming a hypervalent, anionic boron-“ate” complex which 
represents a better leaving-group and readily undergoes transmetalation. An alternatively 
proposed mechanism involves the displacement of halide in the [PdXR
1
L2] complex by base 
to form a [Pd(OR
2
)R
1
L2] complex. The most common employed bases in SMR are K2CO3, 
K3PO4, Na2CO3, NaOH, NaHCO3. In some substrates containing fragile functional groups 
and large molecular weight, SMR cannot occur without the presence of TlOH.
25
  
The most common catalysts used in SMR are Pd(PPh3)4, PdCl2, Pd(OAc)2, Pd2dba3 in 
combination with various phosphine ligands. The Pd(PPh3)4 catalyst, known as “Tetrakis”, is 
cheap and easy to handle but exhibits low activity and is unstable under air. Using Pd(OAc)2 
in the combination with phosphine ligands could significantly improve selectivity and 
activity.
12f,24d
 Pd nanoparticles, Pd supported on inorganic solid materials or polymers 
showed many advantages in various cases.
26
 
SMR can be performed in various solvents. Solvents influences on the activity and the 
selectivity of the reaction. Toluene, 1,4-dioxane, benzene, DMF, THF, MeCN are the most 
common solvents.
1b,18a
 A mixture of organic solvent and water was used to improve the yield 
of coupling product and its high selectivity in SMR.
27
 The biphasic media (organic/aqua) 
affords high solubility of both boron partner and inorganic salt. Additionally, the mixture of 
organic solvents is an alternative choice to make reaction occur faster. These mixture 
generally include two organic solvents with very different in polarities such as toluene-EtOH, 
toluene-MeOH, dioxane-toluene.
28
 Recently, PEG,
7a,29
 neat water,
16a,30
 or ionic liquids
26b
 
were used instead of classical  solvents. The advantages of these solvents are low cost, non-
toxic, thermal stability and feasible to recycle.  
SMR plays an important role in the synthesis of many natural products, drugs such as 
Crizotinib (a potent anti-cancer agent),
31
 Yuehchukene (bisindole alkaloid isolated from 
Murraya paniculata (L.)),
32
 Michellamine B (strong anti-HIV-1, anti-HIV-2 agent),
33
 
Ribisins A, B and D (bioactive polyoxygenerated benzofuranes),
34
 Diazonamide A,
35
 Vitamin 
A
36
 (figure 1.8) and many others. 
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Figure 1.9. SMR as key step in natural product and drug synthesis. 
 
1.1.3 Buchwald-Hartwig amination reactions (BHAR) 
Buchwald-Hartwig amination is one of most important reactions in modern organic synthesis, 
in which C-N bonds formed by Pd-catalyzed cross-coupling of amines with aryl halides. This 
reaction was independently developed by the group of Stephen L. Buchwald and John F. 
Hartwig in 1994.
37
 The development of the BHAR shows many advantages in the efficient 
synthesis of aryl amines, replacing the conventional methods (the Goldberg reaction, 
nucleophilic aromatic substitution, reductive amination, etc.) while significantly expanding 
substrate scope and functional groups tolerance. 
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Figure 1.10. Mechanism of Buchwald-Hartwig reaction
5b,12d,38
 
Initially, the formation of active catalytic species is required. In the case of monodentate 
ligands, for example P(tBu)3, the active monophosphine complex Pd[P(tBu)3] is formed 
(depicted in Figure 1.11).
38
 In the case of bidentate ligands, such as BINAP, the active 
complex form of Pd
0
L is generated from the Pd
0
L2 precusor via ligand dissociation. 
 
Figure 1.11. Forming of active actalytic species of monodentate 
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In the first stage, the active catalytic species PdL readily enters the catalytic cycle via 
oxidative addition with an aryl halide as in all cross-coupling reactions. Then, the amine 
binds to this Pd(II) species to form an coordination bond. The deprotonation with the aid of 
base results in the formation of [PdLAr((NCH2R1)R2)]. Alternatively, the replacement of 
halide by base, subsequent with amine binding afford [PdLAr((NCH2R1)R2)]. At the end of 
the catalytic cycle, the reductive elimination step completes the catalytic cycle to regenerate 
the Pd(0) species. Besides, if amines possess hydrogen atom at the α-position to nitrogen 
atom, the [PdLAr((NCH2R1)R2)] complex can undergo a β-hydride elimination reaction to 
generate an imine as side-product.  
When palladium salts, as Pd(OAc)2 is employed, reduction of Pd(II) to Pd(0) is required. 
Amines containing α-hydrogen atoms may reduce Pd(II) to Pd(0) to enter catalytic cycle, by a 
β-hydride elimination reaction. Besides, primary amines, primary amides need a reductant 
such as a phosphine ligand, a tertiary amine (NEt3). Because of difficulties in the reduction 
from Pd(II) to Pd(0), the employment of Pd(0) stable complexes can directly coordinate to 
dialkylbiaryl ligands generating  active LPd complex to enter the catalytic cycle.  
 
Figure 1.12. Precatalyst of Buchwald-Hartwig amination reaction 
For BHAR media, toluene and 1,4-dioxane solvents are commonly used because of their high 
boiling point and the solubility property of many organic compounds in these solvents. 
Moreover, ethereal solvents such as THF and Bu2O are alternative choices.
5b,12b
 Some 
reactions require more polar solvents, such as DMSO, DMF and DMA.
4b,11b,39
 The solvent 
plays the role of dissolving components in reaction, accelerating reaction by poor solubility 
of inorganic by-products, eliminating side-products. The solvent must be dried and 
deoxygenated. A mixture of two solvents (polar mixing with unpolar solvent) has also known 
as good idea for BHAR.
 4b,11b
 
Strong bases are generally employed in BHAR. The choice of base may influence on reaction 
rate, functional groups tolerance and side products formation. Because of significant pKa 
changing of nucleophile by binding with Pd, the choice of base is not merely based on pKa.
 4b
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NaOtBu or KOtBu in toluene are generally employed in BHAR to afford high yields, high 
reaction rates and low catalyst loadings. Due to the application of relatively strong bases (pKa 
≈ 17.0), reactions with electrophilic groups, such as ketones and esters, may occur as side 
reactions. Some weaker bases, such as NaOMe, NaOH, KOH showed benefit in functional 
groups tolerance. In the case that substrates contain sensitive functional groups, weak 
inorganic bases such as Cs2CO3, K2CO3, K3PO4 are alternative choices.  
BHARs found many applications in the synthesis of natural products, bioactive compounds 
and drugs. For example, A-366833, a selective neuronal nicotinic receptor agonist was 
prepared by C-N coupling as the key step.
40
 Federsel et al. successfully synthesized 5-HT1B 
receptor antagonist using Pd(dba)2/BINAP.
41
 Many important drugs were synthesized using 
BHAR. Imatinib, a tyrosine kinase inhibitor, is used for treatment of chronic myeloid 
leukaemia and gastrointestinal stromal tumors and was developed by Norvartis AG in 2003
42
 
Chida et al. finished the total synthesis of Murrayayoline (a carbazole alkaloid isolated from 
genus Murraya) using two-fold BHAR as key step.
43
 Very recently, Piersanti used 
intramolecular BHAR for the total synthesis of (-)-epi-Indolactam V.
44
  
 
 
Figure 1.13. Some total synthesis natural products and bioactive compounds used BHAR as 
key step 
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1.2 Pd-catalyzed C-H bond activation reactions 
Recently, C-H bond activation reactions have been receiving much attention. C-H activation 
provides many direct routes to form C-C and C-Heteroatom bonds without need of 
prefunctionalization of starting materials leading to low cost and environmentally friendlier 
procedures.  
1.2.1 C-X/C-H coupling reactions 
Over the last decade, C-X/C-H bond activations have been proven to be one of the the most 
efficient methodologies to functionalize and construct polycyclic (hetero)aromatic 
compounds.
45
  
Even though, the efficiency of C-H activation reactions has been dramatically improved in 
recent years. The mechanism of C-H bond activation reactions is still unclear to date. They 
are divided into three general mechanisms: electrophilic substitution, σ-bond metathesis, 
oxidative addition (Figure 1.14). The catalytic cycle is believed to undergo in three main 
steps: firstly, Pd(0) coordinates to an aryl halide in a oxidative addition step resulting in the 
formation of ArPd(II)X complex, followed by C-H bond activation of Ph-H to form 
PhPd(II)Ar species and subsequently finishing with a reductive elimination step to afford the 
product and regenerate Pd(0). Recent research showed that caboxylates assist the C-H 
activation in many cases and are involved in several steps of the catalytic cycle.
46
 The 
mechanism of carboxylate-assisted C-H bond activation is also proposed with assisting by 
pivalic acid.
47
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Figure 1.14. Proposed C-H bond activation reaction mechanism (this picture was copied 
from Chem. Rev. 2011, 111, 1315–1345)46 
The C-H activations have been applied in the synthesis of natural products and drugs as well 
as advanced organic materials.
48
 One of the most notable examples is the formation of 
heterocycles including, pyrroles, indoles, carbazoles, quinazolines, etc.
45b,49
 One interesting 
example includes synthesis of Kibdelone, a potent nematocidal, antibiotic and anticancer 
reagent by intramolecular C-I/C-H annulations by Pd-catalysis.
50
 Functionalization of 
cyclobutane in the total synthesis of Piperarborenine B and D, using C-H activation, is 
another important example. The reaction could give desired products in high stereo-
selectivity.
51
  
 
Figure 1.15. Some total synthesis of natural products and bioactive compounds using C-X/C-
H coupling reactions as key step 
General introduction  15 
 
 
 
1.2.2 C-H/C-H coupling reactions (Oxidative CH bond activation) 
The direct C-C bond formation by oxidative C-H/C-H coupling using non-toxic and 
inexpensive oxidants is an ideal strategy in the development of green and sustainable 
processes. One of the most important applications in C-H/C-H coupling reaction is to form 
the C-C bond with heteroaromatic compounds.
45b
  
 
 
Figure 1.16. Proposed catalytic cycle of oxidative C-H bond activation reaction
52
 
The catalytic cycle of C-H/C-H coupling is assumed to proceed in three steps including two 
C-H activation steps to afford a Pd(II) intermediate species followed by a reductive 
elimination step to form the product and generate a Pd(0) species (Figure 1.16). With the aid 
of oxygen or any other oxidants (such as Cu(OAc)2, AgOAc, Ag2O), this Pd(0) species is 
reoxidized to Pd(II) and begins a new catalytic cycle.   
Many natural carbazoles were synthesized in the employment of Pd(OAc)2 in the 
combination with Cu(OAc)2 or oxygen as oxidant reagent in acetic acid media.
49,53
 It is 
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noteworthy that pivalic acid, a convenient solvent could accelerate to give higher yields of 
cyclized products.
46,54
 Many natural carbazoles, for examples, Mukonine
54
 and Clausine L
52
 
were successfully synthesized. Dragmacidin D, an important drug for treating Pakinson’s and 
Alzheimer’s deseases, was synthesized by C-I/C-H coupling and C-H/C-H coupling.55  
 
 
Figure 1.17. Some total synthesis of natural products and drugs used C-X/C-H coupling 
reactions as key step 
In 2009, Watanabe et al. proposed some possible oxidative coupling mechanisms in detail by 
trapping and deuterium experiments (Figure 1.16).
52
 The first C-H coupling may undergo by 
three different mechanisms including electrophilic substitution, σ-bond metathesis or 
oxidative addition, followed by reductive elimination to afford complex A or B. Afterward, 
the second C-H coupling may occur by four different possibilities including the three 
mechanisms mentioned above or carbopalladation followed by β-hydride elimination to give 
the cyclized product. 
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Figure 1.18. Possible mechanism of oxidative C-H bond activation in detail
52
 
 
1.3 Ligands employed in this dissertation 
Monodentate and bidentate phosphine ligands were utilized in the combination with 
palladium precursors such as Pd(OAc)2, Pd2(dba)3  during the optimizations of Buchwald-
Hartwig reactions. In most cases, bidentate ligands with large bite angles, such as BINAP, 
XantPhos, DPEPhos or Dppf, efficiently influent on Buchwald-Hartwig amination reactions. 
It can be explained by the rigid five membered ring complex of two phosphines coordinating 
to Pd and diphosphine backbond influences. The wider backbone results in the larger angle of 
P-Pd-P and it influents on steric and electronic properties of bidentate ligands. Wide bite 
angles increase steric bulk and favor or disfavor certain geometries of transition metal 
complex. For example, square planar complexes stabilize bite angle around 90º. The wider 
bite angles favor zero-valent complexes and trigonal or tetrahedral geometries. Those ligands 
accelerate reductive elimination and hence reduce β-hydride elimination which leads to by-
products in Buchwald-Hartwig aminations.
38
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The utility of tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) is successfully 
demonstrated in Suzuki reaction with heterocyclic substrates such as thiophene, indole, 
pyridine, quinoxaline. The using of other Pd precursors, such as Pd(OAc)2, Pd[Cl2(MeCN)2], 
Pd[Cl2(PPh3)2], accompanying other phosphine ligands gave lower yield and complex 
reaction mixtures.  
 
Figure 1.19. Monodentate and bidentate phosphine ligands. 
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2 Synthesis of thieno[3,2-b:4,5-b’]diindoles and benzothieno[3,2-
b]indoles  
 
2.1 Introduction 
Thiophene-containing fused acenes have found many applications in organic field-effect 
transistors (OFETs) as well as organic light-emitting diodes (OLEDs).
56
 Especially, great 
effort has been devoted to study of pentacenes, their heterocyclic derivatives and π-extended 
ladder-type analogues due to their excellent charge carrier mobility.
57
 Some heteroatom-
containing pentacenes play an important role in OFETs applications, such as 
anthradithiophene,
58
 tetraceno[2,3-b]thiophene,
59
 indole[3,2-b]carbazole,
60 
5,7,12,14-
tetraazapentacene,
61
  pentathieoacene,
62 
and dibenzo[d,d′]thieno[3,2-b:4,5-b′]dithiophene.63 
The first introduction of both sulphur and nitrogen atoms to multi-cycle-structures was 
developed by Liu and co-workers.
64
 5,6-Disubstituted thieno[3,2-b:4,5-b’]diindoles 3, 
containing one thiophene ring and two pyrrole rings, were synthesized from the 
corresponding indoles. Later, Liu et al. developed the synthesis of dibenzothieno[b,d]pyrroles 
4 from benzothiophene.
65
 The electronic transport increased due to intermolecular sulfur-
sulfur interactions between two neighbouring molecules. In 2009, Balaji and Valiyaveettil 
reported the synthesis of symmetrical and unsymmetrical dibenzothieno-pyrroles 2 and 3.
66
 
Their studies showed that intermolecular sulfur-sulfur interactions, 𝜋-𝜋 stacking and van der 
Waals interactions play an important role to provide high intermolecular charge mobility. 
66
 
In 2010, with the same method, they synthesized a molecule with seven fused rings affording 
diindolodithienopyrroles 4.
66
 These compounds exhibited lower HOMO energy level and 
larger band gap affording environmental stability. 
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Figure 2.1. Organic semiconductors based on fused pentacenes 
Likewise, tetracenes and their heterocyclic analogues were broadly applied in material 
chemistry,
56,67
 but also in medicinal chemistry. In 2005, Wang et al. synthesized a series of 
estrogen receptor ligands, a benzothieno[3,2-b]indole scaffold, which showed a high binding 
affinity for estrogen receptor subtypes (ERα and ERβ) in comparison with the Raloxifene 
drug.
68 
Due to the interesting properties of 5,6-disubstituted thieno[3,2-b:4,5-b’]diindoles and 
benzothieno-[3,2-b]indoles in material and medicinal chemistry, I was interested in 
developing an independent and efficient strategy for their syntheses. In fact, current synthetic 
approaches are often complicated and require several steps. Recently, the group of Prof. 
Langer reported the synthesis of tetrasubstituted thiophenes by site-selective Suzuki-Miyaura 
reactions of tetrabromo-thiophene.
27,69 
During my thesis, I studied a concise and efficient 
two-step synthesis of thieno[3,2-b:4,5-b’]diindoles and benzothieno[3,2-b]indoles by site-
selective Suzuki-Miyaura reactions of tetrabromo-thiophene and 2,3-dibromobenzothiophene, 
respectively, and subsequent palladium catalyzed twofold C-N coupling
5b,12d,19c,70
 with 
amines.
71
 
 
 
2.2 Results and Discussion 
The site-selective Suzuki-Miyaura reaction of tetrabromothiophene (5) with 2.2 equivalents 
of o-bromophenylboronic acid 6, in the presence of 5 mol% of Pd[PPh3]4, afforded the 
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tetrabrominated compound 7 in 91% yield. The Pd-catalyzed two-fold cyclization reactions 
of 7 with amines 8a-s gave the desired thieno[3,2-b:4,5-b’]diindoles 2a-s (Scheme 2.1).  
 
Scheme 2.1. Synthesis of 5,6-disubstituted thieno[3,2-b:4,5-b’]diindoles 2a-s.  
Conditions: i, 2.2 equiv. of 6, 5 mol% of Pd(PPh3)4 catalyst, Na2CO3 (2 M, 10 mL), dioxane 110 °C, 6h. ii, 3 
equiv. of 8, 6 equiv. of NaOtBu, 5 mol% of Pd2(dba)3, ligand (method A: 10 mol% of P(tBu)3·HBF4, method B: 
5 mol% BINAP). 
The cycliczation reaction of 7 with 4-methoxyaniline 8b was chosen for optimizations using 
1,4-dioxane as an internal standard (Table 2.1). The bidentate ligands, such as Dppe and 
DPEPhos, gave excellent yield of 88% and 93%, respectively (entries 10 and 11). Some 
bulky monodentate phosphine ligands, e. g. SPhos and P(tBu)3, also exhibited suitable 
ligands for this reaction (entries 1-6).
15
 Up to 98% yield of 2b was achieved by employment 
of P(tBu)3 as the ligand in combination with Pd2(dba)3 as the catalyst (method A). The yield 
was significant decreased when Pd(OAc)2 instead of Pd2(dba)3 was used as palladium 
precursor 
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.Table 2.1. Optimization for the synthesis of 2b 
Entry Catalyst Ligand Base Yield (%)
a
 
1 Pd2(dba)3 P(tBu)3·HBF4 NaOtBu 98 
2 Pd(OAc)2 P(tBu)3·HBF4 NaOtBu 58 
3 Pd2(dba)3 P(tBu)3·HBF4 KOtBu 63 
4 Pd2(dba)3 P(Cy)3·HBF4 NaOtBu 52 
5 Pd2(dba)3 SPhos NaOtBu 92 
6 Pd2(dba)3 XPhos NaOtBu 61 
7 Pd2(dba)3 DavePhos NaOtBu 76 
8 Pd2(dba)3 BINAP NaOtBu 12 
9 Pd2(dba)3 XantPhos NaOtBu 52 
10 Pd2(dba)3 DPEPhos NaOtBu 88 
11 Pd2(dba)3 Dppe NaOtBu 93 
12 Pd2(dba)3 Dppf NaOtBu 73 
a
 Yields were calculated by 
1
H-NMR of the crude product using dioxane as internal standard. 
With optimized conditions in hand, I studied the scope of the cyclization reaction of 7 with 
different amines. The employment of various anilines afforded the corresponding products 
2a-m in good to excellent yields (Table 2.2). The method A has failed to apply with alkyl 
amines. Only very low yields of the desired products were obtained. With further 
optimization, I found that the use of the bidentate ligand BINAP allowed the synthesis of 
products 2n-s in acceptable yields (method B). The structures of the products were 
established by spectroscopic methods. The structures of 2i, 2k and 2p were independently 
confirmed by X-ray crystal structure analysis. 
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Table 2.2. Synthesis of 2a-r 
2 R Conditions Time (hours) Yield (%)
a
 
a Ph A 14 83 
b 4-(MeO)C6H4 A 14 94 
c 4-MeC6H4 A 14 90 
d 3,5-Me2C6H4 A 14 89 
e 3,5-(MeO)2C6H3 A 14 95 
f 3,4,5-(MeO)3C6H2 A 14 92 
g 4-FC6H4 A 14 94 
h 4-ClC6H4  A 14 86 
i 4-t-BuC6H4  A 14 86 
j 3-CF3C6H4  A 14 88 
k 4-(Et2N)C6H4  A 14 59 
l  
A 14 90 
m 4-(MeS)C6H4 A 14 91 
n n-C3H7 B 14 46 
o n-C5H11 B 14 45 
p n-C7H15 B 14 44 
q PhCH2CH2 B 14 62 
r Bn B 14 53 
s c-Pr B 14 33 
a
 Isolated yields 
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Figure 2.2. Ortep plot of 2i 
 
 
Figure 2.3. Ortep plot of 2k 
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Figure 2.4. Ortep plot of 2p 
 
Besides, benzothieno[3,2-b]indole 9 showed a highly binding affinity to ERα (IC50 = 2.84 
nmol) and made a strong increase of the bone mineral density of ovariectomized mice (Figure 
2.3).
68
 Therefore, I applied my methodology for the synthesis of benzothieno[3,2-b]indoles 
from 2,3-dibromobenzothiophene 10. During the preparation of this thesis, the Suzuki 
reaction of 10 to give 11 was reported for the synthesis of S,P-bridged trans-stilbenes.
72
  The 
Pd-catalyzed cyclization of 11 with amines has not been reported so far. Products 12a-c were 
synthesized in excellent yields using either method A or method B.  
 
Figure 2.5. Potent estrogen receptor ligand 9 
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Scheme 2.2. Synthesis of 5,6-disubstituted thieno[3,2-b:4,5-b’]diindoles 12a-c.  
Conditions: i, 2.2 equiv. of 2, 5 mol% of Pd(PPh3)4 catalyst, Na2CO3 (7 mL, 2M), dioxane, 110 °C, 6h. ii, 3 
equiv. of 8, 6 equiv. of NaOtBu, 5 mol% of Pd2(dba)3, ligand (method A: 10 mol% of P(tBu)3∙HBF4, method B: 
5 mol% BINAP). 
 
Table 2.3. Synthesis of tetracenes 12a-c  
12 R Conditions Time (hours) Yield (%)
a
 
a 4-MeOC6H4 A 8 96 
b n-C7H15 B 8 92 
c Bn B 8 95 
a
 Isolated yields 
 
2.3 Conclusions 
I described a highly efficient and convenient procedure for the synthesis of substituted 
thieno[3,2-b:4,5-b’]diindoles and benzothieno[3,2-b]indoles based on  a new two-step 
strategy which involves Pd-catalyzed C-C and C-N coupling reactions. These results are of 
considerable interest for applications in material sciences and medicinal chemistry. 
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3 Synthesis and physical properties of 5-methyl-5,10-
dihydroindolo[3,2-b]indoles  
 
 
 
3.1 Introduction 
Acenes and heteroacenes are widely known for their applications in organic light-emitting 
diodes (OLEDs), organic field-effect transistors (OFETs) and organic photovoltaic cells.
56,73
 
Tetracene, which represents a p-type semiconductor, is one of the most studied acenes. This 
molecule in the form of single crystal devices possesses hole mobilities as high as 1.3 cm
2
V
-
1
s
-1
.
74
 The introduction of heteroatoms into acenes significantly modifies the electronic 
properties and crystal packing of the molecules as well as improving the stability of the 
materials.
73a
 Therefore, the preparation of new heterotetracenes are atracting much attention. 
In 2009, Liu and coworkers reported that tetrathienoacenes (TTAs) could be used in potential 
OFETs applications, due to their high hole mobilities and on/off current ratio.
75
 Recently, 
Takimiya and co-workers prepared and investigated the synthesis and interesting electronic 
properties of naphthodithiophenes (NDTs) and other chalcogenotetracenes.
76
 The synthesis 
and physical properties of a series of highly substituted benzothieno[3,2-b]benzothiophenes 
and benzoselenopheno[3,2-b]benzoselenophenes were reported by Takimiya’s group.77 
Recently, parent 5,10-dihydroindolo[3,2-b]indole was found to be a promising candidate for 
OFET applications.
78
 Functionalized 5,10-dihydroindolo[3,2-b]indoles are known as 
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important heterotetracenes which represent core building blocks in OLED polymers and 
high-spin organic polymers.
79  
 
Figure 3.1. Molecular structures of tetracene and heterotetracenes for OFET applications 
 
Several synthetic approaches to 5,10-dihydroindolo[3,2-b]indoles have been reported so far. 
Most of the conventional methods base on a C-N bond formation as the key step.
80
 Heller 
reported the first synthesis of 5,10-dihydroindolo[3,2-b]indole by reduction of o,o’-
dinitrobenzil with zinc in the present of acetic acid.
81
 Reduction of 2-(o-nitrophenyl)indole 
with P(OEt)3 was described to give the product in moderate yields.
82
 Then, Grinyov et al. 
reported an efficient synthesis of 5,10-dihydroindolo[3,2-b]indoles by Fischer condensation 
of indolones with hydrazine derivatives.
83
 Recently, Liu et al. reported an interesting method 
for the preparation of 5,10-dihydroindolo[3,2-b]indoles by reduction of 6,12-
dichlorodibenzo[b,f][1,5]diazocines by using an excess of zinc under acidic conditions.
78
 
Generally, most of the reported syntheses of highly functionalized 5,10-dihydroindolo[3,2-
b]indoles are difficult to perform, low yielding or require many synthetic steps. Because of 
their potential application of material science, I was interested in developing a new and 
convernient two-step strategy for the synthesis of highly functionalized 5,10-
dihydroindolo[3,2-b]indoles. My strategy bases on the first site-selective Pd-catalyzed 
Suzuki-Miyaura reaction of N-methyl-2,3-dibromoindole and subsequent cyclization by Pd-
catalyzed two-fold C-N coupling with amines. Site-selective Suzuki-Miyaura reactions of o-
bromophenylboronic acid with several substrates, for examples 2,3-dibromopyridine, 2,3-
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dibromothiophene, 2,3,5-tribromothiophene, 2,3-dibromobenzothiophene, 3'-bromo-4'-iodo-
2-nitro-1,1'-biphenyl, have been previously reported.
72,84
 
3.2 Result and discussion 
2,3-Dibromo-N-methylindole 13 was prepared from N-methylindole in 72% yield by 
bromination of N-methylindole with bromine at -78 ºC.
85
 The site-selective Suzuki-Miyaura 
reaction of 2,3-dibromo-N-methylindole 13 with o-bromophenylboronic acid 6 using  a 
reported procedure of the group of Prof. Langer,
85
 gave 2-aryl-3-bromoindole 14 in 72 % 
yield.  
 
Scheme 3.1. Synthesis of 5,10-dihydroindolo[3,2-b]indoles 5a-o.  
Condition: (i) 1.2 equiv. of 6, 5 mol% of Pd(PPh3)4 catalyst, 3 equiv. of NaOH, THF, H2O, 70 ºC, 4h. (ii) 3 
equiv. of 8, 3 equiv. of NaOtBu, 5% mol of Pd2(dba)3, 10 mol% of XantPhos, toluene, 90 ºC, 6-10h. 
For the optimization of this step, I chose the reaction of 14 with p-toluidine 8b (Table 3.1). 
Some important parameters, which can affect the reaction, including ligand, palladium 
source, solvent and temperature, were examined. Interestingly, up to 89% yield of 15b was 
achieved when XantPhos as ligand, in combination with Pd2(dba)3, was employed. The yields 
decreased when Pd(OAc)2 was used as the palladium source and when the solvents were 
changed. When the temperature was decreased to 90 °C, the yield increased to 91% and the 
reaction mixture contained a smaller amount of side products. 
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Table 3.1. Optimizations for the synthesis of 15b 
Entry Catalyst Ligand Solvent Temperature (ºC) Yield (%)
a
 
1 Pd2(dba)3 BINAP Tol 100 11 
2 Pd2(dba)3 XantPhos Tol 100 89 
3 Pd2(dba)3 DPEPhos Tol 100 - 
4 Pd2(dba)3 Dppe Tol 100 7 
5 Pd2(dba)3 Dppf Tol 100 - 
6 Pd2(dba)3 PCy3.HBF4 Tol 100 - 
7 Pd2(dba)3 PBu3.HBF4 Tol 100 4 
8 Pd2(dba)3 XPhos Tol 100 79 
9 Pd2(dba)3 XPhos.tBu2 Tol 100 - 
10 Pd2(dba)3 SPhos Tol 100 72 
11 Pd2(dba)3 DavePhos Tol 100 4 
12 Pd2(dba)3 RuPhos Tol 100 11 
13 Pd(OAc)2 XantPhos Dioxane 100 57 
14 Pd2(dba)3 XantPhos DMF 100 20 
15 Pd2(dba)3 XantPhos Tol 90 91 
16 Pd2(dba)3 XantPhos Tol 80 82 
a
Yield was calculated by 
1
H-NMR of the crude product using 4-nitroacetophenone as an internal standard 
With the optimized conditions in hand, I studied the scope of the two-fold C-N coupling 
reaction of 14 with various aniline derivatives. The products 15a-o were obtained in good to 
excellent yields with different anilines (Table 3.2). Very good yields were achieved for both 
aniline derivatiarves bearing electron donating and withdrawing substituents. On the other 
hand, the cyclization of 3 with aliphatic amines afforded lower yields (products 15j-o, Table 
3.2).  
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Table 3.2. Synthesis of 15a-t 
15 R Time (h) Temperature (°C) Yield (%)
a
 
a Ph 6 90 80 
b 4-(t-Bu)C6H4 6 90 84 
c 4-MeC6H4 6 90 81 
d 4-FC6H4 6 90 82 
e 3-(CF3)C6H4 6 90 84 
f 4-(MeO)C6H4 6 90 76 
g 4-(MeS)C6H4 6 90 83 
h (4-CN)C6H4 6 90 82 
i n-C3H7 10 90 86 
j Allyl 10 90 84 
k Bn 10 90 72 
l 4-(MeO)C6H4CH2 10 90 79 
m (4-FC6H4)CH2 10 80 64 
n 3-(CF3)C6H4CH2 10 80 60 
o PhCH2CH2 10 90 83 
a
Yield of isolated products 
 
The structures of products 15a-o were determined by spectroscopic methods. The structure of 
15b was independently confirmed by X-ray crystal structure analysis (Figure 3.2). As 
expected, the heterocyclic core structure is planar. The aryl group is twisted out of plane. 
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Figure 3.2. Ortep plot of 15b 
 
3.3 Absorption and Fluorescence Properties 
Some selected 5,10-dihydroindolo[3,2-b]indoles 15 which bear different types of substituents 
located at the nitrogen atom, were investigated by UV-VIS and fluorescence analysis. The 
measurements were performed in acetonitrile as shown in Figure 3.3. The corresponding 
spectral data are summarized in Table 3.3. The UV-VIS absorption spectra of the compounds 
show three absorption bands around 361, 351, 324, and 261 nm with increasing absorption 
strength. The spectra of all derivatives 15 are quite similar indicating that the substituent 
located at the nitrogen atom has only a weak influence. Due to the conjugative effect, the 
bands of derivative 15i shift a little to the longer wavelenghs. Derivative 15a, containing a 
phenyl group at N-position, exhibits a small blue-shift. 
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Table 3.3. Spectroscopic data characterizing the absorption and emission properties of 15 
Comp. 
𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙   
[nm] 
Logε 𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙  
 
𝝀𝟐𝒂𝒃𝒔
𝒎𝒂𝒙   
[nm] 
Logε 𝝀𝟐𝒂𝒃𝒔
𝒎𝒂𝒙  
 
𝝀𝟑𝒂𝒃𝒔
𝒎𝒂𝒙   
[nm] 
Logε  𝝀𝟑𝒂𝒃𝒔
𝒎𝒂𝒙  
 
𝝀𝟒𝒂𝒃𝒔
𝒎𝒂𝒙   
[nm] 
Logε 𝝀𝟒𝒂𝒃𝒔
𝒎𝒂𝒙  
 
15a 361 4.49 349 4.51 324 4.86 260 5.23 
15b 363 3.56 351 3.57 324 3.93 260 4.33 
15d 362 3.34 351 3.35 324 3.73 261 4.15 
15f 363 3.65 352 3.64 324 4.02 261 4.47 
15g 363 3.43 351 4.05 323 4.08 259 3.62 
15i 365 3.34 354 3.35 325 3.83 263 3.28 
15j 363 3.41 351 3.42 325 3.89 262 4.33 
15k 363 3.24 351 4.10 323 4.10 259 4.02 
15l 362 4.29 351 4.28 325 4.75 262 5.18 
15m 363 3.49 351 3.53 325 4.02 262 3.57 
  
The fluorescence spectra were again measured in actonitrile with excitation at 340 nm. The 
fluorescence quantum yields were determined by comparison to the standard quinine 
hemisulfate salt monohydrate (in 0.05M H2SO4) which exhibits a fluorescence yield of 
52%.
86
 All emission spectra have their maximum around 400 nm and exhibit a shoulder at 
around 363 nm.  Derivatives 15a and 15b containing an aromatic substituent located at the 
nitrogen atom exhibit the most blue-shifted emission with a maximum at 398 nm, while 15l, 
containing a 4-methoxybenzyl group, exhibits a slight red-shift (404 nm). The Stokes shift is 
similar for all compounds and varies only in the range of 19 nm and 25 nm. It is important to 
note that the quantum yields of the 5,10-dihydroindolo[3,2-b]indoles 15 are quite high. The 
highest quantum yield (47%) was observed for 15m.  
The band gaps, determined from the crossing of the absorption and fluorescence spectra, vary 
again only slightly among the studied compounds. Derivative 15a, containing a phenyl group, 
has the largest band gap of 3.344 eV, while the smallest band gap of 3.313 eV is observed for 
15l which contains a 4-methoxybenzyl group as the substituent. 
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Figure 3.3. Normalized absorption and emission spectra of selected compounds 15 measured 
in acetonitrile. Emission spectra were recorded with excitation at 340 nm. 
 
Table 3.4. Spectroscopic data characterizing the absorption and emission properties of 15 
Comp. 
𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙   
[nm] 
𝝀𝟏𝒆𝒎
𝒎𝒂𝒙  
[nm] 
𝝀𝟐𝒆𝒎
𝒎𝒂𝒙  
[nm] 
Stokes shift 
[nm] 
λ00
a 
[nm] 
Band gaps
b
 
(eV) 
ϕfluo 
Quantum yield 
15a 361 382 398 21 370.8 3.344 46% 
15b 363 383 398 20 372.6 3.328 46% 
15d 362 382 400 20 372.6 3.328 44% 
15f 363 387 403 24 374.0 3.315 43% 
15g 363 382 399 19 372.8 3.326 30% 
15i 365 388 403 23 377.0 3.289 41% 
15j 363 385 400 22 374.0 3.315 42% 
15k 363 383 399 20 372.6 3.328 31% 
15l 362 387 404 25 374.2 3.313 43% 
15m 363 386 403 23 373.4 3.320 47% 
a
 λ00 is determined from the crossing point of the normalized absorption and emission spectra.
87
 
b
 optical band gaps were calculated from λ00. 
87
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3.4 Conclusions 
In conclusion, I reported a concise, practical and efficient strategy to prepare highly 
functionalized 5,10-dihydroindolo[3,2-b]indoles in very good yields. The reactions 
proceeded with very good site-selectivity in favour of positions 2 and 6. The site-selectivity 
of the reaction of the 2-bromophenylboronic acid with N-methyl-2,3-dibromoindole can be 
explained by the fact that position 2 is less electron rich than position 3. It has been 
previously reported that the oxidative addition of Pd(0) catalysed cross-coupling reactions of 
polyhalogenated substrates proceed by predominant attack at the more electron poor 
position.
88 
Absorption and fluorescence properties of the 5,10-dihydroindolo[3,2-b]indoles 
were studied. Although the substituents have only a small influence on the absorption and 
fluorescence, very good quantum yields were generally observed.  
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4 Synthesis of α- and δ-carbolines  
 
4.1 Introduction 
Carbolines (pyridoindoles) are widely spread in many natural products and synthetic 
bioactive molecules.
89
 Among the class of carbolines, especially β-carbolines and γ-
carbolines are the most present in nature. A smaller number of α-carbolines were also isolated 
as natural alkaloids. Examples of α-carbolines include Grossularine 1 and 2, anticancer 
compounds isolated from Dendrodoa grossularia,
90
 and Mescengricin which exhibit an 
inhibitor of L-glutamate excitotoxicity isolated from Streptomyces griseoflavu.
91
  A few 
researches reported on δ-carbolines, such as Quindoline, Cryptolepine, Cryptoquindoline, 
Cryptomisrine and Jusbetonin.
92
 All of these alkaloids were isolated from Cryptolepis 
sanguinolenta and Justica bentonica which have been traditionally used for the treatment of 
malaria and several infectious diseases in Central and West Africa.
93
 Previous researches in 
medicinal chemistry demonstrated that  α- and δ-carboline derivatives possessed important 
biological properties, such as antitumor,
94
 antimalarial,
95
 antimicrobial,
96
 antiviral,
97
 and anti-
inflammatory
98
 activities. In the context of drug discovery, Implitapide, a potential drug 
containing an α-carboline moiety, was used for the treatment of atherosclerosis in clinical 
trials.
99 
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Figure 4.1. Some bioactive compounds containing α- and δ-carboline substructures. 
Current research indicates that carbolines not only play an important role in many 
applications in medicinal chemistry, but also in material sciences. For example, carbolines 
and their derivatives were commonly employed as electron transport unit in bipolar host 
materials.
100
 The introduction of a carboline unit instead of the carbazole improved the 
electron carrier mobility.
100
 In 2013, CzBPCb and CbBPCb, which were synthesized by Lee 
et al.,  reached above 30% external quantum efficiency in blue phosphorescence organic light 
emitting diodes.
101
 The trimer TATA exhibited a 200 times longer life-time than the analogue 
carrying three carbazole units.
102
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Figure 4.2. Some organic materials contain α-carbolines structure. 
 
Due to the importance of carbolines in both medicinal chemistry and material sciences, the 
synthesis of carbolines has been attracted much attention in developing new synthetic 
methodologies. α-Carbolines were synthesized by various classic methods, including 
intramolecular Diels-Alder reactions,
103
 Graebe-Ullmann reactions of triazoles,
104 
annulations 
of azaindoles
105
 and multi-component reactions.
106
 In 2011, Kumar and Nagarajan prepared 
α-carbolines via two-step Pd-catalyzed amidation of 3-acetyl-2-chloroindoles followed by a 
Vilsmeier-Haack reaction.
107  Recently, several syntheses of carbolines in one-pot procedures 
based on Pd-catalyzed aryl aminations and subsequent intramolecular arylations were 
reported.
108
 In 2013, Moody et al. developed a new method for the synthesis of α-carbolines 
by 6π-electrocyclizations of indole-3-alkenyl oximes.109 Very recently, Yang et al. described 
a convenient approach to α-carbolines by a one-pot tandem reaction of α,β-unsaturated 
ketones with 2-nitrophenylacetonitriles in the presence of zinc dust.
110
 
In contrast to α-, β-, and γ-carbolines, only a few procedures for the synthesis of δ-carbolines 
have been developed so far. In 1997, Yang et al. synthesized δ-carboline derivatives from α-
(o-bromoanilino)alkenenitriles by domino Pd-catalyzed cyclizations.
111
 Dupas et al. 
successfully synthesized 3,4-disubtituted δ-carbolines by  cyclizations of indole amines with 
1,3-dicarbonyl compounds.
112
 In the effort to synthesize bioactive analogues of Eudistomin 
D, Kobayashi and coworkers developed the photocyclizations of N-(4-methoxy-3,5-
dimethylphenyl)pyridin-3-amine which gave mixtures of regioisomeric β- and δ–
carbolines.
113
 In 2011, Ablordeppey et al. described a short pathway for the formation of δ-
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carboline derivatives in moderate yields by another Pd-catalyzed intramolecular arylation of 
N-aryl-3-aminopyridine.
114
  Recently, Kundu et al. synthesized δ-carbolines in good yields by 
an efficient one-pot multicomponent reation using N-Boc-3-amido indoles, aryl aldehydes 
and terminal alkynes under microwave conditions.
115
 δ-Carbolines could also be prepared by 
intramolecular reductive ring closure of 3-nitro-2-phenylpyridines using phosphine 
reagents.
116
 In 2012, the group of Detert synthesized δ-carboline in 6 steps starting from 2-
chloro-3-nitropyridine.
117
 Very recently, Cao et al. reported an interesting synthesis of δ-
carbolines by a Pd-catalyzed cascade reaction of 2-iodoanilines and N-tosyl-enynamines.
118
 
Although, all four types of carbolines can be prepared by general methods, but these methods 
still have limitations in the preparation of starting materials and the tolerance of substrates 
scope. Sakamoto and coworkers firstly reported  a very convenient and general method to 
access all four regioisomeric carbolines in 31-61% yield by Pd-catalyzed intramolecular 
arylation of ortho-bromo-substituted anilinopyridines.
119
 Recently, Cuny and coworkers 
describe a general method for the selective synthesis of α-, β-, γ-, and δ–carbolines in good 
yields employing photostimulated cyclization of anilinohalopyridines.
120
 
In fact, the current synthetic methods are often complicated, low yielding or require many 
synthetic steps to prepare the starting materials. During my thesis, I studied a new and 
efficient two-step strategy for the chemoselective synthesis of α- and δ- carbolines from 
readily available starting materials. My synthesis is based on what are, to the best of my 
knowledge, the first site-selective Suzuki reactions of o-bromophenylboronic acid with 2,3-
dihalopyridines (1-chloro-2-bromopyridine or 2,3-dibromopyridine) and subsequent two-fold 
C-N coupling reactions.  
 
4.2 Results and discussion 
The chemoselective Suzuki-Miyaura reaction of commercially available 2-chloro-3-
bromopyridine 16a with 1.2 equivalents of o-bromophenylboronic acid 6 in the presence of 
5% mol of Pd(PPh3)4 as catalyst afforded product 17a in 85% isolated yield. The reaction 
proceeded chemoselectively at position 3 of bromide atom which is a better leaving group 
than chloride. The subsequent cyclization of 17a with different amines 4, by two-fold Pd-
catalyzed C-N coupling, resulted in the formation of the desired α- carbolines 18 (Scheme 
4.1). 
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Scheme 4.1. Synthesis of of α-carbolines.  
Conditions: (i) 1.2 equiv. of 6, 5.0 mol% of Pd(PPh3)4 catalyst, 3 equiv. of NaOH, THF, H2O, 70 ºC, 4h. (ii) 1.5 
equiv. of 8, 3 equiv. of NaOt-Bu, 5 mol%  of Pd2(dba)3, ligand (method A: 10% of Dppf, method B: 10% of 
DPEPhos), toluene, 100 ºC, 7h. 
The cyclization of 17a with tert-butylaniline 8c was chosen for optimizations using 4-
nitroacetophenone as an internal standard (Table 4.1). Important factors including palladium 
source, ligand, solvent and temperature were examined in detail. The screening of different 
monodentate phosphine ligands, for example, XPhos, XPhos(tBu)2, SPhos, DavePhos, PCy3, 
P(tBu)3 gave 18c in up to 93% yield (Entries 6-11). In order to investigate the effect of 
bidentate ligands in this cyclization, I carried out some further optimizations using bidentate 
phosphine ligands, such as XantPhos, DPEPhos and Dppf. Under optimized condition, using 
Dppf as ligand in combination with Pd2dba3 (method A), afforded up to 97% yield. The 
replacement of Pd(OAc)2 as palladium precursor resulted in a lower yield (85%). During the 
optimizations, toluene was the most suitable solvent for this cyclization. 
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Table 4.1. Optimizations for the synthesis of 18c 
Entry Catalyst Ligand Solvent Time (h) Temperature (ºC) Yield (%)
a 
1 Pd2(dba)3 BINAP Tol 7 100 56 
2 Pd2(dba)3 XantPhos Tol 7 100 93 
3 Pd2(dba)3 DPEPhos Tol 7 100 95 
4 Pd2(dba)3 Dppe Tol 7 100 81 
5 Pd2(dba)3 Dppf Tol 7 100 97 
6 Pd2(dba)3 PCy3·HBF4 Tol 7 100 64 
7 Pd2(dba)3 P(t-Bu)3·HBF4 Tol 7 100 79 
8 Pd2(dba)3 XPhos Tol 7 100 87 
9 Pd2(dba)3 XPhos·tBu2 Tol 7 100 35 
10 Pd2(dba)3 SPhos Tol 7 100 93 
11 Pd2(dba)3 DavePhos Tol 7 100 88 
12 Pd(OAc)2
 
Dppf Tol 7 100 85
b 
13 Pd2(dba)3 Dppf Dioxane 7 100 87 
14 Pd2(dba)3 Dppf DMF 7 100 53 
15 Pd2(dba)3 Dppf Tol 7 110 82 
16 Pd2(dba)3 Dppf Tol 7 80 77 
a 
Yield was calculated by 
1
H-NMR of crude product using 4-nitroacetophenone as an internal standard. 
b
 10 
mol% of Pd(OAc)2 was used. 
 
With the optimized conditions in hand (method A), I was interested in extending the 
substrates scope of the cyclization of 17a with a various amines. The cyclization products 
18a-h, depicted in Table 4.2, were isolated in 83-98% yields. The reaction showed 
compatibility with a variety of functional groups. All the products were proven by 
spectroscopic method. The structure of 18d was independently confirmed by single-crystal 
X-ray diffraction (Figure 4.3).
121
 Unfortunately, the Pd-catalyzed cyclization of 17a with 
aliphatic amines using method A resulted in unsatisfactory yields, due to the formation of 
side products. After some optimization studies, using different conditions, I found that the 
employment of the DPEPhos as the ligand (method B) allowed improvement the yield. Up to 
90% isolated yields of the cyclization products were achieved (products 18i-l).  
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Figure 4.3. Ortep plot of 18d 
 
Table 4.2. Synthesis of α-carbolines 18a-l 
18 R Method
 a
 Yield (%)
a
 
a 
Ph A 92 
b 
4-MeC6H4 A 95 
c 
4-(t-Bu)C6H4 A 94 
d 
4-FC6H4 A 89 
e 
3-(CF3)C6H4 A 88 
f 
4-(MeO)C6H4 A 98 
g 
4-(MeS)C6H4 A 92 
h 
4-(CN)C6H4 A 83 
i 
Bn B 88 
j 
(4-FC6H4)CH2 B 87 
k 
3-(CF3)C6H4CH2 B 90 
l 
n-C3H7 B 91 
a
 Isolated yields 
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With an optimal procedure in hand, I was interested to extending  the synthesis to 
bis(carbolines). Products 20a and 20b were prepared in 46 and 50% yields, respectively, by 
the Pd-catalyzed cyclization of 17a with diamines 19a and 19b. It is noteworthy that product 
20b represents an analogue of the recently developed dNinp ligand.
33
 Thus, my method 
allows for a convenient access to this type of molecule. 
 
 
Scheme 4.2. Synthesis of bis(carbolines) 20a,b.  
Conditions: 2.2 equiv. of 17a, 1 equiv. of 19a (19b), 6 equiv. of NaOtBu, 5% mol of Pd2(dba)3, 10% of Dppf, 
toluene, 110 ºC, 10h. 
My next goal was to apply my methodology to the synthesis of δ-carbolines. The Suzuki-
Miyaura coupling of o-bromophenylboronic acid 6 with 2,3-dibromopyridine 16b proceeded, 
following my optimized procedure, with very good regioselectivity at the more electron-
deficient 2-position of the pyridine ring and afforded product 17b in 96% isolated yield. With 
intermediate 17b in hand, I prepared a series of δ-carbolines 21a-j, using either method A or 
method B, in moderate to excellent yields. The yields were moderate in case of less 
nucleophilic amines carrying an electron withdrawing substituent located at the aryl group. 
The structure of 21b was independently confirmed by X-ray crystal structure analysis (Figure 
4.4).
122
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Scheme 4.3. Synthesis of δ-carbolines 21a-i 
Conditions: (i) 1.2 equiv. of 6, 5% of Pd(PPh3)4 catalyst, 3 equiv. of NaOH, THF, H2O, 70 ºC, 4h. (ii) 3 equiv. of 
8, 6 equiv. of NaOtBu, 5% mol of Pd2(dba)3, ligand (method A: 10 mol% of Dppf, method B: 10 mol% of 
DPEPhos), toluene, 100 ºC, 7h. 
 
Table 4.3. Synthesis of δ-carbolines 21a-i 
21 R Conditions Yield (%) 
a Ph A 83 
b 4-FC6H4 A 73 
c 3-(F3C)C6H4 A 64 
d 4-(MeO)C6H4 A 94 
e 3,5-(MeO)2C6H4 A 75 
f 4-(NC)C6H4 B 42 
g Bn B 92 
h 4-(MeO)C6H4CH2 B 65 
i PhCH2CH2 B 77 
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Figure 4.4. Ortep plot of 21b. 
 
The bis(carboline) 22 was synthesized in 40% isolated yield by the cyclization of 17b with 
diamine 19a (Scheme 4.4). 
 
Scheme 4.4. Synthesis of bis(carboline) 22.  
Condition: 2.5 equiv. of  17b, 1 equiv. of 19a, 6 equiv. of NaOtBu, 5% mol of Pd2(dba)3, 10% of Dppf, toluene, 
100 ºC, 10h. 
 
4.3 Conclusion 
In conclusion, I have successfully developed an efficient two-step synthesis of α- and δ-
carbolines from readily available chemicals. The success of syntheses bases on site-selective 
Suzuki-Miyaura reaction and subsequent two-fold C-N coupling reactions. My results would 
be interesting for further applications in both medicinal chemistry and materials science. 
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5 Synthesis and physical properties of 5,7-Dihydropyrido[3,2-b:5,6-
b']diindoles  
 
 
 
5.1 Introduction 
Carbolines (pyridoindoles) and their derivatives are employed as electronic transport units in 
host materials.
100,102,123
 The replacement of the carbazole unit by a carboline improves the 
electron mobility. The carbazole ring is assumed to accelerate the electron-accepting 
properties owing to its electron deficient ring system. 
100b,c,101-102
 The high quantum efficiency 
was achieved by the combination of the carbazole and carboline unit which improves the 
triplet energy. The materials containing carboline moieties have been studied for the 
development of novel bipolar host materials. In 2013, Lee et al. prepared bi- and triphenyl 
derivatives which contain carbazole and carboline moieties (via the nitrogen atom). These 
compounds exhibit 30% external quantum efficiency and high triplet energy (2.90 eV) in blue 
phosphorescence organic light emitting diodes.
100b,101
 Kwon et al. reported the synthesis of 
the novel compounds, containing three α-carbolinyl substituents attached to a triphenylamine 
moiety, which show a longer life-time than related derivatives containing three carbazole 
moieties.
102
 Recently, Lee et al. demonstrated that related α- and β-carbolines possess a 
higher quantum efficiency and a higher triplet energy than isomeric γ-carbolines.100d  The 
quantum efficiency are up to 22.1 %.
100a
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The organic materials containing acenes and heteroacenes have found many applications in 
organic photovoltaic cells,
73b
  light-emitting diodes (OLEDs),
56a
 and especially in organic 
field-effect transitors (OFETs) due to their optical properties.
56b,73a,124
 In this context, 
pentacene and its heterocyclic derivatives atracted much attention in current research, due to 
their excellent charge mobility. In fact, pentacene-based OFETs exhibit very high charge 
mobilities in the range of 5-40 cm
2
/(Vs).
73a
 However, pentacene derivatives are easily 
oxidized by air,
124
 which limits their practical applications. The replacement of heteroatoms 
in pentacenes results in tuning the electronic properties like solubility, stability and molecular 
packing.
56b,73a,124
 For example, indolocarbazoles,
60
 pentathienoacenes,
62
 
dibenzothienopyrroles,
66a
 tetraazapentacenes,
125
 N-heteropentacenes,
56b,73a,124
  and thiophene-
benzene annulated pentacenes
56b,63,73a,124
 offer excellent OFET properties.  
Due to the importance of both N-heteropentacenes and carbolines in the field of organic 
materials, I was interested in developing a novel class of N-heteropentacenes (5,7-
dihydropyrido[3,2-b:5,6-b']diindoles) which combine the core structures of indoles and δ-
carbolines. My approach to 5,7-dihydropyrido[3,2-b:5,6-b']diindoles relies on the Pd-
catalyzed two-fold C-N coupling of 3,5-dibromo-2,6-bis(2-bromophenyl)pyridine with 2 
equivalents of corresponding amines. Groups of Nozaki, Chida and Verkade published the 
preparation of carbazoles from 2,2’-dihalobiphenyl derivatives and amines (Scheme 5.1).126 
My work herein based on the first site-selective Suzuki reaction of 2,3,5,6-
tetrabromopyridine with ortho-(bromophenyl)boronic acid and subsequent cyclization by 
two-fold palladium catalyzed C-N coupling which is, to the best of my knowledge, not 
reported so far. The products show excellent fluorescence properties with good quantum 
yields. The photophysical and electronic properties were studied in detail experimentally and 
theoretically by DFT calculations. 
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Scheme 5.1. Retrosynthetic analysis of 5,7-dihydropyrido[3,2-b:5,6-b']diindoles 
The 5,7-dihydropyrido[3,2-b:5,6-b']diindole core structure is rather new. To the best of my 
knowledge, only the N-hydrogen substituted parent molecule, 5,7-dihydropyrido[3,2-b:5,6-
b']diindoles, has been reported so far. The compounds were published in a patent in Korean 
language using a different and more complicated synthetic methodology.
127
 However, 
compound characterization, details of the synthesis and the physical properties were not 
provided in the patent which is, therefore, of limited utility for the chemical community.   
5.2 Result and discussion 
2,3,5,6-Tetrabromopyridine (23) was synthesized from 2,6-diaminopyridine according to 
Flower’s procedure. 128  The site-selective Suzuki-Miyaura reaction of 2,3,5,6-
tetrabromopyridine with 2.2 equivalents of o-bromophenylboronic acid 6, using 5% mol 
Pd(PPh3)4 as catalyst, gave adduct 24 in 80% isolated yield. The site-selectivity of the 
reaction is excellent. The twofold C-N coupling cyclization of 24 with different amines 8a-t 
afforded the desired 5,7-dihydropyrido[3,2-b:5,6-b']diindoles in good to excellent yields 
(Scheme 5.2). 
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Scheme 5.2. Synthesis of 5,7-disubstituted 5,7-dihydropyrido[3,2-b:5,6-b']diindoles 25a-t.  
Conditions: (i) 2.2 equiv. of 6, 5% of Pd(PPh3)4, 3 equiv. of NaOH, THF, H2O, 70 ºC, 4 h. (ii) 3 equiv. of 8, 6 
equiv. of NaOtBu, 5% mol of Pd2(dba)3, ligand (method A: 10% of Dppf, method B: 10% of DPEPhos), 
toluene, 100 ºC, 7h. 
The conditions of the annulation reaction of 24 with tert-butylaniline 8c  were optimized 
(Table 5.1). The ligand, palladium precursor, solvent and temperature were examined. The 
monodentate phosphine ligands, such as XPhos, XPhos·tBu2, SPhos, DavePhos, RuPhos, 
PCy3·HBF4, or P(tBu)3·HBF4 afforded 25c in unsatisfactory yields. The optimization 
indicated that the employment of bidentate phosphine ligands, such as BINAP, XantPhos, 
DPEPhos, Dppe, or Dppf, give significantly improved yields. The bidentate ligands with bite 
angles higher than 90º gave the best yields. For example, when Dppf was employed as the 
ligand in combination with Pd2dba3 (method A), product 25c was isolated in up to 90% yield. 
The change to Pd(OAc)2 as the palladium source resulted in lower yields. Toluene was 
demonstrated to be the best solvent. The success of BINAP, XantPhos, DPEPhos, Dppe or 
Dppf can be assumed by their rigid structure and their bidentate character
129
 and the influence 
of diphosphane back-bonding.
130
 The dissociation of one P-Pd bond (arm-off mechanism) has 
been previously reported which leads to an acceleration of the reductive elimination with 
respect to β-hydride emilination. 131   
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Table 5.1. Optimization for the synthesis of 25c 
Entry Catalyst Ligand Solvent Time (h) Temperature (ºC) Yield (%) 
1 Pd2(dba)3 BINAP Tol 7 100 73 
2 Pd2(dba)3 XantPhos Tol 7 100 84 
3 Pd2(dba)3 DPEPhos Tol 7 100 52 
4 Pd2(dba)3 Dppe Tol 7 100 40 
5 Pd2(dba)3 Dppf Tol 7 100 90 
6 Pd2(dba)3 PCy3·HBF4 Tol 7 100 13 
7 Pd2(dba)3 P(tBu)3·HBF4 Tol 7 100 35 
8 Pd2(dba)3 XPhos Tol 7 100 31 
9 Pd2(dba)3 XPhos·tBu2 Tol 7 100 37 
10 Pd2(dba)3 SPhos Tol 7 100 12 
11 Pd2(dba)3 DavePhos Tol 7 100 45 
12 Pd2(dba)3 RuPhos Tol 7 100 32 
13 Pd(OAc)2 Dppf Tol 7 100 34 
14 Pd2(dba)3 Dppf Dioxane 7 100 25 
15 Pd2(dba)3 Dppf DMF 7 100 0 
16 Pd2(dba)3 Dppf Tol 7 110 82 
17 Pd2(dba)3 Dppf Tol 7 80 77 
a
Yield calculated by 
1
H-NMR of crude product using 1,4-dioxane as an internal standard 
 
With the optimized conditions (method A) in hand, I studied the scope of substrates. The 
reaction of 24 with different aniline derivatives afforded products 25a-h in good to excellent 
yields (Table 5.2). Generally, the electron rich (more nucleophilic) anilines gave higher 
yields of corresponding products compared to electron poor anilines. An exception was the 
use of 4-(N,N-diethylaminoaniline), presumably due to interaction of the diethylamino group 
with the catalyst.  
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Table 5.2. Synthesis of 25a-t 
25 R Method Yield (%) 
a Ph A 83 
b 4-tBuC6H4 A 84 
c 3,5-Me2C6H4 A 85 
d 4-FC6H4 A 66 
e 3-(CF3)C6H4 A 70 
f 4-(MeO)C6H4 A 93 
g 3,5-(MeO)2C6H4 A 95 
h 4-(Et2N)C6H4 A 69 
i n-C7H15 B 80 
j n-C3H7 B 86 
k n-C12H25 B 71 
l Allyl B 84 
m Bn B 70 
n 4-(MeO)C6H4CH2 B 60 
o (4-FC6H4)CH2 B 53 
p 3-(CF3)C6H4CH2 B 52 
q PhCH2CH2 B 75 
r 3,4-(MeO)2C6H4CH2CH2 B 56 
s PhCH2CH2CH2 B 68 
t Cyclohexyl B 55 
a
 compounds 25j-o were prepared by my colleague Ngo Ngoc Thang. 
Encouraged by the the successful result above, I applied the method A to alkyl amines and 
only obtained in low yields. Therefore, further optimization for the synthesis of derivative 25l 
was carried out (Table 5.3). Among different tested ligands, DPEPhos gave the best yields of 
alkyl substituted products when it used in combination with Pd2dba3 (method B, Table 5.3). 
Only bidentate ligands catalyzed these reactions, but no obvious correlation between their 
bite angle and yields was observed. 
131-132
 The application of method B allowed the synthesis 
of desired products 25i-t in good yields (Table 5.2). 
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Table 5.3. Optimization for the synthesis of 25l 
Entry Catalyst Ligand Solvent Time (h) Temperature (ºC) Yield (%) 
1 Pd2(dba)3 BINAP Tol 7 100 11 
2 Pd2(dba)3 XantPhos Tol 7 100 17 
3 Pd2(dba)3 DPEPhos Tol 7 100 74 
4 Pd2(dba)3 Dppe Tol 7 100 58 
5 Pd2(dba)3 Dppf Tol 7 100 41 
6 Pd2(dba)3 PCy3·HBF4 Tol 7 100 0 
7 Pd2(dba)3 PBu3·HBF4 Tol 7 100 6 
8 Pd2(dba)3 XPhos Tol 7 100 4 
9 Pd2(dba)3 XPhos·tBu2 Tol 7 100 7 
10 Pd2(dba)3 SPhos Tol 7 100 8 
11 Pd2(dba)3 DavePhos Tol 7 100 7 
12 Pd2(dba)3 RuPhos Tol 7 100 5 
 a
Yield calculated by 
1
H-NMR of crude product using 1,4-dioxane as an internal standard 
 
The structures of product 25a-t were determined by spectroscopic methods. The structures of 
25g and 25j were independently confirmed by X-ray crystal structure analyses (Figures 5.1 
and 5.2).
133
 Moreover, DFT calculations were performed to compare the geometric 
parameters of theoretical and experimental structures. The experimental and calculated 
results indicate that the heterocyclic core structure is planar. Some important calculated bond 
lengths and bond angles of 25j (as an example) are compared with those of the crystal 
structure (Table 5.4). A maximum difference of 0.008Å in bond lengths is observed between 
theoretical and experimental structures, whereas the difference in bond angles reaches to a 
maximum of 0.7 degrees. A good correlation between the theoretical and experimental 
geometric parameters illustrates the validity of the applied computational method.  
 
Synthesis and properties of 5,7-Dihydropyrido[3,2-b:5,6-b']diindoles 53 
 
 
  
 
Figure 5.1. Ortep plot of 25g 
 
 
Figure 5.2. Ortep plot of 25j 
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Table 5.4. Comparison of bond lengths and bond angles of 25j based on DFT calculations 
and X-ray crystal structure analysis 
Bond length Experimental Theoretical Bond Angle Experimental Theoretical 
N1-C1 1.335 1.335 N1-C1-C8 124.7 124.3 
C1-C8 1.427 1.433 N1-C1-C2 128.31 129.08 
N2-C8 1.387 1.386 N2-C2-C6 128.82 129.37 
N1-C17 1.339 1.338 N2-C7-C2 109.55 109.30 
N3-C10 1.380 1.386 C9-C8-N2 130.42 130.12 
C16-C17 1.444 1.447 C12-C10-N3 108.46 108.85 
C9-C10 1.387 1.395 N3-C11-C12 128.56 129.30 
N2-C7 1.392 1.397 N3-C11-C16 109.78 109.31 
 
5.3 Electrochemical properties 
Electrochemical properties of some δ-carbolines with three different concentrations (1 x 10-3; 
3 x 10
-3
; 6 x 10
-3
 mol·L
-1
) using DMF as solvent were studied including Cyclic Voltammetry 
(CV) and Differential Pulse Voltammetry (DPV), (Figure 5.3). Tetrabutylammonium 
hexafluorophosphate (TBAPF6) was used as supporting electrolyte in 0.01 mol·L
-1
 of 
concentration. All potentials were calibrated with the ferrocene/ferrocenium couple (Fc/Fc
+
) 
as internal standard. Oxidation and reduction energy levels were determined from the better-
resolved DPV measurements (Table 5.5). The formal potential of Fc/Fc
+ 
vs. vacuum was 
assumed to be -4.8 eV. 
  
Synthesis and properties of 5,7-Dihydropyrido[3,2-b:5,6-b']diindoles 55 
 
 
 
   
  
    
Figure 5.3. Cyclic Voltammograms and Differential Pulse Voltammograms of 25 
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Table 5.5. Cyclic Voltammetry and Differential Pulse Voltammetry parameters and 
calculated energy values of 25 
Comp. 𝑬𝒓𝒆𝒅𝒐𝒙
𝟏/𝟐
 (V vs 
Fc/Fc+)
a
 
𝑬𝒐𝒙
𝟏/𝟐
 (V) (V vs 
Fc/Fc+)
b
 
𝑬𝑯𝑶𝑴𝑶 
(eV)
c
 
𝑬𝑳𝑼𝑴𝑶 (eV)
d
 ∆Eg (eV)
e
 ∆Egcal. (eV)f 
25a -2.167 1.4 -6.250 -2.683 3.567 4.107 
25b -2.171 1.407 -6.207 -2.629 3.578 4.096 
25c -2.143 1.376 -6.176 -2.657 3.519 4.057 
25d -2.056 1.421 -6.221 -2.744 3.477 4.112 
25g -2.07 1.37 -6.170 -2.730 3.440 4.117 
25i -2.268 1.263 -6.063 -2.532 3.531 4.103 
25k -2.35 1.265 -6.065 -2.450 3.615 4.102 
25l -2.197 1.312 -6.112 -2.603 3.509 4.124 
25m -2.003 1.657 -6.457 -2.797 3.660 4.132 
25n -2.256 1.312 -6.112 -2.544 3.568 4.123 
25q -2.254 1.267 -6.067 -2.546 3.521 4.107 
25r -2.264 1.241 -6.041 -2.536 3.505 4.07 
25s -2.299 1.254 -6.054 -2.501 3.553 4.105 
25t -2.191 1.304 -6.104 -2.609 3.495 4.105 
CBP   -5.91 -2.51 3.40  
a𝐸𝑟𝑒𝑑𝑜𝑥
1/2
 = Eredox + (Eampli /2). Eampli = 0.0501 (V). Eredox values were determined by DPV in Acetonitrile. 
b𝐸𝑜𝑥
1/2
= Eox + (Eampli /2).Eox values were determined by DPV in Acetonitrile.V vsFc/Fc
+
 in 0.1 M TBABF6.  
c
The HOMO levels were estimated from 𝐸𝐻𝑂𝑀𝑂 = -(𝐸𝑜𝑥
1/2
 +4.8) (eV).  
d
The LUMO levels were estimated from 𝐸𝐿𝑈𝑀𝑂  = - (𝐸𝑟𝑒𝑑𝑜𝑥
1/2
 +4.8) (eV).  
e
Electrochemical band gaps ∆Eg were estimated from ∆Eg = 𝐸𝐿𝑈𝑀𝑂  - 𝐸𝐻𝑂𝑀𝑂 .  
f
The band gaps ∆Egcal.were estimated from computational DFT calculation method. 
 
Figure 5.3 depicts voltammograms of 25 with reversible and well-defined redox peaks around 
-2.2 V for the formation and re-oxidation of the reduced forms of 25. However, 
corresponding redox-peaks for the oxidized form are hardly visible in the CVs due to the 
overlapping background current. Therefore, the DPV method was chosen for electrochemical 
Synthesis and properties of 5,7-Dihydropyrido[3,2-b:5,6-b']diindoles 57 
 
 
investigations and revealed the redox signals of the oxidized forms of 25 at ca. +1.3 V. The 
results indicated that the band gaps were independent from the structure. It suggest that the 
5,7-dihydropyrido[3,2-b:5,6-b']diindole core plays the key role for the electrochemical 
properties. Compared to 4,4'-bis(N-carbazolyl)-1,1'-biphenyl (CBP), which is commonly 
used in the host material, 25 possess lower HOMO and lower LUMO levels and slightly 
bigger band gaps. Phenyl substituted derivatives 25a and 25d show the lowest HOMO energy 
levels and band gaps. In contrast, the highest HOMO level and highest LUMO level were 
found in the case of substrates 25r and 25s, presumably cause by thier aliphatic subtituents. 
The band gaps of phenyl substituted groups located in the N-position show smaller band gaps 
than those of derivatives containing aliphatic substituents. Most likely this fact is attributed to 
some electronic interaction of the central heterocyclic core with the phenyl substituents. 
However, it can be anticipated that this interaction is small because of orthogonal twisting of 
the aryl groups.  
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Figure 5.4. Isodensity plot of HOMO and LUMO orbitals of 25a, 25j and 25m 
Density functional theory (DFT) calculations have also been caried out for the determination 
of HOMO-LUMO band gaps.
134
 The difference of theoretical and experimental values is 
given in Table 5.5 (vide supra). The calculated band gaps are slightly higher than the 
experimental values. The comparation between theoretical and experimental band gaps has 
already been discussed in the literature.
135
 The energy of the virtual orbitals (LUMO) is not 
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properly captured by DFT methods, which leads to over-estimated theoretical band gaps. The 
results shown in Table 5.5 demontrate that theoretical and experimental band gaps are only 
slightly influenced by structural modifications. The substituents at nitrogen position can be 
mainly categorized as aliphatic, benzylic and phenyl moieties. HOMO-LUMO gaps have no 
significant differences among various substituents which can conclude that HOMOs and 
LUMOs are not much influenced by the substituents. Towards this end, the HOMO and 
LUMOs of 25a, 25j and 25m were analyzed and the orbital diagrams are depited in Figure 
5.4. As expected, the HOMOs and LUMOs are not extended to the nitrogen substituents and 
only spread over the pyrido-diindole skeleton. The highest calculated HOMO-LUMO band 
gap is for 25m (4.132 eV) which correlate with the highest experimental band gap for the 
same compound (3.66 eV).  
Molecular orbitals and iso density plots of HOMO-2 and LUMO+2 for N-phenyl pyrido-
diindoles 25a are shown as a representative example in Figure 5.5. The HOMO-1, and 
HOMO-2 are almost equal in energy and lie about 0.13 eV lower in energy relative to the 
HOMO. The HOMO-1 and HOMO-2 are mainly centered on the pyrido-diindole skeleton. 
LUMO+1 and LUMO+2 orbitals, on the other hand, have iso densities mostly located on the 
N-phenyl substituents. They are located about 0.36 eV and 0.66 eV higher in energy, 
respectively, than the respective LUMOs.  
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Figure 5.5. Iso density plot of HOMO-2 to LUMO+2 of 25a 
 
5.4 Absorption and Fluorescence Properties 
The optical properties were investigated by UV-VIS and fluorescence spectroscopy in 
acetonitrile and the data is sumarized in Table 5.6. The UV-VIS spectra of various 5,7-
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dihydropyrido[3,2-b:5,6-b']diindoles 25 as main chromophores are shown in Figure 5.6. The 
UV-VIS spectra possess three absorption bands around 290, 310 and 380 nm. No significant 
influence, caused by the substituent located at the nitrogen atom, was observed. The 
absorption band of the compounds 25j, 25k and 25t, containing aliphatic subtituents, are 
slightly red-shifted, presumably due to the positive inductive effect of the alkyl group. For the 
compounds, containing electron withdrawing groups, for example  25d, the absorption bands 
are somewhat shifted to shorter wavelengths.  
 
  
Figure 5.6. Normalized absorption and emission spectra of 25 measured in acetonitrile. 
Emission spectra were recorded at an excitation of 360 nm. 
 
The fluorescence spectra were measured in acetonitrile (excitation at 360 nm) using standard 
quinine hemisulfate salt monohydrate in 0.05M H2SO4 which has a fluorescence yield of 
52%.
86
 The spectra showed emission bands around 400 nm. The Stokes shifts are in the range 
of 20 nm. The UV-VIS and fluorescence spectra show a similar pattern, but the quantum 
yields vary depending on the type of substituents. Derivatives 25i and 25k exhibit the largest 
Stokes shifts, but lowest quantum yield. Compounds 25o and 25p, containing fluorine or 
trifluoromethyl substituents, possess the highest quantum yields 44% and 47%, respectively.  
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Table 5.6. Absorption and emission spectroscopic data of 25 
25 𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙  
[nm] 
Logε 
𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙  
𝝀𝟐𝒂𝒃𝒔
𝒎𝒂𝒙  
[nm] 
Logε 
𝝀𝟐𝒂𝒃𝒔
𝒎𝒂𝒙  
𝝀𝟑𝒂𝒃𝒔
𝒎𝒂𝒙  
[nm] 
Logε 𝝀𝟑𝒂𝒃𝒔
𝒎𝒂𝒙  
 
𝝀𝒆𝒎
𝒎𝒂𝒙 
[nm] 
Stockes 
shift [nm] 
ϕfluo 
(%) 
a 290 4.557 310 4.569 379 4.381 402 23 42 
c 291 4.743 311 4.764 380 4.568 403 23 37 
d 288 4.694 310 4.684 378 4.500 402 24 39 
g 290 4.712 311 4.700 379 4.519 402 23 39 
j 291 4.674 311 4.648 382 4.471 407 25 33 
k 291 4.649 312 4.629 382 4.413 407 25 31 
l 288 4.649 310 4.633 380 4.488 404 24 35 
n 289 4.390 311 4.335 381 4.184 404 23 34 
o 288 4.413 310 4.381 379 4.232 402 23 44 
p 288 4.753 310 4.716 380 4.575 402 22 47 
t 292 4.511 312 4.496 383 4.245 407 24 34 
 
5.5 Conclusion 
In conclusion, I successfully synthesized a novel series of N-heteropentacenes (5,7-
dihydropyrido[3,2-b:5,6-b']diindoles) using Pd-catalyzed site-selective Suzuki reaction and 
two-fold C-N coupling annulations. During the optimization of the reaction condition, the 
employment of bidentate ligands proved to be important. The electrochemical and optical 
properties of the products were studied in detail. The results of DFT calculations and the 
experimental studies demonstrate that N-phenyl-substituted derivatives possess smaller band 
gaps as compared to N-alkyl-substituted derivatives. The smallest band gaps were observed 
for compound 25d. All studied compounds 25a-t exhibited high quantum yields 25a-t (ϕfluo = 
31-47%). The Stokes shifts of 25a-t are not much dependent on the substituents (variation in 
the range of only 22-25 nm). Besides the new and interesting synthesis developed, the 
electronic, optical and electrochemical properties herein might be used as an interesting basis 
for further applications.  
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6 Synthesis and physical properties of Indolo[2,3-b]quinoxalines 
 
 
 
 
6.1 Introduction 
Indolo[2,3-b]quinoxalines found many applications in organic light-emitting diodes 
(OLEDs)
136
 and excitonic solar cells.
137
 Due to their ability to harvest both singlet and triplet 
energy for emission, the device efficiency was improved. In 2010, Thomas et al. reported that 
indolo[2,3-b]quinoxalines 26 lead to a red-shift in absorption and emission spectra as well as 
larger Stokes shifts.
137
 The thermal stability was increased by introduction of indolo[2,3-
b]quinoxaline segments which resulted in a higher glass transition temperature. The 
introduction of bulky and nonplanar structural segments instead of tertiary amine groups 
reduced π-π stacking interactions, which was assumed to decrease luminescence and 
propensity for crystal forming in the solid state,.
136b
 These novel materials exhibited good 
quantum yields in solution and remarkable fluorescence in solid state. Thomas et al. also 
fabricate electronic devices with electron transporting (ETL) and emitting layers (EML) 
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containing compound 27b. These devices exhibited a maximum luminescence of 3910 cd/m
2
 
and maximum external quantum efficiency of 0.46%. In 2011, the novel host material BIQS 
28 was prepared by Cheng et al. for deep-red PhOLEDs.
136c
 The BIQS material possess a 
relatively low LUMO energy that facilitates electron injection allowing a significantly lower 
voltage operation and higher current density. Due to singlet and triplet energies, this material 
provided an efficient energy transfer to deep-red emitting layers,. Two years later, three new 
host materials BIQF, BIQTP, BIQMCz with two indoloquinoline moieties were prepared by 
Cheng et al.
136a
 The host layers in deep-red devices containing these materials exhibited 
EQEmax over 20%. The operational lifetimes were also increased and much longer than in the 
CBP-based devices. 
 
Figure 6.1. Some materials based on indolo[2,3-b]quinoxaline moieties. 
 
Indolo[2,3-b]quinoxalines not only find many important applications in material sciences, but 
also in medicinal chemistry. Many reports show that indolo[2,3-b]quinoxaline derivatives 
exhibit a wide range of interesting biological activities, such as antivirus,
138
 anticancer,
139
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antimicrobial,
140
 and antibacterial activities
141
 A series of indolo[2,3-b]quinoxaline 
derivatives were investigated for bioactivity against Herpes virus. These results indicated that 
B-220 exhibited potent antiviral activity against herpes simplex virus type 1 (HSV-1), 
varicella-zoster virus (VZV) and cytomegalovirus (CMV) (Figure 6.2).
138
 In 2010, 6-(2-
aminoethyl)-6H-indolo[2,3-b]quinoxalines 29 (Figure 6.2) were synthesized by Shibinskaya 
et al. 
142
 The bioactive test showed that these compounds act as potent interferon inducers and 
antiviral agents with low toxicity. Furthermore, 7H-benzo[4,5]indolo[2,3-b]quinoxalines 30, 
modificated from the structure of 29, bind to DNA more strongly (lgKa = 6.23-6.87) than 29 
(lgKa = 5.57-5.89).
143
 The antiviral activity is significantly reduced by the presence of an 
annulated benzene ring present in compound 30. In the antitumor research, Deady et al. 
indicated that quinoxaline derivatives exhibited a broad range of cytotoxic activities 
comparing to tetracyclic quinoline.
139b
 In 2001, Hirata et al. reported that compounds 
NCA0424 and NCA0465 possesses antitumor activity toward various types of blood cancer 
(leukemia), fibrosarcoma sand melanomas.
139a
 Recently, indolo[2,3-b]quinoxaline derivatives 
31 were synthesized and examined against three human cancer cell lines, namely cervical, 
prostate and lung using an MTT assay by Kanugula et al.
144
 The results indicate that 9-
fluoroindolo[2,3-b]quinoxalines, containing CF3, Cl, H substituents located at the 3-position 
of the arene attached to the triazole ring, promoted their bioactivity. 
 
Figure 6.2. Some bioactive compounds containing the indolo[2,3-b]quinoxaline moiety 
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Due to the importance of indolo[2,3-b]quinoxalines in both material sciences and medicinal 
chemistry, I was interested in developing a new and efficient strategy for the synthesis of 
indolo[2,3-b]quinoxalines. Until now, synthetic approaches to these molecules are often 
complicated, low yielding and require several steps. Most of the reported syntheses of 
indolo[2,3-b]quinoxalines base on the cyclocondensation of isatin with o-phenylenediamine 
derivatives. In 1895, Marchlewski firstly synthesized of indolo[2,3-b]quinoxaline by 
condensation of isatin with o-phenylenediamine in the present of AcOH.
145
 In 1980, 
Reisenauer and coworkers described the cyclization of carbodiimide compounds by 
rearrangement of nitrenes to give indolo[2,3-b]quinoxalines in good yields.
146 
Indolo[2,3-
b]quinoxalines could also be synthesized by cyclization of o-phenylenediamine with 1-acetyl-
2-bromo-3-indolinone.
147
 Generally, the synthesis of highly functionalized indolo[2,3-
b]quinoxalines is still limited, because starting materials are not readily available. During my 
thesis, I approached to synthesize indolo[2,3-b]quinoxalines by a one-pot Pd-catalyzed 
domino reaction of 1,2-dibromoquinoxaline with secondary aromatic amines. These reactions 
also gave indolo[2,3-b]quinoxaline derivatives in good yields, but with some limitations with 
regard to the substrates scope. I also want to introduce a second approach by practical and 
efficient two-step synthesis of indolo[2,3-b]quinoxalines based on a Pd-catalyzed Suzuki-
Miyaura reaction of 2,3-dibromoquinoxaline and subsequent Pd-catalyzed two-fold C-N 
coupling annulation with amines.  
6.2 Results and discussion 
I envisaged to synthesize the indolo[2,3-b]quinoxaline scaffold relying on two retrosynthetic 
strategies depicted in Scheme 6.1. My first approach bases on Ackermann’s procedure for the 
one-pot Pd-catalyzed domino synthesis of carbazole derivatives from aryl 1,2-dihalides.
148
 
This approach directly provides the indolo[2,3-b]quinoxaline core structure. The second 
approach is based on a two-step synthesis using a Pd-catalyzed Suzuki reaction and 
subsequent two-fold C-N coupling annulation.
149
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Scheme 6.1. Retrosynthetic analysis of the synthesis of indolo[2,3-b]quinoxalines 
I first started to study the one-pot reaction of 2,3-dibromoquinoxaline (32) with secondary 
aromatic amines using Pd(OAc)2/PCy3·HBF4 as catalyst applying Ackermann’s protocol 
developed for other heterocyclic substrates.
148
 I was pleased to find that the reaction of 32, 
synthesized in two steps from 1,2-diaminobenzene using Li’s procedure,150 with 
diphenylamine afforded indolo[2,3-b]quinoxalines 35a in 90% yield (Scheme 6.2). The 
preparative scope was studied (Table 6.1). The results showed that indolo[2,3-b]quinoxalines 
derived from sterically less bulky amines afforded good yields. The unsymmetrical 
diarylamine, including 33a, could be successfully prepared, albeit, in only moderate yield. In 
contrast, the synthesis of 33e is unsuccessful. In general, sterically encumbered anilines 
containing substituents located at the ortho-position provided low yields or the reactions 
completely failed (formation of complex mixtures). The bis(adduct) 33d instead of the 
desired cyclization product was formed in case of 2-(methoxy)aniline. In addition, all the 
reaction of 32 with amines such as N-alkylanilines or simple anilines ArNH2 failed. The 
failure in case of N-alkylanilines was already reported by Ackermann for cyclization 
reactions with other aromatic dihalides.
16
 I have tried to vary the conditions to optimize the 
yields by changing the palladium precursors in combination with various ligands, but I was 
not able to isolate the products in good yields.  
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Scheme 6.2. Synthesis of indolo[2,3-b]quinoxaline 33a.  
Conditions: (i) 1.5 equiv. of 7, 1 equiv. of secondary amine, 3 equiv. of NaOtBu, 5% mol of Pd(OAc)2, 10% of 
PCy3·HBF4, toluene, 105 ºC, 18h.  
 
Table 6.1. Synthesis of products 33a-f and 35a following the domino C-N/C-H bond 
activation pathway 
Entry Amine Product Yield (%)
a
 
1 
H
N
 
 
90 
2 
H
N
Me  
 
47 
3 
H
N
OMeMeO  
 
54 
 
4 HN
MeMe
 
 
0
b
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Entry Amine Product Yield (%)
a
 
5 HN
MeOOMe
 
 
30 
6 HN
MeO  
 
0
 b
 
7 
H
N
 
 
0
 b
 
a
 Isolated yields; 
b 
formation of a complex mixture 
 
In order to improve the yields and to develop a more efficient procedure for the synthesis of 
indolo[2,3-b]quinoxalines, I studied a second approach relying on a two-step synthesis. In the 
first step, a Suzuki-Miyaura reaction is performed, followed by a twofold C-N coupling 
annulation (Scheme 6.3). The Suzuki-Miyaura reaction of 32 with 2-bromophenylboronic 
acid in the presence of catalytic amounts of Pd(PPh3)4 gave intermediate 34 in 87% isolated 
yield. The Pd-catalyzed twofold C-N coupling annulation of 34 with various amines 8a-t 
afforded the desired products 35a-t in good to excellent yields (Table 6.3).  
 
Scheme 6.3. Synthesis of indolo[2,3-b]quinoxalines 35a-t. 
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Conditions: (i) 1.2 equiv. of 2-bromophenylboronic acid 6, 2.5 % of Pd(PPh3)4 catalyst, 3 equiv. of NaOH, THF, 
H2O, 70 ºC, 4h. (ii) 3 equiv. of 8, 3 equiv. of NaOtBu, 5% mol of Pd2(dba)3, ligand (method A: 10 mol% of 
Dppf, toluene, 100 ºC, 6 h; or method B: 10 mol% of DPEPhos, toluene, 100 ºC, 6h). 
My optimizations started with the annulation reaction of adduct 34 with p-toluidine 8b was 
using 4-nitroacetophenone as an internal standard (Table 6.2). Some important parameters, 
which can influence the reaction outcome including ligand, Pd precursor, solvent and 
temperature, were investigated. The results show that bidentate ligands proved to be better 
ligands than monodentate ligands in this annulation reaction. In fact, up to 92% yield of 35b 
was achieved by employment of Dppf as ligand in combination with Pd2(dba)3 as the Pd 
source (method A).  
Table 6.2. Optimization for the synthesis of 35b 
Entry Pd precursor Ligand Solvent Temperature (ºC) Yield (%)
a
 
1 Pd2(dba)3 BINAP Tol 100 67 
2 Pd2(dba)3 XantPhos Tol 100 84 
3 Pd2(dba)3 DPEPhos Tol 100 76 
4 Pd2(dba)3 Dppe Tol 100 62 
5 Pd2(dba)3 Dppf Tol 100 92 
6 Pd2(dba)3 PCy3·HBF4 Tol 100 52 
7 Pd2(dba)3 PBu3·HBF4 Tol 100 61 
8 Pd2(dba)3 XPhos Tol 100 36 
9 Pd2(dba)3 XPhos·tBu2 Tol 100 40 
10 Pd2(dba)3 SPhos Tol 100 24 
11 Pd2(dba)3 DavePhos Tol 100 15 
12 Pd2(dba)3 RuPhos Tol 100 5 
13 Pd(OAc)2 Dppf Tol 100 52 
14 Pd2(dba)3 Dppf 1,4-Dioxane 100 85 
15 Pd2(dba)3 Dppf DMF 100 14 
16 Pd2(dba)3 Dppf Tol 110 83 
17 Pd2(dba)3 Dppf Tol 80 75 
a
Yield calculated by 
1
H-NMR of the crude product using 4-nitroacetophenone as an internal standard 
 
With the optimized conditions in hand, I studied the scope of the twofold C-N annulation 
reaction of 34 with various amines. The employment of different anilines afforded the 
corresponding products 35a-i in good to excellent yields in 6 hours reaction time only (Table 
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6.3). The results showed that the annulations gave high yields for substrates bearing both 
electron-withdrawing and -donating substituents. In contrast, the reactions of 34 with alkyl 
amines, using my optimized conditions (method A), resulted in the formation of side products 
which were difficult to separate from the main product. Therefore, further optimization for 
the synthesis of derivative 35n, derived from benzyl amine, was carried out. The optimized 
condition obtained with the employment of DPEPhos as ligand in combination with Pd2dba3 
(method B), resulted in the formation of product 35n in up to 96% yield (Table 6.4). The 
application of these conditions allowed for the synthesis of products 35j-t, derived from 
aliphatic amines, in very good yields (Table 6.3). 
Table 6.3. Synthesis of 35a-t 
35 R Method Yield (%)
a
 
a Ph A 83 
b 4-MeC6H4 A 86 
c 4-FC6H4 A 80 
d 3-(CF3)C6H4 A 90 
e 4-(MeO)C6H4 A 98 
f 3,5-(MeO)2C6H4 A 95 
g 4-(MeS)C6H4 A 94 
h 4-(Et2N)C6H4 A 75 
i (4-NC)C6H4 A 83 
j n-C3H7 B 96 
k n-C5H11 B 93 
l n-C7H15 B 85 
m Allyl B 73
 b
 
n Bn B 94 
o 4-(MeO)C6H4CH2 B 92 
p (4-FC6H4)CH2 B 87 
q 3-(CF3)C6H4CH2 B 84 
r PhCH2CH2 B 89 
s PhCH2CH2CH2 B 91 
t Cyclohexyl B 74 
a
Isolated yields  
b
the product was 6-(prop-1-en-1-yl)-6H-indolo[2,3-b]quinoxaline 
formed by isomerization of the allylic double bond. 
c
compounds 35j-o were prepared by my colleague Do Huy Hoang.  
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Table 6.4. Optimization for the synthesis of 35n 
Entry Pd precursor Ligand Solvent Temperature (ºC) Yield (%)
a
 
1 Pd2(dba)3 BINAP Tol 100 51 
2 Pd2(dba)3 XantPhos Tol 100 63 
3 Pd2(dba)3 DPEPhos Tol 100 96 
4 Pd2(dba)3 Dppe Tol 100 14 
5 Pd2(dba)3 Dppf Tol 100 73 
6 Pd2(dba)3 PCy3·HBF4 Tol 100 - 
7 Pd2(dba)3 PBu3·HBF4 Tol 100 15 
8 Pd2(dba)3 XPhos Tol 100 61 
9 Pd2(dba)3 XPhos·tBu2 Tol 100 59 
10 Pd2(dba)3 SPhos Tol 100 25 
11 Pd2(dba)3 DavePhos Tol 100 34 
12 Pd2(dba)3 RuPhos Tol 100 39 
a
Yield calculated by 
1
HNMR of the crude product using 4-nitroacetophenone as an internal standard 
 
The structures of products 35a-t were proved by spectroscopic methods. The structures of 
35e and 35r were independently confirmed by X-ray crystal structure analyses (Figure  6.3 
and 6.4).
151
 The geometric parameters of the X-ray structure for compound 35e were also 
compared with those derived from the DFT calculations. The optimized geometry of 
compound 35e (from DFT calculations) shows a good correlation with the X-ray structure. 
The quinoxaline scaffold is planar, whereas the methoxy phenyl ring has a dihedral angle of 
52.3 degrees from the quinoxaline plane. A few important calculated bond lengths and bond 
angles are compared with the experimental values (Table 6.5). The differences between 
theoretical and experimental bond lengths and bond angles are in the range of 0.015Å and 2.1 
degrees, respectively. 
Table 6.5. Comparison of experimental bond lengths and bond angles with theoretical values, 
calculated at B3LYP/6-31G* 
Bond Length Experimental Theoretical Bond Angle Experimental Theoretical 
N3-C15 1.433 1.425 C1-N1-C5 113.1 114.0 
N1-C5 1.380 1.370 C2-N2-C10 114.57 115.09 
N2-C10 1.373 1.367 C1-N3-C3 108.15 108.09 
N2-C2 1.314 1.314 C1-N3-C15 127.67 125.63 
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Bond Length Experimental Theoretical Bond Angle Experimental Theoretical 
N1-C1 1.306 1.308 C3-N3-C15 124.18 126.25 
N3-C3 1.401 1.407 C18-O1-C21 116.93 118.29 
O-C18 1.369 1.363 N1-C1-N3 126.22 126.59 
O-C21 1.433 1.419 N1-C1-C2 125.21 124.60 
N3-C1 1.379 1.389 N2-C2-C4 130.76 130.98 
 
Figure 6.3. Ortep plot of 35e 
 
Figure 6.4. Ortep plot of 35r 
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6.3 Electrochemical properties 
Electrochemical properties of some compounds were evaluated by Cyclic Voltammetry (CV) 
and Differential Pulse Voltammetry (DPV) measurements with three different concentrations 
(1 x 10
-3
; 3 x 10
-3
; 6 x 10
-3
 mol·L
-1
) in DMF. These solutions also contained 0.01 mol·L
-1
 
tetrabutylammonium hexafluorophosphate (TBAPF6) as supporting electrolyte. All potentials 
were calibrated with the ferrocene/ferrocenium couple (Fc/Fc
+
) as internal standard. 
Oxidation and reduction energy levels were determined from the better-resolved DPV 
measurement (Table 6.6). The formal potential of Fc/Fc
+
 vs. vacuum was assumed to be -4.8 
eV. 
 
    
Cyclic Voltammograms of 35 
    
Differential Pulse Voltammograms of 35 
Figure 6.5. Electrochemical properties of some quinoxaline derivatives. 
 
 
Synthesis and physical properties of Indolo[2,3-b]quinoxalines 75 
 
 
Table 6.6. Electrochemical properties of some synthesized quinoxaline derivatives 
Comp. 𝑬𝒓𝒆𝒅𝒐𝒙
𝟏/𝟐
 (V 
vs Fc/Fc
+
)
a
 
𝑬𝒐𝒙
𝟏/𝟐
 (V) (V vs 
Fc/Fc
+
)
b
 
𝑬𝑯𝑶𝑴𝑶 
(eV)
c
 
𝑬𝑳𝑼𝑴𝑶 
(eV)
d
 
∆Eg (eV)e ∆Egcal. (eV)
f
 
35a -1.395 1.872 -6.672 -3.405 3.267 3.707 
35b -1.488 1.779 -6.579 -3.312 3.267 3.670 
35c -1.456 1.910 -6.710 -3.344 3.366 3.704 
35e -1.456 1.666 -6.466 -3.344 3.122 3.605 
35j -1.496 1.819 -6.619 -3.304 3.315 3.637 
35l -1.508 1.813 -6.613 -3.292 3.321 3.750 
35m -1.545 1.787 -6.587 -3.255 3.332  
35n -1.512 1.874 -6.674 -3.288 3.386 3.784 
35t -1.512 1.813 -6.613 -3.288 3.325 3.744 
CBP   -5.91 -2.51 3.40  
a 𝑬𝒓𝒆𝒅𝒐𝒙
𝟏/𝟐
 = Eredox + (Eampli /2). Eampli = 0.0501 (V). Eredox values were determined by DPV in DMF. 
b𝑬𝒐𝒙
𝟏/𝟐
= Eox + 
(Eampli /2).Eox values were determined by DPV in DMF.V vs Fc/Fc
+
 in 0.1 M TBABF6.  
c 
The HOMO levels were estimated from 𝑬𝑯𝑶𝑴𝑶 = -(𝑬𝒐𝒙
𝟏/𝟐
 +4.8) (eV). 
d
The LUMO levels were estimated from 
𝑬𝑳𝑼𝑴𝑶 = - (𝑬𝒓𝒆𝒅𝒐𝒙
𝟏/𝟐
 +4.8) (eV). 
e Electrochemical band gaps ∆Eg were estimated from ∆Eg = 𝑬𝑳𝑼𝑴𝑶 - 𝑬𝑯𝑶𝑴𝑶. 
d The band gaps ∆Egcal.were estimated from computational DFT calculation method.
 
 
The voltammograms of compound 35 showed a reversible cycle and well-defined redox 
peaks around -1.4 V for the formation and re-oxidation of the reduced forms of 35 (Figure 
6.5). However, corresponding redox-peaks for the oxidized form are hardly visible in the 
CVs, due to the overlapping background current. Thus, the DPV method was chosen for the 
investigation of the electrochemical properties. The experiments showed that the band gaps 
were independent from the exact substitution pattern. It suggests that the quinoxaline core 
plays the key role. Quinoxaline derivatives gave lower HOMO and LUMO levels and slightly 
smaller band gaps compared to 4,4'-bis(N-carbazolyl)-1,1'-biphenyl (CBP), which is 
commonly used as host material. Among derivatives bearing a phenyl substituent located at 
the nitrogen atom, compound 35c, containing an electron withdrawing group, possesses a 
HOMO energy level lower than compound 35a. In contrast, compound 35e, containing an 
electron donating group, provided a shift to a higher HOMO level yielding a smaller band 
gap. Compound 35e, containing a 4-methoxyphenyl substituent, displayed the smallest band 
gap and highest HOMO energy level. It is noteworthy that compounds 35c and 35n, 
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containing a 4-fluorophenyl and a benzyl substituent located at the nitrogen atom, 
respectively, were found to exhibit the lowest HOMO as well as the biggest band gap. 
Density functional theory (DFT) calculations have also been carried out for the determination 
of HOMO-LUMO band gaps.
152
 Table 6.6 describe the difference of theoretical and 
experimental values. The results show the correlation between theoretical and experimental 
band gaps. The comparation of theoretical and experimental band gaps has already been 
discussed in the literature.
135
 The difference between theoretical and experimental HOMO-
LUMO gaps decreases with the increase in the size of the hydrocarbon.
153
  
The results shown in Table 6.6 indicate that structural modifications insignificantly affected 
the band gaps. N-alkylindolo[2,3-b]quinoxalines possess higher HOMO-LUMO band gaps 
compared to their N-phenyl analogues. The highest HOMO-LUMO band gap was calculated 
for 35n (3.78 eV) which correlates with the highest experimental band gap for this compound 
(3.38 eV). N-phenylindolo[2,3-b]quinoxalines exhibit lower band gaps, probably due to 
extended conjugation. The electron delocalization in N-phenylindolo[2,3-b]quinoxalines 
reduces the band gaps. Among N-phenylindolo[2,3-b]quinoxalines, 35a and 35c have 
comparable bands gaps which indicate that the introduction of a fluorine atom has a 
negligible effect. This might be explained by attribution to the high electronegativity of 
fluorine which prevents its lone pairs to delocalize over the organic π frame. The introduction 
of a methyl group at the para position of the N-phenyl group resulting in a decrease of the 
band gap by 0.037 eV whereas a methoxy group at the same position also reduce the band 
gap by 0.1 eV. 
Molecular orbitals and iso density plots of HOMO-2 and LUMO+2 for N-phenylindolo[2,3-
b]quinoxalines are shown in Figure 6.6 as a representative example. The HOMO-1 and 
HOMO-2 are situated at 0.5 and 1.0 eV, respectively.  The HOMO-1 and HOMO-2 are 
mainly centered on the indolo[2,3-b]quinoxaline skeleton whereas the HOMO is also 
extended to the N-phenyl substituent. LUMO+1 and LUMO+2 orbitals are at 1.374 eV and 
1.548 eV higher in energy, respectively. HOMOs and LUMOs of quinoxalines 35a, 35l and 
35t were also analyzed and are depicted in Figure 6.7. The replacement of the phenyl ring of 
35a with an aliphatic heptyl chain in 35l and an alicyclic fragment (cyclohexyl) in 35t does 
not affect the iso densities of the LUMOs, however, a small effect on the HOMO is observed. 
In 35l and 35t, HOMOs are centered on the quinoxaline core whereas in 35a it has some 
density on the N-phenyl ring as well. 
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Figure 6.6. HOMO-2 to LUMO+2 molecular orbitals of quinoxaline 35a 
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Figure 6.7. HOMO and LUMO of 35a, 35l and 35t calculated at B3LYP/6-31G* 
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6.4 Absorption and Fluorescence Properties 
UV-VIS and fluorescence spectra of some selected indolo[2,3-b]quinoxalines 35 were 
performed in acetonitrile (Figure 6.8) and the corresponding spectral data are summarized in 
Table 6.7. The UV-VIS absorption spectra of the compounds possess three bands around 
400 nm, 350 nm, and 270 nm with increasing absorption strength. The subtituent groups at 
nitrogen insignificantly affect the absoption spectra due to the similar UV-VIS band in all 
quinoxalines 35. The compound 35i exhibits a band around 270 nm which seems to be splited 
into two well separated contributions. The absorptions spectra of compounds 35j, 35l and 
35t, bearing an aliphatic group located at the nitrogen atom, are slightly shifted to longer 
wavelength due to the positive inductive effect. In contrast, the absoption bands are blue-
shifted in the case of compounds 35d and 35i, containing electron withdrawing groups.  
  
Figure 6.8. Normalized absorption and emission spectra of selected compounds 35 measured 
in acetonitrile. Emission spectra were recorded with excitation at 350 nm. 
The emission spectra were measured using again acetonitrile as solvent and an excitation 
wavelength of 350 nm. The fluorescence quantum yields were determined by comparison to 
the standard quinine hemisulfate salt monohydrate in 0.05M H2SO4 which has a fluorescence 
yield of 0.52.
86
 The spectra provide emission bands around 480 nm. The bluest emission was 
observed  at 471 nm for the compound 35d, containing a trifluormethyl group In contrast, the 
compound 35e, containing a methoxy group, exhibit the stronglest red-shifted to 538 nm. The 
Stokes shifts show in medium size and in the range of 80 nm to 90 nm. However, the 
compound 35e exhibits a large Stokes shift of 140 nm. The quantum yields of the indolo[2,3-
b]quinoxalines 35 are in the order of a few percent with the highest yield of 8.6% observed 
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for 35l. It is noteworthy that compound 35e shows also an exceptionally low yield of only 
1.1% which seems to correlate with the large red shift of its fluorescence. 
The weak dependence of the absorption and fluorescence spectra on the substituent are in line 
with the small variation of the electrochemical properties and the band gap of the compounds 
(see above). Only 35e exhibits a significant higher HOMO level and smaller band gap than 
the other compounds which correlate to its red shifted fluorescence. The general behavior can 
be explained by the involved orbitals. As shown in Figure 6.7 HOMO and LUMO, which 
determine the fluorescence and the first absorption band, are more or less completely 
restricted to the indolo[2,3-b]quinoxaline core and therefore only little affected by the 
substitution pattern on the nitrogen. Since the energy differences between the HOMO and 
HOMO-1 and HOMO-2 are smaller than those between the LUMO and LUMO+1 and 
LUMO+2 the next higher lying electronically excited states should dominantly contain 
configurations with excitations from HOMO-1 and HOMO-2 to the LUMO. Since the former 
two orbitals are again restricted to the indolo[2,3-b]quinoxaline core (see Fig. 6.6), the 
corresponding absorption bands around 350 nm and 270 nm are also rather insensitive to the 
substituent. 
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Table 6.7. Spectroscopic data characterizing the absorption and emission properties of 35 
Comp. 𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙  
[nm] 
Lgε 
𝝀𝟏𝒂𝒃𝒔
𝒎𝒂𝒙  
𝝀𝟐𝒂𝒃𝒔
𝒎𝒂𝒙  
[nm] 
Lgε 
𝝀𝟐𝒂𝒃𝒔
𝒎𝒂𝒙  
𝝀𝟑𝒂𝒃𝒔
𝒎𝒂𝒙  
[nm] 
Lgε 
𝝀𝟑𝒂𝒃𝒔
𝒎𝒂𝒙  
𝝀𝒆𝒎
𝒎𝒂𝒙 
[nm] 
Stokes shift 
[nm] 
ϕfluo 
Quantum yield 
35a 395 3.616 351 4.353 270 4.696 484 89 5.9 
35b 396 3.738 351 4.491 269 4.848 490 94 5.2 
35c 394 3.809 351 4.547 268 4.903 482 88 5.9 
35d 389 3.684 350 4.338 269 4.642 471 82 4.3 
35e 398 3.954 351 4.795 269 5.188 538 140 1.1 
35f 394 3.387 351 4.078 270 4.451 485 91 4.8 
35i 389 3.463 350 4.133 262 4.500 474 85 4.6 
35j 403 2.827 352 3.728 269 4.126 484 81 6.7 
35l 404 3.952 352 4.939 269 5.334 483 79 8.6 
35n 398 4.220 351 4.934 269 5.322 477 79 7.1 
35p 396 3.615 351 4.278 269 4.672 475 79 7.4 
35t 404 4.144 352 5.005 270 5.402 486 82 7.7 
 
6.5 Conclusion 
In conclusion, I developed two strategies for the synthesis of indolo[2,3-b]quinoxalines. 
The one-pot approach, using domino Pd-catalyzed two-fold C-N coupling and C-H activation 
reactions, afforded indolo[2,3-b]quinoxalines in good yields. However, the substrates 
scope were limited. A two-step approach, relying on a Suzuki coupling reaction followed by 
an annulation by Pd-catalyzed two-fold C-N coupling, afforded indolo[2,3-b]quinoxalines in 
very good yields. The physical properties of indolo[2,3-b]quinoxalines, including 
electronic, electrochemical and optical properties, were examined experimentally and by 
DFT calculations. It turned out that the electronic and spectroscopic properties are quite 
insensitive to the substituents since the relevant orbitals are restricted to the indolo[2,3-
b]quinoxaline core. The substituent might therefore be used to control and optimize the 
solubility, the interaction with the environment, and the crystallization behavior in the solid 
state without changing the electronic properties of the core.    
Synthesis of biscarbazoles  82 
 
 
7 Synthesis of biscarbazoles  
 
7.1 Introduction 
Carbazoles are presented in a number of alkaloids which possess various biological 
properties, such as anti-tumor, antibiotic, anti-inflammatory, anti-viral, and anti-malarial 
activity.
49,154
 Due to the interesting biological activities of carbazoles, many efforts for their 
synthesis have been undertaken.
49,154
 The literature on carbazoles synthesis shows a variety of 
approaches. A representative classic method for the synthesis of carbazoles represent the 
Fischer-Borsche reaction, which relies on the dehydrogenation of 1,2,3,4-
tetrahydrocarbazoles.
155
 The Diels-Alder reaction of pyrano[3,4-b]indoles with alkynes also 
give a simple access to carbazole derivatives.
156
 In addition, carbazoles are available by 
metal-free cyclizations, for example, the deoxygenative cyclization of o-nitrobiphenyls in the 
presence of triethyl phosphate
157
 and the electrocyclization
158
 of 2,3-divinyl indoles. Knölker 
et al. reported an efficient method to construct carbazoles by iron-mediated oxidative 
cyclizations.
159
  In recent years, the synthesis of carbazoles based on palladium-catalyzed 
cyclizations has attracted much attention and a number of methods have been 
developed.
49,148,154,160,126b
 Nozaki et al. described Pd-catalyzed twofold C-N coupling 
reactions of biphenyls containing leaving groups located at C-2 and C-2´.
126b
 A one-pot 
tandem synthesis of carbazoles, based on Pd-catalyzed cross coupling reactions of 
iodoanilines with silylated aryl triflates, was reported by Larock and coworker.
161
 The group 
of Prof. Langer have reported the synthesis of carbazoles by domino ‘twofold Heck / 6π-
electrocyclization’ reactions of 2,3-dibromoindoles.85,162 Carbazoles have also been 
synthesized  by C-H activation reactions. For example, carbazoles are prepared by oxidative 
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Pd-catalyzed cyclizations of diaryl amines. The synthesis of carbazoles from aniline and 1,2-
dihalobenzene derivatives by application of a domino N-H/C-H activation strategy was 
developed by the group of Ackermann.
148
 
 
 
Figure 7.1. Structures of biscarbazoles 
 
Four different core structures of biscarbazoles linked by a carbon and a nitrogen atom are 
theoretically possible, which includes 3,9’- and 2,9’-biscarbazoles as most important 
subgroups (Figure 7.1). Biscarbazoles are present in natural products. For example, the 3,9’-
biscarbazole alkaloids Murastifoline A and B and the 2,9’-biscarbazole Murastifoline F were 
isolated from the plant species Murraya euchrestifolia and M. koenigii, which belong to the 
Rutaceae family (Figure 7.2).
154
 3,9’- and 2,9’-Biscarbazoles have been reported to possess a 
wide range of pharmacological properties.
49,126c,154,163
 In addition, 3,9’-biscarbazoles are also 
reported as potential molecules in material science, due to their photoemission properties.
164
 
Biscarbazoles BCz1 and BCz2 exhibit high quantum efficiencies along with low voltages and 
provide maximum brightness values (Figure 7.2).
165
 Previously, biscarbazoles preparation 
was based on methods developed for the synthesis of simple carbazoles.
1
 For example, 
Bringmann et al. described the total synthesis of Murastifoline F by oxidative dimerization of 
the readily available carbazole alkaloid Murrayafoline A.
163a
 In 2005, total synthesis of 
Murrastifoline A was reported by an efficient Pd-catalyzed reaction based on twofold C-N 
coupling of a 2,2’-dibromobiphenyl derivative with 3-aminocarbazole by the group of 
Chida.
126c,163b
 Very recently, Knölker et al. efficiently synthesized Murrastifoline using an 
Ullmann reaction of the mono-carbazol Murrayafoline A with a 3-bromocarbazole 
derivative.
163c
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Figure 7.2. Some natural products and materials containing a 3,9’-biscarbazole moiety 
 
Syntheses of 3,9’-biscarbazoles, despite their great usefulness and applicability, are not 
general. The syntheses are either complicated and require many synthetic steps or access to 
highly functionalized derivatives is difficult to achieve. In addition, some syntheses are 
limited by not readily available starting materials. The method of oxidative dimerization is 
limited to the production of dimers with identical substitution pattern. During my thesis, I 
developed a new and convenient strategy which can be applied to the synthesis of both 3,9’- 
and 2,9’-biscarbazoles. My strategy takes advantage of known palladium catalyzed C-N and 
C-C coupling reactions which were previously applied to the synthesis of simple carbazoles, 
but not for the synthesis of biscarbazoles.  
 
7.2 Results and Discussion 
The synthesis of carbazoles by twofold Pd catalyzed C-N coupling of 1,1'-biphenyl-2,2'-diyl 
bis(trifluoromethanesulfonate) (36) with anilines was described by Nozaki et al.
70a
 At the 
beginning, I was pleased to apply this methodology to the synthesis of biscarbazoles. The 
double C-N coupling reaction of 36 with p-diaminobenzene afforded carbazole 37, albeit, in 
only 34% yield (Scheme 7.1).  Unfortunately, all attempts to synthesize biscarbazole 38a 
using Ackermann´s method (i.e., the Pd-catalyzed domino C-N/C-C coupling reaction of 37 
with various 1,2-dihalobenzene derivatives) failed.  
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Scheme 7.1. Unsuccessful attempt for the synthesis of 3,9’-biscarbazole 38a  
 
In order to solve this problem, I had to change my strategy. The twofold C-N coupling of 
bistriflate 36 with anisidine, in the employment of Pd2(dba)3 and XantPhos as catalyst, 
afforded carbazole 39a in 95% yield (Scheme 7.2). Treatment of 39a with BBr3 gave 
demethylated product 40a. The hydroxyl group in 40a was converted into a triflate group in 
high yield by using trifluoromethanesulfonic anhydride. Afterwards, I attempted the synthesis 
of biscarbazole 38a by C-N coupling of 41a with 2-iodo-, 2-bromo and 2-chloro-1-
aminobenzene and subsequent cyclization by C-H activation.
160,166
 However, all these 
experiments were unsuccessful. Therefore, I decided to performed a Buchwald-Hartwig 
amination of 41a with aniline (C-N coupling). In the presence of Pd(OAc)2 combinating with 
XPhos, afforded intermediate A in a clean transformation. Subsequently, intermediate A was 
successfully transformed to the desired biscarbazole 38a by Pd-catalyzed oxidative 
intramolecular C-H activation (using air as the oxidant). The transformation of 41a to 38a 
could be successfully performed in a one-pot reaction which gave 86% yield.
167
 The 
employment of pivalic acid as the solvent proved to be important as employment of acetic 
acid resulted in a significant decrease of the yield to 61%.
52,168
 During the optimization, I 
studied the employment of several other oxidants, such as Cu(OAc)2 and Ag2O, but these 
reactions resulted in complex mixtures. Likewise, the simple uncatalyzed reaction of A with 
molecular oxygen under microwave conditions failed.  
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Scheme 7.2. Synthesis of 3,9’-biscarbazole 38a.  
Conditions: i, 4-anisidine (1.2 equiv.), Pd2(dba)3 (2.5 mol %), XantPhos (5 mol %), K3PO4 (2.8 equiv.), toluene, 
100 °C, 5 h; ii, 1) BBr3 (4.0 equiv.), CH2Cl2, -78 ºC to 20 °C, 2) H2O, NaHCO3; iii, pyridine, Tf2O, 0 °C; iv, 
aniline (1.1 equiv.), Pd(OAc)2 (5 mol%), XPhos (10 mol %), Cs2CO3 (1.5 equiv.), toluene, 110 
o
C, 6 h; v, 
Pd(OAc)2 (5 mol%), K2CO3 (1.0 equiv.), pivalic acid, 110 
o
C, air, 72 h. 
 
With the optimized conditions in hand, I studied the scope of substrates (Scheme 7.2). The 
reaction of 41a with different aniline derivatives afforded 3,9’-biscarbazoles 38a-e and 38g, 
38h and 38j in moderate to high yields. No clear correlation of the yields and the substitution 
pattern was observed. The employment of 4-hydroxyaniline and of 4-chloroaniline failed in 
this reaction (formation of complex mixtures). It is assumed that the interaction of the free 
hydroxyl group with the catalyst might be the reason for the failure. The failure of reaction 
with 4-chloroaniline is assumed by a competing oxidative addition and coupling reaction of 
the carbon atom attached to the chlorine atom, although, I cannot provide experimental 
evidence for this assumption.  
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Scheme 7.3. Structures of 3,9’-biscarbazoles 38b-j 
 
The structures of products were determined by spectroscopic methods. The structure of 38b 
was independently confirmed by X-ray crystal structure analysis (Figure 7.3).
169
 The two 
carbazole moieties are twisted out of plane, due to steric reasons. 
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Figure 7.3. Ortep plot of 38b 
 
With the successful strategy outlined above for the synthesis of 3,9’-biscarbazoles, I was 
interested in applying it this methodology to the synthesis of isomeric 2,9’-biscarbazoles. 
Firstly, carbazole 39b was obtained  in 95% yield by the Pd-catalyzed twofold C-N coupling 
of 36 with m-methoxyaniline (Scheme 7.4). Subsequently, the transformation of methoxy 
group in 39b into triflate group in 41b was produced via two steps in high yield. The reaction 
of 41b with aniline by Buchwald-Hartwig amination and subsequent oxidative Pd-catalyzed 
cyclization afforded 2,9’-biscarbazole 42a in 77% yield. I was also able to perform the 
reaction again in a one-pot process. The cyclization proceeded with excellent regioselectivity. 
Interestingly, regioisomeric product 42a’ was not observed as a side-product (NMR of the 
crude product). The reaction of 39b with different anilines gave 2,9’-biscarbazoles 42a-e and 
42g-j in moderate to good yields (except for 42i) (Scheme 7.4). No clear correlation of the 
substitution pattern and the yields of the products were observed. The structures of products 
were determined by spectroscopic methods. The structure of 42c was independently 
confirmed by X-ray crystal structure analysis (Figure 7.4).
170
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Scheme 7.4. Synthesis of 2,9’-biscarbazole 42a.  
Conditions: i, 3-anisidine (1.2 equiv.), Pd2(dba)3 (2.5 mol %), XantPhos (5 mol %), K3PO4 (2.8 equiv.), toluene, 
100 °C, 5 h; ii, 1) BBr3 (4.0 equiv.), CH2Cl2, -78 ºC to 20 ºC, 2) H2O, NaHCO3; iii, pyridine, Tf2O, 0 °C; iv, 
aniline (1.1 equiv.), Pd(OAc)2 (5 mol%), XPhos (10 mol %), Cs2CO3 (1.5 equiv.), toluene, 110 ºC, 6 h; v, 
Pd(OAc)2 (5 mol%), K2CO3 (1.0 equiv.), pivalic acid, 110 ºC, air, 72 h. 
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Scheme 7.5. Structures of 2,9’-biscarbazoles 42b-j 
 
 
Figure 7.4. Ortep plot of 42c 
 
7.3 Conclusions 
In conclusion, I developed a new and efficient strategy for the synthesis of 3,9’- and 2,9’-
biscarbazoles. My strategy bases on the cyclization of 1,1'-biphenyl-2,2'-diyl 
bis(trifluoromethanesulfonate) with 4- or 3-anisidine, transformation of the methoxy to a 
triflate group and subsequent oxidative Pd-catalyzed cyclization with different anilines. The 
strategy is highly efficient as it only requires four steps from simple starting materials and it 
can be applied to the synthesis of both 3,9’- and 2,9’-biscarbazoles. 
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APPENDIX 
8 Experimental section 
8.1 General Remarks 
The coupling reactions were carried out in pressure tubes or Schlenck flask under inert 
atmosphere (Argon 4.6). The back-filled technique was applied to exclude oxygen. The 
solvents for the reactions were purchased from Merck, Sigma Aldrich, Acros Organics. The 
solvents for column chromatography and reaction work-up were distilled prior use.  
 
8.2 Methods for Compound Characterization and Analysis 
8.2.1 Melting Points 
Micro heating table HMK 67/1825 Kuestner (Büchi apparatus); Melting points are 
uncorrected. 
8.2.2 Nuclear Magnetic Reasonance Spectroscopy (NMR) 
Bruker: AM 250, (62.9 MHz); Bruker: ARX 300, (75.4 MHz), Bruker: ARX 500, (125 
MHz). The chemical shifts are given in parts per million (ppm). Coupling constants are given 
in Hz.  
References for 
1
H NMR: TMS(δ = 0.00) or residual deuterated solvent (CDCl3 (δ = 7.26), 
C6D6  (δ = 7.16), (CD3)2CO (δ = 2.05), (CD3)2SO (δ = 2.50)), for 
13
C NMR TMS(δ = 0.00) or 
residual deuterated solvent (CDCl3 (δ = 77.16), C6D6  (δ = 128.06), (CD3)2CO (δ = 29.84; 
206.26), (CD3)2SO (δ = 39.52)) were taken as internal standard. The splitting pattern were 
characterized by s: singlet, d: doublet, t: triplet, q: quartet, quin: quintet, sex: sextet, m: 
multiplet. More complicate coupling peaks are represented by combinations of the respective 
symbol. For example, dt indicate to doublet of triplet. Distortionless enhancement 
polarization transfer (DEPT) spectra were taken to determine the types of carbon signals. 
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8.2.3 Mass Spectroscopy (MS) 
AMD MS40, Varian MAT CH 7, MAT 731 (EI, 70 eV), Intecta AMD 402 (EI, 70 eV and 
CI).  
8.2.4 High Resolution Mass Spectroscopy (HRMS) 
Finnigan MAT 95 or Varian MAT 311; Bruker FT CIR, AMD 402 (AMD Intectra). 
8.2.5 Infrared Spectroscopy (IR) 
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protege 460, Nicolet 360 Smart Orbit 
(ATR); KBr, KAP, Nujol, and ATR; Peaks were characterized with abbreviation: w = weak, 
m = medium, s = strong, br = broad 
8.2.6 X-ray Crystal Structure Analysis 
Bruker X8Apex diffractometer with CCD camera (Mo Kαradiation and graphite 
monochromator, λ= 0.71073 Å). The  structures  were  solved  by  direct methods  and  
refined  by  full-matrix  least-squares  procedures  on  F
2 
with  the  SHELXTL software 
package 
8.2.7 UV/Vis spectroscopy 
Lambda 5 (Perkin Elmer) and Analytic Jena Specord 50 UV/VIS spectrometer in acetonitril.  
8.2.8 Fluorescence  spectroscopy 
Fluoromax4P-0759D-0311-FM. The samples were dissolved in acetonitrile. The quinine 
hemisulfate salt monohydrate in 0.05M H2SO4 which has a fluorescence yield of 0.52, was 
used as standard for the fluorescent quantum yield determination.   
8.2.9 Electrochemical properties 
Cyclic Voltammetry (CV) and Differential Pulse Voltammetry (DPV) measurement were 
performed by mean of µAutolab III potentiostat (Ecochemie, Utrecht, The Netherlands in 
three different concentrations (1 x 10
-3
; 3 x 10
-3
; 6 x 10
-3
 mol·L
-1
) in DMF. All potentials 
were calibrated with the ferrocene/ferrocenium couple (Fc/Fc
+
) as internal standard. The 
formal potential of Fc/Fc
+
 vs. vacuum was assumed to be -4.8 eV. 
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8.3 Chromatographic Methods 
8.3.1 Thin Layer Chromatography (TLC) 
Merck Silica 60 F254 on aluminum aluminum foil from Macherey-Nagel. Detection under 
UV light at 254 nm and/or 365 nm of wavelength and visualize by dipping in TLC stains 
solution including conc. H2SO4/vaniline, Cerium-ammonium-molybdate (CAM), ceric sulfate 
and dragendorff reagent. 
8.3.2 Column  chromatography 
Column chromatography was performed over Merck silica gel (63-200 µm) as nomal column 
and (40-63 µm) as flash column. All the solvent were distilled prior of use.  
 
8.4 Computational Methods 
DFT calculations were performed with the Gaussian 09Revision C.01.
171
 The 
visualization of the results was performed with GaussView. The geometries of indolo[2,3-
b]quinoxalines were optimized using the hybrid functional B3LYP method, which 
consists of Becke’s three-parameter172 (B3) hybrid exchange functional in conjunction 
with the correlation functional of LeeYang and Parr (LYP)
173
 method using 6-31G* basis 
set.
174
 The B3LYP/6-31G* method of DFT has been reliable for the prediction of 
geometric and electronic properties of neutral
135a
 and charged species
175
 ranging from 
simple molecular to polymer structures
176
. Frequency calculations were performed at the 
same method in order to confirm these structures as true minima (absence of an imaginary 
frequency). Molecular orbital calculations are also performed at the B3LYP/6-31G* level 
of theory.   
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8.5 General Procedures and spectroscopic data 
8.5.1 Synthesis of thieno[3,2-b:4,5-b’]diindoles and Benzothieno[3,2-b]indoles  
General procedure 1 for preparation of 3,4-dibromo-2,5-di-(2-bromophenyl)thiophene  7. 
 
2,3,4,5-Tetrabromothiophene (1.00 g, 2.5 mmol), (2-bromophenyl)boronic acid (1.10 g, 5.5 
mmol) and Pd(PPh3)4 (5 mol%, 144 mg, 125 μmol) were dissolved in 1,4-dioxane (40 mL) 
under argon atmosphere. Then, a degassed aqueous solution of 2M Na2CO3 (10 mL) was 
added. The reaction mixture was heated under reflux for 6 h. The solvent was removed in 
vacuo. The residue was extracted with dichloromethane and water. The organic layer was 
dried over MgSO4, filtered, and the solvent was evaporated. The yellow residue was purified 
by column chromatography (silica gel, heptane) to give 7 as a white solid (1.26 g, 91%); mp 
132 C; 1H NMR (250 MHz, CDCl3) δ = 7.68 – 7.59 (m, 2H), 7.41 – 7.16 (m, 6H); 
13
C NMR 
(63 MHz, CDCl3) δ = 137.6, 133.6, 133.1, 132.6, 130.8, 127.3, 124.8, 114.2; IR (ATR, cm
-1
): 
ν = 602 (m), 627 (m), 648 (s), 673 (m), 708 (m), 731 (s), 739 (vs), 985 (m), 1026 (m), 1055 
(m), 1284 (m), 1417 (m), 1431 (m), 1456 (m), 3055 (w); GC-MS (EI, 70 eV): m/z (%) = 552 
(100), 392 (67), 232 (68), 187 (37), 116 (35); HRMS (EI): calcd. for C16H8Br4S ([M]
+
): 
547.70747; found: 547.708302; calcd. for C16H8Br3
81
BrS ([M]
+
): 549.70543; found: 
549.705972; calcd. for C16H8Br2
81
Br2S ([M]
+
): 553.70133; found: 553.701289; calcd. for 
C16H8
81
Br4S ([M]
+
): 555.69929; found: 555.699282. 
3-bromo-2-(2-bromophenyl)benzo[b]thiophene 11 was prepared 
following general procedure 1. 2,3-Dibromobenzo[b]thiophene (500 
mg, 1.7 mmol), 2-bromophenyl boronic acid (412.6 mg, 2.0 mmol) and 
(5 mol%) Pd(PPh3)4 (99 mg, 85 μmol) were dissolved in 1,4-dioxane (30 mL) under argon 
atmosphere. Then, a degassed aqueous solution of 2M Na2CO3 (7 mL) was added. The 
reaction mixture was heated under reflux for 6 hrs. The solvent was removed in vacuo. The 
residue was extracted with dichloromethane and water. The organic layer was dried over 
MgSO4, filtered, and the solvent was evaporated. The yellow residue was purified by column 
chromatography (silica gel, heptane) to give 11 as white solid (592 mg, 94 %); mp 76-78 C; 
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1
H NMR (300 MHz, CDCl3) δ = 7.83 – 7.73 (m, 2H), 7.65 (dd, J = 7.9, 0.8 Hz, 1H), 7.46 – 
7.21 (m, 5H); 
13
C NMR (75 MHz, CDCl3) δ = 138.4, 137.9, 137.3, 134.1, 133.0, 132.5, 
130.6, 127.2, 125.7, 125.2, 124.6, 123.6, 122.3, 108.5; IR (ATR, cm
-1): ν = 559  (w), 602 (m), 
625 (m), 648 (s), 671 (m), 708 (m), 731 (s), 742 (vs), 856 (m), 872 (m), 943 (m), 984 (m), 
1026 (s), 1053 (m), 1119 (w), 1161 (w), 1228 (m), 1261 (m), 1284 (m), 1302 (m), 1417 (m), 
1431 (m), 1456 (s), 1560 (w), 1562 (m), 1587 -(w), 1888 (w), 1925 (w), 1957 (w), 3055 (m), 
3109 (w); GC-MS (EI, 70 eV): m/z (%) = 368 (87), 208 (100), 163 (25), 104 (23); HRMS 
(EI): calcd. for C14H8Br2S ([M]
+
): 365.87080; found: 365.87074; calcd. for C14H8Br
81
BrS 
([M]
+
): 367.86875; found: 367.86875; calcd. for C14H8
81
Br2S ([M]
+
): 369.86670; found: 
369.86651. 
General procedure 2 for double C-N coupling with aniline derivatives, exemplified by: 
5,6-diphenyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2a 
 
Sodium tert-butoxide (105 mg, 1.1 mmol) was added to a pressure tube charged with 
Pd2(dba)3 (16.7 mg, 0.02 mmol) and ligand PtBu3·HBF4 (5.3 mg, 0.2 mmol) under argon 
atmosphere. Compound 7 (100 mg, 0.18 mmol) and aniline (0.1 mL, 1.1 mmol) were added 
to the mixture and the tube was backfilled with argon several times. The mixture was stirred 
at 120 °C in anhydrous toluene (5 mL) for 14 hours. After cooling, the reaction mixture was 
diluted with dichloromethane (5 mL), filtered through a celite pad, and washed with 
dichloromethane (20 mL). The filtrate was concentrated in vacuo. The product was purified 
by flash chromatography (silica gel, dichloromethane/heptane = 1:10) to yield  2a (63 mg, 
84%) as white crystals; mp 266 C; 1H NMR (300 MHz, CDCl3) δ = 7.76 – 7.67 (m, 2H), 
7.22 – 7.03 (m, 10H), 6.99 – 6.92 (m, 6H); 13C NMR (75 MHz, CDCl3) δ = 142.3, 138.9, 
130.2, 129.0, 127.2, 126.5, 123.3, 123.0, 121.6, 120.7, 118.2, 111.3. IR (ATR, cm
-1
): ν = 
565(m), 615 (m), 660 (s), 677 (s), 690 (vs), 729 (vs), 744 (s), 760 (m), 810 (m), 835 (m), 849 
(m), 903 (m), 926 (m), 962 (m), 1003 (m), 1014 (m), 1072 (m), 1115 (m), 1149 (m), 1159 
(m), 1215 (m), 1290 (s), 1308 (s), 1323 (s), 1363 (m), 1385 (m), 1450 (s), 1495 (m), 1516 
(m), 1593 (m), 1878 (w), 1886 (w), 1915 (w), 1942 (w), 1963 (w), 3034 (w), 3057 (w); GC-
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MS (EI, 70 eV): m/z (%) = 414 (100), 308 (5), 207 (11); HRMS (EI): calcd. for C28H18N2S 
([M]
+
): 414.11852; found: 414.118357. 
5,6-Bis(4-methoxyphenyl)-5,6-dihydrothieno[3,2-b:4,5-
b']diindole 2b was prepared following general procedure 2 using 
compound 7 (100 mg, 0.18 mmol) and 4-methoxyaniline (135 mg, 
1.1 mmol). The product was purified by flash chromatography 
(slica gel, ethylacetate/heptane = 1:10) to yield 2b (81 mg, 94 %) 
as white crystals; mp 251 C; 1H NMR (250 MHz, CDCl3) δ = 
7.88 – 7.56 (m, 2H), 7.20 – 7.01 (m, 6H), 7.00 – 6.88 (m, 4H), 6.56 – 6.39 (m, 4H), 3.75 (s, 
6H); 
13
C NMR (63 MHz, CDCl3) δ = 158.3, 142.6, 131.6, 130.6, 128.3, 122.9, 122.7, 120.7, 
120.3, 118.0, 114.2, 111.2, 55.1; IR (ATR, cm
-1): ν = 563 (m), 580 (s), 592 (m), 650 (m), 658 
(w), 741 (vs), 746 (s), 812 (s), 835 (s), 1014 (m), 1030 (s), 1105 (m), 1169 (m), 1182 (m), 
1225 (m), 1250 (vs), 1290 (m), 1300 (m), 1327 (m), 1362 (w), 1406 (w), 1444 (m), 1456 (m), 
1510 (s), 1529 (s), 1606 (w), 1873 (vw), 1894 (vw), 1934 (vw), 2839 (w), 2914 (w), 2964 
(w), 2995 (w), 3016 (w), 3047 (w); GC-MS (EI, 70 eV): m/z (%) = 474 (100), 458 (8), 237 
(6); HRMS (EI): calcd. for C30H22O2N2S ([M]
+
): 474.13965; found: 474.139083. 
5,6-Di-p-tolyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2c was 
prepared following general procedure 2 using compound 7 (100 
mg, 0.18 mmol) and 4-methylaniline (117 mg, 1.1 mmol). The 
product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:10) to yield   2c (73 mg, 92 %) as 
white crystals; mp 211-213 C; 1H NMR (250 MHz, CDCl3) δ = 7.78 – 7.65 (m, 2H), 7.22 – 
7.08 (m, 6H), 6.98 – 6.86 (m, 4H), 6.77 (d, J = 8.0 Hz, 4H), 2.25 (s, 6H); 13C NMR (63 MHz, 
CDCl3) δ = 142.4, 136.7, 136.3, 130.4, 129.5, 126.6, 123.1, 122.7, 121.1, 120.4, 118.1, 111.3, 
21.1; IR (ATR, cm
-1): ν = 559 (m), 586 (m), 640 (m), 658 (m), 681 (m), 710 (s), 729 (vs), 806 
(s), 831 (m), 964 (m), 1001 (m), 1016 (m), 1107 (m), 1213 (s), 1321 (s), 1389 (s), 1450 (s), 
1506 (s), 1514 (s), 1605 (w), 1867 (w), 1878 (w), 1905 (w), 2351 (w), 2727 (w), 2856 (m), 
2918 (m), 3030 (m), 3053 (w); GC-MS (EI, 70 eV): m/z (%) = 442 (100), 221 (10); HRMS 
(EI): calcd. for C30H22N2S ([M]
+
): 442.14982; found: 442.149965. 
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5,6-Bis(3,5-dimethylphenyl)-5,6-dihydrothieno[3,2-b:4,5-
b']diindole 2d was prepared following general procedure 2 
using compound 7 (100 mg, 0.18 mmol) and 3,5-
dimethylaniline (0.14 mL, 1.1 mmol). The product was 
purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:10) to yield the indole 2d (77 mg, 91 %) as white crystals; mp 
258-260 C; 1H NMR (300 MHz, CDCl3) δ = 7.77 – 7.63 (m, 2H), 7.26 (dd, J = 6.8, 2.0 Hz, 
2H), 7.20 – 7.05 (m, 4H), 6.73 (s, 4H), 6.56 (s, 2H), 2.10 (s, 12H); 13C NMR (75 MHz, 
CDCl3) δ = 142.3, 139.0, 138.4, 130.3, 128.5, 123.8, 123.4, 122.8, 121.4, 120.6, 118.2, 111.4, 
21.2; IR (ATR, cm
-1): ν = 544 (m), 650 (m), 685 (s), 725 (vs), 729 (vs), 744 (s), 827 (m), 839 
(s), 1012 (m), 1036 (m), 1115 (m), 1219 (m), 1284 (m), 1298 (m), 1323 (s), 1377 (m), 1392 
(m), 1454 (s), 1464 (m), 1525 (m), 1593 (m), 1867 (vw), 1907 (vw), 1934 (vw), 2854 (w), 
2912 (w), 2943 (w), 3030 (w), 3049 (w); GC-MS (EI, 70 eV): m/z (%) = 470 (100), 235 (7); 
HRMS (EI): calcd. for C32H26N2S ([M]
+
): 470.18112; found: 470.181420. 
5,6-Bis(3,5-dimethoxyphenyl)-5,6-dihydrothieno[3,2-
b:4,5-b']diindole  2e was prepared following general 
procedure 2 using compound 7 (100 mg, 0.18 mmol) and 
3,5-dimethoxyaniline (167 mg, 1.1 mmol). The product was 
purified by flash chromatography (silica gel, 
ethylacetate/heptane = 1:5) to yield 2e (93 mg, 97 %) as 
white crystals; mp 232 C; 1H NMR (500 MHz, CDCl3) δ = 7.75 – 7.66 (m, 2H), 7.30 (dd, J 
= 7.0, 1.8 Hz, 2H), 7.19 – 7.09 (m, 4H), 6.31 (d, J = 2.3 Hz, 4H), 6.09 (t, J = 2.3 Hz, 2H), 
3.64 (s, 12H); 
13
C NMR (126 MHz, CDCl3) δ = 160.6, 141.9, 140.8, 130.0, 123.2, 123.0, 
121.4, 120.7, 118.2, 111.5, 104.8, 99.8, 55.0; IR (ATR, cm
-1): ν = 534 (m), 634 (m), 656 (m), 
663 (m), 681 (s), 704 (m), 731 (s), 744 (vs), 814 (m), 825 (s), 849 (m), 877 (m), 928 (m), 970 
(m), 987 (w), 1012 (m), 1038 (s), 1063 (s), 1155 (s), 1198 (s), 1203 (s), 1286 (s), 1319 (m), 
1358 (m), 1371 (m), 1431 (m), 1452 (s), 1477 (m), 1529 (m), 1593 (s), 1842 (vw), 1859 (vw), 
1894 (vw), 1932 (vw), 2897 (w), 2935 (w), 2953 (w), 2993 (w), 3012 (w), 3049 (w); GC-MS 
(EI, 70 eV): m/z (%) = 534 (100), 267 (4); HRMS (EI): calcd. for C32H26O4N2S ([M]
+
): 
534.16078; found: 534.160294. 
 
General procedures and spectroscopic data  98 
 
 
5,6-Bis(3,4,5-trimethoxyphenyl)-5,6-dihydrothieno[3,2-
b:4,5-b']diindole 2f was prepared following general 
procedure 2 using 7 (100 mg, 0.18 mmol) and 3,4,5-
trimethoxyaniline (201 mg, 1.1 mmol). The product was 
separated via flash chromatography (elutant: 20 % 
ethylacetate – heptane) to yield  2f (99 mg, 92 %) as white 
crystals; mp 214-217 C; 1H NMR (500 MHz, CDCl3) δ = 7.72 (dd, J = 6.0, 2.6 Hz, 2H), 7.31 
(dd, J = 6.3, 2.7 Hz, 2H), 7.21-7.15 (m, 4H), 6.37 (s, 4H), 3.76 (s, 6H), 3.68 (s, 12H). 
13
C 
NMR (126 MHz, CDCl3) δ = 152.9, 142.6, 136.6, 134.9, 130.2, 123.4, 123.2, 121.8, 121.0, 
118.4, 111.4, 103.8, 60.8, 55.9; IR (ATR, cm
-1): ν = 567 (m), 611 (m), 627 (m), 656 (m), 667 
(m), 677 (m), 698 (s), 715 (s), 729 (vs), 771 (m), 829 (m), 910 (m), 999 (s), 1080 (m), 1124 
(vs), 1225 (s), 1290 (s), 1323 (m), 1371 (m), 1417 (s), 1433 (m), 1454 (s), 1504 (s), 1591 (s), 
1842 (vw), 1905 (vw), 2835 (w), 2931 (w), 2951 (w), 2995 (w), 3051 (w); GC-MS (EI, 70 
eV): m/z (%) = 594 (100), 297 (15), 69 (16); HRMS (EI): calcd. for C34H30O6N2S ([M]
+
): 
594.18191; found: 594.182214. 
5,6-Bis(4-fluorophenyl)-5,6-dihydrothieno[3,2-b:4,5-b']diindole 
2g was prepared following general procedure 2 using compound 7 
(100 mg, 0.18 mmol) and 4-fluoroaniline (0.104 mL, 1.1 mmol). 
The product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:10) to yield  2g (77 mg, 95 %) as 
white crystals; mp 298-230 C; 1H NMR (500 MHz, CDCl3) δ = 
7.72 (d, J = 6.9 Hz, 2H), 7.18-7.01 (m, 10H), 6.75 (t, J = 8.5 Hz, 4H); 
13
C NMR (75 MHz, 
CDCl3) δ = 161.5 (d, J = 247.8 Hz), 142.5, 135.0, 130.2, 128.7 (d, J = 8.7 Hz), 123.2, 121.7, 
120.9, 118.3, 116.0 (d, J = 22.8 Hz), 111.1.
19
F NMR (282 MHz, CDCl3) δ = 114.11; IR 
(ATR, cm
-1): ν = 569 (s), 586 (m), 644 (m), 712 (s), 733 (v), (s), 758 (m), 779 (m), 818 (s), 
837 (m), 847 (m), 1001 (m), 1007 (m), 1011 (m), 1092 (m), 1113 (m), 1151 (s), 1209 (s), 
1225 (s), 1267 (m), 1300 (m), 1323 (s), 1367 (m), 1392 (m), 1452 (m), 1506 (s), 1533 (m), 
1606 (w), 1882 (w), 3064 (w), 3115 (w); GC-MS (EI, 70 eV): m/z (%) = 450 (100), 225 (9), 
60 (6); 43 (6);  HRMS (EI): calcd. for C28H16N2F2S ([M]
+
): 450.09968; found: 450.09984. 
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5,6-Bis(4-chlorophenyl)-5,6-dihydrothieno[3,2-b:4,5-b']diindole 
2h was prepared following general procedure 2 using compound 7 
(100 mg, 0.18 mmol) and 4-chloroaniline (140 mg, 1.1 mmol). The 
product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:10) to yield  2h (75 mg, 86 %) as 
white crystals; mp 308 C; 1H NMR (250 MHz, CDCl3) δ = 7.76 – 
7.68 (m, 2H), 7.24 – 7.10 (m, 6H), 7.08 – 6.96 (m, 8H); 13C NMR (63 MHz, CDCl3) δ = 
142.20, 137.53, 133.48, 129.87, 129.33, 128.00, 123.35, 122.13, 121.11, 118.42, 111.09; IR 
(ATR, cm
-1): ν = 569 (m), 615 (w), 634 (w), 652 (w), 679 (m), 723 (m), 737 (vs), 798 (s), 839 
(s), 1014 (m), 1090 (s), 1221 (m), 1269 (m), 1286 (m), 1302 (m), 1323 (s), 1390 (s), 1454 (s), 
1493 (s), 1520 (m), 1591 (w), 1890 (vw), 1900 (vw), 2322 (vw), 2351 (vw), 3053 (w), 3091 
(w); GC-MS (EI, 70 eV): m/z (%) = 482 (100), 335 (7), 241 (10), 205 (9); HRMS (EI): calcd. 
for C28H16N2Cl2S ([M]
+
): 482.04058; found: 482.040632; calcd. for C28H16N2Cl
37
ClS ([M]
+
): 
484.03763; found: 484.038435; calcd. for C28H16N2
37
Cl2S ([M]
+
): 486.03468; found: 
486.034440. 
5,6-Bis(4-(tert-butyl)phenyl)-5,6-dihydrothieno[3,2-b:4,5-
b']diindole 2i was prepared following general procedure 2 using 
compound 7 (100 mg, 0.18 mmol) and 4-(tert-butyl)aniline (0.17 
mL, 1.1 mmol). The product was purified by flash chromatography 
(silica gel, dichloromethane/heptane = 1:10) to yield  2i (83 mg, 87 
%) as white crystals; mp 287 C; 1H NMR (250 MHz, CDCl3) δ = 
7.73 – 7.67 (m, 2H), 7.22 – 7.05 (m, 6H), 7.05 – 6.98 (m, 4H), 6.95 – 6.89 (m, 4H), 1.21 (s, 
18H).
13
C NMR (63 MHz, CDCl3) δ = 149.2, 144.0, 136.9, 131.4, 125.7, 125.6, 124.1, 122.9, 
122.2, 120.9, 118.3, 111.8, 34.4, 31.3; IR (ATR, cm
-1): ν = 544 (s), 557 (m), 573 (m), 584 
(m), 625 (w), 640 (w), 658 (w), 688 (m), 708 (m), 733 (vs), 800 (m), 839 (m), 922 (w), 958 
(w), 995 (m), 1014 (m), 1109 (m), 1194 (m), 1221 (m), 1265 (m), 1279 (m), 1290 (m), 1313 
(s), 1362 (m), 1402 (m), 1450 (m), 1512 (s), 1547 (m), 1574 (w), 1601 (w), 1842 (vw), 1900 
(vw), 2864 (w), 2901 (w), 2928 (w), 2958 (m), 3036 (w), 3053 (w); GC-MS (EI, 70 eV): m/z 
(%) = 526 (100), 494 (13), 454 (15); HRMS (EI): calcd. for C36H34N2S ([M]
+
): 526.24372; 
found: 526.243665. 
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5,6-Bis(3-(trifluoromethyl)phenyl)-5,6-dihydrothieno[3,2-b:4,5-
b']diindole 2j was prepared following general procedure 2 using 
compound 7 (100 mg, 0.18 mmol) and 3-(trifluoromethyl)aniline 
(0.14 mL, 1.1 mmol). The product was purified by flash 
chromatography (silica gel, dichloromethane/heptane = 1:10) to 
yield  2j (88 mg, 89 %) as white crystals; mp 203-205 C; 1H NMR (250 MHz, CDCl3) δ = 
7.76 – 7.68 (m, 2H), 7.36 (s, 2H), 7.33 – 7.26 (m, 2H), 7.25 – 7.08 (m, 10H); 13C NMR (75 
MHz, CDCl3) δ = 142.3, 139.8, 131.5 (q, J = 33.0 Hz), 130.1, 129.6, 129.5, 124.0 (q, J = 2.0 
Hz), 123.7, 123.3 (q, J = 272.5 Hz), 123.2 (q, J = 1.6 Hz),123.1, 121.6, 118.6, 110.9.
19
F 
NMR (282 MHz, CDCl3) δ = 62.73; IR (ATR, cm
-1): ν = 563 (m), 619 (m), 658 (s), 675 (s), 
700 (v), (s), 735 (v), (s), 798 (s), 843 (w), 899 (m), 1011 (m), 1051 (s), 1068 (s), 1093 (s), 
1117 (v), (s), 1165 (s), 1219 (m), 1263 (s), 1302 (s), 1317 (s), 1335 (s), 1392 (m), 1454 (s), 
1495 (m), 1525 (w), 1593 (w), 1886 (v), (w), 1929 (v), (w), 3032 (w), 3055 (w); GC-MS (EI, 
70 eV): m/z (%) = 550 (100), 275 (14); HRMS (EI): calcd. for C30H16N2F6S ([M]
+
): 
550.09329; found: 550.093522. 
4,4'-(Thieno[3,2-b:4,5-b']diindole-5,6-diyl)bis(N,N-
diethylaniline) 2k was prepared following general procedure 2 
using compound 7 (100 mg, 0.18 mmol) and N
1
,N
1
-
diethylbenzene-1,4-diamine (0.18 mL, 1.1 mmol). The product 
was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:2) to yield  2k (60 mg, 60 %) as 
white crystals; mp 256 C; 1H NMR (300 MHz, CDCl3) δ = 7.68 (dd, J = 6.9, 1.6 Hz, 2H), 
7.17 – 7.01 (m, 6H), 6.81 (d, J = 8.9 Hz, 4H), 6.21 (d, J = 8.9 Hz, 4H), 3.22 (q, J = 7.0 Hz, 
8H), 1.09 (t, J = 7.0 Hz, 12H).
13
C NMR (75 MHz, CDCl3) δ = 146.6, 143.3, 131.3, 127.9, 
126.8, 122.9, 122.3, 119.9, 117.8, 111.7, 111.3, 44.3, 12.8; IR (ATR, cm
-1): ν = 565 (m), 580 
(m), 617 (m), 636 (m), 644 (m), 652 (m), 727 (s), 744 (vs), 787 (s), 798 (s), 822 (m), 1009 
(s), 1080 (s), 1159 (m), 1184 (s), 1198 (s), 1267 (s), 1323 (s), 1352 (s), 1375 (s), 1387 (s), 
1408 (m), 1450 (s), 1516 (vs), 1608 (m), 1842 (w), 1857 (w), 1888 (w), 1932 (w), 2868 (m), 
2891 (m), 2928 (m), 2966 (m), 3024 (w), 3047 (w), 3076 (w); GC-MS (EI, 70 eV): m/z (%) = 
556 (100), 512 (8), 97 (11), 83 (11), 57 (19); HRMS (EI): calcd. for C36H36N4S ([M]
+
): 
556.26552; found: 556.264565. 
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5,6-Bis(2,3-dihydro-1H-inden-5-yl)-5,6-dihydrothieno[3,2-b:4,5-
b']diindole 2l was prepared following general procedure 2 using 
compound 7 (100 mg, 0.18 mmol) and 2,3-dihydro-1H-inden-5-
amine (145 mg, 1.1 mmol). The product was purified by flash 
chromatography (silica gel, dichloromethane/heptane = 1:10) to 
yield  2l (81 mg, 91%) as white crystals; mp 246 C; 1H NMR 
(300 MHz, CDCl3) δ = 7.75 – 7.64 (m, 2H), 7.31 – 7.19 (m, 2H), 7.17 – 7.05 (m, 4H), 7.02 – 
6.75 (m, 6H), 2.71 (t, J = 7.3 Hz, 4H), 2.58 (s, 4H), 1.94 (p, J = 7.5 Hz, 4H); 
13
C NMR (75 
MHz, CDCl3) δ = 145.0, 142.5, 142.3, 137.3, 130.4, 124.0, 123.9, 123.3, 122.8, 122.4, 121.2, 
120.5, 118.1, 111.4, 32.6, 32.5, 25.3; IR (ATR, cm
-1): ν = 542 (m), 575 (m), 619 (m), 690 
(m), 729 (vs), 781 (m), 820 (m), 918 (m), 1009 (m), 1115 (m), 1155 (m), 1215 (m), 1296 (m), 
1321 (s), 1363 (m), 1390 (m), 1435 (m), 1452 (s), 1489 (m), 1520 (m), 1583 (w), 1605 (w), 
1867 (w), 1888 (w), 2839 (w), 2929 (w), 3014 (w), 3043 (w); GC-MS (EI, 70 eV): m/z (%) = 
494 (100), 464 (20); HRMS (EI): calcd. for C34H26N2S ([M]
+
): 494.18112; found: 
494.180637. 
5,6-Bis(4-(methylthio)phenyl)-5,6-dihydrothieno[3,2-b:4,5-
b']diindole 2m was prepared following general procedure 2 using 
compound 7 (100 mg, 0.18 mmol) and 4-(methylthio)aniline (0.14 
mL, 1.1 mmol). The product was purified by flash chromatography 
(silica gel, ethylacetate/heptane = 1:10) to yield  2m (82 mg, 90 %) 
as white crystals; mp 262 C; 1H NMR (300 MHz, CDCl3) δ = 
7.75 – 7.66 (m, 2H), 7.22 – 7.07 (m, 6H), 7.01 – 6.90 (m, 4H), 6.90 – 6.80 (m, 4H), 2.47 (s, 
6H); 
13
C NMR (75 MHz, CDCl3) δ = 142.5, 137.9, 135.7, 130.2, 127.2, 126.3, 123.2, 123.0, 
121.5, 120.7, 118.2, 111.3, 15.6; IR (ATR, cm
-1): ν = 569 (m), 638 (m), 648 (m), 692 (m), 
717 (s), 739 (vs), 795 (s), 835 (m), 918 (w), 958 (m), 1014 (m), 1095 (m), 1151 (w), 1176 
(m), 1217 (m), 1292 (m), 1304 (m), 1319 (m), 1392 (s), 1454 (m), 1495 (s), 1531 (m), 1842 
(vw), 1878 (vw), 2848 (w), 2918 (w), 2951 (w), 3047 (w); GC-MS (EI, 70 eV): m/z (%) = 
506 (100), 458 (11); HRMS (EI): calcd. for C30H22N2S3 ([M]
+
): 506.09396; found: 
506.09362. 
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General procedure 3 for double C-N coupling with aniline derivatives, exemplified by: 
5,6-dipropyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2n 
 
Sodium tert-butoxide (105 mg, 1.1 mmol) was added to a pressure tube charged with 
Pd2(dba)3 (16.7 mg, 0.02 mmol) and BINAP (5.7 mg, 0.009 mmol) under argon atmosphere. 
Compound 7 (100 mg, 0.18 mmol) and n-propylamine (0.09 mL, 1.1 mmol) were added to 
this mixture and the tube was backfilled with argon several times. The mixture was heated at 
120 °C in anhydrous toluene (5 mL) for 14 hours. After cooling, the reaction mixture was 
diluted with dichloromethane (5 mL), filtered through a celite pad, and washed with 
dichloromethane (20 mL). The filtrate was concentrated in vacuo. The product was purified 
by flash chromatography (silica gel, dichloromethane/heptane = 1:10) to yield 2n (29 mg, 
46%) as white crystals; mp 162-164 C; 1H NMR (300 MHz, CDCl3) δ = 7.67 (d, J = 7.7 Hz, 
2H), 7.37 (d, J = 8.3 Hz, 2H), 7.30 – 7.03 (m, 4H), 4.49 – 4.31 (t, J = 7.7 Hz, 4H), 2.00 – 
1.80 (m, 4H), 0.94 (t, J = 7.4 Hz, 6H); 
13
C NMR (63 MHz, CDCl3) δ = 141.1, 130.1, 123.0, 
122.3, 119.9, 119.6, 118.3, 110.1, 47.9, 23.9, 11.3; IR (ATR, cm
-1): ν = 563 (m), 615 (m), 
658 (m), 723 (vs), 812 (m), 845 (w), 881 (m), 897 (m), 974 (m), 1012 (m), 1111 (m), 1153 
(m), 1292 (m), 1319 (m), 1367 (m), 1381 (m), 1456 (m), 1520 (w), 1867 (vw), 1915 (vw), 
2850 (w), 2872 (w), 2924 (m), 2953 (w); GC-MS (EI, 70 eV): m/z (%) =  346 (100), 317 
(14), 275 (17); HRMS (EI): calcd. for C22H22N2S ([M]
+
): 346.14982; found: 346.15023. 
5,6-Dipentyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2o was 
prepared following general procedure 3 using compound 7 (100 
mg, 0.18 mmol) and n-pentylamine (0.13 ml, 1.1 mmol). The 
product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:10) to yield  2o (33 mg, 45 %) as 
white crystals; mp 105-107 C; 1H NMR (300 MHz, CDCl3) δ = 
7.71 – 7.61 (m, 2H), 7.36 (d, J = 8.3 Hz, 2H), 7.18 (m, 4H), 4.41 (t, J = 7.8 Hz, 4H), 1.94 – 
1.75 (m, 4H), 1.38 – 1.20 (m, 8H), 0.82 (t, J = 7.0 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ = 
141.1, 130.1, 123.0, 122.3, 119.9, 119.6, 118.3, 110.1, 46.4, 30.4, 29.2, 22.5, 13.9; IR (ATR, 
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cm
-1): ν = 565 (w), 586 (w), 609 (m), 617 (m), 654 (m), 690 (m), 731 (vs), 916 (w), 976 (w), 
1014 (m), 1111 (m), 1138 (m), 1155 (m), 1173 (m), 1232 (m), 1321 (s), 1362 (m), 1377 (m), 
1387 (m), 1456 (s), 1471 (m), 1520 (m), 1606 (w), 1747 (vw), 1790 (vw), 1834 (vw), 1867 
(vw), 1907 (vw), 2858 (m), 2866 (m), 2922 (m), 2949 (m), 3026 (vw), 3055 (w), 3078 (vw); 
GC-MS (EI, 70 eV): m/z (%) =  402 (100), 275 (15); HRMS (EI): calcd. for C26H30N2S 
([M]
+
): 402.21242; found: 402.21232. 
5,6-Diheptyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2p was 
prepared following general procedure 3 using compound 7 (100 
mg, 0.18 mmol) and n-heptylamine (0.16 mL, 1.1 mmol). The 
product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:10) to yield 2p (37 mg, 45 %) as 
white crystals; mp 127-129 C; 1H NMR (250 MHz, CDCl3) δ = 
7.66 (d, J = 7.2 Hz, 2H), 7.35 (d, J = 8.2 Hz, 2H), 7.29 – 7.06 (m, 
4H), 4.40 (t, J = 7.9 Hz, 4H), 1.96 – 1.68 (m, 4H), 1.41 – 1.02 (m, 16H), 0.79 (t, J = 6.7 Hz, 
6H); 
13
C NMR (63 MHz, CDCl3) δ = 141.1, 130.1, 123.0, 122.3, 119.9, 119.6, 118.3, 110.1, 
46.5, 31.6, 30.7, 29.0, 27.0, 22.5, 14.0; IR (ATR, cm
-1): ν = 550 (vw), 567 (w), 588 (w), 609 
(w), 621 (w), 656 (w), 729 (vs), 756 (m), 808 (w), 837 (w), 916 (w), 970 (w), 1012 (m), 1115 
(m), 1157 (m), 1169 (m), 1221 (m), 1321 (s), 1373 (m), 1389 (m), 1458 (s), 1471 (m), 1522 
(w), 1608 (w), 1790 (vw), 1830 (vw), 1867 (vw), 1907 (vw), 2852 (m), 2922 (s), 2947 (m), 
3030 (vw), 3057 (w), 3074 (vw); GC-MS (EI, 70 eV): m/z (%) = 458 (100), 275 (16); HRMS 
(ESI): calcd. for C30H39N2S ([M + H]
+
): 459.28285; found: 459.28189. 
5,6-Diphenethyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2q was 
prepared following general procedure 3 using compound 7 (100 
mg, 0.18 mmol) and 2-phenylethanamine (0.14 mL, 1.1 mmol). 
The product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:7) to yield 2q (53 mg, 62 %) as dark 
brown crystals; mp 141 C; 1H NMR (300 MHz, CDCl3) δ = 7.68 
(dd, J = 7.3, 1.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 7.25 – 7.09 (m, 10H), 6.96 (dd, J = 6.5, 
3.0 Hz, 4H), 4.66 (t, J = 8.0 Hz, 4H), 3.07 (t, J = 8.0 Hz, 4H); 
13
C NMR (75 MHz, CDCl3) δ 
= 140.9, 137.5, 130.0, 128.7, 128.5, 126.8, 123.2, 122.5, 120.3, 119.8, 118.4, 110.1, 47.7, 
36.5; IR (ATR, cm
-1): ν = 538 (m), 557 (m), 567 (w), 590 (w), 615 (m), 633 (m), 696 (vs), 
731 (vs), 845 (w), 904 (w), 974 (w), 1014 (m), 1026 (m), 1076 (w), 1084 (w), 1159 (m), 1232 
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(m), 1284 (m), 1315 (m), 1352 (m), 1387 (m), 1456 (s), 1495 (m), 1516 (w), 1531 (m), 1867 
(vw), 1882 (vw), 2854 (w), 2872 (w), 2924 (w), 2966 (w), 3024 (w), 3055 (w); GC-MS (EI, 
70 eV): m/z (%) = 470 (100), 379 (24), 346 (10), 287(23), 275 (74), 207 (10); HRMS (EI): 
calcd. for C32H26N2S ([M]
+
): 470.18112; found: 470.180791. 
5,6-Dibenzyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2r was 
prepared following general procedure 3 using compound 7 (100 
mg, 0.18 mmol) and 2-benzylamine (0.12 mL, 1.1 mmol). The 
product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:7) to yield 2r (43 mg, 53 %) as dark 
crystals; mp 227-229 C; 1H NMR (300 MHz, CDCl3) δ = 7.75 – 7.67 (m, 2H), 7.26 – 7.08 
(m, 12H), 6.93 – 6.81 (m, 4H), 5.27 (s, 4H); 13C NMR (63 MHz, CDCl3) δ = 141.4, 137.2, 
130.4, 129.0, 127.5, 125.1, 123.0, 122.8, 120.2, 120.0, 118.3, 110.1, 48.7; IR (ATR, cm
-1): ν 
= 557 (s), 592 (m), 609 (m), 652 (s), 690 (vs), 719 (vs), 737 (vs), 758 (m), 843 (m), 904 (m), 
926 (m), 964 (m), 1014 (m), 1032 (m), 1072 (m), 1157 (m), 1167 (m), 1188 (m), 1259 (m), 
1315 (s), 1321 (s), 1346 (s), 1381 (s), 1450 (s), 1495 (m), 1520 (m), 1605 (w), 1886 (w), 
1927 (w), 2848 (w), 2918 (w), 3028 (m), 3063 (w), 3080 (w); GC-MS (EI, 70 eV): m/z (%) = 
442 (100), 365 (12), 351 (60), 260 (7), 91 (9); HRMS (EI): calcd. for C30H22N2S ([M]
+
): 
442.14982; found: 442.14992. 
5,6-Dicyclopropyl-5,6-dihydrothieno[3,2-b:4,5-b']diindole 2s was 
prepared following general procedure 3 using compound 7 (100 
mg, 0.18 mmol) and cyclopropylamine (0.08 mL, 1.1 mmol). The 
product was purified by flash chromatography (silica gel, 
dichloromethane/heptane = 1:7) to yield 2s (20 mg, 33 %) as a yellow solid; mp 222-224 C; 
1
H NMR (300 MHz, CDCl3) δ = 7.67 – 7.53 (m, 4H), 7.28 – 7.08 (m, 4H), 3.86 – 3.75 (m, 
2H), 1.29 – 1.12 (m, 8H); 13C NMR (63 MHz, CDCl3) δ = 142.2, 130.6, 122.9, 122.3, 119.8, 
119.5, 118.2, 112.1, 28.0, 10.1; IR (ATR, cm
-1): ν = 546 (m), 571 (m), 646 (m), 696 (m), 735 
(vs), 760 (m), 804 (m), 829 (m), 874 (m), 926 (m), 976 (m), 1011 (m), 1024 (s), 1055 (m), 
1113 (m), 1151 (m), 1186 (m), 1223 (m), 1259 (m), 1309 (s), 1348 (s), 1394 (s), 1454 (s), 
1531 (m), 1537 (m), 1606 (w), 1807 (w), 1849 (w), 1884 (w), 1921 (w), 2850 (m), 2920 (m), 
3003 (w), 3022 (w), 3049 (w), 3076 (w); GC-MS (EI, 70 eV): m/z (%) = 342 (100), 313 (11), 
299 (17), 268 (8); HRMS (EI): calcd. for C22H18N2S ([M]
+
): 342.11852; found: 342.11827. 
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10-(4-Methoxyphenyl)-10H-benzo[4,5]thieno[3,2-b]indole 12a was 
prepared following general procedure 1 using compound 11 (200 mg, 
0.54 mmol) and 4-methoxyaniline (401 mg, 3.3 mmol). The product 
was purified by flash chromatography (silica gel, ethylacetate/heptane 
= 1:10) to yield 12a (172 mg, 96 %) as white crystals; mp 158-160 
C; 1H NMR (300 MHz, CDCl3) δ = 7.77 (m, 2H), 7.40 (d, J = 6.8 
Hz, 2H), 7.26 – 7.00 (m, 8H), 3.86 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 158.8, 142.5, 
142.3, 137.4, 129.9, 128.4, 126.2, 123.7, 123.3, 123.3, 122.6, 121.3, 119.8, 119.6, 118.6, 
115.5, 114.2, 110.3, 55.0; IR (ATR, cm
-1): ν = 575 (m), 596 (s), 642 (m), 710 (m), 742 (vs), 
806 (m), 827 (m), 858 (m), 1018 (s), 1028 (s), 1057 (m), 1103 (m), 1165 (m), 1182 (m), 1213 
(s), 1248 (s), 1298 (m), 1346 (s), 1421 (m), 1437 (m), 1450 (s), 1512 (s), 1583 (w), 1591 (w), 
1606 (w), 1867 (w), 1894 (w), 2833 (w), 2928 (w), 2955 (w), 3014 (w), 3049 (w); GC-MS 
(EI, 70 eV): m/z (%) = 329 (100), 314 (17), 286 (13), 165 (7), 142 (6); HRMS (EI): calcd. for 
C21H15ONS ([M]
+
): 329.08689; found: 329.08677. 
10-Heptyl-10H-benzo[4,5]thieno[3,2-b]indole 12b was prepared 
following general procedure 3 using compound  11 (200 mg, 0.54 
mmol) and n-heptylamine (0.16 mL, 3.3 mmol). The product was 
purified by flash chromatography (silica gel, dichloromethane/heptane 
= 1:10) to yield 12b (160 mg, 92 %) as a colorless liquid; 
1
H NMR 
(300 MHz, CDCl3) δ = 7.94 – 7.78 (m, 2H), 7.69 (dd, J = 7.8, 0.9 Hz, 
1H), 7.43 – 7.19 (m, 4H), 7.91-7.82 (m, 1H), 4.46 (t, J = 7.5 Hz, 2H), 
1.92 – 1.82 (m, 2H), 1.41 – 1.09 (m, 8H), 0.78 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, 
CDCl3) δ = 143.2, 141.4, 137.4, 127.0, 124.6, 124.2, 123.7, 122.8, 121.6, 119.9, 119.4, 119.3, 
115.3, 109.9, 45.0, 31.7, 30.5, 29.1, 27.0, 22.6, 14.0; IR (ATR, cm
-1): ν = 586 (w), 619 (w), 
663 (m), 723 (vs), 731 (vs), 752 (m), 825 (w), 920 (w), 982 (w), 1020 (m), 1072 (m), 1115 
(m), 1155 (w), 1171 (m), 1252 (w), 1271 (w), 1323 (m), 1346 (m), 1429 (m), 1454 (m), 1491 
(m), 1591 (vw), 1608 (vw), 2852 (m), 2924 (m), 2953 (m), 3026 (vw), 3053 (w); GC-MS (EI, 
70 eV): m/z (%) = 321 (100), 236 (94), 222 (14), 165 (7); HRMS (ESI): calcd. for C21H24NS 
([M + H]
+
): 322.1624; found: 322.1623. 
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10-Benzyl-10H-benzo[4,5]thieno[3,2-b]indole 12c was prepared 
following general procedure 3 using compound 11 (200 mg, 0.54 
mmol) and benzylamine (0.36 mL, 3.3 mmol). The product was 
purified by flash chromatography (silica gel, dichloromethane/heptane 
= 1:7) to yield 12c (162 mg, 95 %) as white crystals; mp 150-152 C; 
1
H NMR (300 MHz, CDCl3) δ = 7.85 – 7.77 (m, 1H), 7.77 – 7.66 (m, 2H), 7.34 (d, J = 8.2 
Hz, 1H), 7.28 – 7.10 (m, 7H), 7.08 (dd, J = 4.6, 3.5 Hz, 2H), 5.70 (s, 2H); 13C NMR (75 
MHz, CDCl3) δ = 143.25, 141.89, 137.75, 137.39, 128.98, 127.61, 126.91, 126.08, 124.53, 
124.30, 123.91, 123.25, 121.91, 120.00, 119.92, 119.50, 115.88, 110.14, 48.41; IR (ATR, cm
-
1): ν = 555 (m), 586 (m), 613 (m), 633 (s), 694 (vs), 719 (vs), 731 (vs), 737 (vs), 804 (m), 833 
(m), 847 (m), 926 (m), 968 (m), 1018 (m), 1068 (m), 1119 (m), 1153 (m), 1174 (m), 1201 
(m), 1257 (m), 1271 (m), 1321 (m), 1348 (s), 1427 (s), 1452 (m), 1495 (m), 1583 (w), 1605 
(w), 1888 (w), 1923 (w), 3022 (w), 3053 (w); GC-MS (EI, 70 eV): m/z (%) = 313 (93), 222 
(100), 91 (23); HRMS (EI): calcd. for C21H15NS ([M]
+
): 313.09197; found: 313.09228. 
 
8.5.2 Synthesis of 5-methyl-5,10-dihydroindolo[3,2-b]indole  
Procedure for prepared of 2,3-dibromo-1-methyl-1H-indole 13 
 
To solution of 1-methyl-1H-indole (1 mL, 8 mmol) in 20 mL THF was added wisely NBS 
(3.14 g, 17.6 mmol) at -78 ºC. Then the mixture was stirred for 5h at this temperature. The 
reaction mixture was treated with water (20 mL). The solvent THF was reduced by 
evaporator in vacuo and then extracted with dihloromethane (3 x 20 mL). The combined 
organic layers were washed with saturated aqueous NaHCO3, dried over MgSO4 and then 
evaporated in vacuo affording yellow syrup. The mixture was separated over column 
chromatography (silica gel, heptane) to yield 2,3-dibromo-1-methyl-1H-indole 13 (2 g, 86%) 
as white solid; m.p. 38-40 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.41 (dt, J = 7.6, 1.1 Hz, 1H), 
7.15 (dd, J = 4.9, 1.2 Hz, 2H), 7.13 – 7.02 (m, 1H), 3.66 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δ = 136.34, 126.96, 122.91, 120.81, 118.86, 114.90, 109.63, 92.68, 32.34; GC/MS (EI, 
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70eV): m/z (%) = 289 (100), 291 (50), 288 (20), 274 (18), 129 (15), 114 (23), 88 (12); 
HRMS (EI): calculated for C9H7Br2N1 ([M
+
]): 286.89398; found: 286.89391, calculated for 
C9H7Br1
81
Br1N1 ([M
+
]): 288.89193; found: 288.89183, calculated for C9H7
81
Br2N1 ([M
+
]): 
290.88988; found: 290.88980. 
Procedure for prepared of 3-bromo-2-(2-bromophenyl)-1-methyl-1H-indole 14.  
 
 
2,3-dibromoindole 13 (1 g, 3.46 mmol), 2-bromophenyl boronic acid 6 (0.83 g, 4.15 mmol), 
Pd(PPh3)4 (200 mg, 173 µmol) and sodium hydroxide (415 mg, 10.38 mmol) were added to 
500 mL Schlenk flask. The mixture was back-filled several times with Argon. To the mixture 
70 mL THF and 10 mL distilled water were added, then, back-filled several times. The 
reaction was heated at 70 ºC for 4h. The solvent was evaporated in vacuo. The residue was 
extracted with dichloromethane and water. The organic layer was dried over MgSO4, filtered 
and the solvent was evaporated in vacuo. The yellow residue was purified by column 
chromatography (silica gel, Heptane/ethylacetate/dichloromethane 3:1:1) to yield 3-bromo-2-
(2-bromophenyl)-1-methyl-1H-indole 14 (0.91 g, 72 %) as white solid; m.p. 83-85 ᵒC; 1H 
NMR (300 MHz, CDCl3) δ 7.71 – 7.66 (m, 1H), 7.59 – 7.52 (m, 1H), 7.44 – 7.12 (m, 6H), 
3.50 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ = 137.12, 136.30, 133.29, 132.95, 132.20, 130.90, 
127.43, 126.80, 125.52, 122.95, 120.48, 119.46, 109.71, 90.75, 31.26; IR (ATR, cm
-1): ν = 
3053  (m), 3018  (w), 2939  (w), 2875  (w), 2833  (w), 1498  (m), 1473  (m), 1460  (s), 1427  
(m), 1412  (m), 1356  (m), 1325  (s), 1319  (s), 1230  (s), 1201  (m), 1173  (w), 1153  (s), 
1126  (m), 1105  (m), 1084  (m), 1009  (m), 947  (m), 922  (m), 808  (w), 729  (vs), 606  (m), 
546  (m); GC-MS (EI, 70 eV): m/z (%) = 365 (100), 204 (82), 176 (22), 102 (26), 88 (13); 
HRMS (EI): calcd. for C15H11Br2N1 ([M
+
]): 362.92528; found: 362.92484, calculated for 
C15H11Br1
81
Br1N1 ([M
+
]): 364.92323; found: 364.92292, calculated for C15H11
81
Br2N1 ([M
+
]): 
366.92118; found: 366.92109. 
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General procedure 4 for double C-N coupling with aniline derivatives, exemplified by: 
5-methyl-10-phenyl-5,10-dihydroindolo[3,2-b]indole 15a 
 
 
Aniline (75 µL, 0.82 mmol) was added to pressure tube charged with 14 (100 mg, 0.27 
mmol), Pd2(dba)3 (12.5 mg, 14 µmol), ligand Xantphos (15.9 mg, 28 µmol) and sodium tert-
butoxide (79 mg, 0.82 mmol) under Argon. The mixture was back-filled with Argon several 
times. The mixture was dissolved in anhydrous toluene (10 mL) and heated to 90 ºC for 6 h. 
After cooling, the reaction mixture was diluted with dichloromethane (20 mL) and filtered 
through a celite pad, washing with dichloromethane (40 mL). The filtrate was evaporated in 
vacuo. The product was separated via flash chromatography (silica gel, 
heptane/dichloromethane 5:1) to yield 15a (65 mg, 80 %) as a white solid; m.p. 130-131 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.88 – 7.81 (m, 1H), 7.66 – 7.41 (m, 6H), 7.37 – 7.26 (m, 
2H), 7.24 – 7.08 (m, 3H), 6.97 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 4.03 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ = 141.32, 140.72, 139.16, 129.64, 127.89, 126.44, 125.53, 125.25, 122.56, 
121.96, 119.65, 118.46, 118.24, 117.63, 116.05, 114.67, 110.99, 109.57, 31.65; IR (ATR, cm
-
1): ν = 3047  (w), 2928  (w), 1593  (m), 1576  (m), 1500  (s), 1471  (s), 1460  (s), 1435  (m), 
1423  (m), 1398  (s), 1365  (m), 1340  (m), 1323  (m), 1309  (m), 1282  (m), 1267  (w), 1232  
(s), 1174  (m), 1151  (m), 1126  (m), 1103  (m), 1076  (m), 1061  (m), 1028  (m), 1014  (m), 
987  (w), 966  (w), 949  (m), 918  (w), 910  (m), 883  (w), 831  (w), 823  (m), 779  (w), 729  
(vs), 700  (vs), 677  (s), 650  (s), 617  (m), 596  (m), 588  (s), 565  (m), 542  (m); GC-MS (EI, 
70 eV): m/z (%) =  296 (100), 281 (45); HRMS (EI): calculated for C21H16N2 ([M
+
]): 
296.13080; found: 296.13042. 
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5-(4-(tert-butyl)phenyl)-10-methyl-5,10-dihydroindolo[3,2-b]indole 
15b was prepared following general procedure 4 using compound  14 
(100 mg, 0.27 mmol) and 4-(tert-butyl)aniline (131 µL, 0.82 mmol). 
The product was purified by flash chromatography (silica gel, 
heptane/dichloromethane 5:1) to yield 15b (81 mg, 84%) as a white 
solid; m.p. 210-213 ºC;  
1
H NMR (250 MHz, C6D6) δ = 7.99 – 7.89 
(m, 2H), 7.84 – 7.75 (m, 1H), 7.73 – 7.65 (m, 2H), 7.48 – 7.33 (m, 
5H), 7.33 – 7.18 (m, 2H), 3.56 (s, 3H), 1.36 (s, 9H); 13C NMR (63 MHz, C6D6) δ = 149.25, 
141.81, 141.43, 137.08, 127.84, 126.67, 125.43, 122.80, 122.22, 119.85, 118.92, 118.62, 
117.99, 116.63, 115.39, 111.46, 109.82, 34.59, 31.46, 30.98; IR (ATR, cm
-1): ν = 3057  (w), 
2960  (m), 2929  (w), 2901  (w), 2864  (w), 1516  (s), 1495  (m), 1471  (s), 1441  (m), 1423  
(m), 1402  (s), 1365  (m), 1329  (m), 1309  (w), 1265  (w), 1234  (s), 1200  (m), 1184  (m), 
1161  (w), 1151  (w), 1136  (m), 1111  (m), 1030  (w), 1022  (w), 1012  (m), 955  (w), 922  
(w), 833  (m), 823  (m), 775  (w), 729  (vs), 712  (m), 685  (m), 665  (w), 607  (w), 590  (m), 
571  (w), 561  (w), 550  (m); GC/MS (EI, 70eV): m/z (%) = 352 (100), 337 (22), 322 
(19),155 (20); HRMS (EI): calculated for C25H24N2 ([M
+
]): 352.19340; found: 352.19295. 
5-methyl-10-(p-tolyl)-5,10-dihydroindolo[3,2-b]indole 15c was 
prepared following general procedure 4 using compound  14 (100 
mg, 0.27 mmol) and p-toluidine (88 mg, 0.82 mmol). The product 
was purified by flash chromatography (silica gel, 
heptane/dichloromethane 5:1) to yield 15c (69 mg, 81 %) as a white 
solid; m.p. 140-141 ºC;  
1
H NMR (300 MHz, Acetone) δ = 7.92 – 
7.85 (m, 1H), 7.48 – 7.29 (m, 7H), 7.14 – 7.00 (m, 3H), 6.87 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 
4.02 (s, 3H), 2.31 (s, 3H); 
13
C NMR (63 MHz, Acetone) δ = 142.29, 141.63, 137.35, 137.20, 
131.14, 128.45, 126.07, 125.85, 123.39, 122.75, 120.40, 118.99, 118.78, 118.71, 116.86, 
115.37, 111.50, 110.69, 31.81, 21.15; IR (ATR, cm
-1
): ν = 3057  (w), 3036  (w), 2918  (w), 
1514  (s), 1487  (m), 1473  (m), 1454  (m), 1441  (m), 1421  (m), 1402  (m), 1365  (m), 1325  
(m), 1304  (w), 1232  (m), 1174  (w), 1153  (m), 1126  (m), 1109  (m), 1063  (w), 1032  (m), 
1012  (m), 968  (w), 951  (m), 918  (m), 822  (m), 796  (w), 760  (w), 748  (m), 727  (vs), 683  
(m), 665  (w), 640  (w), 615  (w), 590  (m), 563  (m), 542  (w); GC/MS (EI, 70eV): m/z (%) 
= 310 (100), 295 (40); HRMS (EI): calculated for C22H18N2 ([M
+
]): 310.14645; found: 
310.14704. 
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5-(4-fluorophenyl)-10-methyl-5,10-dihydroindolo[3,2-b]indole 15d 
was prepared following general procedure 4 using compound  14 
(100 mg, 0.27 mmol) and 4-fluoroaniline (78 µL, 0.82 mmol). The 
product was purified by flash chromatography (silica gel, heptane/ 
dichloromethane 4:1) to yield 15d (71 mg, 82 %) as a white solid; 
m.p. 106-108 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.82 (dd, J = 7.2, 
1.4 Hz, 1H), 7.57 – 7.46 (m, 2H), 7.48 – 7.28 (m, 3H), 7.23 – 7.08 
(m, 5H), 6.96 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 4.01 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ = 
161.11 (d, J = 246.0 Hz), 141.28, 140.91, 135.18 (d, J = 3.0 Hz), 127.75, 127.24 (d, J = 8.4 
Hz), 125.34, 122.62, 122.03, 119.72, 118.32, 118.12, 117.67, 116.53 (d, J = 22.8 Hz), 116.00, 
114.49, 110.69, 109.64, 31.63; IR (ATR, cm
-1): ν = 3055  (w), 2922  (w), 1504  (s), 1471  (s), 
1439  (m), 1423  (m), 1398  (s), 1367  (m), 1323  (m), 1281  (w), 1230  (s), 1217  (s), 1153  
(m), 1134  (m), 1124  (m), 1095  (m), 1061  (m), 1032  (m), 1016  (m), 949  (m), 918  (m), 
872  (m), 841  (m), 827  (s), 808  (s), 785  (m), 760  (m), 725  (vs), 710  (s), 679  (m), 636  
(m), 611  (m), 588  (s), 565  (s), 542  (m); GC/MS (EI, 70eV): m/z (%) = 314 (100), 299 (48),  
157 (10); HRMS (EI): calculated for C21H15F1N2 ([M
+
]): 314.12138; found: 314.12142. 
5-methyl-10-(3-(trifluoromethyl)phenyl)-5,10-dihydroindolo[3,2-
b]indole 15e was prepared following general procedure 4 using 
compound  14 (100 mg, 0.27 mmol) and 3-(trifluoromethyl)aniline 
(103 µL, 0.82 mmol). The product was purified by flash 
chromatography (silica gel, heptane/dichloromethane 4:1) to yield 
15e (84 mg, 84 %) as a white solid; m.p. 86-87 ºC;  
1
H NMR (300 
MHz, CDCl3) δ = 7.90 (s, 1H), 7.88 – 7.74 (m, 2H), 7.64 – 7.46 (m, 3H), 7.35 (dd, J = 15.7, 
8.2 Hz, 2H), 7.22 – 7.12 (m, 3H), 6.99 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 4.00 (s, 3H); 19F NMR 
(282 MHz, CDCl3) δ = -62.54 (s); 
13
C NMR (75 MHz, CDCl3) δ = 141.29, 140.50, 139.84, 
132.26 (q, J = 32.7 Hz), 130.29, 128.40 (d, J = 0.9 Hz), 128.33, 124.63, 123.03, 122.79 (q, J 
= 3.8 Hz), 122.53 (q, J = 272.7 Hz ), 122.52 (d, J = 272.7 Hz), 122.17, 122.09 (q, J = 7.8, 4.1 
Hz), 120.33, 118.59, 117.85, 116.55, 114.43, 110.61, 109.75, 31.60; IR (ATR, cm
-1): ν = 
3061  (w), 2931  (w), 1612  (w), 1595  (m), 1574  (w), 1514  (w), 1495  (s), 1471  (s), 1441  
(s), 1421  (m), 1396  (m), 1373  (m), 1335  (s), 1321  (s), 1308  (s), 1286  (s), 1263  (m), 1232  
(s), 1176  (s), 1163  (s), 1113  (vs), 1095  (s), 1066  (s), 1034  (m), 1020  (m), 1001  (m), 968  
(m), 957  (m), 924  (m), 916  (m), 899  (m), 872  (w), 839  (s), 802  (s), 729  (vs), 706  (vs), 
696  (s), 679  (m), 665  (s), 650  (m), 638  (m), 596  (m), 588  (m), 569  (m), 542  (m); 
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GC/MS (EI, 70eV): m/z (%) = 364 (100), 349 (39); HRMS (EI): calculated for C22H15F3N2 
([M
+
]): 364.11818; found: 364.11786. 
 5-(4-methoxyphenyl)-10-methyl-5,10-dihydroindolo[3,2-b]indole  
15f was prepared following general procedure 4 using compound  14 
(100 mg, 0.27 mmol) and p-anisidine (101 mg, 0.82 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 5:1) to yield 15f (68 mg, 76 %) as a white solid; 
m.p. 114-116 ºC; 
1
H NMR (300 MHz, Acetone) δ = 7.91 – 7.81 (m, 
1H), 7.49 – 7.41 (m, 2H), 7.40 – 7.32 (m, 2H), 7.31 – 7.26 (m, 1H), 
7.14 – 7.00 (m, 5H), 6.86 (m, 1H), 4.01 (s, 3H), 3.75 (s, 3H); 13C NMR (75 MHz, Acetone) δ 
= 159.43, 142.28, 141.93, 132.64, 128.18, 127.70, 126.24, 123.28, 122.73, 120.23, 118.97, 
118.65, 116.65, 115.78, 115.36, 111.40, 110.67, 55.95, 31.82; IR (ATR, cm
-1): ν = 3057  (m), 
2955  (m), 2926  (m), 2912  (m), 2835  (m), 1510  (s), 1473  (s), 1464  (s), 1441  (s), 1421  
(m), 1400  (s), 1367  (m), 1331  (m), 1296  (m), 1284  (m), 1234  (s), 1182  (m), 1169  (m), 
1161  (m), 1151  (m), 1132  (m), 1124  (m), 1107  (s), 1065  (m), 1030  (s), 1018  (m), 968  
(m), 953  (m), 947  (m), 931  (m), 914  (m), 870  (m), 827  (s), 806  (m), 795  (m), 756  (m), 
742  (m), 723  (vs), 685  (m), 675  (m), 665  (m), 640  (m), 613  (m), 590  (s), 573  (s), 542  
(m); GC/MS (EI, 70eV): m/z (%) = 326 (100), 311 (25), 268 (12); HRMS (EI): calculated for 
C21H15N2O1 ([M
+
]): 326.14136; found: 326.14118. 
 5-methyl-10-(4-(methylthio)phenyl)-5,10-dihydroindolo[3,2-
b]indole 15g was prepared following general procedure 4 using 
compound  14 (100 mg, 0.27 mmol) and 4-(methylthio)aniline (102 
µL, 0.82 mmol). The product was purified by flash chromatography 
(silica gel, heptane/ethylacetate 5:1) to yield 15g (78 mg, 83 %) as a 
white solid; m.p. 107-108 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 8.04 – 
7.95 (m, 1H), 7.75 – 7.58 (m, 4H), 7.58 – 7.46 (m, 3H), 7.43 – 7.24 (m, 3H), 7.15 (t, J = 7.5 
Hz, 1H), 4.17 (s, 3H), 2.64 (s, 3H); 
13
C NMR (63 MHz, CDCl3) δ = 141.28, 140.71, 136.48, 
136.32, 127.79, 125.92, 125.16, 122.57, 121.98, 119.68, 118.37, 118.28, 117.64, 116.03, 
114.59, 110.90, 109.59, 31.62, 16.23; IR (ATR, cm
-1): ν = 3057  (w), 2916  (m), 1495  (s), 
1468  (s), 1439  (s), 1419  (m), 1396  (s), 1365  (m), 1323  (s), 1302  (m), 1284  (m), 1265  
(m), 1228  (s), 1180  (m), 1161  (m), 1153  (m), 1132  (m), 1090  (s), 1065  (m), 1030  (m), 
1011  (m), 962  (m), 957  (m), 949  (m), 924  (m), 916  (m), 870  (w), 835  (w), 822  (s), 773  
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(m), 735  (vs), 727  (vs), 700  (s), 687  (s), 679  (s), 634  (m), 602  (m), 588  (s), 569  (m), 544  
(m); GC/MS (EI, 70eV): m/z (%) = 342 (100), 327 (35), 171 (8); HRMS (EI): calculated for 
C22H18N2S1 ([M
+
]): 342.11852; found: 342.11846.  
5-methyl-10-(4-cyanophenyl)-5,10-dihydroindolo[3,2-b]indole 15h 
was prepared following general procedure 4 using compound  14 
(100 mg, 0.27 mmol) and 4-aminobenzonitrile (97 mg, 0.82 mmol). 
The product was purified by flash chromatography (silica gel, 
Heptane/ethylacetate 4:1) to yield 15h (72 mg, 82 %) as a white 
solid; m.p. 158-160 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 7.84 – 7.77 
(m, 1H), 7.76 – 7.59 (m, 4H), 7.58 – 7.48 (m, 1H), 7.39 – 7.31 (m, 
2H), 7.26 – 7.13 (m, 3H), 7.00 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 3.98 (s, 3H); 13C NMR (63 
MHz, CDCl3) δ = 143.01, 141.20, 140.10, 133.63, 128.80, 124.97, 123.86, 123.27, 122.27, 
120.85, 118.73, 118.66, 118.24, 117.98, 117.01, 114.32, 110.73, 109.85, 108.87, 31.55; IR 
(ATR, cm
-1): ν = 3055  (w), 2929  (w), 2218  (m), 1601  (m), 1508  (s), 1470  (s), 1441  (s), 
1423  (m), 1396  (s), 1373  (m), 1346  (m), 1325  (s), 1308  (m), 1279  (w), 1230  (m), 1200  
(w), 1174  (m), 1163  (m), 1155  (m), 1134  (m), 1059  (w), 1034  (m), 1024  (m), 949  (w), 
872  (w), 843  (m), 831  (m), 741  (s), 729  (vs), 687  (w), 681  (w), 673  (w), 646  (w), 607  
(w), 590  (m), 567  (w), 548  (m); GC/MS (EI, 70eV): m/z (%) = 321 (100), 306 (36), 219 
(12), 161 (10); HRMS (EI): calculated for C22H15N3 ([M
+
]): 321.12605; found: 321.12595. 
 5-methyl-10-propyl-5,10-dihydroindolo[3,2-b]indole 15i was 
prepared following general procedure 4 using compound  14 (100 
mg, 0.27 mmol) and n-propylamine (68 µL, 0.82 mmol). The product 
was purified by flash chromatography (silica gel, 
heptane/dichloromethane 5:1) to yield 15i (54 mg, 86 %) as a white 
solid; m.p. 121-122 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 7.81 – 7.71 (m, 2H), 7.36 – 7.02 (m, 
6H), 4.33 (s, 2H), 3.98 (s, 3H), 1.89 (sex, J = 7.3 Hz, 2H), 0.86 (t, J = 7.4 Hz, 3H); 
13
C NMR 
(63 MHz, CDCl3) δ = 141.23, 140.63, 126.54, 125.81, 121.61, 118.15, 117.99, 117.66, 
117.51, 114.73, 109.78, 109.53, 46.80, 31.59, 23.65, 11.68; IR (ATR, cm
-1): ν = 3053  (w), 
2960  (w), 2931  (m), 2874  (w), 1497  (m), 1475  (s), 1466  (m), 1439  (m), 1423  (m), 1406  
(m), 1381  (m), 1363  (s), 1298  (m), 1267  (m), 1246  (w), 1225  (s), 1188  (m), 1151  (m), 
1132  (m), 1119  (m), 1014  (m), 951  (w), 920  (m), 899  (m), 841  (m), 729  (vs), 675  (m), 
660  (m), 644  (m), 590  (m), 575  (m), 567  (m), 544  (m); GC/MS (EI, 70eV): m/z (%) = 
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262 (100), 233 (89), 219 (48); HRMS (EI): calculated for C18H18N2 ([M
+
]): 262.14645; 
found: 262.14588. 
 5-methyl-10-allyl-5,10-dihydroindolo[3,2-b]indole 15j was prepared 
following general procedure 4 using compound  14 (100 mg, 0.27 
mmol) and allylamine (62 µL, 0.82 mmol). The product was purified 
by flash chromatography (silica gel, heptane/dichloromethane 5:1) to 
yield 15j (60 mg, 84 %) as a white solid; m.p. 125-126 ºC; 
1
H NMR 
(250 MHz, CDCl3) δ = 8.08 – 7.65 (m, 2H), 7.62 – 6.95 (m, 6H), 6.17 – 5.90 (m, 1H), 5.20 – 
4.95 (m, 4H), 4.03 (s, 3H); 
13
C NMR (63 MHz, CDCl3) δ = 141.15, 140.60, 133.49, 126.68, 
125.76, 121.75, 121.67, 118.35, 118.16, 117.79, 117.47, 116.67, 115.03, 114.62, 109.84, 
109.47, 47.49, 31.60; IR (ATR, cm
-1): ν = 3063  (w), 2920  (m), 2852  (w), 1643  (w), 1497  
(m), 1475  (s), 1448  (m), 1433  (m), 1406  (s), 1367  (m), 1352  (m), 1294  (w), 1273  (m), 
1246  (m), 1221  (s), 1174  (m), 1149  (m), 1132  (m), 1119  (m), 1061  (w), 1041  (w), 1016  
(m), 993  (m), 976  (m), 953  (w), 943  (w), 924  (m), 914  (m), 904  (m), 841  (m), 831  (m), 
771  (w), 741  (m), 721  (vs), 663  (m), 598  (m), 584  (s), 565  (m), 544  (m); GC/MS (EI, 
70eV): m/z (%) = 260 (47), 219 (100); HRMS (EI): calculated for C18H16N2 ([M
+
]): 
260.13080; found: 260.13081. 
5-methyl-10-benzyl-5,10-dihydroindolo[3,2-b]indole 15k was 
prepared following general procedure 4 using compound  14 (100 
mg, 0.27 mmol) and benzylamine (90 µL, 0.82 mmol). The product 
was purified by flash chromatography (silica gel, 
heptane/dichloromethane 3:1) to yield 15k (61 mg, 72 %) as a white 
solid; m.p. 151-152 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 7.89 – 7.80 
(m, 1H), 7.55 – 7.52 (m, 1H), 7.39 – 7.29 (m, 2H), 7.26 – 7.06 (m, 8H), 7.05 – 6.94 (m, 1H), 
5.61 (s, 2H), 4.05 (s, 3H); 
13
C NMR (63 MHz, CDCl3) δ = 141.16, 140.87, 137.99, 128.77 (x 
2C), 127.42, 126.53 (x 2C), 121.90, 121.67, 118.49, 118.20, 115.10, 114.67, 109.99, 109.46, 
48.82, 31.62; IR (ATR, cm
-1): ν = 3055  (w), 3030  (w), 2935  (w), 1603  (w), 1579  (w), 
1495  (m), 1475  (s), 1448  (m), 1431  (m), 1406  (m), 1387  (m), 1360  (m), 1346  (m), 1340  
(m), 1317  (m), 1300  (m), 1288  (m), 1273  (m), 1246  (m), 1223  (m), 1171  (m), 1149  (w), 
1132  (m), 1122  (m), 1099  (w), 1074  (w), 1028  (w), 1014  (m), 978  (m), 849  (w), 766  
(w), 731  (vs), 694  (s), 658  (m), 594  (w), 584  (m), 569  (w), 536  (w); GC/MS (EI, 70eV): 
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m/z (%) = 310 (49), 219 (100); HRMS (EI): calculated for C22H18 N2 ([M
+
]): 310.14645; 
found: 310.14720. 
 5-methyl-10-(4-methoxybenzyl)-5,10-dihydroindolo[3,2-b]indole 
15l was prepared following general procedure 4 using compound  
14 (100 mg, 0.27 mmol) and 4-methoxybenzylamine (107 µL, 0.82 
mmol). The product was purified by flash chromatography (silica 
gel, heptane/ethylacetate 5:1) to yield 15l (74 mg, 79 %) as a white 
solid; m.p. 161-162 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.86 – 
7.78 (m, 1H), 7.54 (d, J = 7.9 Hz, 1H), 7.32 (dd, J = 8.3, 4.0 Hz, 2H), 7.25 – 6.95 (m, 6H), 
6.74 – 6.62 (m, 2H), 5.49 (s, 2H), 4.00 (s, 3H), 3.60 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 
158.98, 141.22, 140.86, 130.15, 128.44, 127.85, 121.91, 121.70, 118.48, 118.26, 117.77, 
117.54, 115.14, 114.75, 114.20, 114.07, 110.09, 109.51, 55.26, 48.32, 31.63; IR (ATR, cm
-1
): 
ν = 3047  (w), 2928  (w), 1610  (w), 1512  (m), 1497  (m), 1475  (m), 1450  (m), 1437  (m), 
1421  (w), 1404  (m), 1363  (m), 1342  (m), 1311  (w), 1300  (w), 1294  (w), 1271  (m), 1252  
(m), 1221  (m), 1171  (m), 1149  (m), 1132  (m), 1120  (m), 1109  (m), 1030  (m), 1014  (m), 
984  (w), 957  (w), 926  (w), 843  (m), 831  (w), 823  (w), 810  (m), 768  (w), 752  (m), 742  
(s), 727  (vs), 665  (w), 656  (w), 642  (m), 629  (w), 592  (m), 577  (w), 565  (w), 534  (m); 
GC/MS (EI, 70eV): m/z (%) = 340 (53), 219 (100), 121 (32); HRMS (EI): calculated for 
C23H20N2O1 ([M
+
]): 340.15701; found: 340.15763. 
5-methyl-10-(4-fluorobenzyl)-5,10-dihydroindolo[3,2-b]indole 15m 
was prepared following general procedure 4 using compound  14 (100 
mg, 0.27 mmol) and 4-fluorobenzylamine (94 µL, 0.82 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/dichloromethane 3:1) to yield 15m (58 mg, 64 %) as a white 
solid; m.p. 153-154 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.80 (d, J = 
7.6 Hz, 1H), 7.46 (d, J = 7.9 Hz, 1H), 7.28 (t, J = 8.5 Hz, 2H), 7.22 – 6.92 (m, 6H), 6.83 – 
6.77 (m, 2H), 5.44 (s, 2H), 3.95 (s, 3H); 
19
F NMR (282 MHz, CDCl3) δ = -115.08 (s); 
13
C 
NMR (75 MHz, CDCl3) δ = 162.20 (d, J = 245.5 Hz), 141.21, 140.81,
 
133.82 (d, J = 3.1 Hz), 
128.22 (d, J = 8.1 Hz), 126.89, 125.71, 122.06, 121.82, 118.70, 118.36, 117.65, 117.58, 
115.72 (d, J = 21.6 Hz), 115.25, 114.64, 109.94, 109.62, 48.11, 31.61; IR (ATR, cm
-1): ν = 
3055  (w), 2926  (w), 1606  (m), 1508  (s), 1497  (m), 1473  (s), 1448  (m), 1433  (m), 1423  
(m), 1406  (s), 1360  (m), 1340  (m), 1296  (w), 1288  (m), 1271  (m), 1244  (m), 1221  (s), 
General procedures and spectroscopic data  115 
 
 
1171  (m), 1157  (s), 1132  (m), 1122  (m), 1092  (m), 1049  (w), 1014  (m), 978  (m), 957  
(w), 930  (w), 920  (w), 843  (m), 814  (s), 779  (w), 729  (vs), 681  (m), 650  (m), 623  (m), 
592  (m), 580  (m), 567  (m), 542  (w); GC/MS (EI, 70eV): m/z (%) = 328 (44), 219 (100), 
109 (9); HRMS (EI): calculated for C22H17N2F1 ([M
+
]): 328.13703; found: 328.13740. 
5-methyl-10-(3-(trifluoromethyl)benzyl)-5,10-dihydroindolo[3,2-
b]indole 15n was prepared following general procedure 4 using 
compound  14 (100 mg, 0.27 mmol) and 3-
(trifluoromethyl)benzylamine (118 µL, 0.82 mmol). The product was 
purified by flash chromatography (silica gel, 
heptane/dichloromethane 3:1) to yield 15n (62 mg, 60 %) as a white 
solid; m.p. 153-154 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.90 – 7.84 (m, 1H), 7.56 – 7.45 (m, 
2H), 7.45 – 7.09 (m, 8H), 7.01 (ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 5.63 (s, 2H), 4.05 (s, 3H); 19F 
NMR (282 MHz, CDCl3) δ = -62.55 (s); 
13
C NMR (75 MHz, CDCl3) δ = 141.18, 140.83, 
139.12, 131.12 (d, J = 32.3 Hz), 129.81, 129.47, 126.96, 125.65, 124.44 (q, J = 3.8 Hz), 
123.99 (q, J = 274.3 Hz), 123.28 (q, J = 3.8 Hz), 122.17, 121.85, 118.87, 118.39, 117.67, 
117.35, 115.36, 114.51, 109.80, 109.63, 48.46, 31.64; IR (ATR, cm
-1): ν = 3055  (w), 2926  
(w), 1579  (w), 1497  (m), 1473  (m), 1446  (m), 1433  (m), 1406  (m), 1363  (w), 1346  (w), 
1327  (s), 1288  (m), 1271  (m), 1246  (m), 1221  (m), 1186  (m), 1161  (s), 1153  (s), 1117  
(vs), 1092  (s), 1072  (s), 1049  (m), 1014  (m), 1003  (m), 989  (m), 980  (m), 957  (w), 947  
(w), 920  (m), 893  (m), 872  (w), 841  (m), 827  (m), 793  (s), 737  (s), 727  (vs), 700  (s), 
677  (m), 665  (m), 648  (m), 613  (m), 602  (m), 586  (m), 567  (m), 552  (m), 540  (m); 
GC/MS (EI, 70eV): m/z (%) = 378 (52), 219 (100), 159 (8); HRMS (EI): calculated for 
C23H17N2F3 ([M
+
]): 378.13383; found: 378.13375. 
5-methyl-10-phenethyl-5,10-dihydroindolo[3,2-b]indole 15o was 
prepared following general procedure 4 using compound  14 (100 mg, 
0.27 mmol) and phenethylamine (104 µL, 0.82 mmol). The product 
was purified by flash chromatography (silica gel, 
heptane/dichloromethane 4:1) to yield 15o (74 mg, 83 %) as a white 
solid; m.p. 138-139 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 7.98 – 7.88 
(m, 2H), 7.62 – 6.96 (m, 11H), 4.83 – 4.59 (m, 2H), 4.15 (s, 3H), 3.34 
– 3.15 (m, 2H); 13C NMR (63 MHz, CDCl3) δ = 141.22, 140.46, 138.76, 128.87, 128.71, 
126.78, 126.66, 125.39, 121.74, 121.69, 118.32, 118.23, 117.53, 117.46, 114.94, 114.73, 
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109.65, 109.59, 47.13, 36.74, 31.63; IR (ATR, cm
-1): ν = 3026  (w), 2929  (m), 1495  (m), 
1477  (s), 1450  (m), 1439  (m), 1423  (m), 1406  (s), 1362  (m), 1348  (s), 1281  (m), 1228  
(s), 1203  (m), 1167  (m), 1155  (m), 1132  (m), 1122  (m), 1082  (w), 1016  (m), 999  (m), 
850  (w), 829  (w), 742  (s), 727  (vs), 694  (vs), 646  (m), 596  (m), 580  (m), 569  (w), 532  
(m); GC-MS (EI, 70 eV): m/z (%) =  324 (54), 233 (100), 218 (42); HRMS (ESI): calcd. for 
C23H20N2 ([M]
+
): 324.16265; found: 324.16235. 
 
8.5.3 Synthesis of α-,δ-Carbolines  
Procedure for preparation of 3-(2-bromophenyl)-2-chloropyridine   17a.  
 
3-bromo-2-chloropyridine 16a (1 g, 5.2 mmol), 2-bromophenyl boronic acid 2 (1.25 g, 6.2 
mmol), Pd(PPh3)4 (300 mg, 260 µmol) and sodium hydroxide (624 mg, 15.6 mmol) were 
added to 500 mL Schlenk flask. The mixture was back-filled several times with Argon. To 
the mixture 70 mL THF and 10 mL distilled water were added, then, back-filled with argon 
several times. The reaction was heated at 70 ºC for 4h. The solvent was evaporated in vacuo. 
The residue was extracted with dichloromethane and water. The organic layer was dried over 
MgSO4, filtered and the solvent was evaporated in vacuo. The yellow residue was purified by 
column chromatography (silica gel, Heptane/ethylacetate 4:1) to yield 3-(2-bromophenyl)-2-
chloropyridine    17a  (1.19 g, 85 %) as colorless syrup; 
1
H NMR (300 MHz, CDCl3) δ = 8.38 
(dd, J = 4.8, 1.9 Hz, 1H), 7.66 – 7.59 (m, 1H), 7.54 (dd, J = 7.5, 2.0 Hz, 1H), 7.33 (td, J = 
7.6, 1.3 Hz, 1H), 7.29 – 7.13 (m, 3H); 13C NMR (75 MHz, CDCl3) δ = 150.36, 149.18, 
139.84, 138.41, 136.39, 132.88, 130.95, 130.07, 127.42, 123.40, 122.16; IR (ATR, cm
-1): ν = 
3051 (w), 1576 (m), 1558 (m), 1479 (w), 1441 (m), 1427 (m), 1390 (vs), 1300 (w), 1255 (w), 
1242 (w), 1207 (m), 1122 (m), 1103 (s), 1063 (s), 1053 (m), 1026 (m), 997 (s), 945 (w), 802 
(m), 781 (m), 748 (vs), 723 (s), 694 (s), 654 (s), 615 (m), 569 (m), 553 (m); GC-MS (EI, 70 
eV): m/z (%) = 269 (59), 188 (100), 153 (58), 126(29); HRMS (EI): calcd. for C11H7N1Br1Cl1 
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([M]
+
): 266.94449; found: 266.94495; calcd. for C11H7N1
81
Br1Cl1 ([M]
+
): 268.94244; found: 
268.94288; calcd. for C11H7N1Br1
37
Cl1 ([M]
+
): 270.93949; found: 270.94012.  
General procedure 5 for double C-N coupling with aniline derivatives, exemplified by: 
9-phenyl-9H-pyrido[2,3-b]indole 18a 
 
Aniline (52 µL, 0.56 mmol) was added to pressure tube charged with 17a (100 mg, 0.37 
mmol), Pd2(dba)3 (17 mg, 19 µmol), ligand Dppf (21 mg, 37 µmol) and sodium tert-butoxide 
(107 mg, 1.12 mmol) under Argon. The mixture was back-filled with Argon several times. 
The mixture was dissolved in anhydrous Toluene (10 mL) and heated at 110 ºC for 7 h. After 
cooling, the reaction mixture was diluted with dichloromethane (20 mL) and filtered through 
a celite pad, washing with dichloromethane (40 mL). The filtrate was reduced in vacuo. The 
product was separated via flash chromatography (silica gel, heptane/ethylacetate 3:1) to yield 
9-phenyl-9H-pyrido[2,3-b]indole 18a (84 mg, 92%) as a white solid; m.p. 110-111 ºC; 
1
H 
NMR (250 MHz, CDCl3) δ = 8.42 (dd, J = 4.9, 1.6 Hz, 1H), 8.31 (dd, J = 7.7, 1.6 Hz, 1H), 
8.05 (dt, J = 7.7, 0.9 Hz, 1H), 7.63 – 7.48 (m, 4H), 7.47 – 7.33 (m, 3H), 7.33 – 7.22 (m, 1H), 
7.20 – 7.10 (m, 1H); 13C NMR (63 MHz, CDCl3) δ = 151.93, 146.47, 140.11, 136.26, 129.65, 
128.28, 127.64, 127.38, 126.93, 120.91, 120.81, 120.71, 116.36, 116.04, 110.41; IR (ATR, 
cm
-1): ν = 3037 (m), 1591 (s), 1568 (m), 1504 (s), 1473 (s), 1452 (s), 1414 (vs), 1377 (m), 
1354 (m), 1335 (s), 1309 (m), 1290 (s), 1228 (s), 1176 (m), 1167 (m), 1115 (s), 1074 (m), 
1051 (m), 1026 (m), 997 (m), 970 (m), 958 (m), 951 (m), 937 (m), 766 (s), 756 (s), 748 (s), 
735 (vs), 715 (m), 692 (vs), 636 (s), 617 (s), 579 (s), 569 (m); GC-MS (EI, 70 eV): m/z (%) =  
243 (100), 122 (17); HRMS (ESI): calcd. for C17H12N2 ([M + H]
+
): 245.10732; found: 
245.10756. 
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9-(p-tolyl)-9H-pyrido[2,3-b]indole 18b was prepared following general 
procedure 5 using 17a (100 mg, 0.37 mmol) and 4-toluidine (60 mg, 0.56 
mmol). The product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 3:1) to yield 18b (91 mg, 95 %) as a white solid; m.p. 
102-103 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 8.40 (dd, J = 4.9, 1.6 Hz, 
1H), 8.29 (dd, J = 7.7, 1.6 Hz, 1H), 8.04 (d, J = 7.7 Hz, 1H), 7.48 – 7.29 
(m, 6H), 7.28 – 7.19 (m, 1H), 7.18 – 7.09 (m, 1H), 2.39 (s, 3H); 13C NMR (63 MHz, CDCl3) 
δ = 152.10, 146.50, 140.28, 137.60, 133.56, 130.30, 128.21, 127.25, 126.85, 120.87, 120.71, 
120.54, 116.24, 115.87, 110.39, 21.26; IR (ATR, cm
-1): ν = 3039 (w), 2920 (w), 1589 (m), 
1568 (m), 1514 (s), 1475 (m), 1456 (s), 1412 (vs), 1377 (m), 1354 (m), 1336 (s), 1311 (m), 
1290 (s), 1228 (s), 1219 (s), 1200 (m), 1182 (m), 1169 (m), 1155 (w), 1120 (m), 1109 (m), 
1051 (w), 1038 (w), 1018 (m), 997 (m), 966 (w), 951 (w), 941 (w), 924 (m), 841 (w), 812 (s), 
798 (m), 771 (vs), 744 (s), 735 (vs), 714 (s), 702 (s), 646 (m), 633 (s), 617 (m), 577 (s), 571 
(s);  GC-MS (EI, 70 eV): m/z (%) =  258 (100), 242 (17), 128 (9); HRMS (ESI): calcd. for 
C18H14N2 ([M + H]
+
): 259.12297; found: 259.12331. 
9-(4-(tert-butyl)phenyl)-9H-pyrido[2,3-b]indole 18c was prepared 
following general procedure 5 using 17a (100 mg, 0.37 mmol) and 4-tert-
butylaniline (83 mg, 0.56 mmol). The product was purified by flash 
chromatography (silica gel, heptane/ethylacetate 3:1) to yield 18c (105 
mg, 94 %) as a white solid; m.p. 147-148 ºC; 
1
H NMR (250 MHz, CDCl3) 
δ = 8.41 (dd, J = 4.9, 1.6 Hz, 1H), 8.29 (dd, J = 7.7, 1.6 Hz, 1H), 8.06 – 
7.99 (m, 1H), 7.58 – 7.32 (m, 6H), 7.23 (ddd, J = 8.1, 6.7, 1.6 Hz, 1H), 7.19 – 7.08 (m, 1H), 
1.32 (s, 9H); 
13
C NMR (63 MHz, CDCl3) δ = 152.01, 150.43, 146.50, 140.26, 133.51, 128.22, 
126.84, 126.77, 126.63, 120.84, 120.72, 120.56, 116.31, 115.87, 110.55, 34.76, 31.42; IR 
(ATR, cm
-1): ν = 2960 (m), 2902 (w), 2868 (w), 1587 (m), 1568 (m), 1520 (s), 1475 (m), 
1454 (s), 1414 (vs), 1360 (m), 1335 (s), 1288 (s), 1269 (m), 1228 (s), 1186 (m), 1169 (m), 
1153 (w), 1119 (m), 1097 (w), 1018 (m), 997 (m), 930 (m), 833 (m), 825 (m), 800 (w), 769 
(vs), 748 (s), 739 (vs), 687 (m), 638 (s), 617 (m), 580 (m), 569 (m), 552 (s); GC-MS (EI, 70 
eV): m/z (%) = 300 (45),  285 (100), 128 (13); HRMS (EI): calcd. for C21H20N2 ([M]
+
): 
300.16210; found: 300.16183. 
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9-(4-fluorophenyl)-9H-pyrido[2,3-b]indole 18d was prepared following 
general procedure 5 using 17a (100 mg, 0.37 mmol) and 4-fluoroaniline 
(53 µL, 0.56 mmol). The product was purified by flash chromatography 
(silica gel, heptane/ethylacetate 3:1) to yield 18d (87 mg, 89 %) as a white 
solid; m.p. 156-157 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.38 (dd, J = 4.9, 
1.6 Hz, 1H), 8.27 (dt, J = 5.0, 2.5 Hz, 1H), 8.02 (d, J = 7.8 Hz, 1H), 7.55 – 
7.46 (m, 2H), 7.42 – 7.29 (m, 2H), 7.28 – 7.10 (m, 4H) ; 19F NMR (282 MHz, CDCl3) δ = -
112.83 (s); 
13
C NMR (75 MHz, CDCl3) δ = 161.79 (d, J = 247.2 Hz), 152.02, 146.54, 140.17, 
132.23 (d, J = 3.1 Hz), 129.23 (d, J = 8.6 Hz), 128.39, 127.08, 121.04, 120.89, 120.83, 
116.66 (d, J = 22.8 Hz), 116.35, 116.22, 110.19; IR (ATR, cm
-1): ν = 3061 (w), 1589 (m), 
1570 (m), 1510 (s), 1475 (s), 1456 (s), 1416 (s), 1356 (m), 1336 (s), 1294 (s), 1228 (s), 1213 
(s), 1173 (s), 1151 (s), 1119 (s), 1092 (s), 1053 (m), 1020 (m), 1012 (m), 997 (m), 964 (m), 
953 (m), 941 (m), 931 (m), 924 (m), 899 (w), 870 (w), 856 (w), 833 (s), 816 (s), 798 (m), 769 
(vs), 762 (s), 746 (s), 737 (vs), 715 (s), 704 (s), 665 (m), 644 (m), 629 (m), 617 (m), 579 (s), 
569 (s); GC-MS (EI, 70 eV): m/z (%) =  261 (100), 131 (9); HRMS (ESI): calcd. for 
C17H11F1N2 ([M + H]
+
): 263.0979; found: 263.09813. 
9-(3-(trifluoromethyl)phenyl)-9H-pyrido[2,3-b]indole 18e was prepared 
following general procedure 5 using 17a (100 mg, 0.37 mmol) and 4-
fluoroaniline (53 µL, 0.56 mmol). The product was purified by flash 
chromatography (silica gel, heptane/ethylacetate 3:1) to yield 18e (87 mg, 
89 %) as a white solid; m.p. 71-72 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 
8.38 (dd, J = 4.9, 1.6 Hz, 1H), 8.28 (dd, J = 7.7, 1.6 Hz, 1H), 8.02 (dt, J = 7.8, 0.9 Hz, 1H), 
7.87 (s, 1H), 7.84 – 7.76 (m, 1H), 7.68 – 7.59 (m, 2H), 7.41 – 7.35 (m, 2H), 7.26 (ddd, J = 
8.2, 5.4, 2.9 Hz, 1H), 7.20 – 7.13 (m, 1H) ; 19F NMR (282 MHz, CDCl3) δ = -62.70 (s); 
13
C 
NMR (75 MHz, CDCl3) δ = 151.71, 146.56, 139.59, 136.99, 132.14 (q, J = 32.8 Hz), 130.73 
(d, J = 1.0 Hz), 130.25, 128.49, 127.28, 124.47 – 123.68 (m, 2xC), 123.83 (q, J = 272.6 Hz), 
121.31, 121.17, 121.14, 116.66, 116.57, 110.10; IR (ATR, cm
-1): ν = 3051 (w), 1612 (w), 
1591 (m), 1574 (m), 1497 (m), 1477 (m), 1458 (s), 1410 (s), 1358 (m), 1338 (m), 1321 (s), 
1306 (s), 1290 (s), 1275 (s), 1228 (s), 1178 (m), 1167 (s), 1155 (s), 1119 (vs), 1103 (s), 1093 
(s), 1068 (s), 1020 (m), 999 (m), 972 (s), 937 (m), 931 (m), 914 (m), 889 (m), 852 (m), 810 
(s), 796 (s), 771 (s), 760 (m), 744 (s), 737 (vs), 715 (m), 694 (vs), 661 (s), 642 (s), 619 (s), 
582 (m), 565 (m), 528 (s); GC-MS (EI, 70 eV): m/z (%) =  311 (100), 243 (11); HRMS 
(ESI): calcd. for C18H11F3N2 ([M + H]
+
): 313.09471; found: 313.09460. 
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9-(4-methoxyphenyl)-9H-pyrido[2,3-b]indole 18f was prepared 
following general procedure 5 using 17a (100 mg, 0.37 mmol) and p-
anisidine (69 mg, 0.56 mmol). The product was purified by flash 
chromatography (silica gel, heptane/ethylacetate 2:1) to yield 18f (100 
mg, 98 %) as a white solid; m.p. 137-138 ºC; 
1
H NMR (250 MHz, 
CDCl3) δ = 8.40 (dd, J = 4.9, 1.6 Hz, 1H), 8.30 (dd, J = 7.7, 1.6 Hz, 1H), 
8.04 (d, J = 7.7 Hz, 1H), 7.51 – 7.41 (m, 2H), 7.40 – 7.30 (m, 2H), 7.29 – 7.19 (m, 1H), 7.18 
– 7.09 (m, 1H), 7.09 – 7.01 (m, 2H), 3.82 (s, 3H); 13C NMR (63 MHz, CDCl3) δ = 159.00, 
152.24, 146.51, 140.55, 128.90, 128.73, 128.22, 126.86, 120.86, 120.60, 120.49, 116.17, 
115.81, 115.00, 110.30, 55.58; IR (ATR, cm
-1): ν = 3057 (w), 2960 (w), 2935 (w), 2908 (w), 
2835 (w), 1589 (m), 1570 (m), 1512 (s), 1477 (m), 1456 (s), 1441 (m), 1416 (s), 1358 (m), 
1336 (m), 1298 (m), 1288 (s), 1230 (vs), 1190 (m), 1174 (s), 1149 (m), 1117 (s), 1103 (s), 
1053 (w), 1028 (s), 999 (m), 962 (m), 951 (m), 939 (m), 930 (m), 918 (m), 847 (w), 827 (s), 
814 (m), 798 (m), 769 (vs), 744 (s), 735 (vs), 721 (s), 702 (m), 646 (s), 631 (s), 617 (m), 586 
(s), 579 (s), 571 (m), 530 (vs); GC-MS (EI, 70 eV): m/z (%) = 274 (100),  259 (55), 231 (25), 
168 (10), 115 (9); HRMS (EI): calcd. for C18H14O1N2 ([M]
+
): 274.11006; found: 274.10996. 
9-(4-(methylthio)phenyl)-9H-pyrido[2,3-b]indole 18g was prepared 
following general procedure 5 using 17a (100 mg, 0.37 mmol) and 4-
(methylthio)aniline (69 µL, 0.56 mmol). The product was purified by 
flash chromatography (silica gel, heptane/ethylacetate 2:1) to yield 18g 
(99 mg, 92 %) as a white solid; m.p. 136-137 ºC;
 1
H NMR (250 MHz, 
CDCl3) δ = 8.40 (dd, J = 4.9, 1.6 Hz, 1H), 8.30 (dd, J = 7.7, 1.6 Hz, 1H), 
8.04 (dt, J = 7.7, 1.0 Hz, 1H), 7.52 – 7.36 (m, 6H), 7.31 – 7.21 (m, 1H), 7.15 (dd, J = 7.6, 4.8 
Hz, 1H), 2.48 (s, 3H); 
13
C NMR (63 MHz, CDCl3) δ = 150.92, 145.46, 139.03, 137.06, 
132.25, 127.27, 126.70 (x2C), 125.94, 119.92, 119.78, 119.73, 115.32, 115.05, 109.30, 
15.00; IR (ATR, cm
-1): ν = 3039 (w), 2960 (m), 2920 (m), 1626 (w), 1589 (m), 1568 (m), 
1500 (s), 1475 (m), 1452 (m), 1437 (m), 1414 (s), 1356 (m), 1335 (m), 1309 (m), 1300 (m), 
1290 (s), 1259 (m), 1228 (s), 1182 (m), 1169 (m), 1151 (m), 1117 (m), 1103 (m), 1090 (s), 
1049 (m), 1014 (s), 997 (s), 980 (m), 970 (m), 953 (m), 933 (m), 924 (m), 858 (m), 814 (s), 
798 (s), 769 (vs), 735 (vs), 714 (s), 679 (m), 642 (s), 629 (s), 617 (m), 580 (m), 569 (m); GC-
MS (EI, 70 eV): m/z (%) = 290 (100), 275 (50), 243 (24); HRMS (EI): calcd. for C18H14N2S1 
([M]
+
): 290.08722; found: 290.08702. 
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9-(4-cyanophenyl)-9H-pyrido[2,3-b]indole 18h was prepared following 
general procedure 5 using 17a (100 mg, 0.37 mmol) and 4-
aminobenzonitrile (66 mg, 0.56 mmol). The product was purified by flash 
chromatography (silica gel, heptane/ethylacetate 1.5:1) to yield 18h (83 
mg, 83 %) as a white solid; m.p.  179-180 ºC; 
1
H NMR (250 MHz, 
CDCl3) δ = 8.38 (dd, J = 4.9, 1.6 Hz, 1H), 8.29 (dd, J = 7.7, 1.6 Hz, 1H), 
8.03 (d, J = 7.7 Hz, 1H), 7.48 – 7.16 (m, 8H); 13C NMR (63 MHz, CDCl3) δ = 151.32, 
146.45, 140.52, 138.85, 133.45, 128.58, 127.37, 127.28, 121.74, 121.45, 121.28, 118.52, 
117.11, 116.85, 110.41, 110.23; IR (ATR, cm
-1): ν = 3057 (w), 2227 (m), 1603 (m), 1591 
(m), 1574 (m), 1512 (m), 1487 (w), 1475 (w), 1450 (m), 1410 (s), 1356 (m), 1336 (m), 1311 
(w), 1286 (m), 1228 (m), 1217 (m), 1184 (w), 1169 (m), 1155 (w), 1119 (m), 1103 (w), 1057 
(w), 1020 (w), 1001 (w), 960 (w), 953 (w), 945 (w), 928 (w), 856 (m), 833 (m), 823 (m), 800 
(w), 789 (w), 773 (m), 766 (s), 744 (m), 735 (vs), 694 (m), 656 (w), 631 (m), 619 (w), 577 
(m), 569 (m), 550 (s), 532 (m); GC-MS (EI, 70 eV): m/z (%) = 268 (100), 134 (7); HRMS 
(EI): calcd. for C18H10N3 ([M]
+
): 268.08692; found: 268.08700. 
General procedure 6 for double C-N coupling with chain amine derivatives, exemplified 
by: 5-benzyl-5H-pyrido[3,2-b]indole 18i 
 
To pressure tube charged with 17a (100 mg, 0.37 mmol), Pd2(dba)3 (17 mg, 19 µmol), ligand 
DPEPhos (21 mg, 37 µmol) and sodium tert-butoxide (107 mg, 0.12 mmol) under Argon. 
The mixture was back-filled with argon several times. The mixture was dissolved in 
anhydrous toluene (10 mL). Benzylamine (61 µL, 0.56 mmol) was added to the mixture and 
heated at 100 ºC for 7 h. After cooling, the reaction mixture was diluted with 
dichloromethane (20 mL) and filtered through a celite pad, washing with dichloromethane 
(40 mL). The filtrate was reduced in vacuo. The product was separated via flash 
chromatography (silica gel, heptane/ethylacetate 3:1) to yield 18i (85 mg, 88 %) as a white 
solid; m.p. 98-99 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 8.41 (dd, J = 4.9, 1.6 Hz, 1H), 8.20 
(dd, J = 7.7, 1.6 Hz, 1H), 7.99 – 7.92 (m, 1H), 7.36 – 7.20 (m, 2H), 7.19 – 7.01 (m, 7H), 5.58 
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(s, 2H) ; 
13
C NMR (63 MHz, CDCl3) δ = 150.65, 145.10, 138.49, 136.25, 127.55, 127.08, 
126.26, 125.88, 125.68, 119.92, 119.56, 118.93, 114.79, 114.24, 108.80, 43.87; IR (ATR, cm
-
1): ν = 3028 (w), 2960 (w), 2918 (w), 1626 (w), 1589 (m), 1568 (m), 1483 (s), 1466 (s), 1452 
(m), 1431 (s), 1412 (s), 1356 (m), 1348 (m), 1333 (m), 1315 (w), 1292 (m), 1259 (s), 1211 
(s), 1194 (m), 1155 (m), 1128 (m), 1119 (m), 1092 (m), 1078 (m), 1065 (m), 1053 (m), 1030 
(s), 1020 (s), 995 (s), 970 (m), 947 (m), 928 (w), 906 (w), 870 (w), 850 (m), 839 (m), 800 (s), 
791 (s), 773 (vs), 748 (s), 729 (vs), 694 (s), 652 (s), 619 (m), 606 (m), 582 (m), 569 (m), 555 
(s), 528 (s); GC-MS (EI, 70 eV): m/z (%) =  257 (100), 181 (34), 91 (45); HRMS (ESI): 
calcd. for C18H14N2 ([M + H]
+
): 259.12297; found: 259.12298. 
5-(4-fluorobenzyl)-5H-pyrido[3,2-b]indole 18j was prepared 
following general procedure 6 using 17a (100 mg, 0.37 mmol) and 
4-fluorobenzylamine (61 µL, 0.56 mmol). The product was purified 
by flash chromatography (silica gel, heptane/ethylacetate 3:1) to 
yield 18j (90 mg, 87 %) as a white solid; m.p. 103-104 ºC; 
1
H NMR 
(300 MHz, CDCl3) δ = 8.43 (dd, J = 4.9, 1.6 Hz, 1H), 8.25 (dd, J = 7.7, 1.6 Hz, 1H), 8.02 – 
7.96 (m, 1H), 7.36 (ddd, J = 8.3, 7.2, 1.2 Hz, 1H), 7.28 – 7.07 (m, 5H), 6.89 – 6.79 (m, 2H), 
5.57 (s, 2H) ; 
19
F NMR (282 MHz, CDCl3) δ = -115.23 (s); 
13
C NMR (75 MHz, CDCl3) δ = 
161.07 (d, J = 245.4 Hz), 150.56, 145.15, 138.33, 132.02 (d, J = 3.2 Hz), 127.62 (d, J = 8.1 
Hz), 127.20, 125.77, 120.05, 119.63, 119.09, 114.85, 114.47 (d, J = 21.6 Hz), 114.39, 108.65, 
43.24; IR (ATR, cm
-1): ν = 3053 (w), 3034 (w), 2935 (w), 1624 (w), 1587 (m), 1572 (m), 
1508 (s), 1481 (m), 1464 (s), 1439 (m), 1416 (s), 1383 (w), 1354 (m), 1335 (m), 1294 (m), 
1252 (m), 1217 (s), 1207 (s), 1163 (m), 1128 (m), 1119 (m), 1101 (m), 1061 (m), 1049 (m), 
1030 (w), 1020 (m), 1001 (w), 987 (m), 966 (w), 928 (w), 862 (m), 849 (m), 823 (m), 800 
(m), 791 (m), 777 (vs), 762 (s), 746 (s), 735 (vs), 704 (m), 665 (w), 638 (m), 629 (s), 619 
(m), 609 (m), 580 (m), 565 (m); GC-MS (EI, 70 eV): m/z (%) =  276 (100), 181 (30), 109 
(73); HRMS (ESI): calcd. for C18H13F1N2 ([M + H]
+
): 277.11355; found: 277.11394. 
5-(3-(trifluoromethyl)benzyl)-5H-pyrido[3,2-b]indole 18k was 
prepared following general procedure 6 using 17a (100 mg, 0.37 
mmol) and 3-(trifluoromethyl)benzylamine (80 µL, 0.56 mmol). 
The product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 3:1) to yield 18k (109 mg, 90 %) as a white 
solid; m.p. 81-82 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.39 (dd, J 
General procedures and spectroscopic data  123 
 
 
= 4.9, 1.6 Hz, 1H), 8.21 (dd, J = 7.7, 1.6 Hz, 1H), 7.96 (d, J = 7.8 Hz, 1H), 7.49 (s, 1H), 7.39 
– 7.30 (m, 2H), 7.21 – 7.17 (m, 4H), 7.12 – 7.03 (m, 1H), 5.60 (s, 2H); 19F NMR (282 MHz, 
CDCl3) δ = -62.51 (s); 
13
C NMR (75 MHz, CDCl3) δ = 151.65, 146.29, 139.36, 138.47, 
131.04 (q, J = 32.3 Hz), 130.30, 129.26, 128.36, 126.99, 124.38 (q, J = 3.8 Hz), 124.06 (q, J 
= 272.4 Hz), 123.89 (q, J = 3.8 Hz), 121.23, 120.81, 120.37, 115.99, 115.68, 109.55, 44.61; 
IR (ATR, cm
-1): ν = 3053 (w), 1628 (w), 1591 (m), 1572 (m), 1483 (m), 1466 (m), 1450 (w), 
1433 (m), 1416 (s), 1325 (vs), 1296 (m), 1281 (m), 1261 (m), 1217 (m), 1205 (m), 1186 (m), 
1157 (s), 1117 (vs), 1097 (s), 1072 (vs), 1022 (m), 1011 (m), 993 (m), 966 (m), 937 (m), 922 
(m), 903 (m), 868 (m), 852 (m), 800 (s), 791 (s), 771 (s), 744 (s), 735 (s), 702 (vs), 671 (m), 
646 (s), 619 (m), 600 (m), 575 (m), 559 (m); GC-MS (EI, 70 eV): m/z (%) =  326 (100), 181 
(62), 159 (20), 140 (13), 109 (13); HRMS (ESI): calcd. for C19H13F3N2 ([M + H]
+
): 
327.11036; found: 327.11066. 
5-propyl-5H-pyrido[3,2-b]indole 18l was prepared following general 
procedure 6 using 17a (100 mg, 0.37 mmol) and n-propylamine (46 µL, 
0.56 mmol). The product was purified by flash chromatography (silica 
gel, heptane/ethylacetate 3:1) to yield 18l (71 mg, 91 %) as a white liquid; 
1
H NMR (300 MHz, CDCl3) δ = 8.38 (dd, J = 4.9, 1.6 Hz, 1H), 8.16 (dd, 
J = 7.6, 1.6 Hz, 1H), 7.97 – 7.89 (m, 1H), 7.43 – 7.29 (m, 2H), 7.14 (ddd, J = 8.0, 6.9, 1.4 Hz, 
1H), 7.01 (dd, J = 7.6, 4.9 Hz, 1H), 4.37 – 4.26 (m, 2H), 1.90 – 1.73 (m, 2H), 0.86 (t, J = 7.4 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3) δ = 151.61, 145.94, 139.71, 128.03, 126.61, 121.03, 
120.44, 119.62, 115.83, 114.86, 109.38, 43.16, 22.32, 11.65; IR (ATR, cm
-1): ν = 3049 (w), 
2962 (m), 2929 (m), 2874 (w), 1626 (w), 1589 (m), 1570 (m), 1481 (s), 1466 (s), 1443 (m), 
1414 (vs), 1381 (m), 1371 (m), 1360 (m), 1342 (s), 1333 (s), 1313 (w), 1290 (s), 1255 (m), 
1219 (s), 1157 (m), 1138 (m), 1128 (m), 1119 (s), 1090 (w), 1068 (m), 1049 (w), 1018 (w), 
997 (m), 960 (w), 926 (w), 893 (w), 845 (w), 800 (w), 771 (vs), 748 (s), 733 (vs), 712 (m), 
633 (m), 619 (m), 580 (m), 561 (m); GC-MS (EI, 70 eV): m/z (%) = 210 (32), 181 (100), 168 
(82), 140 (12), 127 (14); HRMS (EI): calcd. for C14H14N2 ([M]
+
): 210.11515; found: 
210.11500. 
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General procedure 7 for double C-N coupling with diamine derivatives, exemplified by: 
1,4-bis(9H-pyrido[2,3-b]indol-9-yl)benzene 7a 
 
 
To pressure tube was charged with 17a (200 mg, 0.75 mmol), 1,4-diaminobenzen (37 mg, 
0.34 mmol), Pd2(dba)3 (15 mg, 17 µmol), ligand Dppf (19 mg, 34 µmol) and sodium tert-
butoxide (195 mg, 2.0 mmol) under Argon. The mixture was back-filled with Argon several 
times. The mixture was dissolved in anhydrous Toluene (10 mL) and heated at 110 ºC for 10 
h. After cooling, the reaction mixture was diluted with dichloromethane (20 mL) and filtered 
through a celite pad, washing with dichloromethane (40 mL). The filtrate was reduced in 
vacuo. The product was separated via flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 1:1:1) to yield 1,4-bis(9H-pyrido[2,3-b]indol-9-
yl)benzene 20a (64 mg, 46 %) as a white solid; m.p. 307-308 ºC; 
1
H NMR (300 MHz, 
CDCl3) δ = 8.46 (dd, J = 4.8, 1.4 Hz, 2H), 8.34 (dt, J = 9.4, 4.7 Hz, 2H), 8.09 (d, J = 7.7 Hz, 
2H), 7.87 (s, 4H), 7.62 (d, J = 8.2 Hz, 2H), 7.50 – 7.37 (m, 2H), 7.30 (t, J = 7.5 Hz, 2H), 7.25 
– 7.16 (m, 2H). 13C NMR (75 MHz, CDCl3) δ = 151.90 (x2C), 146.48 (x2C), 139.94 (x2C), 
135.34 (x2C), 128.42 (x2C), 128.32 (x4C), 127.14 (x2C), 121.02 (x4C), 116.61 (x2C), 
116.37 (x2C), 110.73 (x2C); IR (ATR, cm
-1): ν = 3045 (m), 2922 (m), 1591 (m), 1572 (m), 
1518 (s), 1481 (m), 1450 (s), 1406 (s), 1356 (m), 1338 (s), 1317 (m), 1290 (s), 1228 (s), 1173 
(m), 1128 (m), 1120 (m), 1111 (m), 1051 (m), 1018 (m), 999 (m), 928 (m), 918 (m), 827 (m), 
762 (s), 742 (s), 727 (vs), 700 (s), 642 (s), 619 (m), 579 (m), 567 (m), 534 (s); GC-MS (EI, 
70 eV): m/z (%) = 410 (100), 242 (24), 205 (23), 191 (12); HRMS (EI): calcd. for C28H18N4 
([M]
+
): 410.15260; found: 410.15147. 
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9-(6-(9H-indeno[2,1-b]pyridin-9-yl)pyridin-2-yl)-9H-
pyrido[2,3-b]indole 20b was prepared following general 
procedure 7 using 17a (200 mg, 0.75 mmol) and 2,6-
diaminopyridine (37 mg, 0.34 mmol). The product was 
purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 1:1:1) to yield 20b (70 mg, 50 %) as a white solid; 
m.p. 236-237 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.51 (dd, J = 4.8, 1.5 Hz, 2H), 8.43 – 8.29 
(m, 4H), 8.29 – 8.21 (m, 2H), 8.13 (dd, J = 8.8, 7.1 Hz, 1H), 8.00 (t, J = 9.9 Hz, 2H), 7.38 – 
7.14 (m, 6H); 
13
C NMR (75 MHz, CDCl3) δ = 151.36, 149.76, 146.01, 140.02, 139.02, 
128.26, 127.54, 121.79, 121.57, 120.37, 117.76, 117.15, 116.61, 114.34; IR (ATR, cm
-1): ν = 
3047 (w), 2922 (w), 1599 (m), 1591 (s), 1570 (m), 1485 (w), 1450 (vs), 1414 (m), 1400 (vs), 
1362 (m), 1340 (m), 1331 (s), 1286 (s), 1242 (m), 1223 (m), 1209 (m), 1180 (s), 1165 (m), 
1155 (m), 1120 (m), 1105 (m), 1095 (m), 1057 (m), 1039 (m), 1026 (m), 999 (m), 985 (w), 
974 (w), 968 (w), 957 (w), 943 (m), 933 (m), 922 (m), 849 (w), 796 (m), 764 (vs), 744 (s), 
727 (vs), 700 (m), 683 (m), 658 (m), 634 (m), 619 (m), 611 (m), 579 (m), 567 (w), 559 (m); 
GC-MS (EI, 70 eV): m/z (%) = 410 (100), 244 (28), 206 (89); HRMS (EI): calcd. for 
C27H16N5 ([M]
+
): 410.14002; found: 410.13958. 
Procedure for preparation of 3-bromo-2-(2-bromophenyl)pyridine 17b.  
 
2,3-dibromopyridine 1b (1 g, 4.2 mmol), 2-bromophenyl boronic acid 2 (1.0 g, 5.1 mmol), 
Pd(PPh3)4 (244 mg, 211 µmol) and sodium hydroxide (507 mg, 12.7 mmol) were added to 
500 mL Schlenk flask. The mixture was back-filled several times with Argon. To the mixture 
70 mL THF and 10 mL distilled water were added, then, back-filled with argon several times. 
The reaction was heated at 70 ºC for 4h. The solvent was evaporated in vacuo. The residue 
was extracted with dichloromethane and water. The organic layer was dried over MgSO4, 
filtered and the solvent was evaporated in vacuo. The yellow residue was purified by column 
chromatography (silica gel, Heptane/dichloromethane/ethylacetate 4:1:1) to yield 3-bromo-2-
(2-bromophenyl)pyridine  17b  (1.27 g, 96 %) as colorless syrup; 
1
H NMR (300 MHz, 
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CDCl3) δ = 8.57 (dd, J = 4.7, 1.5 Hz, 1H), 7.93 (dd, J = 8.1, 1.5 Hz, 1H), 7.63 – 7.58 (m, 1H), 
7.39 – 7.32 (m, 1H), 7.29 – 7.13 (m, 7H); 13C NMR (75 MHz, CDCl3) δ = 147.84, 140.99, 
140.46, 132.69, 130.23, 130.08, 127.34, 124.13, 122.46, 121.35; IR (ATR, cm
-1): ν = 3053 
(w), 2920 (w), 2850 (w), 1593 (m), 1568 (m), 1549 (m), 1479 (m), 1437 (m), 1412 (s), 1298 
(w), 1269 (w), 1252 (m), 1230 (w), 1211 (w), 1201 (w), 1159 (w), 1124 (m), 1093 (m), 1055 
(m), 1024 (s), 1011 (vs), 943 (m), 793 (s), 777 (m), 748 (vs), 723 (s), 694 (m), 681 (s), 650 
(m), 615 (s), 561 (m); GC-MS (EI, 70 eV): m/z (%) = 313 (37), 234 (99), 233 (100), 153 
(82), 126 (28), 99 (10), 75 (14), 63 (10), 50 (12); HRMS (EI): calcd. for C11H7N1Br2 ([M]
+
): 
310.89398; found: 310.89479; calcd. for C11H7N1Br1
81
Br1 ([M]
+
): 312.89193; found: 
312.89233; calcd. for C11H7N1
81
Br2 ([M]
+
): 314.88988; found: 314.89073. 
 
General procedure 8 for double C-N coupling with aniline derivatives, exemplified by: 
5-phenyl-5H-pyrido[3,2-b]indole 21a 
 
Aniline (44 µL, 479 µmol) was added to pressure tube charged with 17b (100 mg, 0.32 
mmol), Pd2(dba)3 (15 mg, 16 µmol), ligand Dppf (18 mg, 32 µmol) and sodium tert-butoxide 
(92 mg, 0.96 mmol) under Argon. The mixture was back-filled with Argon several times. The 
mixture was dissolved in anhydrous Toluene (10 mL) and heated at 100 ºC for 4 h. After 
cooling, the reaction mixture was diluted with dichloromethane (20 mL) and filtered through 
a celite pad, washing with dichloromethane (40 mL). The filtrate was reduced in vacuo. The 
product was separated via flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 10:1:1) to yield 5-phenyl-5H-pyrido[3,2-b]indole 21a 
(65 mg, 83%) as a white solid; m.p. 99-101 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 8.50 (dd, J = 
4.7, 1.3 Hz, 1H), 8.40 – 8.30 (m, 1H), 7.60 – 7.12 (m, 11H); 13C NMR (63 MHz, CDCl3) δ = 
142.54, 142.26, 141.54, 136.84, 134.31, 130.04, 127.95, 127.80, 126.79, 122.45, 120.87, 
120.83, 120.18, 116.72, 110.04; IR (ATR, cm
-1): ν = 3053 (m), 1622 (m), 1593 (s), 1574 (m), 
1502 (s), 1481 (s), 1452 (s), 1412 (vs), 1371 (m), 1340 (m), 1315 (m), 1304 (s), 1282 (m), 
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1234 (m), 1209 (s), 1178 (m), 1167 (m), 1147 (m), 1119 (m), 1107 (m), 1072 (m), 1026 (m), 
1011 (m), 931 (m), 906 (m), 787 (m), 777 (s), 762 (s), 744 (vs), 727 (vs), 698 (vs), 665 (m), 
642 (m), 633 (s), 615 (s), 582 (m), 567 (m), 534 (m); GC-MS (EI, 70 eV): m/z (%) =  244 
(100), 216 (4), 189 (3), 167 (3), 152 (3), 140 (4), 122 (9), 88 (3), 77 (4), 63 (3), 51 (5), 39 (4); 
HRMS (EI): calcd. for C17H12N2 ([M]
+
): 244.09950; found: 244.09922.  
5-(4-fluorophenyl)-5H-pyrido[3,2-b]indole 21b was prepared following 
general procedure 8 using 17b (100 mg, 0.32 mmol) and 4-fluoroaniline 
(45 µL, 0.48 mmol). The product was purified by flash chromatography 
(silica gel, heptane/dichloromethane/ethylacetate 8:1:1) to yield 21b (61 
mg, 73 %) as a white solid; m.p. 115-117 ºC;  
1
H NMR (250 MHz, 
CDCl3) δ = 8.49 (dd, J = 4.7, 1.3 Hz, 1H), 8.39 – 8.29 (m, 1H), 7.53 – 
7.32 (m, 4H), 7.31 – 7.11 (m, 3H), 6.78 – 6.65 (m, 1H), 6.48 (ddd, J = 6.7, 5.2, 2.9 Hz, 1H); 
19
F NMR (282 MHz, CDCl3) δ = -112.83 (s); 
13
C NMR (63 MHz, CDCl3) δ = 161.79 (d, J = 
248.2 Hz), 142.62, 141.69, 134.45, 132.77, 128.73 (d, J = 8.6 Hz), 128.06, 122.38, 120.94, 
120.27, 117.24, 116.88, 116.50, 115.61 (d, J = 22.4 Hz), 109.80; IR (ATR, cm
-1): ν = 3055 
(m), 3037 (m), 1620 (m), 1587 (m), 1506 (vs), 1477 (s), 1452 (s), 1412 (s), 1354 (m), 1342 
(m), 1311 (s), 1294 (m), 1281 (m), 1215 (s), 1207 (s), 1169 (s), 1151 (s), 1119 (m), 1105 (m), 
1093 (s), 1049 (m), 1034 (m), 1028 (m), 1011 (m), 937 (m), 912 (s), 845 (s), 833 (s), 816 (s), 
781 (s), 764 (m), 742 (vs), 727 (vs), 715 (s), 700 (s), 646 (m), 627 (m), 617 (s), 575 (s), 534 
(s); GC-MS (EI, 70 eV): m/z (%) = 262 (100), 261 (29), 131 (10); HRMS (EI): calcd. for 
C17H11F1N2 ([M]
+
): 262.09008; found: 262.08948. 
5-(3-(trifluoromethyl)phenyl)-5H-pyrido[3,2-b]indole 21c was 
prepared following general procedure 8 using 17b (100 mg, 0.32 
mmol) and 3-(trifluoromethyl)aniline (60 µL, 0.48 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 8:1:1) to yield 21c (64 mg, 64 
%) as a white solid; m.p. 144-146 ºC;  
1
H NMR (250 MHz, CDCl3) δ 
= 8.54 (dd, J = 4.7, 1.3 Hz, 1H), 8.47 – 8.29 (m, 1H), 7.84 – 7.53 (m, 5H), 7.52 – 7.14 (m, 
4H); 
19
F NMR (282 MHz, CDCl3) δ = -62.70 (s); 
13
C NMR (63 MHz, CDCl3) δ = 143.08, 
142.52, 141.17, 137.65, 133.96, 132.76 (q, J = 33.2 Hz), 130.80, 130.03, 128.26, 124.44 (q, J 
= 3.6 Hz), 123.61 (q, J = 3.6 Hz), 122.75, 121.41, 121.09, 120.39, 116.43, 109.66; IR (ATR, 
cm
-1): ν = 3055 (w), 3041 (w), 1622 (m), 1606 (w), 1595 (m), 1579 (w), 1498 (m), 1481 (m), 
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1456 (s), 1412 (s), 1362 (m), 1356 (m), 1333 (m), 1309 (s), 1292 (m), 1275 (m), 1232 (m), 
1217 (m), 1207 (m), 1182 (s), 1163 (s), 1155 (s), 1117 (vs), 1095 (s), 1074 (s), 1028 (m), 
1014 (m), 1001 (m), 966 (m), 945 (m), 935 (m), 928 (m), 918 (m), 906 (m), 854 (w), 810 
(m), 802 (s), 791 (m), 781 (s), 760 (w), 744 (vs), 727 (s), 715 (s), 706 (vs), 673 (m), 663 (s), 
638 (m), 621 (m), 607 (m), 582 (w), 563 (w), 536 (m); GC-MS (EI, 70 eV): m/z (%) = 312 
(100), 242 (8); HRMS (EI): calcd. for C18H11F3N2 ([M]
+
): 312.08688; found: 312.08662. 
5-(4-methoxyphenyl)-5H-pyrido[3,2-b]indole 21d was prepared 
following general procedure 8 using 17b (100 mg, 0.32 mmol) and p-
anisidine (59 mg, 0.48 mmol). The product was purified by flash 
chromatography (silica gel, heptane/dichloromethane/ethylacetate 5:1:1) 
to yield 21d (88 mg, 94 %) as a white solid; m.p. 128-130 ºC; 
1
H NMR 
(250 MHz, CDCl3) δ = 8.53 (dd, J = 4.7, 1.3 Hz, 1H), 8.43 – 8.30 (m, 
1H), 7.55 (dd, J = 8.3, 1.4 Hz, 1H), 7.50 – 7.21 (m, 6H), 7.11 – 6.99 (m, 2H), 3.85 (s, 3H); 
13
C NMR (63 MHz, CDCl3) δ = 159.13, 142.22, 142.06, 134.81, 129.36, 128.30, 127.90, 
122.13, 120.85, 120.59, 120.12, 116.68, 115.22, 109.97, 55.62; IR (ATR, cm
-1): ν = 2955 
(w), 2929 (w), 2837 (w), 1620 (m), 1510 (vs), 1479 (m), 1454 (s), 1441 (m), 1414 (s), 1385 
(w), 1342 (m), 1313 (s), 1300 (m), 1286 (m), 1242 (s), 1209 (s), 1176 (s), 1149 (m), 1120 
(m), 1107 (s), 1066 (m), 1028 (s), 1012 (m), 937 (m), 912 (m), 860 (w), 829 (s), 812 (m), 791 
(s), 748 (vs), 729 (vs), 700 (s), 667 (m), 646 (m), 629 (m), 617 (s), 584 (s), 536 (s); GC-MS 
(EI, 70 eV): m/z (%) = 274 (100), 259 (55), 231 (13), 230 (15), 229 (14), 115 (9); HRMS 
(EI): calcd. for C18H14O1N2 ([M]
+
): 274.11006; found: 274.11009. 
55-(3,5-dimethoxyphenyl)-5H-pyrido[3,2-b]indole 21e was prepared 
following general procedure 8 using 17b (100 mg, 0.32 mmol) and 
3,5-dimethoxyaniline (73 mg, 0.48 mmol). The product was purified 
by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 3:1:1) to yield 21d (88 mg, 94 
%) as a white solid; m.p. 150-152  ºC; 
1
H NMR (250 MHz, CDCl3) δ 
= 8.58 – 8.41 (m, 1H), 8.33 (dd, J = 7.7, 0.7 Hz, 1H), 7.64 (dd, J = 8.3, 1.3 Hz, 1H), 7.53 – 
7.12 (m, 4H), 6.57 (d, J = 2.2 Hz, 2H), 6.45 (t, J = 2.2 Hz, 1H), 3.71 (s, J = 9.9 Hz, 6H); 
13
C 
NMR (63 MHz, CDCl3) δ = 161.82, 142.55, 142.26, 141.37, 138.46, 134.17, 127.95, 122.48, 
120.82, 120.20, 116.99, 110.33, 104.96, 99.76, 93.72, 55.59; IR (ATR, cm
-1): ν = 3051 (m), 
3007 (m), 2970 (m), 2945 (m), 2916 (m), 2841 (m), 1620 (m), 1605 (s), 1583 (s), 1495 (m), 
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1475 (m), 1452 (s), 1425 (s), 1416 (s), 1367 (m), 1342 (m), 1331 (m), 1313 (s), 1296 (s), 
1282 (s), 1252 (m), 1223 (m), 1194 (s), 1147 (vs), 1057 (s), 1009 (s), 991 (m), 928 (m), 906 
(m), 868 (m), 852 (m), 833 (s), 823 (s), 783 (s), 773 (s), 741 (s), 723 (vs), 696 (s), 690 (s), 
675 (s), 660 (s), 621 (s), 607 (s), 573 (s), 557 (m), 532 (m); GC-MS (EI, 70 eV): m/z (%) = 
304 (100), 261 (8), 245 (10), 218 (7); HRMS (EI): calcd. for C19H16O2N2 ([M]
+
): 304.12063; 
found: 304.12015. 
5-(4-cyanophenyl)-5H-pyrido[3,2-b]indole 21f was prepared following 
general procedure 8 using 17b (100 mg, 0.32 mmol) and 4-
aminobenzonitrile (56 mg, 0.48 mmol). The product was purified by 
flash chromatography (silica gel, heptane/dichloromethane/ethylacetate 
4:1:1) to yield 21f (36 mg, 42 %) as a white solid; m.p. 162-164 ºC; 
1
H 
NMR (250 MHz, CDCl3) δ = 8.57 (dd, J = 4.7, 1.3 Hz, 1H), 8.41 – 8.33 
(m, 1H), 7.90 – 7.81 (m, 2H), 7.71 – 7.60 (m, 3H), 7.52 – 7.23 (m, 4H), 13C NMR (63 MHz, 
CDCl3) δ = 143.51, 142.86, 141.21, 140.63, 134.10, 133.45, 128.42, 126.86, 123.12, 121.88, 
121.23, 120.49, 118.10, 116.59, 111.02, 109.77; IR (ATR, cm
-1): ν = 3051 (w), 3007 (w), 
2226 (m), 1616 (w), 1601 (s), 1587 (m), 1558 (w), 1506 (s), 1489 (w), 1479 (m), 1454 (m), 
1412 (s), 1373 (w), 1354 (m), 1340 (m), 1315 (s), 1290 (m), 1246 (w), 1234 (m), 1221 (m), 
1207 (s), 1182 (m), 1169 (m), 1153 (m), 1136 (m), 1128 (m), 1117 (m), 1107 (m), 1053 (w), 
1028 (w), 1014 (m), 978 (w), 968 (w), 953 (w), 935 (w), 916 (m), 885 (w), 841 (s), 783 (s), 
748 (vs), 731 (vs), 723 (s), 667 (m), 656 (m), 631 (m), 619 (s), 582 (w), 567 (m), 552 (s), 528 
(m); GC-MS (EI, 70 eV): m/z (%) = 269 (100), 270 (25), 75 (7), 39 (7); HRMS (EI): calcd. 
for C18H11N3 ([M]
+
): 269.09475; found: 269.09432. 
General procedure 9 for double C-N coupling with chain amine derivatives, exemplified 
by: 5-benzyl-5H-pyrido[3,2-b]indole 21g 
 
To pressure tube charged with 17b (100 mg, 0.32 mmol), Pd2(dba)3 (15 mg, 16 µmol), ligand 
DPEPhos (17 mg, 32 µmol) and sodium tert-butoxide (92 mg, 0.96 mmol) under Argon. The 
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mixture was back-filled with argon several times. The mixture was dissolved in anhydrous 
toluene (10 mL). Benzylamine 4i (52 µL, 0.48 mmol) was added to the mixture and heated at 
100 ºC for 7 h. After cooling, the reaction mixture was diluted with dichloromethane (20 mL) 
and filtered through a celite pad, washing with dichloromethane (40 mL). The filtrate was 
reduced in vacuo. The product was separated via flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 5:1:1) to yield 21g (76 mg, 92 %) as a white solid; m.p.  
137-139 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 8.43 (dd, J = 4.7, 1.2 Hz, 1H), 8.32 (d, J = 7.7 
Hz, 1H), 7.45 – 7.30 (m, 2H), 7.28 – 7.01 (m, 6H), 6.93 (dd, J = 6.7, 2.6 Hz, 2H), 5.26 (s, 
2H); 
13
C NMR (63 MHz, CDCl3) δ = 140.82, 140.75, 140.27, 135.40, 132.91, 127.78, 
126.80, 126.62, 125.25, 121.08, 119.82, 119.07, 118.93, 114.75, 108.14, 45.35; IR (ATR, cm
-
1): ν = 3051 (w), 3028 (w), 2926 (w), 1622 (m), 1603 (w), 1589 (m), 1576 (w), 1558 (w), 
1495 (m), 1483 (m), 1458 (s), 1450 (s), 1414 (s), 1373 (m), 1356 (w), 1335 (s), 1319 (s), 
1281 (w), 1263 (w), 1242 (m), 1211 (m), 1194 (s), 1178 (m), 1149 (m), 1132 (m), 1117 (m), 
1080 (m), 1057 (w), 1047 (w), 1028 (m), 1012 (m), 999 (w), 972 (w), 962 (w), 937 (w), 912 
(w), 845 (m), 802 (w), 789 (m), 781 (s), 742 (vs), 731 (vs), 721 (vs), 694 (s), 644 (m), 621 
(m), 600 (m), 584 (m), 567 (m), 557 (m), 536 (m);  GC-MS (EI, 70 eV): m/z (%) = 258 (88), 
181 (5), 167 (8), 91 (100), 39 (9); HRMS (EI): calcd. for C18H14N2 ([M]
+
): 258.11515; found: 
258.11534. 
5-(4-methoxybenzyl)-5H-pyrido[3,2-b]indole 21h was prepared 
following general procedure 9 using compound  17b (100 mg, 0.32 
mmol) and 4-methoxybenzylamine (63 µL, 0.48 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 3:1:1) to yield 21h (60 mg, 
65 %) as a white solid; m.p. 124-126 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.42 (dd, J = 4.7, 
1.3 Hz, 1H), 8.36 – 8.28 (m, 1H), 7.48 – 7.31 (m, 2H), 7.30 – 7.07 (m, 3H), 6.88 (t, J = 5.8 
Hz, 2H), 6.68 – 6.58 (m, 2H), 5.22 (s, 2H), 3.57 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 
159.15, 141.92, 141.77, 141.37, 134.01, 128.51, 127.90, 127.71, 122.17, 120.94, 120.12, 
120.02, 115.94, 114.27, 109.30, 55.24, 46.00; IR (ATR, cm
-1): ν = 2931 (w), 2835 (w), 1624 
(m), 1610 (m), 1583 (m), 1512 (s), 1485 (s), 1460 (s), 1443 (m), 1412 (s), 1377 (m), 1354 
(w), 1323 (s), 1308 (s), 1246 (vs), 1211 (m), 1203 (m), 1194 (s), 1178 (s), 1155 (m), 1134 
(m), 1113 (s), 1059 (w), 1034 (s), 1009 (m), 984 (m), 962 (m), 939 (w), 864 (w), 845 (s), 837 
(m), 820 (m), 791 (s), 775 (s), 746 (vs), 727 (vs), 708 (s), 665 (m), 640 (m), 625 (s), 600 (s), 
582 (m), 565 (m), 540 (s); GC-MS (EI, 70 eV): m/z (%) = 288 (29), 242 (3), 167 (8), 140 (5), 
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121 (100), 91 (7), 78 (10), 77 (9); HRMS (EI): calcd. for C19H16N2O1 ([M]
+
): 288.12571; 
found: 288.12541. 
5-phenethyl-5H-pyrido[3,2-b]indole 21i was prepared following general 
procedure 9 using compound  17b (100 mg, 0.32 mmol) and 2-
phenylethylamine (60 µL, 0.48 mmol). The product was purified by flash 
chromatography (silica gel, heptane/dichloromethane/ethylacetate 5:1:1) 
to yield 21j (67 mg, 77 %) as a white solid; m.p. 61-63 ºC; 
1
H NMR (300 
MHz, CDCl3) δ = 8.38 (dd, J = 4.7, 1.3 Hz, 1H), 8.29 (d, J = 7.7 Hz, 1H), 
7.38 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.28 – 7.13 (m, 3H), 7.13 – 6.96 (m, 4H), 6.96 – 6.82 (m, 
2H), 4.30 (t, J = 7.2 Hz, 2H), 2.93 (t, J = 7.2 Hz, 2H); 
13
C NMR (63 MHz, CDCl3) δ = 
141.61, 141.46, 140.80, 138.37, 133.73, 128.73, 128.66, 127.66, 126.76, 122.05, 120.91, 
119.88, 119.75, 115.45, 108.91, 44.82, 35.27; IR (ATR, cm
-1): ν = 3051 (w), 3041 (w), 3026 
(w), 3001 (w), 2964 (w), 2939 (w), 2922 (w), 1622 (m), 1603 (w), 1587 (m), 1562 (w), 1483 
(s), 1462 (s), 1452 (s), 1414 (vs), 1377 (m), 1360 (m), 1342 (s), 1319 (s), 1248 (w), 1223 (s), 
1200 (m), 1186 (s), 1151 (m), 1132 (m), 1122 (m), 1080 (m), 1065 (w), 1049 (w), 1028 (m), 
1009 (m), 974 (w), 962 (w), 939 (w), 926 (w), 881 (w), 856 (w), 839 (w), 791 (m), 777 (m), 
764 (w), 742 (vs), 727 (vs), 696 (vs), 642 (w), 623 (m), 613 (m), 606 (m), 590 (m), 582 (w), 
565 (w), 548 (m), 540 (m); GC-MS (EI, 70 eV): m/z (%) = 272 (23),  181 (100), 154 (5), 127 
(12), 91 (5), 78 (5); HRMS (EI): calcd. for C19H16N2 ([M]
+
): 272.13080; found: 272.13063. 
Synthesis of 1,4-bis(5H-pyrido[3,2-b]indol-5-yl)benzene 22 
 
 
A pressure tube was charged with 17b (200 mg, 0.64 mmol), 1,4-diaminobenzene (34 mg, 
0.32 mmol), Pd2(dba)3 (12 mg, 13 µmol), ligand Dppf (14 mg, 26 µmol) and sodium tert-
General procedures and spectroscopic data  132 
 
 
butoxide (147 mg, 1.53 mmol) under Argon. The mixture was back-filled with Argon several 
times. The mixture was dissolved in anhydrous toluene (10 mL) and heated at 100 ºC for 10 
h. After cooling, the reaction mixture was diluted with dichloromethane (20 mL) and filtered 
through a celite pad, washing with dichloromethane (40 mL). The filtrate was reduced in 
vacuo. The product was separated via flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 1:1:1) to yield 1,4-bis(5H-pyrido[3,2-b]indol-5-
yl)benzene 22 (52 mg, 40 %) as a white solid; m.p. 277-279 ºC; 
1
H NMR (250 MHz, CDCl3) 
δ = 8.76 – 8.33 (m, 4H), 7.96 – 7.06 (m, 14H); 13C NMR (63 MHz, CDCl3) δ = 142.02, 
141.51, 140.20, 137.74, 132.99, 127.24, 124.84, 121.75, 120.36, 120.12, 119.37, 115.61, 
108.83; IR (ATR, cm
-1): ν = 3053 (w), 1620 (w), 1595 (m), 1585 (m), 1576 (m), 1497 (s), 
1475 (m), 1450 (s), 1408 (s), 1373 (w), 1362 (w), 1340 (m), 1315 (s), 1306 (s), 1288 (m), 
1263 (m), 1238 (w), 1215 (m), 1203 (s), 1178 (m), 1155 (m), 1120 (m), 1111 (m), 1101 (m), 
1090 (m), 1049 (m), 1026 (m), 1012 (m), 968 (w), 922 (m), 903 (w), 877 (w), 850 (w), 810 
(m), 800 (m), 779 (s), 742 (vs), 727 (vs), 700 (s), 671 (m), 648 (m), 631 (m), 619 (s), 584 
(m), 567 (m), 536 (m); GC-MS (EI, 70 eV): m/z (%) =  410 (100), 242 (28), 205 (11); HRMS 
(ESI): calcd. for C28H18N4 ([M + H]
+
): 411.16042; found: 411.15977.  
 
8.5.4 Synthesis and Properties of 5,7-Dihydropyrido[3,2-b:5,6-b']diindoles 
Procedure for preparation of 2,3,5,6-tetrabromopyridine  
 
 
To solution of pyridine-2,6-diamine (10.9 g, 100 mmol) in 200 mL glacial acetic acid was 
dropwised added 11.4 mL bromine (220 mmol)at 0 ºC. Then the temperature was raised to 
room temperature and the mixture was stirred for 5h. The reaction mixture was treated with 
aqueous Na2SO3 solution to remove residues of bromine. The mixture was neutralized with 
NaOH to pH 8-9. The brown solid (22 g, 83%) was obtained after filtering, washing with 
water and drying in vacuo.  
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To solution of 3,5-dibromopyridine-2,6-diamine (10 g, 37.5 mmol) in 30 mL 48 % HBr was 
dropwised added saturate aqueous NaNO2 (20.7 g, 300 mmol) solution at -3 ˚C. Afterwards, 
the reaction mixture was stirred at the same temperature for 2h, then, the temperature was 
raised to room temperature and kept for additional 2h. The solution was neutralized to pH 8-9 
by NaOH then extracted with ethylacetate. The organic layer was collected, dried over 
MgSO4, filtered and evaporated in vacuo. The mixture was separated over column 
chromatography (silica gel, heptane/dichloromethane 5:1) to yield 2,3,5,6-tetrabromopyridine 
23 (3 g, 20%) as white crystals, m.p. 172-174 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.99 (s, 
1H); 
13
C NMR (63 MHz, CDCl3) δ = 145.32 (s), 140.60 (s), 123.01 (s); IR (ATR, cm
-1): ν = 
3084 (m), 3036 (m), 1529 (m), 1502 (s), 1362 (vs), 1352 (vs), 1288 (s), 1277 (s), 1238 (m), 
1213 (m), 1149 (vs), 1136 (s), 1016 (vs), 945 (m), 931 (m), 897 (vs), 833 (m), 806 (m), 798 
(m), 781 (m), 704 (s), 656 (s), 648 (s); GC-MS (EI, 70 eV): m/z (%) = 395 (100), 314 (42), 
235 (26), 154 (13), 75 (42); HRMS (EI): calcd. for C5H1N1Br3
81
Br1 ([M]
+
): 392.6815; found: 
392.68185; calcd. for C5H1N1Br2
81
Br2 ([M]
+
): 394.67961; found: 394.67983; calcd. for 
C5H1N1Br1
81
Br3 ([M]
+
): 396.67756; found: 396.67761. 
General procedure for preparation of 3,5-dibromo-2,6-bis(2-bromophenyl)pyridine 24.  
 
2,3,5,6-tetrabromopyridine 23 (1 g, 2.5 mmol), 2-bromophenyl boronic acid 6 (1.1 g, 5.5 
mmol), Pd(PPh3)4 (73 mg, 63 µmol) and sodium hydroxide (608 mg, 15.2 mmol) were added 
to 500 mL Schlenk flask. The mixture was back-filled several times with Argon. To the 
mixture 70 mL THF and 10 mL distilled water were added, then, back-filled several times 
with argon. The reaction was heated at 70 ºC for 4h. The solvent was evaporated in vacuo. 
The residue was extracted with dichloromethane and water. The organic layer was dried over 
MgSO4, filtered and the solvent was evaporated in vacuo. The yellow residue was purified by 
column chromatography (silica gel, Heptane/ethylacetate 10:1) to yield 3,5-dibromo-2,6-
bis(2-bromophenyl)pyridine 24 (1.1 g, 80 %) as white solid; m.p. 174-175 ᵒC; 1H NMR (300 
MHz, CDCl3) δ = 8.24 (s, 1H), 7.58 (d, J = 8.0 Hz, 2H), 7.37 – 7.25 (m, 4H), 7.20 (dd, J = 
8.4, 7.3 Hz, 2H); 
13
C NMR (63 MHz, CDCl3) δ = 156.75, 143.78, 139.78, 132.75, 130.33 
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(x2C), 127.37, 122.50, 120.43; IR (ATR, cm
-1): ν = 2922 (m), 2850 (m), 1562 (m), 1529 (m), 
1477 (m), 1470 (m), 1441 (m), 1427 (m), 1406 (s), 1348 (m), 1329 (m), 1284 (m), 1275 (w), 
1265 (m), 1240 (m), 1194 (m), 1117 (m), 1041 (s), 1024 (s), 1005 (s), 984 (m), 951 (m), 889 
(s), 870 (m), 850 (m), 756 (vs), 725 (s), 692 (s), 683 (s), 660 (m), 646 (m), 631 (s), 596 (m), 
532 (m); GC-MS (EI, 70 eV): m/z (%) = 547 (21), 468 (73), 227 (100), 193 (10), 113 (13), 75 
(11); HRMS (EI): calcd. for C17H9N1Br4 ([M]
+
): 542.74630; found: 542.74628; calcd. for 
C17H9N1Br3
81
Br1 ([M]
+
): 544.74425; found: 544.74445; calcd. for C17H9N1Br2
81
Br2 ([M]
+
): 
546.74221; found: 546.74277; calcd. for C17H9N1Br1
81
Br3 ([M]
+
): 548.74016; found: 
548.74086; calcd. for C17H9N1
81
Br4 ([M]
+
): 550.73811; found: 550.73897. 
General procedure 10 for double C-N coupling with aniline derivatives, exemplified by: 
5,7-diphenyl-5,7-dihydropyrido[3,2-b:5,6-b']diindole 25a 
 
Aniline (0.1 mL, 1.09 mmol) was added to a pressure tube charged with 24 (100 mg, 0.18 
mmol), Pd2(dba)3 (8 mg, 9 µmol), ligand Dppf (10 mg, 18 µmol) and sodium tert-butoxide 
(105 mg, 1.09 mmol) under Argon. The mixture was back-filled with Argon several times. 
The mixture was dissolved in anhydrous toluene (10 mL) and heated at 100 ºC for 7 h. After 
cooling, the reaction mixture was diluted with dichloromethane (20 mL) and filtered through 
a celite pad, washing with dichloromethane (40 mL). The filtrate was reduced in vacuo. The 
product was separated via flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 10:1:1) to yield 25a (62 mg, 83%) as a white solide; 
m.p. 298-300 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.69 (d, J = 7.2 Hz, 2H), 7.63 – 7.55   (m, 
9H), 7.50 – 7.38 (m, 8H); 13C NMR (75 MHz, CDCl3) δ = 142.35, 137.85, 137.31, 134.32, 
130.26, 127.86, 127.09, 126.71, 122.55, 121.08, 120.78, 109.80, 96.93; IR (ATR, cm
-1): ν = 
3036 (m), 2926 (w), 2852 (w), 1591 (s), 1497 (s), 1479 (m), 1454 (s), 1435 (m), 1404 (s), 
1387 (s), 1313 (m), 1242 (s), 1205 (m), 1188 (s), 1178 (s), 1155 (m), 1144 (m), 1103 (m), 
1074 (m), 1039 (m), 1028 (m), 1011 (m), 939 (m), 924 (m), 847 (m), 829 (m), 760 (m), 739 
(s), 729 (s), 692 (vs), 667 (m), 638 (s), 623 (m), 615 (s), 582 (s), 567 (m), 536 (s); GC-MS 
(EI, 70 eV): m/z (%) =  409 (100), 332 (8), 204 (14); HRMS (ESI): calcd. for C29H20N3 ([M + 
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H]
+
): 410.16517; found: 41016512; calcd. for C29H20N3Na ([M + Na]
+
): 432.14712; found: 
432.14744. 
5,7-Bis(4-(tert-butyl)phenyl)-5,7-dihydropyrido[3,2-b:5,6-
b']diindole 25b was prepared following general procedure 10 
using compound  24 (100 mg, 0.18 mmol) and 4-(tert-
butyl)aniline (118 mg, 1.09 mmol). The product was purified 
by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 8:1:1) to yield 25b (80 
mg, 84%) as a white solide; m.p. 317-319 ºC;  
1
H NMR (300 MHz, CDCl3) δ = 8.64 (d, J = 
7.5 Hz, 2H), 7.68 – 7.59 (m, 5H), 7.56 – 7.35 (m, 10H), 1.42 (s, 18H); 13C NMR (63 MHz, 
CDCl3) δ = 150.65, 142.37, 138.00, 134.61, 134.27, 126.96, 126.72, 126.46, 122.68, 120.65, 
120.37, 109.76, 96.77, 34.80, 31.39; IR (ATR, cm
-1): ν = 2958 (m), 2902 (w), 2866 (w), 1591 
(m), 1518 (m), 1479 (w), 1456 (s), 1408 (m), 1392 (m), 1363 (m), 1350 (w), 1325 (w), 1309 
(m), 1290 (w), 1261 (m), 1242 (s), 1207 (m), 1188 (m), 1169 (m), 1153 (m), 1147 (m), 1105 
(m), 1036 (m), 1011 (m), 951 (w), 937 (w), 928 (w), 893 (w), 850 (m), 841 (m), 822 (m), 800 
(m), 785 (m), 741 (vs), 729 (vs), 706 (m), 660 (m), 640 (m), 625 (m), 592 (w), 561 (s); GC-
MS (EI, 70 eV): m/z (%) = 521 (100), 491 (9), 253 (15), 217 (93), 172 (21); HRMS (EI): 
calcd. for C37H35N3 ([M]
+
): 521.28255; found: 521.28186. 
5,7-Bis(3,5-dimethylphenyl)-5,7-dihydropyrido[3,2-b:5,6-
b']diindole 25c was prepared following general procedure 
10 using compound  24 (100 mg, 0.18 mmol) and 3,5-
dimethylaniline (175 µL, 1.09 mmol). The product was 
purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 8:1:1) to yield 25c (72 mg, 85%) as a white solide; 
m.p. 306-308 ºC;  
1
H NMR (300 MHz, CDCl3) δ = 8.53 (d, J = 7.6 Hz, 2H), 7.48 (s, 1H), 
7.41 – 7.26 (m, 6H), 7.11 (s, 4H), 7.00 (s, 2H), 2.32 (s, 12H); 13C NMR (75 MHz, CDCl3) δ = 
142.23, 139.85, 138.03, 137.20, 134.29, 129.32, 126.73, 124.49, 122.76, 120.70, 120.38, 
109.80, 96.90, 21.37; IR (ATR, cm
-1): ν = 3045 (w), 2914 (m), 2854 (w), 1589 (s), 1470 (s), 
1456 (s), 1435 (m), 1417 (m), 1404 (s), 1387 (m), 1373 (m), 1311 (m), 1298 (m), 1242 (s), 
1190 (s), 1153 (m), 1138 (m), 1105 (m), 1011 (m), 916 (m), 864 (m), 843 (s), 785 (m), 741 
(vs), 725 (vs), 708 (s), 698 (s), 631 (m), 588 (m), 575 (m), 557 (m); GC-MS (EI, 70 eV): m/z 
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(%) = 465 (100), 233 (12), 79 (7); HRMS (EI): calcd. for C33H27N3 ([M]
+
): 465.21995; 
found: 465.21908. 
5,7-Bis(4-fluorophenyl)-5,7-dihydropyrido[3,2-b:5,6-b']diindole 
25d was prepared following general procedure 10 using 
compound  24 (100 mg, 0.18 mmol) and 4-fluoroaniline (104 µL, 
1.09 mmol). The product was purified by flash chromatography 
(silica gel, heptane/dichloromethane/ethylacetate 8:1:1) to yield 
25d (54 mg, 66 %) as a white solide; m.p. 338-340 ºC;  
1
H NMR 
(300 MHz, CDCl3) δ = 8.53 (d, J = 7.3 Hz, 2H), 7.48 – 7.28 (m, 9H), 7.27 – 7.17 (m, 6H); 
13
C NMR (75 MHz, CDCl3) δ = 162.03 (d, J = 248.1 Hz), 142.62 , 138.39 , 134.62 , 133.36 
(d, J = 3.1 Hz), 129.20 (d, J = 8.6 Hz), 127.24 , 122.94 , 121.00 , 120.96 , 117.44 (d, J = 22.8 
Hz), 109.69 , 96.18; IR (ATR, cm
-1): ν = 3053 (w), 2918 (w), 2848 (w), 1591 (m), 1506 (vs), 
1481 (m), 1456 (s), 1406 (s), 1390 (m), 1311 (s), 1244 (s), 1221 (s), 1192 (s), 1173 (s), 1155 
(s), 1113 (m), 1101 (s), 1041 (m), 1011 (m), 935 (m), 889 (m), 835 (s), 812 (s), 800 (m), 744 
(vs), 723 (vs), 700 (m), 671 (m), 661 (m), 640 (m), 619 (m), 573 (s), 565 (s), 536 (s); GC-MS 
(EI, 70 eV): m/z (%) = 445 (100), 222 (10), 95 (8); HRMS (EI): calcd. for C29H17N3F2 
([M]
+
): 445.13851; found: 445.13827. 
5,7-Bis(3-(trifluoromethyl)phenyl)-5,7-dihydropyrido[3,2-
b:5,6-b']diindole 25e was prepared following general 
procedure 10 using compound  24 (100 mg, 0.18 mmol) and 
3-(trifluoromethyl)aniline (137 µL, 1.09 mmol). The product 
was purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 8:1:1) to yield 25e (70 
mg, 70 %) as a white solide; m.p. 268-269 ºC;  
1
H NMR (300 MHz, CDCl3) δ = 8.49 (d, J = 
7.7 Hz, 2H), 7.81 (s, 2H), 7.71 – 7.63 (m, 6H), 7.47 – 7.26 (m, 7H); 19F NMR (282 MHz, 
CDCl3) δ = -62.78; 
13
C NMR (63 MHz, CDCl3) δ = 141.71, 138.69, 137.91, 133.61, 132.80 
(q, J = 33.2 Hz), 130.85, 129.97, 127.30, 124.35 (q, J = 3.6 Hz), 123.65 (q, J = 3.9 Hz), 
123.53 (q, J = 272.7 Hz), 123.01, 121.25, 120.92, 109.38, 96.01; IR (ATR, cm
-1): ν = 3061 
(w), 2928 (w), 2854 (w), 1591 (m), 1495 (m), 1485 (m), 1460 (s), 1404 (s), 1387 (m), 1354 
(m), 1344 (m), 1323 (s), 1309 (s), 1279 (m), 1271 (m), 1244 (s), 1182 (s), 1173 (s), 1155 (s), 
1115 (vs), 1097 (s), 1070 (s), 1041 (m), 1012 (m), 1003 (m), 962 (m), 931 (w), 918 (m), 904 
(m), 854 (m), 849 (m), 800 (s), 746 (s), 727 (s), 708 (vs), 700 (vs), 669 (m), 661 (s), 646 (m), 
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609 (w), 582 (m), 538 (m); GC-MS (EI, 70 eV): m/z (%) = 545 (100), 273 (22); HRMS (EI): 
calcd. for C31H17N3 ([M]
+
): 545.13212; found: 545.13199. 
5,7-Bis(4-methoxyphenyl)-5,7-dihydropyrido[3,2-b:5,6-
b']diindole 25f was prepared following general procedure 10 
using compound  24 (100 mg, 0.18 mmol) and p-anisidine 
(135 mg, 1.09 mmol). The product was purified by flash 
chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 5:1:1) to yield 25f (80 
mg, 93 %) as a white solide; m.p. 300-302 ºC;  
1
H NMR (300 MHz, CDCl3) δ = 8.67 – 8.58 
(m, 2H), 7.49 – 7.30 (m, 11H), 7.14 – 7.04 (m, 4H), 3.90 (s, 6H); 13C NMR (75 MHz, CDCl3) 
δ = 159.19, 142.89, 138.11, 134.99, 130.05, 128.70, 126.91, 122.84, 120.81, 120.47, 115.51, 
109.78, 96.35, 55.80; IR (ATR, cm
-1): ν = 3047 (m), 2951 (m), 2924 (m), 2835 (m), 1614 
(w), 1589 (m), 1510 (s), 1477 (m), 1456 (s), 1441 (s), 1408 (s), 1392 (m), 1315 (m), 1298 
(m), 1279 (m), 1242 (vs), 1211 (m), 1190 (s), 1180 (s), 1144 (s), 1113 (m), 1103 (s), 1032 (s), 
1007 (m), 953 (m), 928 (m), 887 (m), 835 (s), 825 (s), 810 (m), 793 (m), 742 (vs), 733 (s), 
727 (s), 671 (m), 660 (m), 642 (m), 619 (m), 584 (s), 575 (s), 542 (s); GC-MS (EI, 70 eV): 
m/z (%) = 469 (100), 291 (27), 43 (57); HRMS (EI): calcd. for C31H23O2N3 ([M]
+
): 
469.17848; found: 469.17813. 
5,7-Bis(3,5-dimethoxyphenyl)-5,7-dihydropyrido[3,2-
b:5,6-b']diindole 25g was prepared following general 
procedure 10 using compound  24 (100 mg, 0.18 mmol) 
and 3,5-dimethoxyaniline (168 mg, 1.09 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 4:1:1) to yield 25f 
(92 mg, 95 %) as a white solide; m.p. 230-231 ºC;  
1
H NMR (300 MHz, CDCl3) δ = 8.66 (d, J 
= 6.6 Hz, 2H), 7.74 (s, 1H), 7.46 (dd, J = 26.3, 6.9 Hz, 6H), 6.75 (d, J = 1.9 Hz, 4H), 6.57 (s, 
2H), 3.84 (s, 12H); 
13
C NMR (75 MHz, CDCl3) δ = 161.94, 142.13, 134.11, 127.38, 121.43, 
120.89, 110.03, 105.08, 100.05, 55.67; IR (ATR, cm
-1): ν = 3066 (w), 2999 (w), 2935 (w), 
2841 (w), 1740 (w), 1595 (vs), 1477 (s), 1462 (s), 1446 (m), 1423 (m), 1404 (m), 1346 (m), 
1311 (m), 1300 (m), 1292 (s), 1234 (s), 1201 (vs), 1190 (s), 1151 (vs), 1142 (s), 1065 (s), 
1055 (m), 827 (s), 741 (s), 733 (s), 708 (m), 690 (s), 579 (w); GC-MS (EI, 70 eV): m/z (%) = 
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529 (100), 471 (10), 207 (6); HRMS (EI): calcd. for C33H27O4N3 ([M]
+
): 529.19961; found: 
529.19898. 
5,7-Bis(4-(N,N-diethylamino)phenyl)-5,7-
dihydropyrido[3,2-b:5,6-b']diindole 25h was prepared 
following general procedure 10 using compound  24 (100 
mg, 0.18 mmol) and N
1
,N
1
-diethylbenzene-1,4-diamine 
(182 µL, 1.09 mmol). The product was purified by flash 
chromatography (silica gel, 
Heptane/dichloromethane/ethylacetate 5:1:1) to yield 25h 
(70 mg, 69 %) as a brown solid; m.p. 222-223 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.58 – 
8.49 (m, 2H), 7.38 – 7.23 (m, 11H), 6.72 (d, J = 9.0 Hz, 4H), 3.35 (q, J = 7.0 Hz, 8H), 1.15 (t, 
J = 7.1 Hz, 12H); 
13
C NMR (75 MHz, CDCl3) δ = 147.30, 143.08, 137.58, 135.22, 128.41, 
126.38, 124.72, 122.48, 120.44, 119.79, 112.29, 109.75, 96.57, 44.50, 12.67; IR (ATR, cm
-1
): 
ν = 3043  (w), 2968  (m), 2929  (m), 2897  (w), 2864  (w), 1732  (w), 1606  (m), 1591  (m), 
1520  (vs), 1477  (m), 1460  (s), 1448  (m), 1394  (m), 1373  (m), 1354  (s), 1323  (m), 1309  
(s), 1269  (s), 1240  (s), 1192  (s), 1149  (s), 1140  (s), 1119  (m), 1109  (m), 1097  (m), 1074  
(m), 1047  (m), 1032  (m), 1007  (m), 930  (m), 922  (m), 885  (m), 841  (m), 823  (m), 812  
(s), 793  (m), 785  (m), 750  (vs), 742  (s), 731  (vs), 725  (s), 696  (m), 656  (m), 640  (m), 
621  (m), 561  (s), 536  (s); GC-MS (EI, 70 eV): m/z (%) = 551 (100), 507 (15), 463 (13), 
268 (7), 69 (20), 44 (59); HRMS (ESI): calcd. for C37H37N5 ([M + H]
+
): 552.31217; found: 
552.31208; calcd. for C37H37N5Na ([M + Na]
+
): 574.29412; found: 574.2944. 
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General procedure 11 for double C-N coupling with alkyl amine derivatives, 
exemplified by: 5,7-diheptyl-5,7-dihydropyrido[3,2-b:5,6-b']diindole 25i 
 
To pressure tube charged with 24 (100 mg, 0.18 mmol), Pd2(dba)3 (8 mg, 9 µmol), ligand 
DPEPhos (10 mg, 18 µmol) and sodium tert-butoxide (105 mg, 1.09 mmol) under Argon. 
The mixture was back-filled with Argon several times. The mixture was dissolved in 
anhydrous toluene (10 mL). n-Heptylamine (0.2 mL, 1.09 mmol) was added to the mixture 
and heated at 100 ºC for 7 h. After cooling, the reaction mixture was diluted with 
dichloromethane (20 mL) and filtered through a celite pad, washing with dichloromethane 
(40 mL). The filtrate was reduced in vacuo. The product was separated via flash 
chromatography (silica gel, heptane/dichloromethane/ethylacetate 5:1:1) to yield 25i (66 mg, 
80%) as a white solid; m.p. 162-164 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.58 (d, J = 7.4 Hz, 
2H), 7.59 – 7.46 (m, 2H), 7.39 – 7.28 (m, 5H), 4.16 (t, J = 7.1 Hz, 4H), 1.97 – 1.78 (m, 4H), 
1.41 – 1.19 (m, 16H), 0.86 (t, J = 6.8 Hz, 6H); 13C NMR (63 MHz, CDCl3) δ = 141.49, 
136.62, 133.73, 126.41, 122.32, 120.76, 119.38, 108.60, 94.25, 43.08, 31.82, 29.19, 28.85, 
27.43, 22.69, 14.15; IR (ATR, cm
-1): ν = 3061  (w), 3020  (w), 2953  (w), 2933  (w), 2877  
(w), 2852  (w), 1595  (s), 1466  (s), 1454  (m), 1441  (m), 1410  (m), 1390  (m), 1352  (s), 
1319  (s), 1257  (s), 1227  (m), 1203  (m), 1171  (s), 1124  (m), 1111  (m), 1080  (m), 1068  
(m), 1012  (m), 827  (m), 742  (vs), 729  (vs), 698  (vs), 687  (s), 648  (m), 594  (m), 579  
(m), 563  (m), 544  (s);  GC-MS (EI, 70 eV): m/z (%) = 453 (100), 368 (40), 282 (12), 269 
(25); HRMS (EI): calcd. for C31H39N3 ([M]
+
): 453.31385; found: 453.31353. 
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5,7-Bis(3-(trifluoromethyl)benzyl)-5,7-
dihydropyrido[3,2-b:5,6-b']diindole 25p was 
prepared following general procedure 11 using 
compound  24 (100 mg, 0.18 mmol) and 3-
(trifluoromethyl)benzylamine (157 µL, 1.09 mmol). 
The product was purified by flash chromatography 
(silica gel, heptane/dichloromethane/ethylacetate 5:1:1) to yield 25p (54 mg, 52 %) as a white 
solid; m.p. 229-231 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.53 (d, J = 7.6 Hz, 2H), 7.52 – 7.28 
(m, 9H), 7.18 (m, J = 6.9 Hz, 3H), 6.96 (d, J = 8.7 Hz, 3H), 5.24 (s, 4H); 
19
F NMR (282 
MHz, CDCl3) δ = -62.70 (s); 
13
C NMR (75 MHz, CDCl3) δ = 141.50 (s), 137.49 (s), 133.54 
(s), 131.24 (q, J = 32.5 Hz), 129.46 (s), 129.42 (s), 126.95 (s), 124.55 (q, J = 3.4 Hz), 123.81 
(q, J = 272.5 Hz), 123.12 (q, J = 3.7 Hz), 122.63 (s), 120.81 (s), 120.28 (s), 108.59 (s), 94.52 
(s), 46.11 (s); IR (ATR, cm
-1): ν = 3047 (w), 2926 (w), 1595 (m), 1466 (m), 1443 (m), 1410 
(m), 1327 (vs), 1315 (vs), 1254 (s), 1223 (m), 1182 (s), 1167 (s), 1111 (vs), 1097 (vs), 1070 
(vs), 1007 (m), 968 (m), 949 (m), 937 (m), 930 (m), 916 (m), 881 (m), 862 (m), 823 (m), 804 
(m), 789 (s), 744 (vs), 733 (s), 714 (m), 696 (vs), 661 (s), 634 (m), 615 (m), 602 (m), 582 
(m), 565 (s); GC-MS (EI, 70 eV): m/z (%) = 573 (100), 414 (42), 255 (30), 159 (10); HRMS 
(EI): calcd. for C33H21N3F6 ([M]
+
): 573.16342; found: 573.16519. 
5,7-Diphenethyl-5,7-dihydropyrido[3,2-b:5,6-b']diindole 25q 
was prepared following general procedure 11 using compound  
24 (100 mg, 0.18 mmol) and phenylethylamine (138 µL, 1.09 
mmol). The product was purified by flash chromatography 
(silica gel, heptane/dichloromethane/ethylacetate 5:1:1) to 
yield 25q (64 mg, 75 %) as a white solid; m.p. 124-126 ºC; 
1
H 
NMR (300 MHz, CDCl3) δ = 8.47 (d, J = 7.6 Hz, 2H), 7.38 (m, 2H), 7.30 – 6.79 (m, 15H), 
4.19 (t, J = 6.9 Hz, 4H), 2.93 (t, J = 6.9 Hz, 4H); 
13
C NMR (63 MHz, CDCl3) δ = 141.00, 
138.83, 136.22, 133.46, 128.87, 128.59, 126.68, 126.43, 122.10, 120.70, 119.50, 108.35, 
94.50, 44.77, 34.96; IR (ATR, cm
-1): ν = 2951 (m), 2928 (m), 2874 (m), 2856 (m), 2845 (m), 
1591 (s), 1481 (m), 1470 (s), 1464 (s), 1412 (m), 1387 (m), 1371 (m), 1354 (m), 1319 (s), 
1250 (s), 1230 (s), 1215 (m), 1201 (m), 1186 (m), 1174 (m), 1144 (s), 1124 (m), 1113 (s), 
1070 (m), 1024 (w), 1011 (m), 903 (m), 847 (m), 744 (s), 725 (vs), 706 (s), 696 (m), 673 (m), 
596 (m), 577 (m), 565 (m); GC-MS (EI, 70 eV): m/z (%) = 465 (35), 374 (100), 282 (42); 
HRMS (EI): calcd. for C33H27N3 ([M]
+
): 465.21995; found: 465.21945. 
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5,7-Bis(3,4-dimethoxyphenethyl)-5,7-dihydropyrido[3,2-
b:5,6-b']diindole  25r was prepared following general 
procedure 11 using compound  24 (100 mg, 0.18 mmol) and 
3,4-dimethoxyphenylethylamine (185 µL, 1.09 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/dichloromethane/ethylacetate 3:1:1) to yield 25r (60 
mg, 56 %) as a white solid; m.p. 164-165 ºC; 
1
H NMR (300 
MHz, CDCl3) δ = 8.45 (s, 2H), 7.42 – 7.34 (m, 2H), 7.28 – 
7.16 (m, 4H), 6.72 – 6.50 (m, 5H), 6.19 (s, 2H), 4.29 (d, J = 6.4 Hz, 4H), 3.60 (s, 6H), 3.39 
(s, 6H), 2.92 (s, 4H); 
13
C NMR (75 MHz, CDCl3) δ = 148.94, 147.90, 141.20, 133.51, 
131.47, 126.39, 122.31, 120.71, 120.56, 119.55, 112.48, 111.26, 108.52, 94.37, 55.78, 55.67, 
45.07, 34.52; IR (ATR, cm
-1): ν = 2955 (w), 2937 (w), 2916 (w), 2833 (w), 1597 (m), 1516 
(s), 1464 (m), 1454 (m), 1441 (w), 1435 (w), 1414 (m), 1387 (w), 1354 (m), 1327 (m), 1317 
(m), 1261 (vs), 1236 (s), 1228 (s), 1211 (m), 1198 (m), 1190 (m), 1157 (s), 1136 (s), 1122 
(m), 1041 (w), 1030 (m), 1018 (s), 860 (m), 808 (m), 764 (m), 742 (vs), 727 (vs), 683 (m), 
644 (m), 557 (m); GC-MS (EI, 70 eV): m/z (%) = 585 (45), 434 (100), 284 (27); HRMS 
(ESI): calcd. for C37H35N3O4 ([M + H]
+
): 586.26276; found: 586.2700. 
5,7-Bis(3-phenylpropyl)-5,7-dihydropyrido[3,2-b:5,6-
b']diindole  25s was prepared following general 
procedure 11 using compound  24 (100 mg, 0.18 mmol) 
and 3-phenylpropylamine (156 µL, 1.09 mmol). The 
product was purified by flash chromatography (silica 
gel, heptane/dichloromethane/ethylacetate 5:1:1) to 
yield 25s (61 mg, 68 %) as a white solid; m.p. 194-196 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 
8.46 (d, J = 7.6 Hz, 2H), 7.39 (ddd, J = 8.3, 7.3, 1.2 Hz, 2H), 7.28 – 6.97 (m, 15H), 4.05 (t, J 
= 7.3 Hz, 4H), 2.58 (t, J = 7.5 Hz, 4H), 2.19 – 1.99 (m, 4H); 13C NMR (63 MHz, CDCl3) δ = 
141.30, 140.90, 136.80, 133.47, 128.54, 128.39, 126.34, 126.22, 122.38, 120.61, 119.41, 
108.45, 93.98, 42.10, 33.11, 29.72; IR (ATR, cm
-1): ν = 3024 (w), 2924 (w), 1593 (s), 1497 
(m), 1464 (s), 1452 (s), 1435 (m), 1408 (m), 1387 (m), 1356 (m), 1315 (s), 1250 (s), 1227 
(m), 1207 (m), 1194 (m), 1174 (m), 1163 (m), 1149 (m), 1124 (m), 1111 (m), 1088 (m), 1070 
(m), 1028 (m), 1016 (m), 1009 (m), 928 (w), 831 (m), 768 (m), 742 (vs), 729 (vs), 694 (vs), 
615 (m), 584 (m), 575 (m), 557 (m); GC-MS (EI, 70 eV): m/z (%) = 493 (100), 388 (48), 269 
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(18), 69 (23), 44 (38); HRMS (ESI): calcd. for C35H31N3 ([M + H]
+
): 494.25907; found: 
494.25922; calcd. for C35H31N3Na ([M + Na]
+
): 516.24102; found: 516.2405. 
5,7-Dicyclohexyl-5,7-dihydropyrido[3,2-b:5,6-b']diindole  25t 
was prepared following general procedure 11 using compound  
24 (100 mg, 0.18 mmol) and cyclohexylamine (127 µL, 1.09 
mmol). The product was purified by flash chromatography (silica 
gel, heptane/dichloromethane/ethylacetate 5 :1:1) to yield 25t (42 
mg, 55 %) as a white solid; m.p. 277-279 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.50 (d, J = 
7.7 Hz, 2H), 7.58 (s, 1H), 7.47 – 7.36 (m, 4H), 7.23 (ddd, J = 7.9, 6.0, 2.1 Hz, 2H), 5.19 – 
5.03 (m, 2H), 2.42 – 1.63 (m, 20H); 13C NMR (75 MHz, CDCl3) δ = 140.81, 137.05, 132.62, 
126.12, 122.85, 120.83, 119.21, 109.65, 96.35, 55.93, 28.96, 25.48; IR (ATR, cm
-1): ν =  
2928 (m), 2854 (m), 1591 (m), 1485 (m), 1454 (m), 1416 (m), 1404 (m), 1377 (m), 1344 (m), 
1327 (m), 1304 (m), 1250 (m), 1225 (s), 1188 (s), 1155 (m), 1142 (m), 1126 (m), 1117 (m), 
1072 (m), 1057 (m), 1028 (m), 1012 (m), 968 (m), 893 (m), 837 (m), 742 (s), 729 (vs), 700 
(m), 658 (m), 594 (m), 577 (s), 532 (m); GC-MS (EI, 70 eV): m/z (%) = 421 (100), 256 (31), 
55 (22); HRMS (EI): calcd. for C29H31N3 ([M]
+
): 421.25125; found: 421.25089. 
 
8.5.5 Synthesis and Physical Properties of Indolo[2,3-b]quinoxalines 
Synthesis of 2,3-dibromoquinoxaline 
 
2,3-Dibromoquinoxaline was synthesized in 94% of overall yield using Li’s procedure by 
reflux of 1,2-phenylenediamine with diethyl oxalate, to give 1,4-dihydroquinoxaline-2,3-
dione, and subsequent reaction with PBr5.
150
 M.p. 179-180 ºC. 
1
H NMR (300 MHz, CDCl3) δ 
= 8.08 – 8.01 (m, 2H), 7.86 – 7.78 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = 141.42, 140.97, 
131.49, 128.57; IR (ATR, cm
-1): ν =3097 (m), 3034 (m), 1564 (m), 1549 (s), 1514 (s), 1479 
(m), 1254 (s), 1169 (s), 1126 (m), 1107 (s), 1072 (m), 1059 (m), 957 (vs), 901 (m), 883 (m), 
868 (s), 769 (vs), 692 (m), 677 (m), 621 (m), 582 (s); GC-MS (EI, 70 eV): m/z (%) = 288 
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(96), 209 (95), 128 (61), 102 (100), 75 (98), 50 (59); HRMS (EI): calcd. for C8H4N2Br2 
([M]
+
): 285.87357; found: 285.87325; calcd. for C8H4N2Br1
81
Br1 ([M]
+
): 287.87153; found: 
287.87137; calcd. for C8H4N2
81
Br2 ([M]
+
): 289.86948; found: 289.86935. 
General procedure for the preparation of 2-bromo-3-(2-bromophenyl)quinoxaline 34.  
 
2,3-Dibromoquinoxaline 32 (1 g, 3.5 mmol), 2-bromophenyl boronic acid (837 mg, 4.2 
mmol), Pd(PPh3)4 (100 mg, 87 µmol) and sodium hydroxide (417 mg, 10.4 mmol) were 
added to a 500 mL Schlenk flask. The mixture was back-filled several times with Argon. To 
the mixture 70 mL THF and 10 mL distilled water were added, then, back-filled several 
times. The reaction was heated at 70 ºC for 4h. The solvent was evaporated in vacuo. The 
residue was extracted with dichloromethane and water. The organic layer was dried over 
MgSO4, filtered and the solvent was evaporated in vacuo. The yellow residue was purified by 
column chromatography (silica gel, Heptane/ethylacetate 10:1) to yield 2-bromo-3-(2-
bromophenyl)quinoxaline 34 (1.1 g, 87 %) as white solid. M.p. 127-129 ºC; 
1
H NMR (250 
MHz, CDCl3) δ = 8.20 – 8.07 (m, 2H), 7.90 – 7.79 (m, 2H), 7.73 (dd, J = 7.9, 0.8 Hz, 1H), 
7.55 – 7.35 (m, 3H); 13C NMR (63 MHz, CDCl3) δ = 154.95, 142.47, 140.67, 140.11, 139.38, 
132.99, 131.46, 131.01, 130.84, 130.49, 129.58, 128.57, 127.76, 122.83; IR (ATR, cm
-1): ν 
=3059 (w), 1610 (w), 1556 (m), 1535 (w), 1477 (m), 1433 (m), 1385 (w), 1333 (m), 1290 
(m), 1273 (w), 1252 (m), 1236 (w), 1213 (w), 1167 (w), 1147 (m), 1132 (m), 1084, 1041, 
1024 (m), 999 (w), 970, 955 (m), 943 (m), 885 (m), 870 (w), 862 (w), 752 (vs), 727, 715, 
710, 690 (m), 652 (m), 638 (m), 613 (m), 588, 571 (m), 557 (m); GC-MS (EI, 70 eV): m/z 
(%) = 364 (32), 285 (100), 102 (48), 75 (28), 50 (14); HRMS (EI): calcd. for C14H8N2Br2 
([M]
+
): 361.90488; found: 361.90467;calcd. for C14H8N2Br1
81
Br1 ([M]
+
): 363.90283; found: 
363.90277; calcd. for C14H8N2
81
Br2 ([M]
+
):365.90078; found: 365.90082. 
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General procedure 12 for double C-N coupling with aniline derivatives,exemplified by 
the synthesis of6-phenyl-6H-indolo[2,3-b]quinoxaline(35a) 
 
Aniline 8a (75 µL, 0.82 mmol) was added to a pressure tube charged with 34 (100 mg, 0.28 
mmol), Pd2(dba)3 (12 mg, 14 µmol), ligand Dppf (15mg, 27 µmol) and sodium tert-butoxide 
(79 mg, 0.82 mmol) under Argon. The mixture was back-filled with Argon several times. The 
mixture was dissolved in anhydrous Toluene (10 mL) and heated at 100 ºC for 7 h. After 
cooling, the reaction mixture was diluted with dichloromethane (20mL) and filtered through a 
celite pad, washing with dichloromethane (40 mL). The filtrate was reduced in vacuo. The 
product was separated via flashchromatography (silica gel, heptane/ethylacetate 5:1) to yield 
6-phenyl-6H-indolo[2,3-b]quinoxaline 35a (67 mg, 83%) as a yellow solid; m.p. 238-239 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.56 (d, J = 7.7 Hz, 1H), 8.40 – 8.29 (m, 1H), 8.14 – 8.06 
(m, 1H), 7.84 – 7.59 (m, 7H), 7.59 – 7.38 (m, 3H); 13C NMR (75 MHz, CDCl3) δ = 146.00, 
144.90, 140.72, 140.08, 139.69, 135.50, 131.25, 129.92, 129.24, 128.99, 128.38, 128.13, 
127.27, 126.71, 122.94, 122.02, 119.83, 110.75; IR (ATR, cm
-1): ν =3053 (m), 1608 (m), 
1597 (m), 1581 (m), 1500, 1483 (m), 1470 (m), 1458, 1402, 1390, 1354 (m), 1336 (m), 1317 
(m), 1304 (m), 1252 (m), 1227 (m), 1205, 1174 (m), 1147 (m), 1132 (m), 1126 (m), 1099 
(m), 1072 (m), 1041 (m), 1024 (m), 1014 (m), 1007 (m), 955 (m), 924 (m), 779 (m), 766 (m), 
748 (vs), 719 (m), 694, 687, 648, 590, 567 (m); GC-MS (EI, 70 eV): m/z (%) =  295 (100), 
147 (9), 90 (6), 77 (6); HRMS (ESI): calcd. for C20H14N3 ([M + H]
+
): 296.11822; found: 
296.11835. 
6-(p-Tolyl)-6H-indolo[2,3-b]quinoxaline 35b was prepared 
following general procedure 12 using compound  34 (100 mg, 0.28 
mmol) and toluidine (88 mg, 0.82 mmol). The product was 
purified by flash chromatography (silica gel, heptane/ethylacetate 
5:1) to yield 35b (73 mg, 86%) as a yellow solid; m.p. 216-217 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.50 – 8.43 (m, 1H), 8.29 – 8.22 
(m, 1H), 8.05 – 7.99 (m, 1H), 7.68 – 7.57 (m, 2H), 7.57 – 7.49 (m, 3H), 7.45 – 7.31 (m, 4H), 
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2.43 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ = 146.01, 144.99, 140.66, 140.06, 139.62, 138.04, 
132.68, 131.06, 130.45, 129.17, 128.79, 128.27, 127.02, 126.46, 122.72, 121.73, 119.68, 
110.62, 21.35; IR (ATR, cm
-1): ν =3057 (w), 3034 (w), 2918 (w), 1606 (m), 1585 (m), 1514, 
1485 (m), 1470 (m), 1460, 1404, 1354 (m), 1335 (m), 1317, 1304 (m), 1255 (m), 1227 (m), 
1221 (m), 1205, 1182 (m), 1169 (m), 1130 (m), 1122 (m), 1099 (m), 1043 (m), 1016 (m), 955 
(m), 924 (m), 816 (m), 764, 750 (vs), 721 (m), 710 (m), 673 (w), 633 (m), 602, 579, 567 (m), 
559 (m); GC-MS (EI, 70 eV): m/z (%) = 309 (100), 293 (8), 154 (7), 90 (5); HRMS (EI): 
calcd. for C21H15N3 ([M]
+
): 309.12605; found: 309.12523. 
6-(4-Fluorophenyl)-6H-indolo[2,3-b]quinoxaline 35c was 
prepared following general procedure 12 using compound  34 (100 
mg, 0.28 mmol) and 4-fluoroaniline (78 µL, 0.82 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 5:1) to yield 35c (69 mg, 80 %) as a yellow 
solid; m.p. 219-220 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.55 (d, J 
= 7.8 Hz, 1H), 8.37 – 8.30 (m, 1H), 8.12 – 8.04 (m, 1H), 7.78 – 7.61 (m, 5H), 7.50 – 7.41 (m, 
2H), 7.41 – 7.30 (m, 2H); 19F NMR (282 MHz, CDCl3) δ = -113.01; 
13
C NMR (75 MHz, 
CDCl3) δ = 162.08 (d, J = 247.9 Hz), 146.07, 144.90, 140.70, 140.01 (d, J = 18.0 Hz), 131.43 
(d, J = 3.2 Hz), 131.32, 129.38, 129.18 (d, J = 8.4 Hz), 129.12, 128.32, 126.81, 122.98, 
122.15, 119.92, 116.99 (d, J = 22.9 Hz), 110.52; IR (ATR, cm
-1): ν =3057 (m), 1608 (m), 
1579 (m), 1574 (m), 1514, 1485, 1471 (m), 1460, 1402, 1356 (m), 1335 (m), 1313, 1292 (m), 
1259 (m), 1223, 1203, 1171 (m), 1151 (m), 1130 (m), 1122, 1099, 1043 (m), 1012 (m), 1007 
(m), 949 (m), 924 (m), 872 (m), 831, 812 (m), 800 (m), 764, 748 (vs), 723 (m), 710, 673 (m), 
638 (m), 629 (m), 602, 579, 567 (m), 557 (m), 548 (m); GC-MS (EI, 70 eV): m/z (%) = 313 
(100), 156 (12), 75 (7); HRMS (EI): calcd. for C20H12N3F1 ([M]
+
): 313.10098; found: 
313.10007. 
6-(3-(Trifluoromethyl)phenyl)-6H-indolo[2,3-b]quinoxaline 35d 
was prepared following general procedure 12 using compound  34 
(100 mg, 0.28 mmol) and 3-(trifluoromethyl)aniline (103 µL, 0.82 
mmol). The product was purified by flash chromatography (silica 
gel, heptane/ethylacetate 5:1) to yield 35d (90 mg, 90 %) as a 
yellow solid; m.p. 201-202 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 
8.46 (ddd, J = 7.7, 1.2, 0.7 Hz, 1H), 8.29 – 8.19 (m, 1H), 8.03 – 7.95 (m, 2H), 7.92 (ddd, J = 
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3.7, 3.0, 1.9 Hz, 1H), 7.76 – 7.53 (m, 5H), 7.48 – 7.33 (m, 2H); 19F NMR (282 MHz, CDCl3) 
δ = -62.58; 13C NMR (75 MHz, CDCl3) δ = 145.55, 144.00, 140.39, 140.07, 136.11, 132.31 
(q, J = 33.0 Hz), 131.25, 130.40, 130.32, 130.31, 129.33, 129.11, 128.23, 126.90, 124.49 (q, 
J = 3.7 Hz), 123.85 (q, J = 3.9 Hz), 122.92, 123.74 (q, J = 272.5 Hz),122.41, 120.16, 110.31; 
IR (ATR, cm
-1): ν =3051 (w), 3028 (w), 1608 (w), 1597 (w), 1579 (w), 1574 (w), 1495 (m), 
1464 (m), 1446 (m), 1406, 1356 (m), 1329, 1308 (m), 1279 (w), 1250 (m), 1230 (m), 1205 
(m), 1167, 1134 (m), 1126 (m), 1113, 1105, 1095, 1068, 1045 (m), 1011 (m), 987 (w), 976 
(w), 958 (m), 943 (m), 924 (w), 904 (m), 874 (w), 860 (w), 854 (w), 802 (m), 795 (m), 768 
(m), 748 (vs), 719 (m), 700, 671, 656 (m), 631 (w), 615 (w), 588 (m), 567 (w), 546 (w); GC-
MS (EI, 70 eV): m/z (%) = 363 (100), 294 (9); HRMS (ESI): calcd. for C21H12F3N3 ([M + 
H]
+
): 364.10561; found: 364.10566; calcd. for C37H37N5Na ([M + Na]
+
): 574.29412; found: 
574.2944. 
6-(4-Methoxyphenyl)-6H-indolo[2,3-b]quinoxaline 35e was 
prepared following general procedure 12 using compound  34 (100 
mg, 0.28 mmol) and p-anisidine (101 mg, 0.82 mmol). The product 
was purified by flash chromatography (silica gel, 
heptane/ethylacetate 3:1) to yield 35e (88 mg, 98 %) as a yellow 
solid; m.p. 226-228 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.57 (d, J 
= 7.6 Hz, 1H), 8.35 (d, J = 8.9 Hz, 1H), 8.15 – 8.05 (m, 1H), 7.80 – 7.55 (m, 5H), 7.44 (m, 
2H), 7.21 – 7.13 (m, 2H), 3.94 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 159.42, 145.47, 
140.85, 139.42, 131.35, 129.13, 129.00, 128.72, 128.38, 128.02, 126.67, 123.02, 121.87, 
119.53, 115.27, 113.39, 110.68, 55.77; IR (ATR, cm
-1): ν =3076 (w), 3053 (m), 3022 (m), 
2956 (m), 2933 (m), 2912 (m), 2839 (m), 1606 (m), 1585 (m), 1578 (m), 1512, 1506, 1487 
(m), 1464, 1446, 1406, 1356 (m), 1336 (m), 1313 (m), 1296, 1244, 1230, 1205, 1178, 1167, 
1136, 1128, 1103, 1041 (m), 1026, 1009 (m), 968 (m), 955 (m), 939 (m), 924 (m), 870 (m), 
852 (m), 829, 820, 804 (m), 795 (m), 768, 748 (vs), 723, 715, 669 (m), 642 (m), 629 (m), 
602, 579, 569, 550; GC-MS (EI, 70 eV): m/z (%) = 325 (100), 310 (39), 282 (18), 141 (8); 
HRMS (ESI): calcd. for C21H15N3O ([M + H]
+
): 326.12879; found: 326.12858. 
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6-(3,5-Dimethoxyphenyl)-6H-indolo[2,3-b]quinoxaline 35f was 
prepared following general procedure 12 using compound  34 
(100 mg, 0.28 mmol) and 3,5-dimethoxyaniline (126 mg, 0.82 
mmol). The product was purified by flash chromatography (silica 
gel, heptane/ethylacetate 2:1) to yield 35f (93 mg, 95 %) as a 
yellow solid; m.p. 188-189 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 
8.45 (d, J = 7.6 Hz, 1H), 8.28 – 8.20 (m, 1H), 8.07 – 8.00 (m, 1H), 7.71 – 7.47 (m, 4H), 7.35 
(ddd, J = 8.1, 6.9, 1.3 Hz, 1H), 6.81 (d, J = 2.3 Hz, 2H), 6.54 (m, 1H), 3.79 (s, 6H); 
13
C NMR 
(75 MHz, CDCl3) δ = 161.59, 145.81, 144.67, 140.60, 140.16, 139.77, 136.91, 131.08, 
129.25, 128.83, 128.35, 126.55, 122.66, 121.86, 119.84, 110.92, 105.51, 100.33, 55.66; IR 
(ATR, cm
-1): ν =2993 (w), 2956 (w), 2926 (w), 1606 (m), 1591 (m), 1508 (w), 1491 (m), 
1458, 1427 (m), 1404 (m), 1363 (w), 1325 (m), 1298 (m), 1257 (m), 1242 (m), 1207 (m), 
1194, 1153, 1134 (m), 1124 (m), 1107 (m), 1066 (m), 1051 (m), 1039 (m), 1014 (m), 1003 
(m), 993 (m), 953 (m), 933 (m), 912 (m), 877 (m), 860 (m), 847, 818 (m), 791 (m), 768, 735 
(vs), 721, 688, 667 (m), 640 (m), 631 (m), 617 (m), 607 (m), 600 (m), 584, 577 (m), 565 (m), 
534 (m); GC-MS (EI, 70 eV): m/z (%) =355 (100), 325 (13), 268 (12); HRMS (EI): calcd. for 
C22H17O2N3 ([M]
+
): 355.13153; found: 355.13066. 
6-(4-(Methylthio)phenyl)-6H-indolo[2,3-b]quinoxaline 35g was 
prepared following general procedure 12 using compound  34 (100 
mg, 0.28 mmol) and 4-(methylthio)aniline (103 µL, 0.82 mmol). 
The product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 3:1) to yield 35g (88 mg, 94 %) as a white 
solid; m.p. 249-250ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.47 (d, J 
= 7.4 Hz, 1H), 8.28 – 8.20 (m, 1H), 8.06 – 7.98 (m, 1H), 7.72 – 7.53 (m, 5H), 7.51 – 7.30 (m, 
4H), 2.53 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ = 145.88, 144.73, 140.58, 140.17, 139.82, 
138.69, 132.30, 131.09, 129.28, 128.89, 128.23, 127.62, 127.52, 126.56, 122.73, 121.91, 
119.85, 110.56, 15.92; IR (ATR, cm
-1): ν =2955 (m), 2920, 2850 (m), 1608 (m), 1579 (m), 
1498, 1483 (m), 1460, 1431 (m), 1402, 1352 (m), 1335 (m), 1311, 1296 (m), 1252 (m), 1230 
(m), 1203, 1184 (m), 1132 (m), 1124 (m), 1115 (m), 1103, 1090, 1041 (m), 1012 (m), 1003 
(m), 984 (m), 970 (m), 955 (m), 937 (m), 922 (m), 904 (w), 870 (m), 854 (w), 833 (m), 816, 
768 (vs), 748 (vs), 719, 702, 661 (m), 634 (m), 625 (m), 590, 567, 548 (m); GC-MS (EI, 70 
eV): m/z (%) = 341 (100), 326 (36), 294 (20), 102 (6); HRMS (ESI): calcd. for C24H22N4 ([M 
+ H]
+
): 342.09467; found: 342.10916. 
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5,7-Bis(4-(N,N-diethylamino)phenyl)-6H-indolo[2,3-
b]quinoxaline 35h was prepared following general procedure 12 
using compound  34 (100 mg, 0.28 mmol) and N
1
,N
1
-
diethylbenzene-1,4-diamine (137 µL, 0.82 mmol). The product 
was purified by flash chromatography (silica gel, 
Heptane/ethylacetate 3:1) to yield 35h (76 mg, 75 %) as a yellow 
solid; m.p. 228-229 ºC;  
1
H NMR (300 MHz, CDCl3) δ = 8.50 – 
8.39 (m, 1H), 8.26 – 8.19 (m, 1H), 8.05 – 8.00 (m, 1H), 7.70 – 7.50 (m, 3H), 7.45 – 7.27 (m, 
4H), 6.84 – 6.73 (m, 2H), 3.37 (q, J = 7.1 Hz, 4H), 1.17 (t, J = 7.1 Hz, 6H); 13C NMR (75 
MHz, CDCl3) δ = 147.61, 146.39, 145.80, 140.82, 140.23, 139.58, 130.90, 129.22, 128.57, 
128.39, 128.29, 126.09, 122.55, 122.47, 121.29, 119.45, 112.09, 110.74, 44.55, 12.69; IR 
(ATR, cm
-1): ν =2970 (w), 2926 (w), 2866 (w), 1626 (w), 1608 (m), 1578 (w), 1522, 1489 
(m), 1462 (m), 1446 (m), 1429 (w), 1404 (m), 1371 (m), 1352 (m), 1333 (m), 1315 (m), 1279 
(m), 1259 (m), 1228 (m), 1203, 1194, 1169 (m), 1157 (m), 1149 (m), 1134 (m), 1122 (m), 
1101 (m), 1080 (m), 1041 (m), 1014 (m), 1003 (m), 978 (m), 953 (m), 924 (m), 864 (m), 849 
(m), 814, 798, 758, 735 (vs), 723, 712, 667 (m), 640 (m), 631 (m), 596, 575, 563 (m), 548 
(m), 532 (m); GC-MS (EI, 70 eV): m/z (%) = 366 (67), 351 (100), 322 (28), 294 (14), 243 
(35), 194 (13), 165 (22); HRMS (ESI): calcd. for C24H22N4 ([M + H]
+
): 367.18780; found: 
367.19184. 
5,7-Bis(4-cyanophenyl)-6H-indolo[2,3-b]quinoxaline 35i was 
prepared following general procedure 12 using compound  34 
(100 mg, 0.28 mmol) and 4-aminobenzonitrile (97 mg, 0.82 
mmol). The product was purified by flash chromatography (silica 
gel, heptane/ethylacetate 3:1) to yield 35i (73 mg, 83 %) as a 
yellow solid; m.p. 272-273 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 
8.47 (d, J = 7.7 Hz, 1H), 8.28 – 8.21 (m, 1H), 8.03 – 7.97 (m, 1H), 7.96 – 7.85 (m, 4H), 7.74 
– 7.51 (m, 4H), 7.46 – 7.38 (m, 1H); 13C NMR (75 MHz, CDCl3) δ = 145.27, 143.33, 140.25, 
140.17, 140.11, 139.68, 133.65, 131.31, 129.34, 129.32, 128.20, 127.20, 127.02, 123.06, 
122.85, 120.49, 118.40, 110.91, 110.52; IR (ATR, cm
-1): ν =2922 (m), 2852 (m), 2227 (m), 
1601 (s), 1583 (m), 1506 (s), 1485 (m), 1456 (s), 1400 (s), 1354 (m), 1319 (s), 1304 (m), 
1257 (m), 1238 (m), 1228 (m), 1219 (m), 1198 (s), 1169 (m), 1151 (m), 1136 (m), 1124 (s), 
1103 (s), 1043 (m), 1014 (m), 955 (m), 949 (m), 922 (m), 837 (s), 823 (m), 769 (m), 758 (s), 
746 (vs), 725 (m), 715 (m), 698 (m), 669 (m), 631 (m), 598 (s), 571 (m), 555 (s), 538 (s); 
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GC-MS (EI, 70 eV): m/z (%) = 320 (100), 160 (9), 102 (7); HRMS (EI): calcd. for C21H12N4 
([M]
+
): 320.10565; found: 320.10491. 
General procedure 13 for double C-N coupling with alkyl amine derivatives, 
exemplified by 6-(4-fluorobenzyl)-6H-indolo[2,3-b]quinoxaline 35p 
 
To a pressure tube charged with 34 (100 mg, 0.28 mmol), Pd2(dba)3 (13 mg, 14 µmol), ligand 
DPEPhos (15 mg, 27 µmol) and sodium tert-butoxide (79 mg, 0.82 mmol) under Argon. The 
mixture was back-filled with Argon several times. The mixture was dissolved in anhydrous 
toluene (10 mL). p-fluorobenzylamine (94 µL, 0.82 mmol) was added to the mixture and 
heated at 100 ºC for 7 h. After cooling, the reaction mixture was diluted with 
dichloromethane (20 mL) and filtered through a celite pad, washing with dichloromethane 
(40 mL). The filtrate was reduced in vacuo. The product was purified by flash 
chromatography (silica gel, heptane/ ethylacetate 4:1) to yield 35p (78 mg, 87 %) as a yellow 
solid; m.p. 176-177 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.40 (d, J = 7.7 Hz, 1H), 8.24 (dd, J 
= 8.3, 1.5 Hz, 1H), 8.05 (dd, J = 8.4, 1.3 Hz, 1H), 7.72 – 7.48 (m, 3H), 7.31 – 7.17 (m, 4H), 
6.94 – 6.83 (m, 2H), 5.57 (s, 2H); 19F NMR (282 MHz, CDCl3) δ = -114.59;
13
C NMR (75 
MHz, CDCl3) δ = 162.30 (d, J = 246.1 Hz), 145.70, 144.08, 140.63, 140.01, 139.59, 132.30 
(d, J = 3.2 Hz), 131.05, 129.39, 129.00 (d, J = 8.2 Hz), 128.92, 127.88, 126.23, 122.82, 
121.29, 119.74, 115.74 (d, J = 21.6 Hz), 109.97, 44.36; IR (ATR, cm
-1): ν =3057 (w), 3045 
(w), 1632 (w), 1610 (m), 1581 (m), 1508 (s), 1489 (m), 1468 (s), 1443 (w), 1435 (w), 1406 
(s), 1363 (m), 1344 (m), 1325 (m), 1309 (w), 1300 (w), 1267 (w), 1240 (m), 1230 (w), 1217 
(s), 1200 (s), 1171 (w), 1157 (m), 1140 (w), 1126 (w), 1117 (m), 1097 (m), 1066 (w), 1039 
(w), 1016 (w), 1007 (w), 984 (w), 955 (w), 939 (w), 858 (m), 850 (m), 825 (m), 768 (m), 762 
(s), 746 (vs), 729 (m), 721 (m), 712 (m), 690 (m), 640 (m), 631 (w), 617 (m), 592 (m), 571 
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(m), 557 (w), 534 (w); GC-MS (EI, 70 eV): m/z (%) = 327 (100), 232 (11), 218 (8), 109 (79), 
90 (14); HRMS (EI): calcd. for C21H14N3F1 ([M]
+
): 327.11663; found: 327.11625. 
6-(3-(Trifluoromethyl)benzyl)-6H-indolo[2,3-b]quinoxaline 
35q was prepared following general procedure 13 using 
compound  34 (100 mg, 0.28 mmol) and 
trifluoromethylbenzylamine (118 µL, 0.82 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 4:1) to yield 35q (87 mg, 84 %) as a yellow solid; m.p. 161-162 ºC; 
1
H 
NMR (300 MHz, CDCl3) δ = 8.44 – 8.38 (m, 1H), 8.28 – 8.21 (m, 1H), 8.07 – 8.01 (m, 1H), 
7.72 – 7.40 (m, 5H), 7.40 – 7.19 (m, 4H), 5.65 (s, 2H);19F NMR (282 MHz, CDCl3) δ = -
114.59; 
13
C NMR (75 MHz, CDCl3) δ = 145.69, 143.97, 140.60, 139.99, 139.71, 137.63, 
131.22 (q, J = 32.4 Hz), 131.15, 130.48, 129.43, 129.00, 127.89, 126.35, 124.68 (q, J = 3.7 
Hz), 124.12 (q, J = 3.8 Hz), 123.93 (q, J = 272.4 Hz), 122.89, 121.48, 119.84, 109.79, 44.67; 
IR (ATR, cm
-1): ν =3064 (w), 1612 (m), 1587 (m), 1489 (m), 1468 (s), 1452 (w), 1435 (w), 
1410 (s), 1358 (w), 1338 (s), 1325 (s), 1275 (m), 1267 (w), 1244 (m), 1196 (s), 1163 (m), 
1151 (s), 1111 (s), 1099 (vs), 1074 (s), 1043 (m), 1009 (m), 989 (m), 978 (w), 951 (w), 941 
(w), 933 (w), 914 (m), 891 (w), 864 (w), 852 (w), 804 (m), 766 (m), 746 (vs), 729 (m), 721 
(m), 704 (s), 698 (s), 675 (w), 661 (m), 648 (m), 629 (m), 607 (m), 600 (m), 592 (m), 575 
(m), 552 (m), 534 (w); GC-MS (EI, 70 eV): m/z (%) = 377 (100), 232 (25), 218 (11), 159 
(27), 90 (19); HRMS (EI): calcd. for C22H14N3F3 ([M]
+
): 377.11343; found: 377.11287. 
6-Phenethyl-6H-indolo[2,3-b]quinoxaline 35r was prepared 
following general procedure 13 using compound  34 (100 mg, 
0.28 mmol)and phenylethylamine (104 µL, 0.82 mmol). The 
product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 5:1) to yield 35r (79 mg, 89 %) as a 
yellow solid; m.p. 155-156 ºC; 
1
H NMR (300 MHz, CDCl3) δ 
= 8.39 (d, J = 7.7 Hz, 1H), 8.23 (dd, J = 8.2, 1.3 Hz, 1H), 8.07 (dd, J = 8.4, 1.1 Hz, 1H), 7.74 
– 7.49 (m, 3H), 7.35 – 7.04 (m, 7H), 4.69 – 4.56 (m, 2H), 3.22 – 3.09 (m, 2H); 13C NMR (63 
MHz, CDCl3) δ = 145.46, 144.32, 140.63, 140.05, 139.31, 138.46, 130.86, 129.31, 128.86, 
128.69, 128.58, 127.86, 126.65, 125.97, 122.71, 120.80, 119.42, 109.35, 43.11, 34.74; IR 
(ATR, cm
-1): ν =3055 (w), 2933 (w), 1610 (m), 1581 (m), 1487 (m), 1466 (s), 1439 (m), 1410 
(s), 1394 (m), 1360 (m), 1344 (m), 1321 (m), 1286 (w), 1259 (w), 1244 (m), 1205 (m), 1184 
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(m), 1176 (m), 1151 (m), 1138 (m), 1117 (s), 1066 (m), 1039 (m), 1032 (m), 1014 (m), 999 
(m), 982 (w), 947 (w), 930 (w), 868 (w), 766 (s), 756 (s), 742 (vs), 725 (m), 704 (s), 692 (s), 
640 (m), 619 (w), 594 (s), 571 (m), 559 (m), 532 (m); GC-MS (EI, 70 eV): m/z (%) = 323 
(16), 232 (100), 219 (61), 129 (10), 102 (10), 91 (9); HRMS (EI): calcd. for C22H17N3 ([M]
+
): 
323.14170; found: 323.14153. 
6-(3-Phenylpropyl)-6H-indolo[2,3-b]quinoxaline 35s was 
prepared following general procedure 13 using compound  
34 (100 mg, 0.28 mmol) and phenylpropylamine (117 µL, 
0.82 mmol). The product was purified by flash 
chromatography (silica gel, heptane/ethylacetate 5:1) to yield 
35s (84 mg, 91 %) as a yellow solid; m.p. 180-181 ºC; 
1
H 
NMR (300 MHz, CDCl3) δ = 
1
H NMR (300 MHz, CDCl3) δ 8.40 (d, J = 7.2 Hz, 1H), 8.23 
(dd, J = 8.2, 1.3 Hz, 1H), 8.07 (dd, J = 8.4, 1.1 Hz, 1H), 7.81 – 7.47 (m, 3H), 7.45 – 7.00 (m, 
7H), 4.46 (t, J = 7.2 Hz, 2H), 2.84 – 2.57 (m, 2H), 2.24 (dt, J = 14.7, 7.5 Hz, 2H); 13C NMR 
(63 MHz, CDCl3) δ = 145.68, 144.33, 141.01, 140.61, 140.01, 139.25, 130.92, 129.31, 
128.72, 128.39, 128.35, 127.79, 126.06, 125.94, 122.77, 120.82, 119.51, 109.44, 41.01, 
33.21, 29.73; IR (ATR, cm
-1): ν =3055 (w), 2955 (w), 2931 (w), 2837 (w), 1610 (m), 1581 
(m), 1514 (s), 1489 (m), 1466 (s), 1439 (m), 1423 (w), 1408 (s), 1398 (m), 1365 (m), 1344 
(m), 1327 (m), 1304 (m), 1271 (m), 1246 (s), 1196 (s), 1184 (s), 1157 (w), 1142 (m), 1115 
(s), 1066 (m), 1032 (s), 1005 (m), 984 (w), 953 (w), 933 (w), 858 (w), 835 (m), 820 (m), 802 
(w), 762 (s), 742 (vs), 721 (m), 714 (m), 685 (s), 650 (m), 633 (m), 615 (m), 590 (s), 571 (m), 
557 (w), 540 (m); GC-MS (EI, 70 eV): m/z (%) = 337 (35), 233 (100); HRMS (ESI): calcd. 
for ([M + H]
+
): 338.16517; found: 338.16549; calcd. for C23H19N3Na ([M + Na]
+
): 
360.14712; found: 360.14751. 
6-Cyclohexyl-6H-indolo[2,3-b]quinoxaline 35t was prepared 
following general procedure 13 using compound  34 (100 mg, 0.28 
mmol) and cyclohexylamine (90 µL, 0.82 mmol). The product was 
purified by flash chromatography (silica gel, heptane/ethylacetate 
5:1) to yield 35t (61 mg, 74 %) as a yellow solid; m.p. 215-216 ºC; 
1
H NMR (250 MHz, CDCl3) δ = 8.52 (d, J = 7.7 Hz, 1H), 8.30 (dd, J = 8.2, 1.2 Hz, 1H), 8.15 
(dd, J = 8.3, 1.2 Hz, 1H), 7.81 – 7.57 (m, 4H), 7.36 (ddd, J = 8.0, 4.8, 3.4 Hz, 1H), 4.97 (m, 
1H), 2.59 (tt, J = 12.4, 6.1 Hz, 2H), 2.23 – 0.59 (m, 8H); 13C NMR (63 MHz, CDCl3) δ = 
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145.68, 144.03, 140.60, 140.05, 139.06, 130.76, 129.29, 128.70, 128.05, 126.02, 122.96, 
120.53, 119.96, 111.27, 54.09, 30.38, 26.40, 25.71; IR (ATR, cm
-1): ν =2931 (m), 2854 (m), 
1608 (w), 1579 (m), 1574 (m), 1485 (m), 1460 (m), 1435 (w), 1404 (s), 1383 (m), 1346 (m), 
1327 (m), 1321 (m), 1298 (m), 1263 (w), 1252 (w), 1234 (m), 1205 (s), 1124 (m), 1117 (s), 
1090 (w), 1066 (m), 1043 (m), 1009 (m), 980 (w), 945 (m), 889 (m), 862 (w), 850 (w), 804 
(w), 764 (m), 746 (vs), 717 (m), 696 (w), 638 (m), 592 (s), 569 (m), 540 (w); GC-MS (EI, 70 
eV): m/z (%) = 301 (20), 219 (100); HRMS (EI): calcd. for C20H19N3 ([M]
+
): 301.15735; 
found: 301.15679. 
General procedure 14 for C-N coupling/C-H bond activation, exemplified by: 6-phenyl-
6H-indolo[2,3-b]quinoxaline 35a 
 
To a pressure tube charged with 2,3-dibromoquinoxaline 32 (100 mg, 0.35 mmol), Pd(OAc)2 
(3 mg, 14 µmol), ligand PCy3·HBF4 (11 mg, 29 µmol) and sodium tert-butoxide (83 mg, 
0.87mmol) under Argon. The mixture was back-filled with Argon several times. The mixture 
was dissolved in anhydrous toluene (10 mL). Diphenylamine (49 mg, 0.29mmol) was added 
to the mixture and heated at 105 ºC for 18 h. After cooling, the reaction mixture was diluted 
with dichloromethane (20 mL) and filtered through a celite pad, washing with 
dichloromethane (40 mL). The filtrate was reduced in vacuo. The product was separated via 
flash chromatography (silica gel, heptane/ethylacetate 5:1) to yield 35a (77 mg, 90%) as a 
yellow solid; m.p. 230-231ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.49 – 8.41 (m, 1H), 8.27 – 
8.20 (m, 1H), 8.03 – 7.97 (m, 1H), 7.70 – 7.51 (m, 7H), 7.48 – 7.39 (m, 2H), 7.39 – 7.31 (m, 
1H); 
13
C NMR (75 MHz, CDCl3) δ = 145.86, 144.74, 140.60, 140.18, 139.82, 135.43, 
131.03, 129.80, 129.27, 128.83, 128.26, 127.99, 127.16, 126.51, 122.70, 121.86, 119.86, 
110.62; IR (ATR, cm
-1): ν =3054 (w), 1608 (w), 1597 (w), 1581 (m), 1571 (w), 1501 (m), 
1483 (m), 1470 (m), 1458 (m), 1451 (m), 1403 (s), 1390 (m), 1354 (w), 1336 (w), 1318 (m), 
1303 (m), 1252 (m), 1226 (m), 1219 (m), 1205 (s), 1174 (m), 1166 (m), 1133 (m), 1126 (m), 
1100 (m), 1073 (w), 1042 (w), 1025 (w), 1015 (w), 1007 (w), 954 (w), 949 (w), 780 (m), 766 
(m), 758 (m), 748 (vs), 719 (w), 694 (s), 687 (s), 649 (m), 590 (s), 485 (m), 451 (s), 428 (w); 
General procedures and spectroscopic data  153 
 
 
GC-MS (EI, 70 eV): m/z (%) = 295 (100), 147 (10); HRMS (EI): calcd. for C20H13N3 
([M]
+
):295.11040; found: 295.10963. 
6-Mesityl-9-methyl-6H-indolo[2,3-b]quinoxaline 33a was prepared 
following general procedure 14 using compound  32 (100 mg, 0.35 
mmol) and 2,4,6-trimethyl-N-(p-tolyl)aniline (65 mg, 0.29 mmol). 
The product was purified by flash chromatography (silica gel, 
heptane/ethylacetate 5:1) to yield 33a (48 mg, 47 %) as a yellow 
solid; m.p.175-176 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.31 – 8.20 
(m, 2H), 8.03 – 7.94 (m, 1H), 7.65 – 7.53 (m, 2H), 7.36 – 7.30 (m, 
1H), 7.02 (s, 2H), 6.81 (d, J = 8.3 Hz, 1H), 2.48 (s, 3H), 2.33 (s, 3H), 1.82 (s, 6H); 
13
C NMR 
(75 MHz, CDCl3) δ = 145.80, 142.90, 141.03, 139.92, 139.52, 139.07, 137.45, 132.42, 
131.04, 130.35, 129.65, 129.30, 128.58, 128.23, 126.08, 122.74, 119.66, 110.07, 21.30, 
21.29, 17.88; IR (ATR, cm
-1): ν =3019 (w), 2944 (w), 2913 (w), 2855 (w), 1609 (w), 1587 
(w), 1577 (w), 1483 (s), 1471 (m), 1454 (m), 1441 (m), 1394 (m), 1386 (m), 1377 (m), 1361 
(w), 1349 (m), 1326 (w), 1316 (m), 1303 (m), 1289 (m), 1251 (m), 1237 (m), 1206 (m), 1197 
(m), 1179 (m), 1143 (w), 1130 (m), 1124 (m), 1112 (m), 1044 (m), 1032 (w), 1015 (w), 960 
(w), 949 (w), 912 (m), 884 (m), 863 (w), 852 (m), 815 (w), 806 (s), 773 (w), 755 (vs), 749 
(s), 728 (m), 719 (m), 678 (w), 670 (w), 656 (w), 642 (w), 630 (m), 603 (w), 596 (m), 586 
(m), 571 (m), 565 (m), 549 (w), 540 (w), 522 (w), 516 (w), 512 (w), 508 (w), 498 (w), 485 
(m), 472 (w), 449 (vs), 428 (m), 422 (m), 409 (w), 400 (w), 396 (w), 393 (w), 389 (w), 380 
(w); GC-MS (EI, 70 eV): m/z (%) = 351 (100), 336 (20), 320 (7), 160 (11), 119 (7); HRMS 
(EI): calcd. for C24H21N3 ([M]
+
): 351.17300; found: 351.17195. 
9-Methoxy-6-(4-methoxyphenyl)-6H-indolo[2,3-b]quinoxaline 33b 
was prepared following general procedure 14 using compound  32 
(100 mg, 0.35 mmol) and bis(4-methoxyphenyl)amine (66 mg, 0.29 
mmol). The product was purified by flash chromatography (silica 
gel, heptane/ethylacetate 1:1) to yield 33b (56 mg, 54 %) as a yellow 
solid; m.p.163-164 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.26 – 8.20 
(m, 1H), 8.03 – 7.98 (m, 1H), 7.93 (d, J = 2.5 Hz, 1H), 7.62 (m, 2H), 7.56 – 7.49 (m, 2H), 
7.30 (d, J = 8.9 Hz, 1H), 7.17 (dd, J = 8.6, 2.9 Hz, 1H), 7.11 – 7.04 (m, 2H), 3.91 (s, 3H), 
3.85 (s, 3H); 
13
C NMR (63 MHz, CDCl3) δ = 159.05, 155.31, 146.25, 140.69, 139.95, 139.84, 
139.43, 129.13, 128.70, 128.36, 128.20, 128.16, 126.24, 120.47, 119.88, 115.04, 111.51, 
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104.45, 56.12, 55.59; IR (ATR, cm
-1): ν =3054 (w), 3017 (w), 2993 (w), 2837 (m), 1614 (w), 
1572 (w), 1512 (s), 1487 (vs), 1473 (s), 1466 (s), 1458 (s), 1454 (s), 1438 (s), 1420 (m), 1395 
(s), 1388 (s), 1293 (s), 1247 (s), 1197 (vs), 1185 (s), 1174 (vs), 1164 (s), 1138 (m), 1126 (s), 
1107 (m), 1040 (s), 1031 (s), 1024 (s), 954 (m), 925 (m), 888 (m), 827 (vs), 809 (s), 802 (m), 
793 (s), 764 (s), 756 (vs), 751 (s), 719 (m), 712 (m), 652 (m), 635 (m), 631 (m), 624 (m), 603 
(s), 590 (s), 561 (m), 555 (m), 549 (m), 525 (m), 518 (m), 489 (m), 455 (s), 435 (m), 419 (m); 
GC-MS (EI, 70 eV): m/z (%) = 355 (100), 340 (76), 269 (12), 178 (7); HRMS (EI): calcd. for 
C22H17O2N3 ([M]
+
): 355.13153; found: 355.13112. 
 
8.5.6 Synthesis of biscarbazoles 
General procedure for the preparation of 2,2’-biphenylene ditriflate 36.  
 
 
 
To a solution of 2,2’-dihydroxyl biphenyl (4.3 g, 23 mmol) in DCM was added pyridine (7.0 
mL) under Argon atmosphere. Then, Tf2O (13.0 g, 46 mmol) was slowly added at O ºC. The 
reaction was stirred at the same temperature for 3 h until the reaction completed. The reaction 
mixture was diluted by DCM and subsequently washed with 1M HCl, 1M NaHCO3 and 
brine. The organic layer was dried over MgSO4, filtered and the solvent was evaporated in 
vacuo. The colorless residue was purified by column chromatography (silica gel, 
ethylacetate/heptane = 1:10) to yield 1,1'-biphenyl]-2,2'-diyl bis(trifluoromethanesulfonate) 
36 (9.3 g, 90.3 %, white solid); mp 35-36 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 7.48 – 7.26 
(m, 8H); 
19
F NMR (282 MHz, CDCl3) δ = -74.38 (s); 
13
C NMR (75 MHz, CDCl3) δ = 147.01, 
132.75, 130.90, 129.55, 128.68, 118.50 (q, J = 320.1 Hz), 121.81;  IR (ATR, cm
-1): ν = 1504 
(w), 1473 (m), 1452 (w), 1439 (w), 1414 (vs), 1400 (s), 1277 (w), 1244 (s), 1201 (vs), 1165 
(m), 1149 (s), 1132 (vs), 1111 (s), 1084 (s), 1045 (m), 1012 (w), 991 (w), 955 (w), 935 (w), 
893 (s), 872 (vs), 779 (s), 769 (vs), 760 (s), 735 (m), 725 (s), 667 (w), 646 (w), 619 (s), 588 
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(s), 571 (vs); GC-MS (EI, 70 eV): m/z (%) =  450 (64), 317 (6), 184 (100), 168 (90), 156 
(25), 139 (20), 128 (37), 102 (19), 69 (30); HRMS (EI): calcd. for C14H8O6F6S2 ([M]
+
): 
449.96610; found: 449.96583. 
General procedure 15 for the preparation of N-(4-methoxyphenyl)carbazole 39a.  
 
To 50 mL pressure tube was added successively 2,2’-biphenylylene ditriflate 36(460 mg, 
1.021 mmol), p-anisidine (151 mg, 1.226 mmol), Pd2dba3 (23 mg, 0.026 mmol),  XantPhos 
(59 mg, 0.102 mmol), K3PO4 (650 mg, 3.062 mmol) and backfilled with argon 3 times. Then, 
the mixture was dissolved in 20 mL of toluene, subsequently, backfilled with argon 3 times. 
The reaction mixture was carried out at 100 ºC under argon atmosphere for 5 hours and 
controlled by TLC. The reaction was cooled down to ambient temperature then the solvent 
was removed by evaporating in vacuo. The crude product was extracted with EtOAc and 
water several times. The collected organic layer was dried over anhydrous MgSO4, filtered 
and concentrated under in vacuo. The residue was purified by silica gel column 
chromatography (silica gel, ethylacetate/heptane = 1:10) to give N-(4-
methoxyphenyl)carbazole 39a (265 mg, 95 %) as white solid; mp 156-157 ºC; 
1
H NMR (300 
MHz, CDCl3) δ = 8.19 – 8.10 (m, 2H), 7.48 – 7.24 (m, 9H), 7.12 (d, J = 9.0 Hz, 2H), 3.92 (s, 
3H); 
13
C NMR (75 MHz, CDCl3) δ = 159.02, 141.53, 130.47, 128.73, 125.98, 123.25, 
120.39, 119.78, 115.21, 109.83, 55.75;  IR (ATR, cm
-1): ν = 1591 (w), 1510 (s), 1479 (m), 
1450 (s), 1336 (m), 1317 (m), 1246 (s), 1240 (s), 1228 (s), 1178 (s), 1147 (m), 1120 (m), 
1107 (m), 1028 (s), 997 (m), 908 (m), 852 (w), 829 (s), 810 (m), 798 (m), 748 (vs), 725 (s), 
698 (m), 642 (m), 621 (s), 611 (m), 584 (s), 569 (s), 532 (s); GC-MS (EI, 70 eV): m/z (%) = 
273 (100), 258 (47), 230 (12), 228 (30); HRMS (EI): calcd. for C19H15ON ([M]
+
): 273.11482; 
found: 273.11474. 
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 N-(4-methoxyphenyl)carbazole 39b was prepared following 
procedure 15 using 2,2’-biphenylylene ditriflate 36 (460 mg, 1.021 
mmol), m-anisidine (138 µL, 1.226 mmol). The crude product was 
separated via flash chromatography (silica gel, ethylacetate/heptane = 
1:10) to yield 39b (265 mg, 95 %) as colorless syrup; 
1
H NMR (300 
MHz, CDCl3) δ = 8.05 (dd, J = 7.7, 0.6 Hz, 2H), 7.46 – 7.27 (m, 5H), 7.25 – 7.12 (m, 2H), 
7.12 – 6.97 (m, 2H), 6.91 (dd, J = 8.3, 2.5 Hz, 1H), 3.76 (s, 3H); 13C NMR (63 MHz, CDCl3) 
δ = 160.94, 140.95, 138.96, 130.66, 126.07, 123.49, 120.41, 120.04, 119.44, 113.38, 112.80, 
110.04, 55.63;  IR (ATR, cm
-1
): ν = 3051 (w), 2955 (w), 2933 (w), 2833 (w), 1927 (w), 1890 
(w), 1861 (vw), 1593 (s), 1576 (m), 1495 (s), 1477 (s), 1450 (s), 1362 (m), 1335 (m), 1311 
(s), 1281 (s), 1250 (s), 1227 (s), 1184 (m), 1153 (s), 1119 (m), 1099 (m), 1088 (m), 1078 (m), 
1039 (s), 1003 (m), 995 (m), 984 (m), 970 (m), 918 (m), 872 (m), 845 (m), 833 (m), 825 (m), 
779 (m), 744 (vs), 721 (vs), 692 (vs), 652 (m), 636 (m), 615 (m), 588 (m), 559 (m); GC-MS 
(EI, 70 eV): m/z (%) = 273 (100), 258 (7), 241 (5), 228 (19); HRMS (EI): calcd. for 
C19H15ON ([M]
+
): 273.11484; found: 273.11482. 
General procedure 16 for the preparation of N-(4-
hydroxyphenyl)carbazole 40a. 
To a solution of 39a (265 mg, 0.970 mmol) in DCM at -78 ºC was 
dropped slowly BBr3 (367 µl, 3.880 mmol). The temperature was 
raised to ambient temperature. The reaction was controlled by TLC until the starting material 
completely disappeared. The reaction mixture was poured to ice aqua solution of NaHCO3. 
The aqueous layer was extracted with DCM three times. The organic residue was dried over 
MgSO4, filtered, and the solvent was evaporated in vacuo. The crude product was purified 
over flash silica gel column chromatography (silica gel, ethylacetate/heptane = 1:10) to give 
40a (239 mg, 95 %); mp 106-107 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.18 – 8.11 (m, 2H), 
7.44 – 7.36 (m, 4H), 7.35 – 7.23 (m, 4H), 7.05 (d, J = 8.8 Hz, 2H). 13C NMR (63 MHz, 
CDCl3) δ = 155.00, 141.50, 130.72, 128.99, 126.00, 123.28, 120.40, 119.82, 116.72, 109.81; 
IR (ATR, cm
-1
): ν = 3196 (m), 3043 (w), 1622 (w), 1593 (m), 1512 (s), 1479 (m), 1450 (s), 
1363 (m), 1335 (m), 1315 (m), 1248 (m), 1228 (s), 1219 (s), 1178 (s), 1165 (m), 1147 (m), 
1099 (m), 1028 (w), 1014 (m), 1003 (w), 910 (m), 833 (s), 820 (m), 746 (vs), 723 (vs), 665 
(m), 623 (s), 611 (m), 584 (s), 567 (m), 532 (m); GC-MS (EI, 70 eV): m/z (%) = 259 (100), 
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241 (6), 228 (10); HRMS (ESI): calcd. for C18H14ON ([M + H]
+
): 260.10699; found: 
260.10686; calcd. for C18H13ONNa ([M + Na]
+
): 282.08894; found: 282.08872. 
 N-(4-hydroxyphenyl)carbazole 40b was prepared following 
procedure 16 with carbazole 39b (265 mg, 0.970 mmol) to give 40b 
(231 mg, 92 %) as colorless syrup; 
1
H NMR (250 MHz, CDCl3) δ = 
8.09 – 8.03 (m, 2H), 7.41 – 7.31 (m, 5H), 7.25 – 7.16 (m, 2H), 7.07 
(ddd, J = 7.9, 1.9, 0.9 Hz, 1H), 6.96 (m, 1H), 6.84 (ddd, J = 8.2, 2.5, 
0.9 Hz, 1H), 4.86 (s, 1H); 
13
C NMR (63 MHz, CDCl3) δ = 156.67, 140.71, 138.99, 130.79, 
125.93, 123.37, 120.26, 119.96, 119.48, 114.48, 114.06, 109.88; IR (ATR, cm
-1): ν = 3537 
(w), 3271 (m), 3047 (w), 1599 (s), 1576 (m), 1498 (s), 1485 (m), 1471 (m), 1450 (s), 1367 
(m), 1346 (m), 1335 (m), 1321 (m), 1304 (m), 1261 (m), 1252 (m), 1230 (s), 1209 (m), 1178 
(m), 1165 (m), 1151 (s), 1124 (m), 991 (m), 920 (m), 872 (m), 849 (m), 781 (m), 748 (vs), 
742 (vs), 719 (vs), 696 (vs), 667 (m), 636 (m), 615 (m), 584 (m), 573 (m), 557 (m); GC-MS 
(EI, 70 eV): m/z (%) = 259(100), 241 (4), 228 (8), 204 (4); HRMS (EI): calcd. for C18H13ON 
([M]
+
): 259.09917; found: 259.09925. 
General procedure 17 for the preparation of N-(4- trifluoromethanesulfonate)carbazole  
41a . 
 
 
To a solution of  N-(4-hydroxyphenyl)carbazole 40a (239 mg, 0.921 mmol) in DCM was 
added pyridine (298 µL, 3.690 mmol) under Argon atmosphere. Then, Tf2O (234 µL, 1.383 
mmol) was dropwise added at 0 
º
C. The reaction was carried at same temperature in 3 h until 
starting material disappeared (controlled by TLC). The reaction mixture was diluted with 
DCM and subsequently washed with 1M HCl, 1M NaHCO3 and brine. The organic layer was 
dried over MgSO4, filtered and the solvent was evaporated in vacuo. The colorless residue 
was purified by column chromatography over silica gel (silica gel, ethylacetate/heptane = 
1:10) to yield -(4- trifluoromethanesulfonate)carbazole 41a ( 310 mg, 86 %) as white solid; 
mp 112 - 114 ºC; 
1
H NMR (300 MHz, CDCl3) δ = 8.18 – 8.12 (m, 2H), 7.72 – 7.65 (m, 2H), 
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7.57 – 7.50 (m, 2H), 7.48 – 7.36 (m, 4H), 7.36 – 7.29 (m, 2H); 19F NMR (282 MHz, CDCl3) 
δ = -72.65 (s); 13C NMR (63 MHz, CDCl3) δ = 147.99, 140.64, 138.12, 128.89, 126.40, 
123.82, 123.19, 120.72, 120.65, 109.59;  IR (ATR, cm
-1): ν = 3063  (w), 2924  (w), 1593  
(w), 1504  (s), 1477  (m), 1452  (s), 1421  (s), 1412  (s), 1365  (w), 1335  (m), 1315  (m), 
1248  (m), 1228  (s), 1215  (vs), 1167  (m), 1134  (vs), 1101  (m), 1026  (w), 1016  (m), 1001  
(w), 916  (m), 887  (vs), 841  (s), 820  (m), 787  (m), 764  (w), 752  (vs), 725  (s), 696  (s), 
644  (m), 619  (s), 611  (vs), 602  (vs), 573  (s), 565  (m), 530  (s); GC-MS (EI, 70 eV): m/z 
(%) = 391 (51), 259 (20), 258 (100), 230 (15), 228 (28), 69 (9); HRMS (EI): calcd. for 
C19H12O3NF3S ([M]
+
): 391.04845; found: 391.04852. 
 N-(3- trifluoromethanesulfonate)carbazole  41b was prepared 
following procedure 17 with carbazole 40b (231 mg, 0.891 mmol) to 
give 41b (328 mg, 94 %) as white solid;  mp 76-78 ºC, 
1
H NMR (300 
MHz, CDCl3) δ = 7.97 (m, 2H), 7.50 (dd, J = 6.4, 4.6 Hz, 2H), 7.38 
(t, J = 2.0 Hz, 1H), 7.29 – 7.24 (m, 4H), 7.16 (m, 3H). 19F NMR (282 
MHz, CDCl3) δ = -72.63 (s). 
13
C NMR (75 MHz, CDCl3) δ = 150.33, 140.40, 139.83, 131.53, 
126.90, 126.51, 123.92, 120.90, 120.67, 120.32, 120.14, 109.56; IR (ATR, cm
-1): ν = 3072  
(w), 3047  (w), 3024  (w), 1605  (m), 1585  (w), 1574  (w), 1495  (s), 1483  (s), 1454  (s), 
1417  (vs), 1404  (m), 1365  (m), 1335  (m), 1315  (m), 1250  (m), 1230  (m), 1209  (vs), 
1184  (s), 1163  (m), 1136  (s), 1119  (s), 1095  (s), 1084  (m), 1028  (m), 1003  (w), 984  (s), 
964  (w), 924  (m), 904  (m), 877  (s), 847  (m), 798  (s), 771  (m), 764  (m), 750  (vs), 741  
(s), 725  (s), 692  (s), 660  (m), 636  (m), 623  (m), 606  (s), 567  (s), 536  (m); GC-MS (EI, 
70 eV): m/z (%) = 391 (100), 258 (57), 230 (58), 228 (42), 202 (12), 69 (13); HRMS (EI): 
calcd. for C19H12O3NF3S ([M]
+
): 391.04845; found: 391.04816. 
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General procedure 18 for C-N coupling and C-H activation reaction, exemplified by 9H-
3,9'-bicarbazole (38a) 
 
Cesium carbonate (125 mg, 0.383 mmol) was added to a pressure tube charged with 
Pd(OAc)2 (3 mg, 0.013 ammol) and ligand XPhos (12 mg, 0.026 mmol) under argon 
atmosphere. N-(4- trifluoromethanesulfonate)carbazole 41a (100 mg, 0.256 mmol) and 
aniline (26 µL, 0.281 mmol) were added to the mixture and  the tube was backfilled with 
argon several times. The mixture was stirred at 110 °C in anhydrous toluene (5 mL) for 6 
hours. After cooling, the reaction mixture was diluted with dichloromethane (10 mL), filtered 
through a celite pad, and washed with dichloromethane (20 mL). The filtrate was 
concentrated in vacuo. Pivalic acid was added to the mixture of filtrate charged with 
Pd(OAc)2 (3 mg, 0.013 mmol) and potassium carbonate (35 mg, 0.256 mmol). The mixture 
was stirred at 110 °C under air atmosphere for 72 hours, controlled by TLC. The solution was 
then cooled to room temperature, diluted with DCM and washed with a saturated aqueous 
solution of sodium carbonate, dried over Magnesium sulfate, filtered and evaporated in 
vacuo. The product was purified by flash chromatography (silica gel, ethylacetate/heptane = 
1:10) to yield 38a (73 mg, 86%) as white solid; mp 211-212 °C; 
1
H NMR (250 MHz, CDCl3) 
δ = 8.07 (m, 3H), 7.90 (d, J = 7.8 Hz, 1H), 7.46 – 7.07 (m, 11H); 13C NMR (63 MHz, CDCl3) 
δ = 142.06, 140.30, 138.71, 129.56, 126.71, 125.99, 125.58, 124.50, 123.21, 123.14, 120.72, 
120.40, 120.05, 119.71, 111.73, 111.05, 109.99; IR (ATR, cm
-1): ν = 3394  (m), 3076  (w), 
3051  (m), 3020  (w), 2926  (w), 1595  (m), 1574  (m), 1495  (m), 1485  (m), 1475  (s), 1462  
(s), 1448  (s), 1346  (m), 1333  (m), 1311  (s), 1273  (m), 1230  (s), 1203  (m), 1163  (m), 
1149  (m), 1126  (m), 1117  (m), 1097  (m), 1024  (m), 1011  (m), 1003  (m), 957  (m), 926  
(m), 918  (m), 845  (m), 820  (s), 742  (vs), 733  (s), 719  (vs), 660  (m), 650  (s), 631  (m), 
615  (m), 580  (m), 571  (s); GC-MS (EI, 70 eV): m/z (%) = 332 (100), 166 (14), 139 (4); 
HRMS (EI): calcd. for C24H16N2 ([M]
+
): 332.13080; found: 332.13072. 
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 6-nitro-9H-3,9'-bicarbazole 38b was prepared following general 
procedure 18 using compound 41a (100 mg, 0.256 mmol) and p-
nitroaniline (39 mg, 0.281 mmol). The product was purified by 
flash chromatography (silica gel, ethylacetate/heptane = 1:3) to 
yield 38b (96 mg, 95 %) as red solid; mp 306-308 °C;
 1
H NMR 
(300 MHz, DMSO) δ = 12.35 (s, 1H), 9.32 (d, J = 2.2 Hz, 1H), 8.72 (d, J = 1.8 Hz, 1H), 8.39 
– 8.22 (m, 3H), 7.87 (d, J = 8.5 Hz, 1H), 7.79 – 7.65 (m, 2H), 7.37 (m, 6H); 13C NMR (75 
MHz, DMSO) δ = 144.00, 140.97, 140.13, 140.10, 129.42, 126.29, 126.14, 123.68, 122.49, 
122.09, 121.71, 120.43, 120.34, 119.76, 118.33, 113.27, 111.50, 109.70; IR (ATR, cm
-1): ν = 
3307  (m), 2955  (w), 2922  (w), 2850  (w), 1608  (m), 1585  (m), 1495  (s), 1475  (s), 1448  
(s), 1315  (s), 1308  (s), 1288  (s), 1228  (s), 1200  (s), 1163  (s), 1147  (m), 1128  (s), 1103  
(m), 1078  (s), 1030  (m), 1016  (m), 889  (m), 852  (m), 823  (s), 816  (s), 748  (vs), 741  (s), 
731  (s), 721  (vs), 683  (s), 654  (s), 640  (s), 625  (s), 613  (s), 590  (s), 567  (s), 557  (s), 528  
(s); GC-MS (EI, 70 eV): m/z (%) = 377 (2), 329 (51), 314 (16), 114 (14), 73 (33), 60 (45), 44 
(100); HRMS (ESI): calcd. for C24H16O2N3 ([M + H]
+
): 378.1237; found: 378.12327; calcd. 
for C24H15O2N3Na ([M + Na]
+
): 400.10565; found: 400.10522. 
 6-fluoro-9H-3,9'-bicarbazole 38c was prepared following 
general procedure 18 using compound  41a (100 mg, 0.256 mmol) 
and p-fluoroaniline (27 µL, 0.281 mmol). The product was 
purified by flash chromatography (silica gel, ethylacetate/heptane 
= 1:10) to yield 38c (90 mg, 63 %) as red solid; mp 238-240 °C;
 
1
H NMR (300 MHz, DMSO) δ = 11.62 (s, 1H), 8.41 (d, J = 2.0 
Hz, 1H), 8.26 (d, J = 7.6 Hz, 2H), 8.06 (dd, J = 9.4, 2.6 Hz, 1H), 7.76 (d, J = 8.6 Hz, 1H), 
7.57 (m, 2H), 7.42 (ddd, J = 8.2, 7.0, 1.2 Hz, 2H), 7.37 – 7.22 (m, 5H). 13C NMR (75 MHz, 
DMSO) δ = 156.47 (d, J = 232.6 Hz), 141.23, 139.92, 136.95, 127.70, 126.08, 125.30, 123.19 
(d, J = 4.2 Hz), 122.69 (d, J = 10.1 Hz), 122.35, 120.40, 119.71, 119.59, 113.95 (d, J = 25.6 
Hz), 112.51, 112.18 (d, J = 9.1 Hz), 109.64, 106.35 (d, J = 23.9 Hz); IR (ATR, cm
-1
): ν = 
3394  (m), 3053  (w), 2953  (w), 2920  (w), 2850  (w), 1587  (m), 1574  (m), 1495  (s), 1466  
(s), 1448  (s), 1315  (m), 1284  (m), 1244  (m), 1228  (s), 1171  (m), 1151  (s), 1140  (m), 
1124  (m), 1115  (m), 850  (m), 812  (s), 752  (vs), 744  (s), 721  (s), 656  (s), 646  (s), 615  
(m), 596  (m), 575  (s), 565  (s), 544  (s), 532  (m); GC-MS (EI, 70 eV): m/z (%) = 350 (100), 
174 (15); HRMS (ESI): calcd. for C24H16FN2 ([M + H]
+
): 351.1292; found: 351.12844; calcd. 
for C24H15OFN2Na ([M + Na]
+
): 373.11115; found: 373.11065. 
General procedures and spectroscopic data  161 
 
 
 6-methoxy-9H-3,9'-bicarbazole 38d was prepared following 
general procedure 18 using compound  41a (100 mg, 0.256 mmol) 
and p-anisidine (35 mg, 0.281 mmol). The product was purified 
by flash chromatography (silica gel, ethylacetate/heptane = 1:5) to 
yield 38d (93 mg, 53 %) as white solid; mp 256-257 °C; 
1
H NMR 
(300 MHz, DMSO) δ = 11.46 (s, 1H), 8.36 (d, J = 1.9 Hz, 1H), 
8.26 (d, J = 7.7 Hz, 2H), 7.80 (d, J = 2.4 Hz, 1H), 7.71 (d, J = 8.5 Hz, 1H), 7.54 – 7.39 (m, 
4H), 7.35 – 7.24 (m, 4H), 7.08 (dd, J = 8.8, 2.5 Hz, 1H), 3.81 (s, 3H); 13C NMR (75 MHz, 
DMSO) δ = 153.17, 141.32, 139.54, 135.31, 127.23, 126.06, 124.45, 123.48, 122.64, 122.33, 
120.40, 119.52, 119.29, 115.66, 112.20, 111.95, 109.68, 103.39, 55.56; IR (ATR, cm
-1): ν = 
3417  (m), 3045  (w), 2928  (w), 2829  (m), 1622  (m), 1589  (s), 1581  (s), 1574  (s), 1497  
(s), 1470  (m), 1464  (m), 1450  (s), 1435  (m), 1360  (s), 1335  (m), 1313  (m), 1294  (s), 
1232  (s), 1201  (s), 1173  (m), 1151  (m), 1140  (m), 1032  (m), 808  (m), 773  (s), 752  (vs), 
727  (s), 656  (m), 648  (m), 617  (m), 607  (m), 569  (s), 528  (m); GC-MS (EI, 70 eV): m/z 
(%) = 362 (100), 347 (26), 319 (16), 290 (5), 174 (14); HRMS (ESI): calcd. for C25H17N2O 
([M - H]
-
): 361.13464; found: 361.13557. 
5,7-dimethoxy-9H-3,9'-bicarbazole 38e was prepared 
following general procedure 18 using compound 41a (100 mg, 
0.256 mmol) and 3,5-dimethoxyaniline (43 mg, 0.281 mmol). 
The product was purified by flash chromatography (silica gel, 
ethylacetate/heptane = 1:4) to yield 38e (100 mg, 50 %) as 
white solid; mp 125-127 °C; 
1
H NMR (300 MHz, CDCl3) δ = 
8.32 (d, J = 2.0 Hz, 1H), 8.26 – 8.15 (m, 2H), 8.09 (s, 1H), 7.50 (dd, J = 8.4, 0.4 Hz, 1H), 
7.46 – 7.34 (m, 5H), 7.34 – 7.25 (m, 3H), 6.56 (d, J = 1.9 Hz, 1H), 6.34 (d, J = 1.9 Hz, 1H), 
3.94 (s, 3H), 3.91 (s, 3H); 
13
C NMR (75 MHz, CDCl3) δ = 160.97, 156.90, 142.35, 142.24, 
137.96, 129.65, 125.89, 124.09, 123.44, 123.09, 121.42, 120.30, 119.49, 110.65, 110.20, 
106.90, 91.59, 87.00, 55.85, 55.52; IR (ATR, cm
-1): ν = 3400  (w), 2918  (w), 2839  (w), 
1633  (m), 1622  (m), 1614  (m), 1591  (m), 1495  (s), 1464  (s), 1450  (s), 1435  (m), 1335  
(m), 1329  (m), 1315  (m), 1290  (s), 1230  (s), 1209  (s), 1196  (s), 1149  (s), 1120  (s), 1099  
(m), 1049  (m), 918  (m), 806  (s), 750  (vs), 723  (s), 656  (s), 642  (m), 557  (m); GC-MS 
(EI, 70 eV): m/z (%) = 392 (100), 334 (22), 196 (12), 167 (7), 140 (22); HRMS (ESI): calcd. 
for C26H21N2O2 ([M + H]
+
): 393.15975; found: 393.1595; calcd. for C26H20N2O2Na ([M + 
Na]
+
): 415.1417; found: 415.14155. 
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 6-methyl-9H-3,9'-bicarbazole 38g was prepared following general 
procedure 18 using compound 41a (100 mg, 0.256 mmol) and p-
toluidine (30 mg, 0.281 mmol). The product was purified by flash 
chromatography (silica gel, ethylacetate/heptane = 1:10) to yield 38g 
(89 mg, 34 %) as white solid; mp 231-232 °C;
 1
H NMR (300 MHz, 
CDCl3) δ = 8.15 – 8.07 (m, 3H), 7.76 (d, J = 0.7 Hz, 1H), 7.46 (m, 
2H), 7.39 – 7.14 (m, 9H), 2.44 (s, 3H); 13C NMR (75 MHz, CDCl3) δ = 142.08, 139.05, 
138.57, 129.45, 129.38, 128.09, 125.96, 125.39, 124.38, 123.36, 123.21, 120.59, 120.38, 
119.67, 119.60, 111.69, 110.73, 110.01, 21.56; IR (ATR, cm
-1): ν = 3410  (m), 3057  (w), 
2916  (w), 2852  (w), 2831  (w), 1593  (m), 1583  (m), 1574  (m), 1497  (s), 1479  (m), 1464  
(s), 1452  (s), 1358  (m), 1338  (m), 1317  (m), 1296  (m), 1277  (m), 1242  (m), 1230  (s), 
1153  (m), 820  (s), 806  (m), 748  (vs), 723  (vs), 658  (m), 646  (m), 575  (s), 540  (m), 528  
(m); GC-MS (EI, 70 eV): m/z (%) = 346 (100), 173 (9); HRMS (ESI): calcd. for C25H19N2 
([M + H]
+
): 347.15428; found: 347.15337; calcd. for C25H18N2Na ([M + Na]
+
): 369.13622; 
found: 369.13578. 
 6-(tert-butyl)-9H-3,9'-bicarbazole 38h was prepared following 
general procedure 18 using compound 41a (100 mg, 0.256 mmol) 
and 4-(tert-butyl)aniline (45 µL, 0.281 mmol). The product was 
purified by flash chromatography (silica gel, ethylacetate/heptane = 
1:10) to yield 38h (99 mg, 70 %) as white solid; mp 183-185 °C; 
1
H 
NMR (250 MHz, CDCl3) δ = 8.28 – 7.87 (m, 4H), 7.60 – 7.05 (m, 
10H), 1.34 (s, 9H); 
13
C NMR (63 MHz, CDCl3) δ = 143.20, 142.16, 139.18, 138.43, 129.36, 
125.94, 125.36, 124.80, 123.20, 122.90, 120.39, 119.65, 116.72, 111.67, 110.57, 110.02, 
34.86, 32.06; IR (ATR, cm
-1
): ν = 3408  (m), 3045  (w), 2953  (m), 2862  (w), 1622  (m), 
1614  (m), 1595  (m), 1574  (m), 1495  (s), 1470  (s), 1450  (s), 1362  (m), 1335  (m), 1315  
(m), 1294  (m), 1281  (m), 1242  (m), 1230  (s), 1201  (m), 1163  (m), 1138  (m), 1117  (m), 
808  (s), 746  (vs), 723  (vs), 661  (m), 648  (m), 627  (vs), 577  (m), 546  (m), 536  (m); GC-
MS (EI, 70 eV): m/z (%) = 388 (100), 373 (63), 332 (10), 207 (9), 187 (13), 173 (24); HRMS 
(ESI): calcd. for C28H25N2 ([M + H]
+
): 389.20123; found: 389.20074. 
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 8-(9H-carbazol-9-yl)-11H-benzo[a]carbazole 38j was 
prepared following general procedure 18 using compound  41a 
(100 mg, 0.256 mmol) and naphthalene-2-amine (40 mg, 0.281 
mmol). The product was purified by flash chromatography 
(silica gel, ethylacetate/heptane = 1:10) to yield 38j (98 mg, 42 
%) as white solid; mp 220-222 °C; 
1
H NMR (300 MHz, CDCl3) 
δ = 8.90 (s, 1H), 8.18 (d, J = 1.9 Hz, 1H), 8.13 – 8.10 (m, 3H), 8.00 (d, J = 8.6 Hz, 1H), 7.96 
(d, J = 7.5 Hz, 1H), 7.69 (d, J = 8.5 Hz, 1H), 7.61 (d, J = 8.7 Hz, 1H), 7.58 – 7.46 (m, 3H), 
7.36 – 7.30 (m, 4H), 7.25 – 7.19 (m, 2H); 13C NMR (75 MHz, CDCl3) δ = 141.95, 137.57, 
135.86, 132.74, 130.05, 129.21, 125.86, 125.68, 125.21, 124.52, 123.13, 121.15, 120.80, 
120.55, 120.28, 119.60, 119.24, 119.12, 118.30, 112.11, 109.90; IR (ATR, cm
-1
): ν = 3417  
(w), 3045  (w), 2918  (w), 2848  (w), 1593  (m), 1514  (m), 1495  (s), 1477  (m), 1464  (m), 
1450  (s), 1417  (m), 1385  (m), 1358  (m), 1335  (m), 1313  (m), 1304  (m), 1281  (m), 1230  
(s), 1205  (m), 1169  (m), 1157  (m), 1146  (m), 1117  (m), 1105  (m), 806  (s), 748  (vs), 723  
(s), 687  (m), 650  (m), 604  (m), 565  (m), 550  (m); GC-MS (EI, 70 eV): m/z (%) = 382 
(100), 216 (6), 190 (25); HRMS (ESI): calcd. for C28H19N2 ([M + H]
+
): 383.15428; found: 
383.15362; calcd. for C28H18N2Na ([M + Na]
+
): 405.13622; found: 405.13638. 
 9H-2,9'-bicarbazole 42a was prepared following general 
procedure 18 using compound 41b (100 mg, 0.256 mmol) and 
aniline (26 µL, 0.281 mmol). The product was purified by 
flash chromatography (silica gel, ethylacetate/heptane = 1:10) 
to yield 42a (65 mg, 77 %) as white solid; mp 298-300 °C; 
1
H 
NMR (300 MHz, Acetone) δ = 10.61 (s, 1H), 8.40 (d, J = 8.2 Hz, 1H), 8.29 – 8.20 (m, 3H), 
7.78 – 7.72 (m, 1H), 7.61 (m, 1H), 7.50 – 7.38 (m, 6H), 7.33 – 7.23 (m, 3H); 13C NMR (63 
MHz, Acetone) δ = 142.28, 141.82, 141.72, 135.91, 126.95, 126.89, 124.14, 123.66, 123.52, 
122.23, 121.18, 121.11, 120.72, 120.28, 118.82, 112.02, 110.76, 110.47; IR (ATR, cm
-1): ν = 
3414  (m), 3053  (w), 2926  (w), 1603  (m), 1489  (m), 1460  (m), 1450  (s), 1441  (s), 1362  
(m), 1336  (m), 1321  (m), 1230  (s), 1201  (m), 1157  (m), 1095  (m), 999  (m), 978  (m), 937  
(m), 918  (m), 849  (m), 818  (m), 752  (s), 742  (s), 723  (vs), 663  (s), 631  (m), 615  (m), 
565  (s); GC-MS (EI, 70 eV): m/z (%) = 332 (100), 166 (16); HRMS (EI): calcd. for 
C24H16N2 ([M]
+
): 332.13080; found: 332.13106. 
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6-nitro-9H-2,9'-bicarbazole 42b was prepared following 
general procedure 18 using compound 41b (100 mg, 
0.256 mmol) and p-nitroaniline (39 mg, 0.281 mmol). The 
product was purified by flash chromatography (silica gel, 
ethylacetate/heptane = 1:3) to yield 42b (61 mg, 63 %) as 
red solid; mp 310-312 °C; 
1H NMR (300 MHz, Acetone) δ 10.42 (s, 1H), 8.36 (d, J = 8.3 Hz, 
1H), 8.27 – 8.20 (m, 2H), 7.80 (d, J = 2.5 Hz, 1H), 7.71 (d, J = 1.5 Hz, 1H), 7.56 – 7.25 (m, 
8H), 7.12 (dd, J = 8.8, 2.5 Hz, 1H), 3.93 (s, 3H); 
13
C NMR (63 MHz, DMSO) δ = 144.02, 
141.82, 140.47, 140.28, 135.81, 126.29, 122.92, 122.76, 121.97, 121.82, 121.56, 120.54, 
120.10, 119.04, 117.68, 111.45, 110.14, 109.76; IR (ATR, cm
-1): ν = 3348  (m), 3059  (w), 
2916  (w), 1610  (s), 1593  (m), 1583  (m), 1506  (s), 1477  (s), 1464  (m), 1450  (s), 1365  
(m), 1331  (s), 1319  (s), 1309  (s), 1279  (s), 1248  (s), 1228  (s), 1196  (m), 1159  (s), 1124  
(s), 1099  (s), 1084  (s), 1028  (m), 1014  (m), 1003  (m), 982  (m), 916  (m), 893  (m), 866  
(m), 849  (m), 841  (m), 823  (s), 748  (vs), 725  (vs), 692  (s), 663  (s), 636  (m), 627  (m), 
615  (m), 584  (s), 573  (s), 565  (s), 528  (m); GC-MS (EI, 70 eV): m/z (%) = 377 (100), 331 
(34), 281 (4), 189 (8), 173 (26); HRMS (ESI): calcd. for C24H15O2N3Na ([M + Na]
+
): 
400.10565; found: 400.10564. 
 6-methoxy-9H-2,9'-bicarbazole 42c was prepared 
following general procedure 18 using compound 41b 
(100 mg, 0.256 mmol) and p-anisidine (35 mg, 0.281 
mmol). The product was purified by flash 
chromatography (silica gel, ethylacetate/heptane = 1:5) to 
yield 42c (47 mg, 51 %) as white solid; mp 225-227 °C; 
1
H NMR (300 MHz, Acetone) δ = 
10.42 (s, 1H), 8.36 (d, J = 8.3 Hz, 1H), 8.27 – 8.20 (m, 2H), 7.80 (d, J = 2.5 Hz, 1H), 7.71 (d, 
J = 1.5 Hz, 1H), 7.56 – 7.25 (m, 9H), 7.12 (dd, J = 8.8, 2.5 Hz, 1H), 3.93 (s, 3H); 13C NMR 
(63 MHz, Acetone) δ = 155.14, 142.32, 142.25, 136.59, 135.74, 126.86, 124.11, 123.56, 
122.28, 121.10, 120.69, 118.31, 116.35, 112.71, 110.76, 110.48, 103.79, 56.15; IR (ATR, cm
-
1
): ν = 3415  (m), 3053  (w), 2993  (w), 1608  (m), 1589  (m), 1489  (s), 1471  (m), 1462  (m), 
1448  (s), 1427  (s), 1335  (m), 1319  (m), 1308  (m), 1288  (s), 1252  (m), 1225  (s), 1217  
(s), 1201  (s), 1169  (s), 1159  (s), 1126  (m), 1115  (m), 1095  (m), 1030  (s), 1012  (m), 1003  
(m), 980  (m), 914  (m), 906  (m), 895  (m), 860  (m), 850  (m), 837  (s), 822  (m), 804  (vs), 
775  (m), 754  (vs), 744  (vs), 725  (vs), 708  (s), 663  (s), 652  (m), 615  (m), 606  (s), 588  
(m), 565  (m), 553  (m), 528  (s); GC-MS (EI, 70 eV): m/z (%) = 362 (100), 347 (21), 330 
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(14), 290 (6), 207 (6), 159 (68), 145 (29), 133 (15); HRMS (EI): calcd. for C25H18N2O 
([M]
+
): 362.14136; found: 362.14150. 
8-methoxy-9H-2,9'-bicarbazole 42d was prepared following 
general procedure 18 using compound 41b (100 mg, 0.256 
mmol) and o-anisidine (32 µL, 0.281 mmol). The product 
was purified by flash chromatography (silica gel, 
ethylacetate/heptane = 1:5) to yield 42d (75 mg, 81 %) as 
white solid; mp 269-270 °C; 
1
H NMR (300 MHz, CDCl3) δ 8.40 (s, 1H), 8.24 (d, J = 8.3 Hz, 
1H), 8.20 – 8.15 (m, 2H), 7.75 (d, J = 7.9 Hz, 1H), 7.62 (d, J = 1.4 Hz, 1H), 7.51 – 7.37 (m, 
5H), 7.34 – 7.20 (m, 4H), 7.01 – 6.94 (m, 1H), 4.05 (s, 3H); 13C NMR (63 MHz, CDCl3) δ = 
145.75, 141.38, 139.72, 135.26, 130.49, 125.88, 123.92, 123.26, 123.04, 121.61, 120.37, 
120.25, 119.76, 118.83, 112.86, 109.93, 109.70, 106.29, 55.58; IR (ATR, cm
-1
): ν = 3412  
(m), 3055  (w), 2931  (w), 2839  (w), 1614  (w), 1579  (m), 1504  (m), 1450  (s), 1433  (s), 
1381  (m), 1365  (m), 1335  (m), 1323  (m), 1313  (m), 1306  (m), 1269  (m), 1259  (m), 1240  
(m), 1230  (s), 1188  (w), 1155  (m), 1093  (m), 1063  (w), 1016  (s), 980  (w), 931  (w), 918  
(m), 893  (w), 868  (w), 847  (m), 823  (m), 781  (m), 746  (vs), 723  (s), 685  (m), 665  (m), 
617  (m), 577  (m), 563  (m), 555  (m), 536  (m); GC-MS (EI, 70 eV): m/z (%) = 362 (100), 
347 (7), 319 (27), 181 (7), 159 (10); HRMS (ESI): calcd. for C25H19N2O ([M + H]
+
): 
363.14919; found: 363.14883; calcd. for C25H18N2O Na ([M + Na]
+
): 385.13113; found: 
385.13157. 
6-fluoro-9H-2,9'-bicarbazole 42e was prepared following 
general procedure 18 using compound 41b (100 mg, 0.256 
mmol) and 4-fluoroaniline (27 µL, 0.281 mmol). The product 
was purified by flash chromatography (silica gel, 
ethylacetate/heptane = 1:10) to yield 42e (56 mg, 63 %) as 
white solid; mp 274-276 °C;
 1
H NMR (300 MHz, DMSO) δ = 11.52 (s, 1H), 8.40 (d, J = 8.3 
Hz, 1H), 8.27 (d, J = 7.7 Hz, 2H), 8.08 (dd, J = 9.4, 2.6 Hz, 1H), 7.70 (d, J = 1.5 Hz, 1H), 
7.57 (dd, J = 8.9, 4.4 Hz, 1H), 7.49 – 7.24 (m, 8H); 19F NMR (282 MHz, DMSO) δ = -124.46 
(s); 
13
C NMR (63 MHz, DMSO) δ = 156.61 (d, J = 232.4 Hz), 141.35, 140.55, 136.91, 
134.71, 126.17, 122.61, 122.53 (d, J = 10.4 Hz), 122.09, 121.55 (d, J = 4.2 Hz), 120.47, 
119.89, 117.28, 113.61 (d, J = 25.1 Hz), 112.08 (d, J = 9.3 Hz), 109.72, 109.40, 105.98 (d, J 
= 23.8 Hz); IR (ATR, cm
-1): ν = 3412  (m), 3051  (w), 2918  (w), 1610  (m), 1593  (m), 1585  
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(m), 1487  (m), 1464  (m), 1450  (s), 1362  (m), 1336  (m), 1317  (m), 1282  (m), 1271  (m), 
1248  (m), 1230  (s), 1169  (s), 1157  (s), 1122  (m), 1111  (m), 1095  (m), 1053  (m), 1024  
(m), 1014  (m), 999  (m), 978  (m), 935  (m), 912  (m), 860  (m), 849  (m), 816  (s), 800  (m), 
779  (m), 750  (vs), 723  (vs), 710  (s), 663  (s), 654  (m), 638  (m), 615  (m), 594  (s), 575  
(m), 563  (s), 540  (m), 528  (m); GC-MS (EI, 70 eV): m/z (%) = 350 (100), 175 (11), 157 
(6); HRMS (EI): calcd. for C24H15FN2 ([M]
+
): 350.12138; found: 350.12096. 
 6-(tert-butyl)-9H-2,9'-bicarbazole 42g was prepared 
following general procedure 18 using compound 41b (100 
mg, 0.256 mmol) and 4-(tert-butyl)aniline (45 µL, 0.281 
mmol). The product was purified by flash chromatography 
(silica gel, ethylacetate/heptane = 1:10) to yield 7g (60 
mg, 60 %) as white solid; mp 238-239 °C; 
1
H NMR (300 MHz, DMSO) δ = 11.36 (s, 1H), 
8.42 (d, J = 8.2 Hz, 1H), 8.29 (d, J = 7.7 Hz, 1H), 8.24 (d, J = 1.5 Hz, 1H); 7.67 (d, J = 1.6 
Hz, 1H), 7.62 – 7.40 (m, 6H), 7.38 – 7.26 (m, J = 11.4, 6.7, 2.9 Hz, 3H), 1.45 (s, 9H); 13C 
NMR (75 MHz, DMSO) δ = 141.59, 140.71, 140.67, 138.62, 133.89, 126.18, 123.85, 122.62, 
122.17, 121.84, 121.42, 120.50, 119.86, 117.00, 116.33, 110.65, 109.74, 109.07, 34.45, 
31.87; IR (ATR, cm
-1): ν = 3400  (m), 3080  (w), 3051  (w), 3020  (w), 2956  (m), 2899  (w), 
2866  (w), 1608  (m), 1500  (m), 1477  (m), 1462  (m), 1450  (s), 1429  (m), 1381  (w), 1363  
(m), 1331  (m), 1313  (m), 1294  (m), 1279  (w), 1255  (m), 1246  (m), 1232  (s), 1207  (w), 
1155  (m), 1140  (m), 1117  (w), 980  (w), 928  (w), 918  (w), 889  (w), 839  (m), 812  (s), 
746  (vs), 723  (s), 702  (w), 665  (s), 634  (s), 615  (m), 565  (m); GC-MS (EI, 70 eV): m/z 
(%) = 388 (100), 373 (79), 332 (13), 207 (12), 187 (16), 172 (32), 41 (10); HRMS (EI): calcd. 
for C28H24N2 ([M]
+
): 388.19340; found: 388.19264. 
6-methyl-9H-2,9'-bicarbazole 42h was prepared following 
general procedure 18 using compound 41b (100 mg, 0.256 
mmol) and p-toluidine (31 mg, 0.281 mmol). The product was 
purified by flash chromatography (silica gel, 
ethylacetate/heptane = 1:10) to yield 42h (45 mg, 51 %) as 
white solid; mp 287-289 °C; 
1
H NMR (250 MHz, DMSO) δ = 11.36 (s, 1H), 8.29 (dd, J = 
14.4, 8.0 Hz, 3H), 8.01 (s, 1H), 7.64 (d, J = 1.6 Hz, 1H), 7.45 (dd, J = 8.4, 3.6 Hz, 5H), 7.40 
– 7.20 (m, 5H), 2.49 (s, 3H); 13C NMR (63 MHz, DMSO) δ = 140.70, 140.64, 138.77, 
134.06, 127.79, 127.38, 126.23, 122.65, 122.27, 121.75, 121.44, 120.53, 120.17, 119.91, 
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117.11, 110.95, 109.81, 109.15, 21.18; IR (ATR, cm
-1
): ν = 3417  (m), 3047  (w), 2916  (w), 
2850  (w), 1608  (m), 1595  (m), 1504  (m), 1489  (m), 1477  (m), 1450  (s), 1377  (m), 1362  
(m), 1335  (m), 1315  (m), 1304  (m), 1294  (m), 1277  (m), 1244  (m), 1230  (s), 1174  (m), 
1155  (m), 1146  (m), 1134  (m), 1120  (m), 1095  (m), 1039  (m), 1024  (m), 980  (m), 935  
(m), 916  (m), 876  (m), 860  (m), 847  (m), 818  (m), 804  (s), 750  (vs), 723  (vs), 663  (s), 
654  (m), 638  (m), 615  (m), 584  (s), 563  (s), 532  (m); GC-MS (EI, 70 eV): m/z (%) = 346 
(100), 330 (9), 173 (9); HRMS (EI): calcd. for C25H18N2 ([M]
+
): 346.14645; found: 
346.14639. 
  9H-[2,9'-bicarbazole]-6-carbonitrile 42i was prepared 
following general procedure 18 using compound 41b (100 
mg, 0.256 mmol) and 4-aminobenzonitrile (33 mg, 0.281 
mmol). The product was purified by flash chromatography 
(silica gel, ethylacetate/heptane = 1:5) to yield 42i (19 mg, 
21 %) as white solid; mp 297-299 °C;
 1
H NMR (300 MHz, DMSO) δ = 12.06 (s, 1H), 8.83 
(d, J = 1.1 Hz, 1H), 8.52 (d, J = 8.3 Hz, 1H), 8.27 (d, J = 7.7 Hz, 2H), 7.85 – 7.77 (m, 2H), 
7.77 – 7.69 (m, 1H), 7.55 – 7.38 (m, 5H), 7.38 – 7.25 (m, 2H); 13C NMR (75 MHz, DMSO) δ 
= 142.47, 141.05, 140.52, 135.54, 128.98, 126.29, 125.91, 122.74, 122.49, 122.37, 121.00, 
120.56, 120.48, 120.08, 118.74, 112.35, 109.86, 109.77, 100.84; IR (ATR, cm
-1
): ν = 3284  
(w), 3059  (w), 2918  (w), 2848  (w), 2229  (m), 1603  (s), 1477  (s), 1450  (s), 1435  (m), 
1396  (m), 1365  (m), 1335  (s), 1319  (m), 1308  (m), 1288  (m), 1254  (s), 1228  (s), 1200  
(m), 1155  (m), 1146  (m), 1132  (m), 1120  (m), 1097  (m), 1016  (m), 1003  (m), 914  (m), 
899  (m), 885  (m), 847  (m), 816  (s), 810  (s), 748  (vs), 723  (s), 663  (m), 629  (s), 615  (s), 
592  (m), 575  (m), 563  (m), 544  (m), 528  (m); GC-MS (EI, 70 eV): m/z (%) = 357 (100), 
281 (9), 253 (8), 207 (29), 191 (15), 178 (48), 164 (15), 97 (10); HRMS (EI): calcd. for 
C25H15N3 ([M]
+
): 357.12605; found: 357.12555. 
 5,7-dimethoxy-9H-2,9'-bicarbazole 42j  was prepared 
following general procedure 18 using compound 41b (100 
mg, 0.256 mmol) and 3,5-dimethoxyaniline (43 mg, 0.281 
mmol). The product was purified by flash chromatography 
(silica gel, ethylacetate/heptane = 1:4) to yield 42j (47 mg, 
47 %) as white solid; mp 282-284 °C; 
1
H NMR (300 MHz, DMSO) δ = 10.51 (s, 1H), 7.42 – 
7.35 (m, 3H), 6.73 (d, J = 1.6 Hz, 1H), 6.66 – 6.51 (m, 4H), 6.48 – 6.37 (m, 3H), 5.82 (d, J = 
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1.8 Hz, 1H), 5.55 (d, J = 1.8 Hz, 1H), 3.18 (s, 3H), 3.02 (s, 3H); 
13
C NMR (63 MHz, DMSO) 
δ = 160.12, 156.02, 142.54, 140.72, 139.47, 132.01, 126.09, 122.48, 121.97, 121.46, 120.42, 
119.72, 117.48, 109.68, 108.47, 105.32, 90.99, 87.21, 55.48, 55.42; IR (ATR, cm
-1
): ν = 3398  
(s), 3003  (w), 2968  (w), 2933  (m), 2918  (m), 2839  (m), 1628  (m), 1606  (s), 1585  (s), 
1574  (m), 1514  (m), 1502  (m), 1477  (m), 1446  (s), 1427  (s), 1360  (m), 1333  (m), 1315  
(s), 1306  (s), 1279  (s), 1234  (s), 1223  (m), 1205  (s), 1198  (s), 1147  (s), 1124  (s), 1117  
(s), 1095  (m), 1049  (s), 1020  (m), 1011  (m), 997  (m), 991  (m), 980  (m), 947  (m), 933  
(m), 920  (m), 874  (m), 850  (m), 820  (m), 804  (vs), 789  (m), 756  (vs), 744  (s), 727  (vs), 
690  (m), 665  (s), 644  (m), 633  (m), 615  (m), 598  (m), 582  (m), 569  (m), 550  (m); GC-
MS (EI, 70 eV): m/z (%) = 392 (100), 377 (17), 349 (6), 334 (22), 196 (10); HRMS (ESI): 
calcd. for C26H21N2O2 ([M + H]
+
): 393.15975; found: 393.15893; calcd. for C26H21N2O2Na 
([M + Na]
+
): 415.1417; found: 415.14089. 
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8.6 CRYSTALLOGRAPHY REPORTS 
8.6.1 Crystal data and structure refinement for compound 2p 
Identification code   av_ht1h088 
Empirical formula   C30H38N2S 
Formula weight 458.68 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.)   P21/c 
Space group (Hall)   -P 2ybc 
Unit cell dimensions   a = 26.9277 (11) Å α = 90.00º 
b = 8.3141 (4) Å β = 104.439 (2)° 
c = 24.3306 (10) Å γ = 90.00º 
Volume   5275.1 (4)  Å
3
 
Z   8 
Density (calculated)  1.155 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.14 mm
-1
 
F(000)   1984 
Crystal size  0.80 × 0.12 × 0.02 mm 
Θrange for data collection   5.3–55.3° 
Index ranges   h = -36→36, k = -11→11, l = -33→33 
Reflections collected   70216 
Independent reflections 14038, Rint = 0.094 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.895, Tmax = 0.997 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   14038/0/599 
Goodness-of-fit on F2 0.98 
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Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.054, wR(F2) = 0.102 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.127, wR(F2) = 0.120 
Largest diff. peak and hole 0.26 e Å
-3 
and -0.32 e Å
-3
 
 
8.6.2 Crystal data and structure refinement for compound 2i 
Identification code   av_ht1h145 
Empirical formula   C36H34N2S·C6H12 
Formula weight 610.87 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.)   C2/c 
Space group (Hall)   -C 2yc 
Unit cell dimensions   a = 10.4817 (8) Å α = 90.00º 
b = 24.3518 (19) Å β = 98.238(5)º 
c = 13.6216 (11) Å γ = 90.00º 
Volume  3441.0 (5)  Å
3
 
Z   4 
Density (calculated)  1.179 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.13 mm
-1
 
F(000)   1312 
Crystal size  0.34 × 0.20 × 0.05 mm 
Θrange for data collection   4.5–43.8° 
Index ranges   h = -13→13, k = -31→27, l = -15→17 
Reflections collected   12582 
Independent reflections 3744 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.959, Tmax = 0.994 
Crystallography reports  171 
 
 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   3744/15/227 
Goodness-of-fit on F2 1.01 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.057, wR(F2) = 0.120 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.120, wR(F2) = 0.129 
Largest diff. peak and hole 0.36 e Å
-3
 and -0.27 e Å
-3
 
 
8.6.3 Crystal data and structure refinement for compound 2k 
Identification code   ch_ht1h142 
Empirical formula   C36H36N4S 
Formula weight 556.75 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.)   P¯1 
Space group (Hall)   -P 1 
Unit cell dimensions   a = 16.4194 (6) Å α = 84.990 (2)° 
b = 16.7949 (6) Å β = 82.485 (2)° 
c = 21.7769 (7) Å γ = 88.123 (2)° 
Volume  5929.5 (4)  Å
3
 
Z   8 
Density (calculated)  1.247 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.14 mm
-1
 
F(000)   2368 
Crystal size  0.23 × 0.18 × 0.12 mm 
Θrange for data collection   4.7–51.2° 
Index ranges   h = -21→22, k = -22→22, l = -29→26 
Reflections collected   141031 
Crystallography reports  172 
 
 
Independent reflections 31470 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.968, Tmax = 0.983 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   31470/0/1520 
Goodness-of-fit on F2 1.01 
Final R indices [I>2σ(I)]   R[F2 > 2(F2)] = 0.050, wR(F2) = 0.050 
R indices (all data)   R[F
2
 > 2(F2)] = 0.098, wR(F2) = 0.119 
Largest diff. peak and hole 0.25 e Å
-3
 and  -0.35 e Å
-3
 
 
8.6.4 Crystal data and structure refinement for compound 15b 
Identification code   is_1h003 
Empirical formula   C25H24N2 
Formula weight 352.46 
Temperature (K)   173 K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.)   P21/c 
Space group (Hall)   -P 2ybc 
Unit cell dimensions   a = 9.8957 (3) Å α = 90.00º 
b = 23.4982 (7) Å β = 103.811 (2)° 
c = 8.5844 (3) Å γ = 90.00º 
Volume   1938.43 (11)  Å
3
 
Z   4 
Density (calculated)  1.208 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.07 mm
-1
 
F(000)   752 
Crystal size  0.38 × 0.16 × 0.14 mm 
Crystallography reports  173 
 
 
Θrange for data collection   5.5–60.0° 
Index ranges   h = -13→13, k = -32→32, l = -12→12 
Reflections collected   27546 
Independent reflections 5629 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.974, Tmax = 0.990 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   5629/80/294 
Goodness-of-fit on F2 1.03 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.051, wR(F2) = 0.051 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.097, wR(F2) = 0.133 
Largest diff. peak and hole 0.24 e Å
-3 
and -0.26 e Å
-3
 
 
8.6.5 Crystal data and structure refinement for compound 18d 
Identification code   av_ht3h114 
Empirical formula   C17H11FN2 
Formula weight 262.28 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.)   P¯1 
Space group (Hall)   -P 1 
Unit cell dimensions   a = 6.2637 (4) Å α = 78.235 (4)° 
b = 9.6026 (6) Å β = 81.016 (4)° 
c = 11.1057 (8) Å γ = 74.565 (4)° 
Volume   626.68 (7)  Å
3
 
Z   2 
Density (calculated)  1.390 Mg m
-3
 
Crystallography reports  174 
 
 
Absorption coefficient  (mm
-1
) 0.09 mm
-1
 
F(000)   272 
Crystal size  0.16 × 0.13 × 0.09 mm 
Θrange for data collection   2.2–24.4° 
Index ranges   h = -8→8, k = -12→12, l = 0→14 
Reflections collected   2973 
Independent reflections 2973 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.672, Tmax = 0.746 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   2973 /30/159 
Goodness-of-fit on F
2
 1.03 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.060, wR(F2) = 0.118 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.111, wR(F2) = 0.139 
Largest diff. peak and hole 0.25 e Å
-3
 and -0.21 e Å
-3
 
 
8.6.6 Crystal data and structure refinement for compound 21b 
Identification code   is_jj2h210 
Empirical formula   C17H11FN2 
Formula weight 262.28 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.)   C2/c 
Space group (Hall)   -C 2yc 
Unit cell dimensions   a = 13.9224 (7) Å α = 90.00º 
b = 11.0347 (5) Å β = 94.077 (2)° 
c = 16.4227 (9) Å γ = 90.00º 
Crystallography reports  175 
 
 
Volume   2516.6 (2)  Å
3
 
Z   8 
Density (calculated)  1.384 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.09 mm
-1
 
F(000)   1088 
Crystal size  0.66 × 0.23 × 0.19 mm 
Θrange for data collection   4.7–60.5° 
Index ranges   h = -18→17, k = -14→15, l = -17→21 
Reflections collected   15409 
Independent reflections 3322, Rint = 0.033 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.941, Tmax = 0.983 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   3322/0/218 
Goodness-of-fit on F
2
 1.04 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.043, wR(F2) = 0.101 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.077, wR(F2) = 0.116 
Largest diff. peak and hole 0.15 e Å
-3 
and -0.20 e Å
-3
 
 
8.6.7 Crystal data and structure refinement for compound 25g 
Identification code   is_ht2h121p 
Empirical formula   C33H28ClN3O4·1.5(CHCl3) 
Formula weight 745.09 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.)   P¯1 
Space group (Hall)   -P 1 
Crystallography reports  176 
 
 
Unit cell dimensions   a = 12.1069 (2) Å α = 67.635 (1)° 
b = 12.5752 (2) Å β = 64.074 (1)° 
c = 13.7247 (3) Å γ = 81.170 (1)° 
Volume   1737.68 (6)  Å
3
 
Z   2 
Density (calculated)  1.424 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.50 mm
-1
 
F(000)   766 
Crystal size  0.22 × 0.17 × 0.15 mm 
Θrange for data collection   6.0–51.1° 
Index ranges   h = -17→15, k = -17→17, l = -19→19 
Reflections collected   48893 
Independent reflections 10557, Rint = 0.045 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.898, Tmax = 0.929 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   10557/0/374 
Goodness-of-fit on F
2
 0.93 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.055, wR(F2) = 0.124 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.104, wR(F2) = 0.138 
Largest diff. peak and hole 0.30 e Å
-3
and
 
-0.29 e Å
-3
 
 
8.6.8 Crystal data and structure refinement for compound 25j 
Identification code   is_ht2h167 
Empirical formula   C23H23N3·0.043(CHCl3)·0.458(C6H12) 
Formula weight 385.00 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystallography reports  177 
 
 
Crystal system Triclinic 
Space group (H.-M.)   P¯1 
Space group (Hall)   -P 1 
Unit cell dimensions   a = 9.7236 (2) Å α = 92.999 (1)° 
b = 12.5815 (2) Å β = 99.527 (1)° 
c = 17.7524 (3) Å γ = 96.347 (1)° 
Volume   2123.17 (7)  Å
3
 
Z   4 
Density (calculated)  1.204 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.09 mm
-1
 
F(000)   826 
Crystal size  0.22 × 0.19 × 0.08 mm 
Θrange for data collection   5.1–60.5° 
Index ranges   h = -12→12, k = -16→16, l = -23→23 
Reflections collected   57048 
Independent reflections 10170, Rint = 0.037 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.981, Tmax = 0.993 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   10170/3/560 
Goodness-of-fit on F
2
 1.01 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.056, wR(F2) = 0.127 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.097, wR(F2) = 0.151 
Largest diff. peak and hole 0.48 e Å
-3 
and -0.43 e Å
-3
 
 
8.6.9 Crystal data and structure refinement for compound 35e 
Identification code   is_ht2h182 
Empirical formula   C21H15N3O 
Crystallography reports  178 
 
 
Formula weight 325.36 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.)   P¯1 
Space group (Hall)   -P 1 
Unit cell dimensions   a = 5.9259 (3) Å α = 79.323 (3)° 
b = 11.0893 (6) Å β = 78.333 (3)° 
c = 12.3340 (6) Å γ = 86.450 (3)° 
Volume   779.78 (7)  Å
3
 
Z   2 
Density (calculated)  1.386 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.09 mm
-1
 
F(000)   340 
Crystal size  0.43 × 0.07 × 0.03 mm 
Θ range for data collection   6.9–45.1° 
Index ranges   h = -7→8, k = -15→15, l = -16→16 
Reflections collected   18870 
Independent reflections 4102, Rint = 0.070 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.963, Tmax = 0.997 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   4102/0/228 
Goodness-of-fit on F
2
 1.01 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.058, wR(F2) = 0.101 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.144, wR(F2) = 0.132 
Largest diff. peak and hole 0.28 e Å
-3
 and -0.23 e Å
-3
 
 
Crystallography reports  179 
 
 
8.6.10 Crystal data and structure refinement for compound 35r 
Identification code   is_ht3h053 
Empirical formula   C23H19N3 
Formula weight 337.41 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Triclinic 
Space group (H.-M.)   P¯1 
Space group (Hall)   -P 1 
Unit cell dimensions   a = 7.3149 (3) Å α = 72.116 (2)° 
b = 15.0792 (8) Å β = 88.582 (2)° 
c = 16.8977 (8) Å γ = 77.750 (2)° 
Volume   V = 1731.78 (14)  Å
3
 
Z   4 
Density (calculated)  1.294 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.08 mm
-1
 
F(000)   712 
Crystal size  0.99 × 0.23 × 0.05 mm 
Θ range for data collection   4.4–50.2° 
Index ranges   h = -10→10, k = -20→20, l = -23→23 
Reflections collected   44254 
Independent reflections 9574, Rint = 0.043 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.927, Tmax = 0.996 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   9574/18/482 
Goodness-of-fit on F
2
 1.02 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.053, wR(F2) = 0.117 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.110, wR(F2) = 0.145 
Crystallography reports  180 
 
 
Largest diff. peak and hole 0.37 e Å
-3
 and -0.26 e Å
-3
 
 
8.6.11 Crystal data and structure refinement for compound 38b 
Identification code   is_dh1h017 
Empirical formula   C24H15N3O2 
Formula weight 377.39 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.)   P21/c 
Space group (Hall)   -P 2ybc 
Unit cell dimensions   a = 12.7311 (10) Å α = 90.00º 
b = 15.7373 (13) Å β = 104.025 (2)° 
c = 9.2462 (7) Å γ = 90.00º 
Volume   1797.3 (2)  Å
3
 
Z   4 
Density (calculated)  1.395 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.09 mm
-1
 
F(000)   784 
Crystal size  0.53 × 0.09 × 0.03 mm 
Θ range for data collection   5.2–53.3° 
Index ranges   h = -16→17, k = -21→21, l = -10→12 
Reflections collected   19875 
Independent reflections 5202, Rint = 0.058 
Absorption correction   multi-scan 
Max. and min. transmission   Tmin = 0.953, Tmax = 0.997 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   5202/0/266 
Crystallography reports  181 
 
 
Goodness-of-fit on F
2
 1.01 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.055, wR(F2) = 0.095 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.130, wR(F2) = 0.122 
Largest diff. peak and hole 0.21 e Å
-3
 and -0.25 e Å
-3
 
 
8.6.12 Crystal data and structure refinement for compound 42c 
Identification code   is_t12 
Empirical formula   C25H18N2O 
Formula weight 362.41 
Temperature  173 K 
Wavelength  0.71073 Å 
Crystal system Monoclinic 
Space group (H.-M.)   P21/c 
Space group (Hall)   -P 2ybc 
Unit cell dimensions   a = 12.6024 (5) Å α = 90.00º 
b = 7.6803 (2) Å β = 102.443 (2)° 
c = 19.0480 (7) Å γ = 90.00º 
Volume   1800.35 (11)  Å
3
 
Z   4 
Density (calculated)  1.337 Mg m
-3
 
Absorption coefficient  (mm
-1
) 0.08 mm
-1
 
F(000)   760 
Crystal size  0.24 × 0.21 × 0.20 mm 
Θ range for data collection   4.9–62.9° 
Index ranges   h = -17→19, k = -9→11, l = -25→28 
Reflections collected   25408 
Independent reflections 6521 
Absorption correction   multi-scan 
Crystallography reports  182 
 
 
Max. and min. transmission   Tmin = 0.981, Tmax = 0.984 
Refinement method   Full-matrix least-squares on F2 
Data/ restraints / parameters   6521/0/258 
Goodness-of-fit on F
2
 1.03 
Final R indices [I>2σ(I)]   R[F2 > 2σ(F2)] = 0.051, wR(F2) = 0.116 
R indices (all data)   R[F
2
 > 2σ(F2)] = 0.085, wR(F2) = 0.135 
Largest diff. peak and hole 0.34 e Å
-3
 and -0.30 e Å
-3
 
Calculations   183 
 
 
8.7 Calculations 
B3LYP/6-31G* optimized geometries. The cartesian coordinates are given in Å. 
Compound  25a 
C -1.126407 -1.767076 -0.042458 
 
H 1.916335 1.964987 -1.790622 
C -1.170014 -0.337161 -0.041114 
 
C 3.849912 4.069411 0.065808 
C -0.000046 0.420361 -0.027618 
 
H 4.918466 3.501185 1.851519 
C 1.169955 -0.337165 -0.040918 
 
H 2.679072 4.3279 -1.727224 
C 1.126313 -1.767073 -0.042269 
 
H 4.195843 5.098944 0.087135 
H -0.000038 1.503976 -0.001474 
 
C -4.711415 -1.172356 -0.01231 
N -0.000057 -2.48438 -0.040317 
 
C -3.079173 -3.500412 -0.029725 
N -2.504063 0.070485 -0.016178 
 
C -4.467278 -3.60396 -0.025048 
N 2.504026 0.07046 -0.015648 
 
C -5.270104 -2.450125 -0.020251 
C -2.958994 1.416375 0.011063 
 
H -5.339614 -0.287781 -0.018493 
C -2.557971 2.313822 -0.986968 
 
H -2.446068 -4.382541 -0.043144 
C -3.807778 1.851371 1.037091 
 
H -4.93702 -4.58346 -0.029493 
C -2.995984 3.637433 -0.950014 
 
H -6.352086 -2.551733 -0.025641 
H -1.91783 1.965043 -1.791477 
 
C 4.711347 -1.172567 -0.01184 
C -4.257111 3.171451 1.055369 
 
C 5.269966 -2.450354 -0.020017 
H -4.100473 1.155746 1.817295 
 
C 4.467061 -3.604137 -0.024926 
C -3.849589 4.069509 0.066818 
 
C 3.078974 -3.500491 -0.029537 
H -2.680246 4.328076 -1.727205 
 
H 5.339594 -0.288034 -0.017928 
H -4.916708 3.501192 1.853377 
 
H 6.351939 -2.552038 -0.025501 
H -4.195421 5.099067 0.088529 
 
H 4.936719 -4.583677 -0.029589 
C 2.959044 1.416312 0.011044 
 
H 2.445844 -4.382603 -0.043002 
C 3.808749 1.851357 1.036316 
 
C -2.497844 -2.228837 -0.022272 
C 2.557217 2.313731 -0.986699 
 
C -3.31832 -1.075067 -0.004205 
C 4.258204 3.171394 1.054082 
 
C 3.318248 -1.075162 -0.00368 
H 4.102033 1.155801 1.816351 
 
C 2.497704 -2.228886 -0.021897 
C 2.995385 3.637302 -0.950226 
     
 
Compound  25b 
C -1.12618200 -3.16257800 -0.03348800  C 5.27107200 -3.84157600 0.00164600 
C -1.16974800 -1.73265300 -0.05653400  C 4.46925500 -4.99609900 0.01645600 
C 0.00007200 -0.97489600 -0.05719700  C 3.08098300 -4.89395700 0.00918700 
C 1.16997200 -1.73252800 -0.05680300  H 5.33797500 -1.67911300 -0.03429100 
C 1.12655100 -3.16245700 -0.03374400  H 6.35318500 -3.94235700 -0.00110000 
H 0.00000800 0.10903400 -0.05198200  H 4.93989800 -5.97512800 0.02950600 
N 0.00022500 -3.87986400 -0.01957300  H 2.44883500 -5.77690500 0.01109800 
N -2.50331500 -1.32428700 -0.03903800  C -2.49783000 -3.62335000 -0.00540500 
Calculations   184 
 
 
N 2.50351400 -1.32403200 -0.03964400  C -3.31755400 -2.46861500 -0.00739400 
C -2.95754200 0.02208500 -0.03226900  C 3.31786400 -2.46828800 -0.00813800 
C -2.56942300 0.90810800 -1.03995200  C 2.49824900 -3.62309800 -0.00596700 
C -3.79819500 0.48374900 0.98834800  C -4.36150900 4.16749800 0.03378500 
C -3.00646200 2.23383000 -1.01990100  C 4.36098900 4.16798200 0.03467000 
H -1.93466100 0.55546900 -1.84735300  C -3.84208800 5.00684200 -1.14879200 
C -4.24114700 1.80265500 0.98441100  H -2.74784000 5.06857700 -1.15639100 
H -4.09224700 -0.19175100 1.78581900  H -4.16969900 4.60116900 -2.11278600 
C -3.85517600 2.71474300 -0.01370400  H -4.22896900 6.02915100 -1.07309400 
H -2.68165400 2.88972900 -1.81971900  C -3.88442300 4.83538900 1.34568100 
H -4.89296100 2.12790000 1.79020000  H -4.24429800 5.87013500 1.39892300 
C 2.95759200 0.02238200 -0.03251800  H -4.25612900 4.30821600 2.23054300 
C 3.79860200 0.48375100 0.98794100  H -2.79005600 4.85263100 1.40215900 
C 2.56895800 0.90877000 -1.03968600  C -5.90837400 4.17725800 -0.01134700 
C 4.24137600 1.80271700 0.98435800  H -6.28289200 5.20739000 0.02612000 
H 4.09307300 -0.19201900 1.78502800  H -6.27733400 3.71415700 -0.93351400 
C 3.00581700 2.23454700 -1.01926400  H -6.34531300 3.63409000 0.83317300 
H 1.93394100 0.55638200 -1.84699600  C 3.88462100 4.83514400 1.34719900 
C 3.85487000 2.71516900 -0.01321500  H 4.25703400 4.30763700 2.23156500 
H 4.89348200 2.12770600 1.79001300  H 4.24429100 5.86994800 1.40070200 
H 2.68060100 2.89072700 -1.81868700  H 2.79028700 4.85210800 1.40441200 
C -4.71078200 -2.56489000 -0.01224900  C 5.90782400 4.17806500 -0.01145400 
C -3.08045300 -4.89425900 0.00990800  H 6.27628000 3.71541100 -0.93404600 
C -4.46871500 -4.99652000 0.01751300  H 6.28216500 5.20825500 0.02619100 
C -5.27063700 -3.84206700 0.00288800  H 6.34541300 3.63463800 0.83256200 
H -5.33773300 -1.67960500 -0.03303900  C 3.84065100 5.00780200 -1.14716100 
H -2.44823200 -5.77715500 0.01168300  H 4.16752400 4.60251300 -2.11156500 
H -4.93926800 -5.97559000 0.03069000  H 2.74639600 5.06952700 -1.15389300 
H -6.35274200 -3.94294500 0.00041300  H 4.22757900 6.03008500 -1.07134800 
C 4.71110100 -2.56444800 -0.01334300      
 
Compound  25c 
C -1.12631400 -2.31520400 -0.09049500 
 
H -6.35254800 -3.09719400 -0.08960100 
C -1.16997500 -0.88538500 -0.06449700 
 
C 4.71107900 -1.71895700 -0.05203600 
C 0.00002800 -0.12845800 -0.03849400 
 
C 5.27066200 -2.99593700 -0.08280600 
C 1.17005800 -0.88533300 -0.06464600 
 
C 4.46859900 -4.15012700 -0.10744000 
C 1.12647100 -2.31515600 -0.09065400 
 
C 3.08040000 -4.04725200 -0.10935300 
H 0.00001700 0.95445500 0.00424900 
 
H 5.33788300 -0.83347100 -0.04219200 
N 0.00009300 -3.03260900 -0.10098500 
 
H 6.35276300 -3.09680700 -0.09046000 
N -2.50348200 -0.47763000 -0.03301300 
 
H 4.93893300 -5.12915700 -0.12933900 
N 2.50354500 -0.47751000 -0.03342700 
 
H 2.44783400 -4.92945700 -0.13768000 
C -2.95727700 0.86929700 0.01649300 
 
C -2.49791900 -2.77657200 -0.07896300 
C -2.55585700 1.77755700 -0.96794900 
 
C -3.31772500 -1.62239400 -0.04116300 
Calculations   185 
 
 
C -3.80082100 1.28503000 1.05270000 
 
C 3.31784500 -1.62221900 -0.04165200 
C -2.98191500 3.10953200 -0.91889300 
 
C 2.49810400 -2.77644800 -0.07935200 
H -1.91899400 1.43564100 -1.77897600 
 
H 4.17797900 4.53513900 0.15956600 
C -4.25877500 2.60504500 1.10587100 
 
H -4.17837000 4.53494200 0.15833800 
H -4.08833400 0.57339900 1.82129100 
 
C 5.20079900 3.04818500 2.20197500 
C -3.83482200 3.50300800 0.11816000 
 
H 6.24850900 2.92350500 1.89737400 
C 2.95725500 0.86944300 0.01651200 
 
H 5.05831300 4.10537100 2.44947800 
C 3.80052400 1.28497300 1.05301500 
 
H 5.05648000 2.46292600 3.11603000 
C 2.55599200 1.77789800 -0.96781300 
 
C 2.51788500 4.10182100 -1.96020500 
C 4.25833800 2.60502300 1.10663000 
 
H 2.42832300 3.63479100 -2.94700100 
H 4.08793200 0.57315500 1.82147500 
 
H 1.53166200 4.51313800 -1.70538800 
C 2.98192000 3.10989900 -0.91832800 
 
H 3.21018700 4.94547500 -2.04639000 
H 1.91933700 1.43611100 -1.77905800 
 
C -2.51770200 4.10123800 -1.96089700 
C 3.83453300 3.50318600 0.11904200 
 
H -3.21016200 4.94470900 -2.04761300 
C -4.71095300 -1.71923500 -0.05139000 
 
H -1.53167400 4.51286100 -1.70581900 
C -3.08012600 -4.04741800 -0.10886400 
 
H -2.42764200 3.63392300 -2.94751200 
C -4.46831700 -4.15039300 -0.10677400 
 
C -5.20152500 3.04842200 2.20088100 
C -5.27045200 -2.99625500 -0.08207300 
 
H -5.05820900 4.10532900 2.44911900 
H -5.33783000 -0.83380300 -0.04150500 
 
H -6.24915400 2.92493400 1.89552000 
H -2.44749500 -4.92957300 -0.13726500 
 
H -5.05833900 2.46247800 3.11467000 
H -4.93858700 -5.12945500 -0.12859300 
     
 
Compound  25d 
C -1.126454 -2.139354 -0.040529 
 
C 3.842045 3.671628 0.044935 
C -1.169574 -0.709292 -0.046332 
 
H 4.845848 3.183584 1.877286 
C -0.000003 0.04879 -0.038409 
 
H 2.770109 3.949823 -1.792429 
C 1.169562 -0.7093 -0.046301 
 
C -4.711221 -1.541264 -0.012331 
C 1.126432 -2.139361 -0.0405 
 
C -3.081273 -3.871463 -0.015769 
H -0.000001 1.132887 -0.019334 
 
C -4.469579 -3.973008 -0.008256 
N -0.000013 -2.856486 -0.035187 
 
C -5.271421 -2.818462 -0.009852 
N -2.503238 -0.301662 -0.026575 
 
H -5.33835 -0.655741 -0.022644 
N 2.50323 -0.30168 -0.026497 
 
H -2.449601 -4.754657 -0.022956 
C -2.958245 1.043986 -0.00315 
 
H -4.940444 -4.951921 -0.004829 
C -2.602264 1.926072 -1.031982 
 
H -6.353448 -2.919137 -0.011909 
C -3.764103 1.496923 1.050035 
 
C 4.711203 -1.541303 -0.012206 
C -3.034941 3.250845 -1.006033 
 
C 5.271391 -2.818506 -0.009702 
H -1.994853 1.566518 -1.856536 
 
C 4.469539 -3.973045 -0.008114 
C -4.219561 2.813814 1.07236 
 
C 3.081234 -3.871486 -0.015662 
H -4.025757 0.814992 1.852681 
 
H 5.338342 -0.655787 -0.022511 
C -3.842001 3.671659 0.045105 
 
H 6.353417 -2.91919 -0.011731 
H -2.770114 3.949936 -1.792274 
 
H 4.940395 -4.951962 -0.004666 
H -4.845759 3.183534 1.87746 
 
H 2.449552 -4.754674 -0.02286 
C 2.95825 1.043965 -0.003158 
 
C -2.498298 -2.600566 -0.018439 
Calculations   186 
 
 
C 3.764144 1.496946 1.04998 
 
C -3.318235 -1.446501 -0.008649 
C 2.602252 1.926002 -1.032026 
 
C 3.318218 -1.446526 -0.00856 
C 4.219622 2.813831 1.072223 
 
C 2.498272 -2.600584 -0.018363 
H 4.025808 0.815055 1.852657 
 
F -4.271704 4.949344 0.068682 
C 3.034948 3.25077 -1.006158 
 
F 4.271769 4.949308 0.068431 
H 1.994813 1.566416 -1.856545 
     
 
Compound  25g 
C -1.12665200 2.74813700 0.07960200 
 
H -6.35111300 3.53510200 -0.01263300 
C -1.17047500 1.31766400 0.04874000 
 
C 4.70949300 2.15698900 -0.02211000 
C -0.00017500 0.55964500 0.02566900 
 
C 5.26809900 3.43446300 0.00156400 
C 1.16991300 1.31801300 0.04812900 
 
C 4.46541000 4.58780900 0.04803900 
C 1.12572100 2.74847300 0.07905400 
 
C 3.07759900 4.48401200 0.07630300 
H -0.00000700 -0.52366900 -0.02042000 
 
H 5.33507900 1.27123300 -0.05620300 
N -0.00057000 3.46538800 0.09530700 
 
H 6.34995300 3.53672000 -0.01593600 
N -2.50442400 0.91413800 0.00303000 
 
H 4.93526900 5.56722600 0.06310200 
N 2.50391700 0.91485200 0.00167300 
 
H 2.44499900 5.36572500 0.11692100 
C -2.96998900 -0.42917300 -0.06725100 
 
C -2.49712400 3.21183100 0.05505900 
C -2.67653800 -1.31117100 0.98702500 
 
C -3.31742800 2.05940400 0.00020000 
C -3.71557900 -0.83897000 -1.16572200 
 
C 3.31663300 2.06030300 -0.00139700 
C -3.15064900 -2.62178200 0.91328900 
 
C 2.49606000 3.21252900 0.05387200 
H -2.11803400 -0.94727600 1.83956300 
 
O -4.91475100 -2.47396100 -2.32877600 
C -4.19108700 -2.16042700 -1.21834400 
 
O -2.94763500 -3.56880700 1.87460800 
H -3.92681000 -0.16208900 -1.98518300 
 
O 4.91290900 -2.47445600 -2.32971600 
C -3.90820200 -3.05428800 -0.18752000 
 
O 2.95111200 -3.56615900 1.87701200 
H -4.25675500 -4.07917400 -0.19315100 
 
C -5.40701800 -3.79921400 -2.46062300 
C 2.96989400 -0.42838200 -0.06785800 
 
H -5.93932900 -3.82571300 -3.41294300 
C 3.71438900 -0.83888000 -1.16679800 
 
H -4.58969800 -4.53173400 -2.47976800 
C 2.67800200 -1.30949000 0.98758600 
 
H -6.10095700 -4.05335700 -1.64886700 
C 4.19037800 -2.16019700 -1.21874900 
 
C -2.25474600 -3.19178300 3.05323300 
H 3.92443800 -0.16262700 -1.98708300 
 
H -1.22769300 -2.87136200 2.83180700 
C 3.15261400 -2.61996000 0.91455700 
 
H -2.77493400 -2.38552700 3.58646600 
H 2.12022600 -0.94504200 1.84036700 
 
H -2.22642800 -4.08356900 3.68192900 
C 3.90906800 -3.05318200 -0.18673000 
 
C 2.25978500 -3.18819800 3.05626000 
H 4.25806800 -4.07791900 -0.19177900 
 
H 2.78038300 -2.38113600 3.58786500 
C -4.71032600 2.15577100 -0.01972300 
 
H 1.23226000 -2.86846400 2.83602600 
C -3.07894100 4.48317800 0.07783500 
 
H 2.23279700 -4.07932700 3.68594500 
C -4.46679100 4.58665100 0.05031600 
 
C 5.40556200 -3.79962800 -2.46097800 
C -5.26922400 3.43311200 0.00426600 
 
H 4.58852000 -4.53249800 -2.47849500 
H -5.33573600 1.26988000 -0.05345100 
 
H 5.93673900 -3.82676000 -3.41391300 
H -2.44651600 5.36503000 0.11815000 
 
H 6.10058100 -4.05276600 -1.64983200 
H -4.93687700 5.56595500 0.06565000 
    
 
 
Calculations   187 
 
 
Compound  25i 
C -2.92593300 -1.45014800 -0.05428800 
 
H 2.98980000 -2.52437800 1.36470800 
C -1.62241500 -1.33192100 0.53007200 
 
C 3.75373300 -3.46308100 -0.42862800 
C -1.07342000 -0.08127100 0.81531200 
 
H 3.77709900 -2.54370400 -1.03210700 
C -1.90233200 0.99538300 0.49823800 
 
H 3.45837200 -4.26904000 -1.11618700 
C -3.19440000 0.78636400 -0.08571300 
 
C 5.15979200 -3.74863300 0.11429400 
H -0.08326700 0.04412200 1.24189300 
 
H 5.45858100 -2.93789700 0.79564100 
N -3.70951400 -0.41392200 -0.36246600 
 
H 5.13601800 -4.66378900 0.72468400 
N -1.10178300 -2.60244300 0.72543400 
 
C 6.21959800 -3.90149600 -0.98440400 
N -1.69691800 2.35744000 0.65705300 
 
H 6.23929200 -2.98908000 -1.59736300 
C -1.93838500 -4.93455700 0.23314600 
 
H 5.92338700 -4.71524000 -1.66143300 
C -4.25364000 -3.59633800 -0.73249000 
 
C 7.62327400 -4.17860800 -0.43656000 
C -4.17173600 -4.98652500 -0.75645800 
 
H 8.35544900 -4.28065300 -1.24559700 
C -3.02540700 -5.64393100 -0.27826700 
 
H 7.96138000 -3.36562800 0.21786200 
H -1.05749300 -5.45739000 0.59404700 
 
H 7.64451200 -5.10510300 0.15040600 
H -5.13306900 -3.07616600 -1.10041400 
 
C -0.48692600 2.97412900 1.17283800 
H -4.99917100 -5.57065400 -1.14925900 
 
H -0.07836300 2.31737500 1.95067700 
H -2.98001700 -6.72938800 -0.30834600 
 
H -0.77079400 3.90582100 1.67547200 
C -3.05821300 4.41213400 0.10187300 
 
C 0.57687300 3.25041100 0.09905600 
C -4.27988300 4.83018100 -0.42645400 
 
H 0.82389400 2.30760500 -0.40711600 
C -5.23684000 3.90781300 -0.88289400 
 
H 0.14688600 3.90907600 -0.66679600 
C -4.98822900 2.53886900 -0.81986300 
 
C 1.84840000 3.88065600 0.68068900 
H -2.32659600 5.13836100 0.44388600 
 
H 2.26043600 3.22073800 1.45906300 
H -4.49168300 5.89442400 -0.48738100 
 
H 1.59162000 4.82279200 1.18768100 
H -6.17716500 4.26897600 -1.28970900 
 
C 2.92864400 4.15231300 -0.37449600 
H -5.71850900 1.81568700 -1.17067900 
 
H 3.18048400 3.21085600 -0.88471500 
C -3.17633000 -2.86537500 -0.22449700 
 
H 2.51956400 4.81687200 -1.14944200 
C -2.02656900 -3.54034700 0.25880900 
 
C 4.20628500 4.77290000 0.20489900 
C -2.81490600 3.03785900 0.16740000 
 
H 4.61306200 4.10897500 0.98244400 
C -3.77089900 2.09737000 -0.29434000 
 
H 3.95532700 5.71599700 0.71315200 
C 0.22953900 -2.90608200 1.22185300 
 
C 5.28960300 5.04001700 -0.84803700 
H 0.50802700 -2.12604500 1.94026700 
 
H 5.53911900 4.09817900 -1.35719200 
H 0.17341000 -3.84179600 1.79050500 
 
H 4.88435200 5.70571500 -1.62326200 
C 1.29116600 -3.01745000 0.11640700 
 
C 6.56338200 5.65563500 -0.26007200 
H 0.98718300 -3.80238700 -0.58833500 
 
H 7.01033700 4.99630600 0.49423100 
H 1.30919900 -2.07965400 -0.45473000 
 
H 7.31721400 5.83341100 -1.03543100 
C 2.68969600 -3.32138000 0.66779400 
 
H 6.35204300 6.61653200 0.22522100 
 
Compound  25k 
C -5.75656600 -1.12627100 -0.26575000 
 
H -3.16614900 3.92744800 1.78058000 
C -4.52191100 -1.17223500 0.46075900 
 
C -1.76291100 3.08819800 0.34683000 
C -3.86641700 -0.00019200 0.83994200 
 
H -1.55878300 2.10560800 -0.09927900 
Calculations   188 
 
 
C -4.52185300 1.17201300 0.46116800 
 
H -2.04706400 3.75034800 -0.48157700 
C -5.75650400 1.12633300 -0.26538700 
 
C -0.50233700 3.62367000 1.03663500 
H -2.92306200 -0.00032700 1.37684600 
 
H -0.25151700 2.98194700 1.89490100 
N -6.37487600 0.00011000 -0.62845400 
 
H -0.71115900 4.61968200 1.45474000 
N -4.17550400 -2.49811500 0.67275300 
 
C 0.71082200 3.71083100 0.10115500 
N -4.17539100 2.49780600 0.67358200 
 
H 0.93544600 2.70884700 -0.29324500 
C -5.21178700 -4.70704600 0.01532200 
 
H 0.45228600 4.32848100 -0.77142800 
C -7.23614700 -3.08864300 -1.15288700 
 
C 1.96334200 4.28515400 0.77533800 
C -7.31093600 -4.47802900 -1.21398000 
 
H 2.20886200 3.68192500 1.66223600 
C -6.30779500 -5.27411800 -0.63545200 
 
H 1.74240300 5.29611700 1.14875400 
H -4.44242100 -5.33724400 0.45163900 
 
C 3.18506900 4.34250100 -0.15092200 
H -8.00334000 -2.46186900 -1.59779400 
 
H 3.41534600 3.32826900 -0.50975600 
H -8.15000200 -4.95345000 -1.71407500 
 
H 2.93462300 4.93040000 -1.04647100 
H -6.38265800 -6.35663200 -0.69661600 
 
C 4.43146900 4.94030700 0.51429300 
C -5.21159000 4.70699500 0.01687700 
 
H 4.67451500 4.36132000 1.41782800 
C -6.30760500 5.27432300 -0.63366400 
 
H 4.20401600 5.95957500 0.86040200 
C -7.31080600 4.47846300 -1.21240700 
 
C 5.65836700 4.97990800 -0.40603100 
C -7.23607400 3.08905400 -1.15176600 
 
H 5.41284800 5.55067900 -1.31399500 
H -4.44218700 5.33702100 0.45337600 
 
H 5.89066200 3.95905400 -0.74429500 
H -6.38242700 6.35685900 -0.69447400 
 
C 6.90153600 5.58987900 0.25421200 
H -8.14986800 4.95408600 -1.71231500 
 
H 6.67082400 6.61322900 0.58600500 
H -8.00329900 2.46244800 -1.59685200 
 
H 7.14331300 5.02361300 1.16611800 
C -6.14672900 -2.49898700 -0.50598600 
 
C 8.13098600 5.62044800 -0.66275700 
C -5.14286200 -3.31294400 0.07814000 
 
H 8.36435400 4.59674100 -0.99202100 
C -5.14271600 3.31287100 0.07922800 
 
H 7.88947900 6.18400700 -1.57647400 
C -6.14663900 2.49914800 -0.50511900 
 
C 9.37350000 6.23436900 -0.00507600 
C -2.95428400 -2.96154800 1.30884900 
 
H 9.14154700 7.25809400 0.32187300 
H -2.71252500 -2.26898500 2.12443300 
 
H 9.61490400 5.67196800 0.90827500 
H -3.16652000 -3.92819600 1.77942900 
 
C 10.59669300 6.25847100 -0.92736800 
C -1.76293500 -3.08833900 0.34641000 
 
H 10.87400000 5.24558500 -1.24469100 
H -2.04681600 -3.75024600 -0.48228900 
 
H 10.39891400 6.84504800 -1.83306700 
H -1.55874100 -2.10560200 -0.09934500 
 
C 5.65850900 -4.97980900 -0.40535500 
C -0.50250000 -3.62394700 1.03637600 
 
H 5.41306500 -5.55080100 -1.31320000 
H -0.71140900 -4.62005100 1.45422200 
 
H 5.89078600 -3.95902500 -0.74384300 
H -0.25187500 -2.98240500 1.89483200 
 
C 6.90166000 -5.58957600 0.25510500 
C 0.71085500 -3.71090800 0.10113600 
 
H 6.67094800 -6.61282400 0.58721200 
H 0.93546100 -2.70887400 -0.29314500 
 
H 7.14341700 -5.02302400 1.16684000 
H 0.45255500 -4.32851800 -0.77154500 
 
C 8.13112700 -5.62044300 -0.66183700 
C 1.96330300 -4.28515800 0.77551800 
 
H 7.88960500 -6.18425600 -1.57539500 
H 2.20868000 -3.68188600 1.66242400 
 
H 8.36453100 -4.59683900 -0.99139400 
H 1.74234700 -5.29611600 1.14893900 
 
C 9.37360800 -6.23421500 -0.00396600 
C 3.18515700 -4.34249300 -0.15057900 
 
H 9.14161500 -7.25782500 0.32331700 
H 3.41536200 -3.32828700 -0.50953400 
 
H 9.61504100 -5.67152800 0.90920100 
H 2.93488800 -4.93055400 -1.04607000 
 
C 10.59679900 -6.25867600 -0.92625500 
C 4.43154500 -4.94005300 0.51487700 
 
H 11.46664500 -6.70063100 -0.42688300 
H 4.67448800 -4.36082700 1.41828500 
 
H 10.39898100 -6.84552600 -1.83176900 
Calculations   189 
 
 
H 4.20413300 -5.95925200 0.86122000 
 
H 10.87416300 -5.24590500 -1.24389700 
C -2.95400500 2.96100300 1.30954500 
 
H 11.46656400 6.70053400 -0.42813500 
H -2.71201400 2.26810200 2.12476700 
     
 
Compound  25l 
C -1.12669200 -1.03403100 -0.05520000 
 
H 4.95219300 -3.77769700 0.49975900 
C -1.17266600 0.37023600 -0.33854900 
 
H 2.46064800 -3.59725500 0.45631200 
C -0.00005600 1.11322600 -0.47899600 
 
C -2.49910900 -1.48380600 0.03941100 
C 1.17258600 0.37027100 -0.33869200 
 
C -3.31470300 -0.34651400 -0.18467400 
C 1.12667500 -1.03400200 -0.05532400 
 
C 3.31465200 -0.34646700 -0.18511200 
H -0.00008200 2.18172600 -0.67052100 
 
C 2.49911400 -1.48376700 0.03908500 
N 0.00001100 -1.73581000 0.08676900 
 
C -2.97692000 2.11297000 -0.69060900 
N -2.50040400 0.76416000 -0.42619500 
 
H -2.17200200 2.64349200 -1.21415900 
N 2.50030900 0.76418000 -0.42665700 
 
H -3.82059900 2.05944300 -1.38894400 
C -4.70844000 -0.43212500 -0.15701900 
 
C 2.97688900 2.11314000 -0.68986400 
C -3.08756400 -2.72715000 0.28653000 
 
H 2.17193800 2.64426000 -1.21278100 
C -4.47694500 -2.81980400 0.30894300 
 
H 3.82042300 2.06023100 -1.38844400 
C -5.27404100 -1.68311300 0.09024100 
 
C 3.37822100 2.86418500 0.55756900 
H -5.33483900 0.44153700 -0.30549500 
 
H 2.64098600 2.87177900 1.36003500 
H -2.46052900 -3.59729200 0.45662100 
 
C -3.37795500 2.86498800 0.55631400 
H -4.95206100 -3.77782400 0.50032100 
 
H -2.64020200 2.87392400 1.35828400 
H -6.35646600 -1.77622100 0.11867100 
 
C -4.54228900 3.49440800 0.70845500 
C 4.70840200 -0.43201700 -0.15758600 
 
H -5.29955600 3.49444400 -0.07361600 
C 5.27406400 -1.68298000 0.08964500 
 
H -4.78477400 4.03802200 1.61715500 
C 4.47702000 -2.81969700 0.30842700 
 
C 4.54219400 3.49433900 0.70952600 
C 3.08763700 -2.72709500 0.28614500 
 
H 4.78486400 4.03728500 1.61857600 
H 5.33475000 0.44166700 -0.30613400 
 
H 5.29894500 3.49565600 -0.07304300 
H 6.35649300 -1.77606200 0.11799500 
     
 
Compound  25m 
C 1.64451800 -1.85031700 -0.01490900 
 
C -2.83087500 0.42130200 -1.42405800 
C 1.50419000 -0.55241500 -0.60131700 
 
H -2.06872900 0.95270100 -2.00613200 
C 0.24923000 -0.03167500 -0.91583400 
 
H -3.56169000 0.04765000 -2.15229400 
C -0.81319700 -0.88786900 -0.62478200 
 
C 3.02541700 1.29200100 -1.38195200 
C -0.58405900 -2.17585800 -0.03709900 
 
H 2.45577800 1.35321500 -2.31853000 
H 0.11550600 0.96432900 -1.32507600 
 
H 4.08256300 1.30301300 -1.66907700 
N 0.62177200 -2.65985000 0.27041100 
 
C -3.51788400 1.38129500 -0.46186300 
N 2.76378500 0.00604500 -0.76303500 
 
C -4.66854100 2.06404800 -0.87263200 
N -2.17954200 -0.71572000 -0.80145100 
 
C -3.00228700 1.62895200 0.81527400 
C 5.11013600 -0.77754500 -0.22862500 
 
C -5.29050700 2.98447100 -0.02778300 
Calculations   190 
 
 
C 3.80711400 -3.12211500 0.71252000 
 
H -5.08364100 1.87266200 -1.86052200 
C 5.19405500 -3.00827400 0.76530500 
 
C -3.62560900 2.54519300 1.66295000 
C 5.83373400 -1.84725600 0.29931600 
 
H -2.11629300 1.09684300 1.14995100 
H 5.62239600 0.11557000 -0.57454000 
 
C -4.76984600 3.22707000 1.24412200 
H 3.29925200 -4.01241300 1.07128500 
 
H -6.18557500 3.50373000 -0.36016200 
H 5.78899000 -3.82110500 1.17197200 
 
H -3.21686200 2.72457000 2.65380700 
H 6.91675200 -1.77510700 0.35267400 
 
H -5.25542800 3.93839800 1.90673500 
C -4.20679700 -2.13582600 -0.31032800 
 
C 2.70542200 2.50010600 -0.51167400 
C -4.60367100 -3.37249700 0.19867200 
 
C 2.20459200 3.66667500 -1.10029500 
C -3.66673100 -4.30692000 0.67257800 
 
C 2.93881300 2.48331200 0.86848100 
C -2.30392400 -4.02106200 0.64824600 
 
C 1.94782000 4.80094400 -0.32805800 
H -4.94071700 -1.41408400 -0.65509400 
 
H 2.01356400 3.68902800 -2.17166400 
H -5.66282100 -3.61343700 0.23322600 
 
C 2.67873900 3.61442700 1.64236600 
H -4.01236900 -5.25937000 1.06445600 
 
H 3.31783800 1.57973300 1.33790100 
H -1.57062500 -4.73386400 1.01358100 
 
C 2.18425700 4.77701000 1.04687100 
C 3.06210200 -2.06358700 0.18582500 
 
H 1.55594700 5.69824400 -0.79968200 
C 3.71932500 -0.89812100 -0.28547800 
 
H 2.86153400 3.58669300 2.71331900 
C -2.83851700 -1.85785700 -0.33770900 
 
H 1.98024200 5.65643600 1.65163900 
C -1.88330700 -2.78874000 0.14032900 
     
 
Compound  25n 
C 2.37178200 -2.04797100 0.14949000 
 
H 2.66759600 0.85714600 -2.62419200 
C 2.01403200 -0.91141500 -0.64320600 
 
H 4.23717600 1.23128500 -1.94256200 
C 0.70143300 -0.70978900 -1.06898300 
 
C -3.32603900 -0.07606600 -0.91748900 
C -0.18869400 -1.70753100 -0.66982600 
 
C -4.62693700 0.14609500 -1.36856200 
C 0.25490300 -2.81723800 0.12361400 
 
C -2.91161700 0.57057800 0.25730800 
H 0.40087700 0.16260200 -1.63981800 
 
C -5.50559400 0.99369400 -0.68593700 
N 1.51258700 -2.99427500 0.53580100 
 
H -4.97426600 -0.34860300 -2.27372300 
N 3.14707900 -0.14216300 -0.86365400 
 
C -3.77107300 1.41074000 0.95043800 
N -1.54958700 -1.84513500 -0.90673300 
 
H -1.90705000 0.40502400 0.63687000 
C 5.56691200 -0.34270700 -0.15100500 
 
C -5.07603600 1.63126400 0.48209500 
C 4.69628600 -2.72638100 1.12975300 
 
H -6.51020000 1.13763400 -1.06668900 
C 6.02867200 -2.32695900 1.19841000 
 
H -3.45718200 1.90972700 1.86193200 
C 6.45434000 -1.14782300 0.56375900 
 
C 2.59209900 2.29720300 -1.02499300 
H 5.91332500 0.57037100 -0.62638000 
 
C 1.92307400 3.25058300 -1.80593300 
H 4.35287500 -3.63415500 1.61695200 
 
C 2.72800000 2.54240200 0.34246900 
H 6.74681300 -2.92870400 1.74820800 
 
C 1.41439000 4.41434300 -1.24282400 
H 7.49744000 -0.85044200 0.63150400 
 
H 1.79819700 3.08065700 -2.87378700 
C -3.28242500 -3.55755400 -0.24945600 
 
C 2.21801700 3.70426500 0.92690500 
C -3.45699500 -4.75782800 0.43948700 
 
H 3.23295900 1.81401700 0.97106100 
C -2.38391600 -5.39893100 1.08227200 
 
C 1.55935300 4.64997600 0.13187500 
C -1.10532200 -4.84784600 1.04981800 
 
H 0.89277300 5.15218400 -1.84437800 
H -4.12211800 -3.06078300 -0.72498100 
 
H 2.33802800 3.85726100 1.99332700 
Calculations   191 
 
 
H -4.44797900 -5.20193700 0.48294600 
 
O 1.02344500 5.81724500 0.59320100 
H -2.55728600 -6.33163800 1.61168800 
 
O -5.84002700 2.47478600 1.23587800 
H -0.26867800 -5.33266800 1.54412100 
 
C 1.13450200 6.10612700 1.97795600 
C 3.78990700 -1.93628600 0.41754800 
 
H 2.18400500 6.17984900 2.29243600 
C 4.23194800 -0.74934400 -0.22194900 
 
H 0.64667500 7.07186700 2.12199700 
C -1.99672700 -3.01287100 -0.28341500 
 
H 0.62735900 5.34919900 2.59073700 
C -0.90660800 -3.64678000 0.36316000 
 
C -7.17070300 2.72989500 0.81677000 
C -2.37833200 -0.96174500 -1.71064100 
 
H -7.58993500 3.41833900 1.55280800 
H -1.69856000 -0.35115600 -2.31579600 
 
H -7.19911100 3.19949000 -0.17562200 
H -2.95282800 -1.57156700 -2.41967600 
 
H -7.77151600 1.81086300 0.79724600 
C 3.18781600 1.05905200 -1.67836800 
     
 
Compound  25q 
C 1.12655600 1.85764800 -0.09112100 
 
C 2.94581200 -2.14427600 -1.25387200 
C 1.17258000 0.67000300 -0.89056800 
 
H 1.94825100 -2.33077200 -0.83877300 
C -0.00006900 0.04105800 -1.31266800 
 
C -2.93565600 -0.76766300 -1.96065200 
C -1.17275700 0.66995600 -0.89060400 
 
H -2.27177500 -0.81694800 -2.83334000 
C -1.12680300 1.85760900 -0.09116500 
 
H -3.93558500 -0.53301100 -2.33730300 
H -0.00004400 -0.86099200 -1.91624500 
 
C -2.94569700 -2.14441900 -1.25390100 
N -0.00014200 2.45204300 0.30941600 
 
H -1.94807600 -2.33085900 -0.83892300 
N 2.49851200 0.33786300 -1.12771100 
 
H -3.11357800 -2.90386100 -2.02901100 
N -2.49866700 0.33778000 -1.12781500 
 
H 3.11363200 -2.90369900 -2.02901400 
C 4.70882200 1.37355900 -0.45835300 
 
C -3.99286200 -2.27751300 -0.17035600 
C 3.08451300 3.30787500 0.84718700 
 
C -5.29944200 -2.67460300 -0.48905400 
C 4.47282000 3.40258500 0.88385200 
 
C -3.69211700 -1.98328400 1.16574500 
C 5.27124500 2.44329700 0.23741300 
 
C -6.28121000 -2.76774800 0.49783500 
H 5.34140600 0.62708200 -0.92796400 
 
H -5.54790000 -2.92095400 -1.51989800 
H 2.45435100 4.03965800 1.34395100 
 
C -4.67119100 -2.07489500 2.15596500 
H 4.94598800 4.22122700 1.41881300 
 
H -2.68335600 -1.67721400 1.43178400 
H 6.35357900 2.52940100 0.28447600 
 
C -5.96920200 -2.46624400 1.82499000 
C -4.70904000 1.37342300 -0.45855800 
 
H -7.28716700 -3.08184800 0.23146200 
C -5.27152100 2.44314700 0.23718200 
 
H -4.41846800 -1.84000000 3.18644900 
C -4.47315100 3.40245100 0.88366400 
 
H -6.73146700 -2.54020700 2.59591800 
C -3.08484100 3.30777200 0.84706200 
 
C 3.99311500 -2.27734000 -0.17045800 
H -5.34159200 0.62695300 -0.92822500 
 
C 5.29966800 -2.67439400 -0.48931000 
H -6.35385900 2.52922800 0.28418300 
 
C 3.69252500 -1.98311500 1.16568000 
H -4.94636400 4.22108100 1.41860400 
 
C 6.28155700 -2.76751500 0.49746200 
H -2.45471500 4.03957100 1.34385000 
 
H 5.54801500 -2.92074100 -1.52018100 
C 2.49917500 2.24566900 0.15196200 
 
C 4.67171900 -2.07470000 2.15578200 
C 3.31526600 1.28661400 -0.49945900 
 
H 2.68379000 -1.67706000 1.43183600 
C -3.31548100 1.28650100 -0.49959400 
 
C 5.96970100 -2.46602000 1.82465400 
C -2.49944700 2.24558100 0.15186300 
 
H 7.28749000 -3.08158500 0.23096300 
C 2.93560500 -0.76750500 -1.96058900 
 
H 4.41911500 -1.83981100 3.18629700 
Calculations   192 
 
 
H 2.27170800 -0.81683600 -2.83326100 
 
H 6.73205800 -2.53996500 2.59549200 
H 3.93549800 -0.53272600 -2.33726200 
     
 
Compound  25r 
C 1.12677700 3.84682800 -0.09603000 
 
H 2.19666000 -0.10037200 1.25498600 
C 1.17240000 2.43771400 -0.35349600 
 
C -3.66335000 -1.49013700 0.50792500 
C 0.00032100 1.69180000 -0.48200400 
 
C -2.79031100 -2.56931600 0.41317600 
C -1.17159200 2.43794700 -0.35343300 
 
C -5.04224700 -1.72857300 0.35054900 
C -1.12567000 3.84706100 -0.09595800 
 
C -3.26795800 -3.86393500 0.16699500 
H 0.00021900 0.62172300 -0.66369800 
 
H -1.72113800 -2.41534600 0.53946300 
N 0.00062700 4.55233600 0.03262000 
 
C -5.53424400 -3.00739700 0.10512600 
N 2.49871200 2.04047500 -0.44140500 
 
H -5.73172600 -0.89486400 0.43504100 
N -2.49800300 2.04098300 -0.44122800 
 
C -4.63097900 -4.09793300 0.00959000 
C 4.70751500 3.24192700 -0.19480100 
 
H -2.56429300 -4.68622400 0.10587900 
C 3.08959800 5.54292100 0.21730700 
 
C 3.66290500 -1.49086100 0.50851500 
C 4.47916200 5.63537500 0.23964200 
 
C 2.78966100 -2.56996800 0.41496700 
C 5.27509300 4.49538600 0.03558800 
 
C 5.04166200 -1.72957100 0.35025500 
H 5.33670700 2.36980100 -0.34702600 
 
C 3.26696100 -3.86478600 0.16912300 
H 2.46314800 6.41592900 0.37454300 
 
H 1.72060200 -2.41578600 0.54195500 
H 4.95492800 6.59568400 0.41728900 
 
C 5.53331100 -3.00857800 0.10512600 
H 6.35769700 4.58828000 0.05905100 
 
H 5.73131700 -0.89591800 0.43383900 
C -4.70653700 3.24285400 -0.19443600 
 
C 4.62982900 -4.09904800 0.01082000 
C -5.27386100 4.49640600 0.03603300 
 
H 2.56312400 -4.68700300 0.10898400 
C -4.47769600 5.63623800 0.24005800 
 
O 5.19870600 -5.31463500 -0.22660400 
C -3.08815300 5.54351900 0.21761100 
 
O 6.84891800 -3.32538700 -0.05317300 
H -5.33588200 2.37083500 -0.34663800 
 
O -6.85000600 -3.32395700 -0.05232400 
H -6.35644500 4.58951800 0.05958000 
 
O -5.20020100 -5.31332400 -0.22803300 
H -4.95325500 6.59663700 0.41777300 
 
C 4.34348000 -6.44050400 -0.31645700 
H -2.46154600 6.41642100 0.37481700 
 
H 3.62795000 -6.34136700 -1.14418300 
C 2.49966000 4.29690700 -0.01108100 
 
H 4.99524400 -7.29569200 -0.50449000 
C 3.31329800 3.15430700 -0.21952500 
 
H 3.79040400 -6.60470900 0.61841100 
C -3.31233000 3.15496300 -0.21926800 
 
C 7.80257200 -2.28137000 0.03955100 
C -2.49845400 4.29741000 -0.01086400 
 
H 7.78433900 -1.80243300 1.02787200 
C 2.96436700 0.67631500 -0.61060000 
 
H 8.77514500 -2.75211300 -0.11498400 
H 2.24801600 0.14227400 -1.24409800 
 
H 7.64335100 -1.51684200 -0.73311500 
H 3.90809100 0.70187600 -1.16552500 
 
C -7.80346700 -2.27988900 0.04188800 
C 3.15539100 -0.08242000 0.72345600 
 
H -7.64485000 -1.51491100 -0.73045300 
H 3.85219700 0.48822800 1.34935100 
 
H -8.77622400 -2.75043600 -0.11207100 
C -2.96392400 0.67695300 -0.61069800 
 
H -7.78429500 -1.80156400 1.03048500 
H -2.24759000 0.14283500 -1.24414000 
 
C -4.34523000 -6.43929500 -0.31903300 
H -3.90754500 0.70281000 -1.16579900 
 
H -4.99728000 -7.29429600 -0.50693100 
C -3.15544500 -0.08189600 0.72320500 
 
H -3.63033100 -6.33992500 -1.14727700 
H -3.85221600 0.48887600 1.34902500 
 
H -3.79145600 -6.60400600 0.61533200 
Calculations   193 
 
 
H -2.19684900 -0.10017800 1.25496500 
     
 
Compound  25s 
C 1.17175700 3.07450800 0.15053700 
 
C 3.65682400 -2.15246300 -1.32992200 
C 1.19877000 1.85759700 -0.60614600 
 
H 4.57779900 -1.91924700 -1.88125700 
C 0.01663100 1.22602200 -0.99432100 
 
H 2.90358600 -2.42024500 -2.08358800 
C -1.14539700 1.88798700 -0.59648600 
 
C -2.96593300 0.38878900 -1.50770300 
C -1.08061900 3.10290600 0.16112500 
 
H -2.24591000 0.13317100 -2.29445400 
H 0.00188700 0.29540600 -1.55289500 
 
H -3.89708900 0.65948500 -2.01970100 
N 0.05502500 3.69686200 0.53494800 
 
C -3.20027600 -0.81749500 -0.58489600 
N 2.51987000 1.50376400 -0.83769600 
 
H -2.25762600 -1.09117500 -0.09474900 
N -2.47705500 1.56856500 -0.81703400 
 
H -3.89295600 -0.52888900 0.21511500 
C 4.74440100 2.50656400 -0.18294800 
 
C -3.76415900 -2.03145600 -1.34875100 
C 3.15632800 4.51461300 1.05351500 
 
H -3.06655600 -2.31123800 -2.14975500 
C 4.54695000 4.57672100 1.09963000 
 
H -4.70068300 -1.73798600 -1.84273700 
C 5.32810700 3.58209700 0.48712700 
 
C -4.01511700 -3.22710800 -0.45375600 
H 5.36250300 1.74326200 -0.64649300 
 
C -3.05321200 -4.23532800 -0.31040900 
H 2.54128000 5.27599400 1.52397800 
 
C -5.20589100 -3.33528200 0.27767800 
H 5.03507700 5.39944500 1.61437100 
 
C -3.27124200 -5.31999400 0.54050700 
H 6.41179500 3.64735800 0.53677300 
 
H -2.12543600 -4.17237500 -0.87577700 
C -4.66936200 2.62675900 -0.14090000 
 
C -5.42889900 -4.41690100 1.12983400 
C -5.21959600 3.71517600 0.53666500 
 
H -5.96790100 -2.56523800 0.17464800 
C -4.40789400 4.68796900 1.14442900 
 
C -4.46069500 -5.41396500 1.26441500 
C -3.01975000 4.59060100 1.08562600 
 
H -2.51357000 -6.09378800 0.63409600 
H -5.31092100 1.88038200 -0.60006700 
 
H -6.36078000 -4.48344400 1.68532000 
H -6.30079500 3.80781200 0.59613000 
 
H -4.63390500 -6.25917700 1.92502600 
H -4.87024100 5.52155700 1.66544700 
 
C 3.89993300 -3.33201300 -0.41174100 
H -2.38139600 5.33498100 1.55222100 
 
C 2.85901000 -4.20877900 -0.07809500 
C 2.55028800 3.44594000 0.38750800 
 
C 5.16270300 -3.55333600 0.15373300 
C 3.34924500 2.45020200 -0.22946100 
 
C 3.07083400 -5.27395700 0.79785600 
C -3.27655000 2.53492300 -0.19999300 
 
H 1.87287100 -4.05689100 -0.51272600 
C -2.44700400 3.50861300 0.41172500 
 
C 5.38023500 -4.61715600 1.03018700 
C 2.96959300 0.30109100 -1.51550100 
 
H 5.98516600 -2.88703300 -0.09886000 
H 2.22937600 0.04936700 -2.28443300 
 
C 4.33347200 -5.48120400 1.35600900 
H 3.89767400 0.53922700 -2.04882200 
 
H 2.25067200 -5.94442000 1.04144300 
C 3.18895500 -0.89355000 -0.57404600 
 
H 6.36842300 -4.77308100 1.45514000 
H 3.93018400 -0.62212600 0.18743700 
 
H 4.50117800 -6.31194900 2.03611600 
H 2.25678200 -1.10805300 -0.03665600 
     
 
 
Calculations   194 
 
 
Compound  25t 
C -1.12593300 -1.84458200 0.00010200 
 
H -2.02076000 1.98263600 -0.00011300 
C -1.17648900 -0.41419600 -0.00016800 
 
C -4.09567500 3.26541900 -1.26770000 
C 0.00002900 0.33757100 -0.00048900 
 
H -4.62378700 1.16779600 -1.36259000 
C 1.17656700 -0.41417800 -0.00042200 
 
H -3.09898500 1.53895200 -2.15470000 
C 1.12604700 -1.84455800 -0.00010100 
 
C -4.09596500 3.26537000 1.26708700 
H 0.00001800 1.42223900 -0.00073700 
 
H -4.62407600 1.16772500 1.36178500 
N 0.00006200 -2.56123900 0.00011700 
 
H -3.09944400 1.53888100 2.15423800 
N -2.50756600 -0.00707400 -0.00016500 
 
C -4.87858800 3.64079300 -0.00038900 
N 2.50765200 -0.00702600 -0.00083300 
 
H -4.67929800 3.50559600 -2.16486900 
C -4.71323000 -1.27978300 0.00029600 
 
H -3.18129000 3.87532700 -1.32003400 
C -3.05900400 -3.58564100 0.00055100 
 
H -4.67979900 3.50550200 2.16413200 
C -4.44486400 -3.70957500 0.00068400 
 
H -3.18160200 3.87528900 1.31965700 
C -5.25736200 -2.56408000 0.00056200 
 
H -5.10867300 4.71350600 -0.00039600 
H -5.36939900 -0.41752300 0.00019100 
 
H -5.84380300 3.11334100 -0.00051000 
H -2.41209500 -4.45793200 0.00065300 
 
C 2.94367700 1.39224000 -0.00005500 
H -4.90311100 -4.69450800 0.00089900 
 
C 3.71525800 1.77521100 1.27907100 
H -6.33859500 -2.67476500 0.00067300 
 
C 3.71550000 1.77640600 -1.27869300 
C 4.71334600 -1.27972500 -0.00078500 
 
H 2.02064900 1.98264300 0.00010300 
C 5.25747400 -2.56401300 -0.00059300 
 
C 4.09552800 3.26489900 1.26829900 
C 4.44497400 -3.70951800 -0.00026300 
 
H 4.62373600 1.16724100 1.36218100 
C 3.05911800 -3.58557300 -0.00008500 
 
H 3.09891900 1.53797200 2.15447900 
H 5.36951800 -0.41745900 -0.00099800 
 
C 4.09570800 3.26612500 -1.26647900 
H 6.33870800 -2.67468700 -0.00068500 
 
H 4.62407800 1.16861200 -1.36217700 
H 4.90320400 -4.69446000 -0.00013900 
 
H 3.09937400 1.53990800 -2.15444100 
H 2.41221200 -4.45786700 0.00019400 
 
C 4.87835600 3.64100100 0.00114800 
C -2.49386400 -2.30753600 0.00029600 
 
H 4.67920300 3.50459900 2.16556100 
C -3.31851800 -1.15215000 0.00015600 
 
H 3.18114500 3.87477600 1.32103000 
C 3.31864000 -1.15208400 -0.00061300 
 
H 4.67944300 3.50682400 -2.16343500 
C 2.49398100 -2.30747000 -0.00025500 
 
H 3.18125500 3.87595400 -1.31865700 
C -2.94374500 1.39216000 -0.00021400 
 
H 5.10828600 4.71374300 0.00169400 
C -3.71531900 1.77574100 -1.27917700 
 
H 5.84365100 3.11368900 0.00096300 
C -3.71559900 1.77569500 1.27859600 
     
 
Compound 35a 
C 0.88403490 1.26867119 0.00043202 
 
C -2.75897757 3.33247501 -0.16858799 
C 0.34410298 -0.07263597 -0.02039398 
 
H -3.57076845 1.32785178 -0.19592400 
N 2.17607697 1.50438132 0.03903002 
 
H 0.55190061 4.17466637 -0.02922298 
N -1.04508013 0.00383091 -0.05028798 
 
H -1.71737766 5.22356825 -0.13747299 
C -1.93694110 -1.10595426 -0.01490698 
 
H -3.73877369 3.79837495 -0.23048500 
C -2.98019217 -1.13530835 0.91847509 
 
C 3.29726439 -2.04852785 0.06018002 
C -1.76445798 -2.17148432 -0.90565605 
 
C 4.66093448 -1.85624170 0.10054903 
Calculations   195 
 
 
C -3.85917814 -2.21788252 0.94342309 
 
C 5.20640739 -0.54817655 0.12028003 
H -3.09007626 -0.32058730 1.62721315 
 
C 4.37777623 0.55124345 0.09968003 
C -2.63791595 -3.25685248 -0.86065105 
 
H 2.85927945 -3.04194496 0.04566002 
H -0.94687992 -2.14801024 -1.61662610 
 
H 5.32767558 -2.71415171 0.11789003 
C -3.69081403 -3.28206958 0.05621102 
 
H 6.28440645 -0.41688245 0.15211003 
H -4.66814820 -2.23313459 1.66862615 
 
H 4.76755617 1.56458456 0.11428303 
H -2.49754287 -4.08311954 -1.55206010 
 
C -0.24370627 2.17380115 -0.03140898 
H -4.37259501 -4.12745171 0.08198803 
 
C -1.40721429 1.36540598 -0.06554699 
C -2.67702744 1.93952191 -0.14485499 
 
C 2.96900614 0.39027131 0.05854102 
C -0.34720441 3.56645425 -0.05516298 
 
C 2.41605822 -0.93860584 0.03823502 
C -1.61284755 4.14281317 -0.11931699 
 
N 1.06567414 -1.16325099 -0.00346998 
 
Compound 35b 
C 1.50609500 1.11363200 0.00145000 
 
H 0.15580000 5.65183700 -0.12054800 
C 0.60090600 -0.01411600 -0.02273000 
 
H -2.19061700 4.87042100 -0.21756600 
N 2.81101100 0.96508500 0.04216800 
 
C 2.85522400 -2.76044800 0.05941600 
N -0.70601100 0.46054000 -0.05518200 
 
C 4.21600700 -2.97163500 0.10259700 
C -1.88047400 -0.34514200 -0.02783500 
 
C 5.11687000 -1.87766800 0.12507900 
C -2.88538600 -0.09402100 0.91171500 
 
C 4.64209000 -0.58539800 0.10447200 
C -2.03317600 -1.39824900 -0.93605900 
 
H 2.14816600 -3.58431800 0.04261300 
C -4.03754400 -0.87896300 0.92550600 
 
H 4.60548400 -3.98596800 0.11997000 
H -2.76026200 0.70643100 1.63430000 
 
H 6.18666800 -2.06402000 0.15915000 
C -3.18174500 -2.18417500 -0.89762300 
 
H 5.30879000 0.27151700 0.12138200 
H -1.25199300 -1.59976100 -1.66004200 
 
C 0.68804600 2.30617100 -0.02879900 
C -4.20601900 -1.93999000 0.02772000 
 
C -0.65933400 1.86787600 -0.06656900 
H -4.81319600 -0.66796200 1.65798600 
 
C 3.24715300 -0.33109700 0.06075900 
H -3.28739700 -3.00020900 -1.60883200 
 
C 2.33303200 -1.44290800 0.03739200 
C -1.70982200 2.78391200 -0.14187900 
 
N 0.97551500 -1.26713000 -0.00684300 
C 0.99016200 3.66977300 -0.04636400 
 
C -5.43761500 -2.81377800 0.07212100 
C -0.05562900 4.58673400 -0.10733000 
 
H -5.25843800 -3.72349700 0.66065400 
C -1.38678400 4.14145200 -0.15917400 
 
H -6.28402500 -2.29129700 0.52971100 
H -2.74184200 2.45534400 -0.19388600 
 
H -5.73940000 -3.13297600 -0.93146400 
H 2.02630900 3.99322900 -0.01762000 
     
 
Compound 35c 
C 1.45443800 1.14565500 0.00025800 
 
H -2.83142400 2.36387200 -0.20266100 
C 0.58370100 -0.00800600 -0.02691100 
 
H 1.88982900 4.03940700 -0.01360000 
N 2.76297300 1.03483500 0.04348600 
 
H -0.02837800 5.64260300 -0.11725900 
N -0.73718500 0.42839900 -0.06236400 
 
H -2.35058600 4.79337900 -0.22000400 
C -1.88537100 -0.41185900 -0.03074200 
 
C 2.91583900 -2.68814300 0.05620900 
Calculations   196 
 
 
C -2.88935800 -0.19330900 0.92069000 
 
C 4.28213000 -2.85924100 0.10298000 
C -2.00579200 -1.46917600 -0.94084900 
 
C 5.15043800 -1.73934700 0.12931300 
C -4.01907300 -1.00929000 0.95106100 
 
C 4.63831600 -0.46143800 0.10892900 
H -2.78023000 0.60800600 1.64426700 
 
H 2.23347000 -3.53249600 0.03664900 
C -3.12255700 -2.30072700 -0.90286600 
 
H 4.70113500 -3.86168400 0.12030500 
H -1.22003800 -1.64401400 -1.66622300 
 
H 6.22508200 -1.89443900 0.16613200 
C -4.11552200 -2.05307600 0.03843500 
 
H 5.27968000 0.41449100 0.12871400 
H -4.80927200 -0.85546300 1.67824600 
 
C 0.60162100 2.31396100 -0.03043900 
H -3.23422700 -3.12824000 -1.59539700 
 
C -0.73232000 1.83708800 -0.07196200 
C -1.80916800 2.72152700 -0.14730700 
 
C 3.23667600 -0.24808100 0.06176900 
C 0.86370400 3.68580400 -0.04502500 
 
C 2.35574500 -1.38642700 0.03456200 
C -0.20854800 4.57179700 -0.10629400 
 
N 0.99358000 -1.24954700 -0.01291500 
C -1.52594900 4.08814400 -0.16138700 
 
F -5.20270300 -2.85070600 0.06898200 
 
Compound 35e 
C -1.94433515 0.98383808 -0.02813700 
 
H -1.18283809 5.65874845 0.05586200 
C -0.90287907 -0.01850100 0.03164900 
 
H 1.24037609 5.18249739 0.21706102 
N -3.21817625 0.66844905 -0.09454701 
 
C -2.78486521 -3.03214823 -0.05557000 
N 0.33034403 0.61967705 0.08954101 
 
C -4.10625331 -3.41634326 -0.12285201 
C 1.59975212 -0.02763200 0.11410101 
 
C -5.13886339 -2.44715618 -0.18070801 
C 2.57871020 0.30385802 -0.82320906 
 
C -4.83357237 -1.10456209 -0.17105601 
C 1.87351815 -1.01021707 1.07645208 
 
H -1.97891215 -3.75841128 -0.01139300 
C 3.83099429 -0.31489002 -0.79696506 
 
H -4.36253134 -4.47235734 -0.13215601 
H 2.36254618 1.04495508 -1.58656512 
 
H -6.17505647 -2.76955821 -0.23330302 
C 3.10782624 -1.64240413 1.09556808 
 
H -5.60371142 -0.34034403 -0.21478302 
H 1.11103009 -1.28005910 1.79828814 
 
C -1.28634610 2.27168917 0.00399600 
C 4.09928231 -1.29583710 0.16445401 
 
C 0.10446901 2.00872516 0.08068501 
H 4.57396035 -0.03486800 -1.53466412 
 
C -3.48393926 -0.67320405 -0.10274001 
H 3.33298426 -2.40779218 1.83128314 
 
C -2.43582119 -1.65830612 -0.04326100 
C 1.02914608 3.05086923 0.16370901 
 
N -1.11331809 -1.30969810 0.02690400 
C -1.75835613 3.58630227 -0.00704500 
 
O 5.27945540 -1.96943815 0.27979202 
C -0.83831406 4.62888735 0.06389500 
 
C 6.31737848 -1.67036613 -0.64027705 
C 0.53699904 4.35659233 0.15244001 
 
H 7.15424754 -2.31543118 -0.36699503 
H 2.09286516 2.85495922 0.24207002 
 
H 6.01555446 -1.88655514 -1.67359613 
H -2.82593422 3.77588629 -0.06539600 
 
H 6.63063951 -0.62032004 -0.56809604 
 
Compound 35j 
C 0.23248100 -1.07219400 0.01091800 
 
H 5.88253400 -0.95383400 0.31711400 
C 0.10158500 0.34902900 -0.23358700 
 
H 3.86211700 -2.41312100 0.44254600 
N 1.40163900 -1.64840000 0.17413600 
 
C -1.11106200 -1.61186300 0.02298400 
Calculations   197 
 
 
N -1.23631900 0.65923700 -0.37214500 
 
C -1.98070100 -0.51368800 -0.21052400 
C -3.36441300 -0.69000800 -0.26175900 
 
C 2.47836100 -0.80698300 0.09634300 
C -1.62970000 -2.89535300 0.20468100 
 
C 2.33067700 0.60512100 -0.14593200 
C -3.01032600 -3.07477500 0.15299800 
 
N 1.10259600 1.18956100 -0.31187300 
C -3.86122500 -1.98162100 -0.07817900 
 
C -1.75788400 2.00156200 -0.58720400 
H -4.03774000 0.14341900 -0.43609800 
 
H -0.95992100 2.57334000 -1.07009300 
H -0.95789900 -3.72982900 0.38226800 
 
H -2.59340700 1.93591800 -1.29490700 
H -3.43428300 -4.06476800 0.29250000 
 
C -2.19976900 2.70068900 0.70658200 
H -4.93557200 -2.14122700 -0.11405600 
 
H -1.33888300 2.75588100 1.38367700 
C 3.49298000 1.41339400 -0.21233700 
 
H -2.95800600 2.08751300 1.21021200 
C 4.74269500 0.85659700 -0.04851300 
 
C -2.75125500 4.10433300 0.43941500 
C 4.88921400 -0.53252500 0.18999100 
 
H -1.99796100 4.74358300 -0.03656400 
C 3.78021100 -1.34569500 0.26090300 
 
H -3.62600000 4.07215900 -0.22198900 
H 3.35998700 2.47538300 -0.39573100 
 
H -3.05805500 4.58998200 1.37170500 
H 5.62646400 1.48670500 -0.10209700 
     
 
Compound 35l 
C 2.46051500 0.72348300 -0.14027000 
 
N 1.36519100 -1.33366000 0.59817700 
C 1.35602100 -0.03862600 0.40407500 
 
C -0.98769700 0.40639000 1.19347600 
N 3.59430800 0.15916900 -0.48906900 
 
H -0.82584700 -0.53085700 1.73361800 
N 0.31192300 0.82017300 0.68210700 
 
H -1.32380200 1.15492900 1.92135800 
C -0.02624500 3.30512500 0.41561200 
 
C -2.04047200 0.20822000 0.09349800 
C 2.62954300 3.29005000 -0.60275000 
 
H -1.66921400 -0.54604800 -0.61205200 
C 1.91016700 4.47950500 -0.50903900 
 
H -2.15401900 1.14101400 -0.47515700 
C 0.59942100 4.48012600 -0.00463700 
 
C -3.39878200 -0.22766300 0.65709500 
H -1.04129200 3.32380100 0.79983600 
 
H -3.27434700 -1.16108600 1.22532600 
H 3.64394700 3.27260700 -0.98991700 
 
H -3.75533200 0.52278000 1.37866400 
H 2.36297200 5.41370600 -0.82770400 
 
C -4.46419200 -0.43254300 -0.42780700 
H 0.05404600 5.41789300 0.05978000 
 
H -4.10406400 -1.17808900 -1.15172100 
C 2.67403000 -3.33992900 0.40910700 
 
H -4.59062200 0.50267200 -0.99300700 
C 3.84365000 -3.97887200 0.05926600 
 
C -5.82350600 -0.87867700 0.12582900 
C 4.93447400 -3.24846500 -0.47419700 
 
H -5.69719200 -1.81550000 0.68875400 
C 4.83841800 -1.88603200 -0.64955600 
 
H -6.18332400 -0.13486900 0.85253200 
H 1.82724400 -3.88192800 0.81940300 
 
C -6.88897500 -1.08102600 -0.95928100 
H 3.93321200 -5.05365500 0.19268500 
 
H -6.52833300 -1.82278100 -1.68603300 
H 5.84867100 -3.76941000 -0.74476000 
 
H -7.01665100 -0.14417600 -1.52002900 
H 5.65770800 -1.30064700 -1.05598700 
 
C -8.24274800 -1.53022000 -0.39995800 
C 2.02331900 2.10295200 -0.18719900 
 
H -8.64608600 -0.79138600 0.30359500 
C 0.69743300 2.11521800 0.32146300 
 
H -8.98085900 -1.66678300 -1.19849200 
C 3.65000700 -1.19521200 -0.29952100 
 
H -8.15324800 -2.48247600 0.13731700 
C 2.54169900 -1.93871700 0.24203800 
     
 
Calculations   198 
 
 
Compound 35m 
C 0.25237600 -0.96411700 0.01394600 
 
H 5.68033500 1.52467400 -0.06185300 
C 0.14018000 0.46427400 -0.19292100 
 
H 5.90497600 -0.92793000 0.30027000 
N 1.41461100 -1.55925200 0.15770700 
 
H 3.86580500 -2.36280000 0.40014000 
N -1.19545800 0.79625600 -0.31221500 
 
C -1.09780700 -1.48695700 0.01130400 
C -3.34056300 -0.53109300 -0.24925600 
 
C -1.95538500 -0.37336800 -0.18914700 
C -1.63045900 -2.77003500 0.15222500 
 
C 2.50239800 -0.73074900 0.09708500 
C -3.01257700 -2.93214800 0.09027200 
 
C 2.37331200 0.68835600 -0.11189000 
C -3.85082900 -1.82278100 -0.10792300 
 
N 1.15186100 1.29175200 -0.25869500 
H -4.00112800 0.31811700 -0.38446400 
 
C -1.69263500 2.14445300 -0.55964200 
H -0.96824900 -3.61699500 0.30483400 
 
H -0.80499100 2.74052500 -0.79913500 
H -3.44772000 -3.92139200 0.19715900 
 
H -2.34169100 2.13676800 -1.44434100 
H -4.92680700 -1.96947600 -0.14980200 
 
C -2.41799700 2.73953100 0.62138300 
C 3.54564800 1.48260200 -0.16520300 
 
C -3.62307800 3.30426000 0.55236600 
C 4.78837300 0.90541300 -0.01916000 
 
H -1.87963500 2.70497400 1.56800600 
C 4.91694100 -0.49057700 0.18699100 
 
H -4.18028700 3.35128300 -0.38170300 
C 3.79744300 -1.29046600 0.24368400 
 
H -4.09607500 3.75114400 1.42214200 
H 3.42632700 2.55022500 -0.32352500 
     
 
Compound 35n 
C 1.31366500 -1.17197100 0.08738200 
 
C 0.25065800 -2.15438200 0.12640200 
C 0.73540900 0.03743800 -0.46025200 
 
C -0.90513400 -1.50974700 -0.38685100 
N 2.57699400 -1.24357800 0.43987400 
 
C 3.29906800 -0.09635200 0.24966300 
N -0.59923600 -0.18875200 -0.73487000 
 
C 2.70886700 1.09786700 -0.29757900 
C -2.12129700 -2.18484400 -0.49444500 
 
N 1.38779600 1.15464200 -0.65751100 
C 0.18981900 -3.48832500 0.53489100 
 
C -1.49356200 0.77663900 -1.35970600 
C -1.02163300 -4.16731600 0.42604500 
 
H -0.85111300 1.60296700 -1.68109400 
C -2.15857700 -3.51816400 -0.08260000 
 
H -1.92812200 0.32681800 -2.26111900 
H -3.01179300 -1.69136900 -0.86883700 
 
C -2.59998600 1.28647600 -0.45127100 
H 1.07775500 -3.97572100 0.92623100 
 
C -2.30979900 1.76554600 0.83277900 
H -1.09110700 -5.20524500 0.73793000 
 
C -3.92320800 1.31927100 -0.90290400 
H -3.09540800 -4.06407200 -0.15502900 
 
C -3.32548400 2.26347400 1.64726600 
C 3.51981500 2.24745200 -0.46679300 
 
H -1.28436800 1.74731100 1.19248600 
C 4.85154500 2.22163300 -0.11347800 
 
C -4.94207400 1.82201600 -0.09026900 
C 5.43368100 1.04744900 0.42506700 
 
H -4.15963500 0.95122000 -1.89944600 
C 4.67279500 -0.08652700 0.60260800 
 
C -4.64510700 2.29372100 1.18800700 
H 3.05547400 3.13738900 -0.88093500 
 
H -3.08706300 2.63077300 2.64191800 
H 5.46364600 3.10937500 -0.24815200 
 
H -5.96554200 1.83902200 -0.45543400 
H 6.48531300 1.04582700 0.69777700 
 
H -5.43565000 2.68172900 1.82463300 
H 5.09196400 -1.00034200 1.01285700 
     
 
Calculations   199 
 
 
Compound 35t 
C 1.18318800 1.20567400 -0.00008000 
 
C -1.10012100 1.45236600 -0.00020300 
C 0.54437000 -0.09156600 -0.00014500 
 
C 3.19790300 0.17560400 0.00000300 
N 2.48965900 1.34607500 0.00000200 
 
C 2.54867800 -1.10987600 -0.00011900 
N -0.82888700 0.07503200 -0.00032100 
 
N 1.18500100 -1.23427800 -0.00019100 
C -2.32469000 2.12789000 -0.00026500 
 
C -1.76471800 -1.05680300 -0.00021000 
C 0.11605400 3.58011500 0.00028700 
 
C -2.62268300 -1.11498800 1.27785300 
C -1.10444400 4.24942000 0.00022000 
 
C -2.62327200 -1.11488300 -1.27785100 
C -2.30586000 3.52337900 -0.00004600 
 
H -1.10788200 -1.93367900 -0.00042800 
H -3.26930700 1.59746300 -0.00044500 
 
C -3.52967500 -2.35658700 1.26817500 
H 1.05823000 4.12009400 0.00043700 
 
H -3.24225200 -0.21258800 1.35831800 
H -1.13070100 5.33503000 0.00036300 
 
H -1.96383800 -1.12442100 2.15424300 
H -3.25188000 4.05833200 -0.00009200 
 
C -3.53009600 -2.35662600 -1.26780000 
C 3.34800000 -2.28047000 -0.00011800 
 
H -3.24307400 -0.21260600 -1.35792400 
C 4.72273400 -2.18866200 -0.00001000 
 
H -1.96489000 -1.12411900 -2.15459000 
C 5.36267800 -0.92417300 0.00010200 
 
C -4.39513400 -2.41605500 0.00033400 
C 4.61536100 0.23230700 0.00011800 
 
H -4.16179200 -2.36069500 2.16468600 
H 2.83929200 -3.23983300 -0.00019900 
 
H -2.90580700 -3.26062000 1.32247100 
H 5.32491500 -3.09329500 -0.00001200 
 
H -4.16249400 -2.36091100 -2.16410900 
H 6.44784200 -0.87149200 0.00018100 
 
H -2.90611900 -3.26057800 -1.32219200 
H 5.07824200 1.21458100 0.00020800 
 
H -5.00472300 -3.32827400 0.00045300 
C 0.11914300 2.18392500 0.00005000 
 
H -5.09867200 -1.57012700 0.00042300 
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List of Abbreviations 
°
C   Degrees Celsius  
13
C   Carbon 13  
19
F   Fluorine 19 
1
H   Hydrogen, proton  
9-BBN   9-Borabicyclo[3.3.1]nonane  
Å   Angstrom, 10-8m  
Ac          Acetyl 
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